Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ATP2A1 "ATP2A, SERCA1" ENSG00000196296 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1" O14983 16 28878405-28904509 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 456.3;tongue: 209.0" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 19.8" "Region enriched" "Detected in single" 8 "thalamus: 14.3" "Not detected" "Not detected" "CAB002310, CAB032706" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB002310: AB_564139, CAB032706: AB_2061286" "unprognostic (2.37e-1)" "unprognostic (6.81e-2)" "unprognostic (2.23e-5)" "unprognostic (5.35e-2)" "unprognostic (2.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.87e-1)" "unprognostic (5.22e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-4)" "unprognostic (1.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-2)" 7.6 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.1 1.1 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.6 0.1 12.6 7.0 0.3 456.3 0.2 0.2 0.1 0.1 0.1 0.1 0.9 0.0 0.0 4.2 209.0 6.5 0.2 0.1 1.6 3.1 0.7 0.2 4.7 1.5 0.6 4.8 5.2 9.6 5.8 0.4 1.6 8.9 2.3 1.3 0.4 0.4 2.9 4.4 7.6 2.7 0.4 3.2 5.1 2.4 0.1 0.7 3.8 19.8 2.7 11.8 9.0 0.2 1.1 2.6 4.1 1.1 0.6 0.5 4.9 0.2 14.3 5.2 6.5 0.3 9.7 10.9 6.1 9.7 1.8 7.4 16.9 6.8 5.7 0.0 0.6 6.2 4.9 3.3 4.5 3.4 3.7 3.4 2.7 2.0 3.0 6.3 5.6 2.8 9.5 5.8 7.4 5.9 15.0 2.9 0.0 0.1 0.7 1.0 0.0 1.3 1.6 1.1 1.0 0.0 0.8 1.4 1.3 0.0 4.7 0.2 3.1 1.5 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.3 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.1 1.0 0.0 0.5 0.0 0.2 0.1 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.3 2.9 0.3 0.0 0.0 0.0 0.1 0.5 0.2 0.3 0.0 0.0 4.6 0.0 0.0 1.8 3.0 0.1 0.6 0.0 0.6 0.0 CTSG CG ENSG00000100448 "Cathepsin G" P08311 14 24573522-24576260 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "bone marrow: 450.3" "Cell type enriched" "Detected in some" 9 "granulocytes: 500.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.5;memory CD8 T-cell: 3.5;myeloid DC: 5.1;naive CD8 T-cell: 1.8;neutrophil: 7.1;NK-cell: 5.2;plasmacytoid DC: 5.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "THP-1: 448.1" "Not detected" "Not detected" "CAB000110, HPA047737" Enhanced "Intracellular and membrane" NA NA 67000 "CAB000110: , HPA047737: AB_2680140" "unprognostic (1.67e-1)" "unprognostic (2.57e-2)" "unprognostic (6.92e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.57e-4)" "unprognostic (4.05e-2)" "unprognostic (4.13e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" "unprognostic (1.63e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.91e-4)" 15.1 0.5 0.0 6.0 0.0 450.3 6.0 0.0 0.6 10.0 5.1 0.0 2.8 1.1 6.2 19.7 6.4 0.8 16.7 23.4 0.0 0.0 2.1 2.0 9.2 3.7 0.0 0.0 1.5 3.4 0.8 0.5 3.0 0.0 8.2 3.2 2.6 6.3 6.9 1.1 19.5 8.9 14.9 0.0 10.7 3.2 2.8 0.0 15.6 0.5 12.0 5.1 2.9 3.3 0.0 5.7 7.1 6.5 5.2 3.5 12.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 448.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 66.4 0.0 0.0 6.5 0.0 1.1 1.0 0.0 0.0 1.0 3.5 5.1 0.0 0.0 1.8 7.1 5.2 0.0 5.7 0.0 12.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 11.9 58.0 0.0 0.0 5.7 0.0 0.6 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 1.0 0.0 500.2 0.0 0.2 0.0 0.0 0.0 0.0 4.7 0.0 4.7 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 HIST1H3I "H3.f, H3/f, H3FF" ENSG00000275379 "Histone cluster 1 H3 family member i" P68431 6 27871905-27872315 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 236.8" "Cell type enhanced" "Detected in single" 15 "Alveolar cells type 2: 1.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.0" "Cell type enhanced" "Detected in many" "NK-cell: 12.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 4.6;MOLT-4: 8.4;NB-4: 5.6;REH: 8.8" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.60e-1)" "unprognostic (5.58e-2)" "unprognostic (8.16e-2)" "unprognostic (1.06e-1)" "unprognostic (6.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-2)" 1.0 0.8 0.0 16.7 0.0 7.9 2.4 0.0 0.4 0.9 2.9 0.0 1.6 0.4 0.4 1.4 7.1 0.5 2.9 1.8 0.0 0.4 0.4 1.9 9.2 0.0 0.0 0.4 5.0 0.4 0.0 2.4 0.0 0.5 0.4 0.0 1.0 0.7 0.4 0.4 3.6 0.4 0.0 10.2 0.8 1.8 0.0 236.8 0.6 11.6 14.5 0.4 0.0 4.1 4.7 1.0 1.2 12.4 2.4 2.2 1.3 1.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.2 2.9 0.4 0.0 0.5 0.9 0.0 0.0 0.5 1.3 1.7 4.6 0.0 0.0 1.0 2.8 0.7 0.7 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.4 5.6 1.3 0.2 0.0 8.8 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.6 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.2 0.5 2.4 0.6 2.0 0.8 2.0 1.5 3.3 4.1 1.7 2.2 1.0 12.4 0.5 4.7 1.9 2.2 0.0 1.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 FXYD7 ENSG00000221946 "FXYD domain containing ion transport regulator 7" P58549 19 35143250-35154301 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 24.4;brain: 76.1" "Cell type enhanced" "Detected in some" 8 "Melanocytes: 3.3;Sertoli cells: 6.5;Spermatogonia: 5.5;T-cells: 5.0" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 24.4" "Group enriched" "Detected in many" 22 "B-cells: 8.1;NK-cells: 24.4;T-cells: 12.9" "Cell line enhanced" "Detected in some" "HAP1: 3.2;HMC-1: 9.8;Karpas-707: 3.4;NTERA-2: 2.8;WM-115: 5.7" "Low region specificity" "Detected in all" HPA026916 Approved NA NA "HPA026916: AB_1849217" "unprognostic (1.25e-3)" "unprognostic (8.73e-3)" "unprognostic (4.64e-2)" "unprognostic (6.95e-4)" "unprognostic (8.47e-2)" "unprognostic (1.73e-2)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (1.90e-1)" "unprognostic (3.08e-2)" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (6.90e-5)" "unprognostic (1.51e-2)" "unprognostic (3.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" 1.5 1.7 46.9 2.8 31.6 1.8 1.6 3.0 76.1 1.7 1.5 4.7 0.0 1.9 1.9 1.2 1.7 1.8 1.7 1.5 41.9 20.1 1.3 1.4 1.6 3.7 19.8 26.2 1.8 1.5 1.2 0.1 1.4 10.1 1.4 1.5 0.0 1.8 1.6 2.9 1.9 1.7 1.5 8.7 3.2 1.7 1.7 1.6 0.0 1.4 0.0 2.8 1.8 0.4 8.1 0.6 0.3 0.0 24.4 12.9 2.4 1.2 0.4 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.3 0.0 0.6 1.0 0.3 0.0 0.0 0.4 3.2 0.0 0.4 0.5 0.2 0.4 0.8 0.0 0.2 0.0 9.8 0.9 0.0 0.0 0.0 0.2 0.1 0.3 0.8 3.4 0.0 0.0 0.1 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.2 0.2 0.0 0.7 0.5 0.0 0.0 0.5 0.4 1.3 0.2 0.0 0.1 0.0 0.0 0.8 0.2 5.7 0.0 0.0 0.0 8.1 0.0 5.0 8.1 12.9 9.2 0.0 7.3 4.2 7.2 0.3 24.4 0.0 0.6 3.6 2.4 46.9 31.6 3.0 76.1 41.9 20.1 19.8 26.2 10.1 1.6 0.0 2.2 3.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 1.0 0.0 1.1 0.0 0.1 1.6 0.0 0.6 0.0 0.0 1.1 0.3 3.3 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 6.5 0.8 1.0 5.5 1.0 0.2 5.0 0.0 0.0 PITPNM2 "NIR3, RDGB2, RDGBA2" ENSG00000090975 "Phosphatidylinositol transfer protein membrane associated 2" Q9BZ72 12 122983480-123150015 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "lymphoid tissue: 169.5" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Horizontal cells: 38.1;Late spermatids: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Group enriched" "Detected in many" 4 "NK-cells: 4.7;T-cells: 2.3" "Cell line enhanced" "Detected in many" "HEL: 16.1;JURKAT: 20.1;MOLT-4: 29.7;WM-115: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003414, HPA003978" Approved Supported Vesicles NA NA Vesicles "HPA003414: AB_1855410, HPA003978: AB_1855411" "unprognostic (2.43e-1)" "unprognostic (9.29e-2)" "unprognostic (2.00e-1)" "unprognostic (5.39e-2)" "unprognostic (2.14e-1)" "unprognostic (6.76e-2)" "unprognostic (2.26e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (9.28e-2)" "unprognostic (1.50e-3)" "unprognostic (7.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.19e-2)" "unprognostic (9.99e-2)" 3.4 5.9 3.3 3.2 7.9 3.5 3.1 9.3 8.0 3.9 3.5 2.4 3.2 3.5 3.6 5.2 3.7 2.5 2.2 4.6 2.8 2.2 3.7 4.3 5.1 6.1 2.4 2.6 14.0 2.5 5.3 4.2 3.0 2.3 2.7 1.6 3.7 2.7 3.1 3.3 3.0 3.6 4.5 2.5 3.3 2.7 14.8 2.2 169.5 2.3 2.2 4.3 4.7 2.7 0.8 0.0 0.1 0.1 4.7 2.3 1.6 2.4 4.9 1.6 2.3 1.1 2.2 9.6 0.4 0.6 1.3 0.7 2.1 2.1 0.0 2.1 0.8 2.7 7.1 1.3 1.2 0.4 0.1 1.5 16.1 2.8 5.7 0.8 0.6 3.4 1.0 2.1 1.7 1.3 6.2 2.5 20.1 3.6 0.2 1.6 1.6 29.7 3.3 1.8 0.7 2.2 8.6 0.1 6.1 2.3 2.6 1.4 0.5 3.5 2.9 2.3 0.9 0.6 1.7 7.4 1.9 2.1 3.1 2.8 0.5 0.5 11.4 4.7 1.2 14.3 0.0 0.0 0.1 2.3 0.0 0.2 0.4 0.6 1.7 0.0 0.8 1.5 1.4 0.0 4.7 0.1 0.0 1.1 1.6 3.3 7.9 9.3 8.0 2.8 2.2 2.4 2.6 2.3 2.2 0.0 5.3 0.8 0.5 3.2 15.9 6.1 2.5 0.0 2.3 8.7 51.1 1.0 1.7 2.8 25.0 6.7 4.3 0.0 3.9 5.0 1.9 0.6 1.1 12.9 0.4 38.1 0.0 6.2 0.8 77.8 1.7 0.6 1.7 1.0 3.7 3.7 3.7 0.0 4.6 2.2 15.5 0.0 2.8 3.6 2.3 1.4 3.1 1.0 2.3 0.4 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990783 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "blood: 58.1;lymphoid tissue: 193.6" "Group enriched" "Detected in many" 5 "granulocytes: 73.2;T-cells: 103.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1" "Group enriched" "Detected in many" 134 "granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1" "Cell line enhanced" "Detected in some" "HEL: 31.0;HMC-1: 131.1;MOLT-4: 44.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002223, HPA011157, CAB012978" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 75000 "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 4.8 1.8 1.6 27.6 3.0 8.5 2.5 6.6 2.3 3.9 10.8 2.0 2.0 4.9 7.7 3.1 4.3 4.2 5.8 3.1 1.9 1.9 6.0 3.3 7.8 33.2 1.7 1.7 3.0 2.7 1.4 6.0 2.8 1.8 8.5 2.8 3.1 12.2 5.4 2.0 5.8 9.0 3.1 1.9 13.9 5.1 2.3 1.7 193.6 7.3 4.6 50.3 6.4 5.4 0.2 0.2 38.2 0.2 15.7 58.1 26.8 0.1 0.3 0.2 0.4 0.6 0.3 0.8 0.8 0.2 0.2 0.3 0.3 0.5 0.1 1.1 0.3 0.1 0.4 0.4 0.2 0.1 0.2 0.5 31.0 0.7 0.5 0.1 0.9 131.1 0.3 0.6 0.2 0.1 0.4 0.1 10.5 0.4 3.7 0.1 0.8 44.6 6.1 0.5 0.0 0.4 0.5 0.1 3.9 0.3 0.2 0.8 0.1 0.1 0.3 0.3 0.2 0.4 5.1 0.6 0.6 3.0 0.6 0.2 1.2 1.0 0.4 7.9 0.4 0.5 38.2 0.2 0.1 47.9 0.2 33.5 0.2 46.9 47.9 0.1 0.2 44.6 42.6 2.3 15.7 0.1 0.2 58.1 26.8 1.6 3.0 6.6 2.3 1.9 1.9 1.7 1.7 1.8 1.7 0.0 19.1 1.9 1.7 6.4 10.4 0.4 7.6 0.0 4.5 8.7 5.9 1.9 1.7 1.3 0.1 2.4 0.7 0.0 0.5 0.8 2.7 1.8 73.2 2.6 14.9 6.4 0.0 8.6 6.5 0.0 1.4 9.0 10.1 1.8 1.5 5.7 0.7 0.0 0.7 0.4 10.7 0.0 3.4 1.4 2.4 4.5 2.3 103.8 1.3 0.7 BIN1 "AMPH2, AMPHL, SH3P9" ENSG00000136717 "Bridging integrator 1" O00499 2 127048027-127107355 "Disease related genes, Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "skeletal muscle: 399.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 141.1;Proximal tubular cells: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0" "Group enriched" "Detected in many" 9 "B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001945, HPA003894, HPA005437" Enhanced Supported Cytosol NA NA 1200000 Cytosol "CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284" "unprognostic (2.20e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" "unprognostic (9.65e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-3)" "unprognostic (1.26e-2)" "unprognostic (2.57e-1)" "unprognostic (2.41e-3)" "unprognostic (3.22e-3)" 9.5 12.1 21.0 6.7 26.8 3.7 4.2 10.3 24.9 6.2 5.4 36.2 3.6 5.3 5.6 7.3 8.8 7.8 6.4 3.1 24.8 15.2 10.3 4.9 4.6 9.3 26.8 15.8 6.8 5.3 7.3 4.9 6.5 17.3 9.2 4.4 7.9 4.9 7.2 399.9 2.7 5.0 11.6 22.1 10.4 6.1 3.1 26.8 0.0 4.7 30.8 7.3 9.0 7.9 34.1 4.0 1.1 0.6 31.2 45.0 22.4 15.1 8.3 10.1 11.9 30.1 24.2 3.4 4.6 10.0 11.0 7.2 32.0 9.4 0.0 14.2 8.6 6.4 2.0 4.4 7.5 2.9 1.7 1.2 4.4 13.7 2.1 27.2 0.0 0.8 22.1 1.8 23.8 4.3 14.4 14.9 1.5 0.9 0.5 13.5 0.3 1.4 12.7 7.5 33.8 9.5 3.5 11.1 1.4 38.9 0.0 6.6 18.7 16.7 6.5 5.1 11.2 0.4 2.8 17.7 12.7 12.5 16.1 15.3 0.4 0.4 0.0 18.7 0.8 5.8 0.1 0.6 0.1 37.0 0.3 32.5 32.2 38.4 36.9 2.8 34.1 36.2 34.4 1.1 31.2 0.5 4.0 45.0 22.4 21.0 26.8 10.3 24.9 24.8 15.2 26.8 15.8 17.3 26.8 8.9 10.6 66.3 7.8 16.6 141.1 4.5 33.1 0.0 4.5 14.0 117.8 1.6 31.5 12.8 13.4 15.7 11.3 0.0 26.0 3.7 58.0 22.0 2.3 15.3 125.1 28.6 44.2 12.9 18.1 43.3 72.8 30.7 21.9 1.8 25.6 20.3 17.5 21.0 28.7 176.2 129.8 12.9 30.2 1.1 7.5 7.9 2.4 89.9 41.2 8.1 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 106.8" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 54.5;Ito cells: 49.7;Pancreatic endocrine cells: 54.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 7 "amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9" "Group enriched" "Detected in many" 6 "classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078061 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA078061: " "prognostic unfavorable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 2.2 1.1 39.7 4.7 42.7 5.4 1.8 1.3 106.8 4.2 5.2 2.4 2.1 6.4 2.9 1.6 2.5 1.3 7.5 3.2 44.1 7.7 2.2 6.4 4.8 2.2 4.6 43.9 6.0 12.3 1.0 2.4 4.2 4.9 4.3 8.1 0.8 5.4 7.4 1.7 1.7 8.1 3.0 2.3 4.0 9.8 4.5 1.5 0.5 1.3 0.3 2.0 6.5 1.3 0.4 2.4 3.4 5.4 2.8 3.0 1.4 11.8 14.7 14.6 6.9 6.3 1.5 31.5 7.9 9.0 9.1 6.7 23.6 19.9 0.0 9.9 6.8 14.9 9.6 0.2 15.3 19.8 0.2 1.1 13.0 2.8 10.3 0.6 1.2 0.1 2.4 1.0 24.1 2.3 31.0 7.4 3.0 2.8 7.6 23.7 2.8 1.2 1.7 15.3 10.9 13.2 1.4 9.6 1.2 4.9 9.0 19.7 8.0 1.3 6.5 0.7 18.8 3.1 1.6 17.6 15.4 25.8 9.1 25.5 0.1 0.0 0.2 17.8 1.1 23.5 0.0 5.4 3.4 2.3 4.8 0.0 0.1 0.5 3.0 2.4 0.4 0.2 2.5 1.4 2.8 1.3 0.0 0.0 1.4 39.7 42.7 1.3 86.4 44.1 7.7 4.6 43.9 4.9 1.5 0.0 13.4 5.7 13.3 2.3 0.4 1.1 17.8 5.3 7.9 10.4 2.0 12.1 3.3 54.5 16.1 6.0 12.3 0.0 27.4 3.5 12.2 16.4 20.8 16.3 21.6 0.0 14.9 49.7 10.4 13.6 34.8 5.3 0.0 1.8 18.9 0.5 54.2 10.5 31.5 3.3 1.1 6.5 8.2 0.6 0.4 1.0 2.2 4.4 26.4 13.6 LINC00854 TMEM106A-AS1 ENSG00000236383 "Long intergenic non-protein coding RNA 854" 17 43216941-43305397 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 10.4;testis: 18.1" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.4;Ciliated cells: 4.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 8.9;Hep G2: 9.3;HMC-1: 7.0" NA NA "unprognostic (3.14e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-3)" "unprognostic (4.29e-2)" "unprognostic (3.95e-2)" "unprognostic (7.19e-4)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "unprognostic (1.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (2.10e-1)" "unprognostic (2.88e-4)" "unprognostic (2.11e-1)" "unprognostic (3.88e-2)" "unprognostic (5.95e-2)" "unprognostic (3.08e-2)" 0.0 0.0 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.1 1.3 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.7 1.4 0.0 0.0 1.6 0.3 18.1 0.9 0.0 0.0 2.7 2.3 7.4 1.4 10.4 1.0 0.4 1.2 4.6 0.9 1.4 0.1 0.1 2.1 1.4 0.0 0.4 0.0 4.1 1.2 2.3 1.3 0.7 0.7 1.4 0.1 0.0 0.0 1.5 3.4 1.7 8.9 9.3 0.8 1.2 7.0 0.0 0.5 0.1 0.0 0.7 0.0 2.3 0.6 1.5 0.0 4.0 2.1 5.6 0.7 1.7 0.6 3.5 1.2 0.4 0.0 0.4 3.1 0.1 0.9 1.4 1.0 1.0 0.8 2.6 3.8 1.8 1.3 1.7 0.9 1.8 0.5 0.5 1.0 2.8 1.6 7.4 1.4 1.4 1.0 1.1 0.5 1.1 0.5 0.5 0.5 2.7 0.6 0.6 4.2 10.4 0.5 2.3 0.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 41.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "basal ganglia: 2.6" "Cell type enhanced" "Detected in many" "NK-cell: 5.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Hep G2: 4.7;HSkMC: 5.4" "HPA011024, HPA011093" Uncertain Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA011024: AB_10599292, HPA011093: AB_10600889" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 28.3 52.7 0.0 1.6 2.6 0.0 68.6 0.3 0.1 0.0 3.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.1 0.6 0.2 1.8 0.2 0.1 0.8 0.1 0.0 0.0 1.1 0.3 0.1 0.1 0.2 1.7 0.0 0.9 0.2 1.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.1 0.6 4.3 1.8 1.5 0.0 0.5 5.5 1.8 0.1 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.9 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.9 0.5 0.7 1.8 0.7 1.2 0.5 1.4 0.8 1.6 0.0 5.5 0.3 1.5 1.8 0.1 0.0 2.6 0.3 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.3 0.1 41.3 0.0 0.0 0.0 4.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 TCF7 TCF-1 ENSG00000081059 "Transcription factor 7" P36402 5 134114711-134151865 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 326.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2" "Group enriched" "Detected in many" 19 "NK-cells: 14.2;T-cells: 35.8" "Cell line enriched" "Detected in many" 6 "MOLT-4: 170.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB019403, HPA058863, HPA070505" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275" "unprognostic (3.63e-3)" "unprognostic (1.98e-3)" "unprognostic (1.03e-1)" "unprognostic (5.08e-3)" "unprognostic (1.70e-1)" "unprognostic (6.74e-2)" "unprognostic (1.12e-1)" "unprognostic (6.38e-2)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (2.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.90e-1)" "unprognostic (4.10e-2)" 1.8 3.6 1.3 21.8 1.5 5.2 3.1 0.9 1.2 2.1 3.3 2.5 2.2 5.6 1.4 16.3 2.7 16.1 2.6 1.6 1.5 1.2 2.7 3.7 4.0 41.8 1.3 1.0 2.5 7.2 0.2 6.1 1.4 4.7 2.9 2.3 3.6 7.9 1.8 0.9 2.9 15.1 0.9 3.3 14.4 3.7 2.4 1.1 326.1 4.4 2.2 32.5 3.3 1.5 1.2 0.1 1.0 0.1 14.2 35.8 6.9 0.0 1.0 1.1 3.9 0.5 2.1 1.5 0.3 0.5 0.1 0.1 8.0 2.5 0.0 1.9 1.7 4.3 0.1 1.7 0.4 0.0 0.3 1.7 0.0 1.1 6.0 0.0 0.0 0.2 0.1 0.0 1.6 0.0 0.7 0.2 29.0 1.0 0.0 0.1 0.0 170.0 0.1 1.2 2.5 1.4 0.2 0.0 0.1 0.4 0.1 0.4 3.4 0.8 0.2 0.2 0.9 0.2 0.9 0.2 11.0 0.0 5.0 0.3 0.1 0.0 0.0 5.8 0.0 0.5 0.7 0.1 1.0 4.4 0.0 10.3 1.2 17.8 10.4 0.0 0.4 35.8 21.8 0.7 14.2 0.0 0.1 2.1 6.9 1.3 1.5 0.9 1.2 1.5 1.2 1.3 1.0 4.7 1.1 3.0 3.4 22.9 24.6 14.0 27.8 2.7 10.2 1.4 0.0 3.5 68.7 20.0 0.0 5.8 2.4 4.7 21.4 0.0 8.9 23.4 10.8 11.6 20.7 3.2 6.4 9.5 12.1 6.7 5.2 1.7 5.8 4.9 10.1 9.0 12.7 8.3 15.8 17.3 4.2 0.8 53.0 0.0 16.9 3.9 9.4 9.9 25.1 47.5 14.4 12.3 LCK ENSG00000182866 "LCK proto-oncogene, Src family tyrosine kinase" P06239 1 32251239-32286165 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 112.2;lymphoid tissue: 153.0" "Cell type enriched" "Detected in many" 10 "T-cells: 207.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "gdT-cell: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2" "Group enriched" "Detected in many" 13 "NK-cells: 42.8;T-cells: 112.2" "Group enriched" "Detected in some" 6 "JURKAT: 66.9;MOLT-4: 93.9;U-698: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003494, CAB003816" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB003816: AB_562158, HPA003494: AB_1852751" "unprognostic (6.38e-3)" "unprognostic (5.45e-3)" "unprognostic (8.39e-2)" "prognostic favorable (2.96e-6)" "unprognostic (2.20e-2)" "prognostic favorable (2.91e-4)" "unprognostic (4.78e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.65e-5)" "unprognostic (3.07e-2)" "unprognostic (3.80e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (8.15e-2)" "unprognostic (4.05e-2)" "unprognostic (7.39e-2)" "unprognostic (1.17e-2)" 2.6 0.7 0.4 28.2 0.5 3.8 1.3 0.3 0.5 1.7 3.9 0.5 0.9 2.2 1.1 4.5 2.3 1.6 3.8 1.0 0.4 0.4 3.0 2.3 6.6 34.9 0.9 0.5 1.2 0.8 0.0 0.8 0.7 0.6 2.2 1.9 1.3 8.4 1.3 0.9 1.0 16.5 0.7 1.0 28.9 3.5 0.7 0.5 153.0 2.9 1.5 27.1 5.8 2.1 6.1 0.5 2.5 0.3 42.8 112.2 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 11.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 93.9 0.0 1.0 0.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 54.1 0.0 0.0 0.0 0.6 0.3 0.4 83.4 0.3 77.5 4.0 86.1 90.2 0.3 6.1 97.0 91.3 2.5 42.8 0.3 0.5 112.2 109.3 0.4 0.5 0.3 0.5 0.4 0.4 0.9 0.5 0.6 0.5 0.0 16.0 20.4 0.9 4.0 0.0 1.1 2.5 2.7 2.3 3.5 0.0 0.2 0.0 0.3 0.1 1.6 0.0 0.0 0.4 0.1 2.0 0.8 4.7 1.0 0.3 0.0 2.4 3.7 4.9 0.0 0.0 0.6 3.3 0.0 0.0 0.0 2.7 0.0 0.4 1.1 0.0 0.0 0.9 3.7 1.9 2.8 0.3 207.5 0.4 1.0 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754385-116769228 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 101.7;lymphoid tissue: 164.4" "Cell type enriched" "Detected in many" 11 "T-cells: 299.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 44.4;MAIT T-cell: 42.5;memory CD4 T-cell: 65.3;memory CD8 T-cell: 74.2;naive CD4 T-cell: 34.2;naive CD8 T-cell: 52.4;NK-cell: 101.7;T-reg: 62.3" "Group enriched" "Detected in many" 9 "NK-cells: 101.7;T-cells: 74.2" "Group enriched" "Detected in some" 24 "HDLM-2: 58.9;JURKAT: 39.9;MOLT-4: 43.3" "Region enhanced" "Detected in single" "basal ganglia: 0.3" "Low region specificity" "Detected in some" "CAB002430, HPA003883" Enhanced NA NA "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favorable (4.36e-4)" "prognostic favorable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favorable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favorable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favorable (3.97e-5)" "prognostic favorable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 3.0 1.1 0.6 14.5 0.5 2.4 1.7 0.5 0.6 2.9 6.0 0.6 0.6 4.8 1.7 2.1 3.8 3.1 4.8 1.4 0.6 0.6 3.3 2.5 8.1 33.0 1.2 0.6 1.9 1.6 0.0 1.0 1.0 1.0 2.9 4.7 2.3 4.1 1.3 1.0 1.2 18.8 0.9 1.8 28.8 6.5 1.1 0.8 164.4 3.5 3.4 30.8 7.7 2.7 0.3 9.3 1.4 0.5 101.7 74.2 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.9 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.1 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.5 0.1 44.4 0.3 42.5 0.3 65.3 74.2 9.3 0.2 34.2 52.4 1.4 101.7 0.2 2.0 62.3 45.9 0.6 0.5 0.5 0.6 0.6 0.6 1.2 0.6 1.0 0.8 3.0 27.0 1.5 0.4 4.4 0.0 0.8 0.0 0.0 4.5 3.5 0.0 0.0 0.0 0.0 13.2 2.4 0.0 0.0 0.0 0.0 2.1 0.1 4.7 0.9 0.7 0.0 2.9 9.8 7.0 4.0 0.6 8.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 4.7 0.2 0.2 3.1 0.0 299.5 0.1 0.1 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 64.3;lymphoid tissue: 22.1" "Cell type enriched" "Detected in some" 22 "T-cells: 112.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 45.7;NK-cell: 64.3" "Group enriched" "Detected in many" 42 "NK-cells: 64.3;T-cells: 45.7" "Cell line enhanced" "Detected in some" "HeLa: 9.3;Karpas-707: 3.8;SuSa: 3.7" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 2.4 0.5 1.2 5.8 1.4 5.6 2.3 1.0 2.7 1.7 3.3 0.7 1.2 1.5 5.5 3.9 1.7 2.5 2.4 2.6 1.6 1.3 1.9 2.0 5.9 10.3 2.3 0.6 1.2 1.4 0.3 1.3 3.6 1.5 1.9 2.5 2.0 3.1 0.3 0.5 1.0 5.0 2.1 2.6 22.1 5.2 1.4 0.5 3.5 1.9 3.0 2.9 2.9 1.8 0.1 0.0 1.2 0.1 64.3 45.7 5.1 0.4 1.6 0.1 0.1 0.5 0.4 0.8 0.0 0.0 0.8 1.7 0.0 1.3 0.2 0.1 0.4 3.3 0.3 0.6 2.8 1.1 0.9 0.4 2.1 9.3 0.0 0.1 0.6 0.4 1.0 0.0 0.3 0.0 0.0 0.8 0.7 1.3 3.8 0.8 0.0 0.2 2.8 0.0 0.1 0.0 0.9 0.2 0.3 0.2 0.0 0.5 0.1 0.8 0.0 0.3 3.7 0.3 0.0 2.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 2.1 0.8 0.0 0.2 0.0 0.0 45.7 0.0 5.8 0.1 0.0 7.9 0.0 0.0 0.0 6.9 1.2 64.3 0.1 0.0 0.0 5.1 1.2 1.4 1.0 0.9 1.6 1.3 2.3 0.6 1.5 0.5 0.0 1.1 0.0 0.2 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.1 1.6 1.7 1.3 3.2 0.0 0.6 0.0 5.0 0.0 1.9 0.0 0.0 0.3 1.1 0.6 1.5 0.0 0.3 0.5 0.2 0.1 0.1 112.3 0.0 0.4 SBK1 Sbk ENSG00000188322 "SH3 domain binding kinase 1" Q52WX2 16 28292519-28323849 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6" "Cell type enriched" "Detected in many" 8 "Cone photoreceptor cells: 76.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4" "Group enriched" "Detected in many" 10 "NK-cells: 1.4;T-cells: 4.3" "Cell line enhanced" "Detected in some" "AF22: 15.3;AN3-CA: 11.0;NTERA-2: 15.8;REH: 16.7;SCLC-21H: 24.3;SH-SY5Y: 22.9" "Region enriched" "Detected in all" 5 "cerebellum: 306.7" NA NA "unprognostic (5.15e-2)" "prognostic favorable (6.88e-4)" "unprognostic (2.08e-1)" "unprognostic (6.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.71e-2)" "unprognostic (5.71e-3)" "unprognostic (3.66e-3)" "unprognostic (1.17e-1)" "unprognostic (1.62e-2)" "unprognostic (2.87e-2)" "unprognostic (6.38e-2)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (3.50e-2)" "unprognostic (7.91e-2)" "unprognostic (5.03e-3)" 0.9 2.0 8.0 1.8 7.3 2.0 1.7 31.1 17.5 1.7 1.2 1.5 0.0 1.1 1.9 1.3 1.5 1.6 1.0 1.8 9.9 5.6 1.6 0.9 1.8 2.7 6.0 4.0 1.1 2.7 4.2 4.1 0.8 8.3 2.6 1.2 1.4 3.8 1.0 39.6 1.4 1.1 0.9 3.1 2.8 1.6 2.3 3.1 22.1 2.6 0.0 1.7 1.2 0.3 0.2 0.2 0.2 0.1 1.4 4.3 0.4 0.1 0.2 15.3 11.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.3 0.3 4.6 0.1 0.0 1.5 0.5 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 5.8 0.0 1.0 0.0 1.8 7.0 0.1 15.8 1.0 0.1 16.7 0.8 0.1 0.1 0.9 24.3 22.9 0.4 1.4 0.2 1.9 1.7 0.0 0.4 0.0 2.4 0.2 0.1 0.2 0.0 0.2 0.1 0.2 0.9 0.2 0.1 0.1 4.3 0.0 1.4 0.0 1.2 2.4 0.0 0.2 1.4 3.0 0.1 1.4 0.1 0.2 1.4 0.4 8.0 7.3 31.1 17.5 9.9 5.6 6.0 4.0 8.3 3.1 3.0 0.3 0.0 0.8 0.6 9.4 3.1 2.5 2.7 3.4 0.0 76.6 0.0 1.7 6.1 1.0 0.0 0.0 0.0 4.8 0.0 0.4 1.5 0.0 0.2 0.1 0.0 5.8 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.3 4.2 4.7 0.0 0.0 0.5 2.7 0.0 0.3 1.4 2.3 0.1 0.1 2.5 0.8 0.3 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Group enriched" "Detected in some" 4 "granulocytes: 62.3;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 47.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 0.4 0.1 0.4 0.0 0.8 0.2 0.0 0.2 0.5 47.0 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.7 0.0 0.2 0.2 0.2 1.6 0.1 0.2 0.1 0.1 0.1 5.8 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 0.0 1.7 0.0 0.4 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.0 0.0 0.4 0.3 62.3 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.8 5.0 53.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 12.9 0.0 0.3 CD38 ENSG00000004468 "CD38 molecule" P28907 4 15778275-15853230 "Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins" "Hydrolase, Receptor, Transferase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 94.9;seminal vesicle: 104.1" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 15.3" "Group enriched" "Detected in all" 4 "B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3" "Cell line enhanced" "Detected in some" "Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6" "Low region specificity" "Detected in all" "CAB002493, HPA022132, CAB025255, HPA052381" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807" "unprognostic (1.27e-2)" "unprognostic (8.06e-3)" "unprognostic (1.06e-2)" "prognostic favorable (9.68e-4)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (2.74e-1)" "unprognostic (8.51e-2)" "unprognostic (5.87e-2)" "unprognostic (6.15e-6)" "unprognostic (5.23e-1)" "unprognostic (4.34e-1)" "unprognostic (6.63e-6)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (2.12e-2)" "unprognostic (2.13e-1)" 4.1 3.3 3.8 17.6 8.5 9.3 2.6 0.7 12.0 1.0 3.2 10.4 14.6 4.3 0.7 0.9 2.3 2.4 1.5 5.0 4.0 4.2 1.2 5.4 4.7 16.1 4.9 3.1 0.6 0.7 0.0 2.5 0.6 3.1 10.8 2.7 4.4 2.8 104.1 14.2 0.5 6.2 0.9 1.8 20.6 2.0 0.7 2.5 94.9 2.8 2.0 13.2 7.6 0.9 9.0 5.1 1.3 2.2 15.3 2.3 3.7 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 50.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 14.2 0.0 0.0 12.8 3.1 0.0 0.0 0.0 10.3 0.0 8.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 2.2 0.2 0.0 0.0 0.0 0.0 11.0 0.1 9.6 0.1 2.4 0.1 0.0 1.7 0.0 1.1 2.2 0.3 9.0 1.4 1.2 4.1 6.6 2.3 1.8 1.3 15.3 1.4 5.1 2.1 3.7 3.8 8.5 0.7 6.2 4.0 4.2 4.9 3.1 3.1 2.5 3.0 10.8 23.4 0.4 0.0 0.0 0.8 0.0 49.5 18.2 0.0 9.8 0.2 0.0 0.0 1.6 0.1 0.0 46.7 0.0 0.0 0.5 10.7 39.1 1.3 4.6 0.0 0.0 3.1 31.1 0.0 0.0 10.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 2.2 1.4 0.0 0.5 30.5 0.7 0.1 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell type enriched" "Detected in many" 5 "Suprabasal keratinocytes: 7442.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" "Cell line enhanced" "Detected in many" "A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 32.0 5.2 0.0 0.0 1.3 2.0 9.0 0.1 4.3 0.2 0.3 39.6 34.0 0.0 13.0 0.3 1.6 18.0 9.8 51.9 0.4 0.1 9.5 0.0 0.0 8.8 1.5 0.0 0.1 17.8 14.0 0.9 30.2 3.0 0.0 0.0 0.1 0.0 0.1 28.0 0.0 0.0 28.8 23.3 2.1 0.0 0.0 1.3 51.3 21.2 0.1 0.0 7.8 0.0 3.1 8.6 13.0 0.0 0.0 5.0 15.2 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 98.3 94.2 3.7 121.7 1442.2 1.4 15.2 94.3 261.0 92.1 193.7 0.0 0.7 195.6 125.9 15.0 6.0 1.3 0.0 120.1 1.1 57.3 55.5 7.0 2.0 1.0 0.0 47.4 5.5 0.8 67.8 12.0 5.1 290.1 4.6 4.2 9.3 137.6 5.8 14.9 4.4 0.7 0.0 14.2 7.1 16.4 7442.2 1.9 5.3 11.0 72.7 GNLY "D2S69E, LAG-2, LAG2, NKG5, TLA519" ENSG00000115523 Granulysin P22749 2 85685175-85698854 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 444.6" "Cell type enhanced" "Detected in many" 26 "Alveolar cells type 2: 120.7;Melanocytes: 75.9;T-cells: 467.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 226.1;NK-cell: 444.6" "Group enriched" "Detected in many" 55 "NK-cells: 444.6;T-cells: 226.1" "Cell line enhanced" "Detected in some" "BEWO: 1.4;JURKAT: 1.5;NB-4: 3.4;SuSa: 1.4;U-2197: 2.0;U-87 MG: 2.5" "CAB025186, HPA058021" Enhanced "Secreted to blood" NA NA 2920000 "CAB025186: , HPA058021: AB_2683581" "unprognostic (5.80e-2)" "unprognostic (5.64e-3)" "unprognostic (6.68e-2)" "prognostic favorable (3.48e-5)" "unprognostic (4.34e-2)" "unprognostic (9.22e-2)" "unprognostic (2.60e-1)" "unprognostic (2.79e-2)" "prognostic favorable (6.60e-5)" "unprognostic (2.61e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (8.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.86e-1)" "prognostic favorable (8.07e-4)" 7.1 1.0 2.1 3.5 2.3 72.0 3.3 1.2 2.0 1.7 2.4 5.8 0.0 1.2 31.5 2.2 4.4 2.0 2.1 4.0 2.3 3.2 1.8 5.7 20.8 10.7 3.8 0.8 1.0 0.6 0.1 1.4 45.2 3.6 3.2 2.1 4.9 2.6 1.9 5.7 0.8 12.4 1.4 4.2 34.3 1.5 0.7 1.8 2.0 2.4 3.9 5.9 2.3 1.6 0.8 1.5 6.1 0.8 444.6 226.1 175.3 0.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 0.6 0.3 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.5 0.7 0.0 1.5 0.3 0.8 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 2.0 0.0 0.3 0.1 0.0 2.5 0.6 0.0 4.0 0.7 0.4 226.1 0.6 61.2 0.8 26.0 96.4 0.6 0.5 7.4 89.8 6.1 444.6 0.8 1.5 1.0 175.3 2.1 2.3 1.2 2.0 2.3 3.2 3.8 0.8 3.6 1.8 11.9 120.7 9.9 0.3 6.3 0.0 1.6 0.0 6.7 11.4 0.0 2.0 1.0 1.7 0.0 0.0 9.8 1.3 70.0 0.0 1.3 3.2 0.1 48.8 1.5 5.5 0.0 1.7 14.7 5.7 0.0 0.3 5.7 75.9 0.0 0.3 0.0 0.0 0.0 0.0 7.2 0.1 0.0 3.1 0.2 0.2 6.8 0.9 467.7 0.2 0.5 RLN2 "bA12D24.1.1, bA12D24.1.2, H2, RLXH2" ENSG00000107014 "Relaxin 2" P04090 9 5299868-5304969 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.0" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 8.6;Spermatocytes: 10.5;Syncytiotrophoblasts: 11.3" "Cancer enhanced" "Detected in some" "prostate cancer: 6.7" "Region enriched" "Detected in single" 64 "basal ganglia: 44.0" "Group enriched" "Detected in many" 39 "gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0" "Group enriched" "Detected in many" 47 "B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5" "Cell line enhanced" "Detected in some" "Daudi: 5.2;HEL: 20.2;T-47d: 5.8;U-266/84: 9.2" "Secreted to blood" NA NA 24400 "unprognostic (1.63e-3)" "unprognostic (1.26e-1)" "unprognostic (2.09e-3)" "unprognostic (2.84e-1)" "unprognostic (2.03e-2)" "unprognostic (9.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (2.50e-3)" "unprognostic (9.18e-2)" "unprognostic (1.74e-6)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (1.88e-2)" "unprognostic (8.41e-4)" 0.6 0.0 0.6 1.6 44.0 0.0 3.2 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 7.5 0.6 0.6 0.6 0.6 2.0 0.6 0.7 3.5 0.6 0.6 0.6 0.9 5.2 5.8 0.7 0.6 6.2 0.3 0.6 0.6 0.7 0.6 0.4 0.8 0.6 0.6 1.4 0.4 4.2 0.6 0.6 0.9 0.6 3.0 0.6 0.6 2.8 0.0 0.0 0.0 4.9 6.5 1.4 2.8 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.3 1.5 5.2 0.4 0.0 0.0 0.9 0.0 2.7 0.7 4.1 1.9 20.2 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.5 0.0 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.6 2.7 2.9 0.0 0.6 0.1 0.2 5.8 0.1 0.2 0.0 0.5 0.0 0.1 1.3 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.5 2.8 4.3 3.5 0.0 2.1 6.2 4.6 0.0 4.9 0.0 0.0 2.0 1.4 0.6 44.0 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 3.0 1.1 0.5 2.3 0.5 1.5 1.6 0.0 4.0 1.2 1.8 0.0 6.0 6.6 2.5 7.4 0.3 0.0 0.0 1.4 1.7 0.2 1.3 0.0 0.0 0.5 3.2 3.5 0.0 0.0 3.4 0.6 0.0 0.0 0.0 1.2 8.6 0.7 0.0 0.4 0.8 1.8 0.0 0.1 10.5 2.8 1.1 11.3 2.9 1.0 0.3 ZAP70 "SRK, STD, ZAP-70" ENSG00000115085 "Zeta chain of T cell receptor associated protein kinase 70" P43403 2 97713560-97739862 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 37.4;lymphoid tissue: 107.1" "Cell type enriched" "Detected in many" 4 "T-cells: 96.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 41 "gdT-cell: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9" "Group enriched" "Detected in many" 53 "NK-cells: 26.4;T-cells: 37.4" "Group enriched" "Detected in some" 11 "JURKAT: 39.8;MOLT-4: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB002625, HPA003134" Enhanced NA NA "CAB002625: , HPA003134: AB_1080629" "unprognostic (4.11e-3)" "prognostic favorable (6.89e-5)" "unprognostic (3.82e-3)" "prognostic favorable (9.66e-8)" "unprognostic (5.78e-2)" "prognostic favorable (3.93e-6)" "unprognostic (2.30e-3)" "unprognostic (1.09e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-2)" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.02e-8)" "unprognostic (1.29e-1)" "unprognostic (1.65e-1)" "unprognostic (6.40e-2)" "unprognostic (5.83e-3)" 2.2 0.5 0.3 18.1 0.6 11.2 1.5 0.7 0.6 1.2 3.7 0.7 0.3 2.9 1.2 1.1 1.7 1.5 2.8 0.9 0.4 0.8 2.2 2.3 5.8 28.1 0.8 0.6 0.9 1.3 0.0 0.7 0.9 0.6 2.1 0.6 1.0 5.5 1.0 0.7 1.0 12.3 0.7 0.7 24.8 3.2 1.4 0.6 107.1 2.5 1.1 20.8 3.0 1.7 0.4 0.2 0.5 0.2 26.4 37.4 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.2 0.0 0.0 57.4 0.1 0.0 0.0 0.0 2.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 37.4 0.1 25.4 0.0 19.6 29.2 0.0 0.4 14.3 21.9 0.5 26.4 0.2 0.2 19.9 14.3 0.3 0.6 0.7 0.6 0.4 0.8 0.8 0.6 0.6 0.6 8.9 22.3 1.4 0.0 1.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.1 2.3 0.6 1.7 0.0 0.0 3.1 0.8 0.7 0.0 1.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 1.4 1.7 1.3 0.0 96.4 0.0 0.1 CD247 "CD3H, CD3Q, CD3Z" ENSG00000198821 "CD247 molecule" P20963 1 167430640-167518610 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 62.8;lymphoid tissue: 129.5" "Cell type enriched" "Detected in many" 10 "T-cells: 248.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 26 "gdT-cell: 62.8;MAIT T-cell: 35.4;memory CD4 T-cell: 32.4;memory CD8 T-cell: 36.7;naive CD4 T-cell: 41.3;naive CD8 T-cell: 33.5;NK-cell: 33.4;T-reg: 39.0" "Group enriched" "Detected in many" 31 "NK-cells: 33.4;T-cells: 62.8" "Group enriched" "Detected in some" 25 "HDLM-2: 46.4;JURKAT: 34.6;MOLT-4: 48.9" "Region enhanced" "Detected in single" "thalamus: 0.7" "Low region specificity" "Detected in all" "CAB004651, HPA008750" Enhanced NA NA "CAB004651: AB_425347, HPA008750: AB_1857863" "prognostic favorable (9.12e-4)" "unprognostic (3.21e-3)" "unprognostic (7.09e-3)" "prognostic favorable (8.63e-6)" "unprognostic (1.99e-2)" "prognostic favorable (3.98e-4)" "unprognostic (1.79e-2)" "unprognostic (1.11e-2)" "unprognostic (5.46e-3)" "unprognostic (9.73e-3)" "unprognostic (1.33e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (1.60e-1)" "unprognostic (5.33e-2)" "unprognostic (4.02e-2)" "unprognostic (5.94e-3)" 2.3 0.5 0.9 13.5 2.1 17.8 1.3 1.2 1.1 1.4 4.4 0.7 0.7 2.9 1.5 1.6 1.4 1.2 2.9 1.0 0.8 1.4 1.9 3.2 7.3 24.3 1.0 0.5 1.0 0.5 0.0 0.6 1.3 0.7 2.0 1.8 1.7 3.3 0.4 1.4 0.6 9.8 0.8 0.9 28.6 2.7 0.9 0.5 129.5 1.8 0.9 18.1 3.5 1.4 1.5 0.4 1.4 0.2 33.4 62.8 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.1 0.0 62.8 0.2 35.4 1.5 32.4 36.7 0.2 0.5 41.3 33.5 1.4 33.4 0.1 0.4 39.0 31.4 0.9 2.1 1.2 1.1 0.8 1.4 1.0 0.5 0.7 0.5 3.0 26.0 2.2 0.1 1.3 0.2 0.4 2.5 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.7 0.1 5.8 0.6 0.3 3.2 0.0 5.5 5.9 0.0 0.0 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.1 1.5 0.5 0.1 248.3 0.0 0.0 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304545-118316175 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 294.2" "Cell type enriched" "Detected in some" 31 "T-cells: 377.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 36 "gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8" "Group enriched" "Detected in many" 29 "NK-cells: 21.8;T-cells: 62.0" "Group enriched" "Detected in some" 67 "JURKAT: 80.1;MOLT-4: 108.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 3.9 1.0 0.5 16.7 0.7 6.8 1.9 0.5 0.7 2.1 4.7 0.9 0.7 4.4 2.0 1.4 3.3 3.0 4.0 1.4 0.5 0.5 3.3 2.6 7.3 40.9 1.3 0.6 1.5 1.3 0.0 0.9 1.2 0.9 2.6 3.9 1.9 6.4 1.1 0.8 1.3 21.1 1.1 1.9 34.5 4.6 1.2 0.5 294.2 3.4 2.1 37.8 6.3 3.0 0.2 0.9 1.4 0.2 21.8 62.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.1 0.1 0.3 0.0 0.0 108.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.4 0.0 0.1 0.0 1.3 0.2 0.2 59.5 0.1 50.2 0.1 50.7 55.7 0.1 0.2 61.3 62.0 1.4 21.8 0.2 0.9 46.8 32.9 0.5 0.7 0.5 0.7 0.5 0.5 1.3 0.6 0.9 0.5 0.0 11.3 4.5 0.3 4.6 0.0 0.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 6.5 0.2 0.0 0.0 0.0 0.0 1.0 0.1 7.0 0.8 0.3 0.0 0.0 12.3 7.3 0.0 0.0 2.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 4.6 0.2 377.3 0.2 0.3 CD7 "GP40, LEU-9, Tp40, TP41" ENSG00000173762 "CD7 molecule" P09564 17 82314868-82317602 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 54.1;lymphoid tissue: 127.6" "Cell type enriched" "Detected in many" 29 "T-cells: 440.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 54.1" "Group enriched" "Detected in many" 21 "NK-cells: 54.1;T-cells: 19.0" "Cell line enhanced" "Detected in some" "BEWO: 5.6;Hep G2: 21.4;JURKAT: 11.4;MOLT-4: 48.7" "CAB002594, HPA039079" Enhanced NA NA "CAB002594: , HPA039079: AB_2676337" "unprognostic (3.14e-3)" "prognostic favorable (5.51e-4)" "unprognostic (1.89e-2)" "prognostic favorable (2.03e-5)" "unprognostic (7.69e-3)" "unprognostic (1.09e-3)" "unprognostic (3.28e-2)" "unprognostic (1.34e-1)" "prognostic favorable (2.69e-4)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-1)" "prognostic unfavorable (7.75e-11)" "unprognostic (4.69e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (1.55e-3)" 4.7 0.7 0.5 23.4 0.4 14.5 1.7 0.4 0.3 1.9 8.0 0.3 0.5 7.7 1.8 1.9 3.4 2.4 3.5 1.4 0.5 0.6 2.8 4.1 9.5 50.2 0.9 0.0 1.6 1.0 0.0 1.0 4.0 0.4 2.7 1.0 1.8 6.0 1.1 0.5 1.0 17.5 0.5 1.6 33.0 4.6 0.9 0.1 127.6 2.2 1.0 33.3 4.6 2.2 0.1 1.7 0.6 0.1 54.1 19.0 7.1 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 21.4 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 17.6 0.0 15.1 0.1 7.9 12.8 0.0 0.0 19.0 18.9 0.6 54.1 0.1 1.7 6.8 7.1 0.5 0.4 0.4 0.3 0.5 0.6 0.9 0.0 0.4 0.1 0.0 0.0 5.6 0.5 6.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.9 4.2 0.0 0.5 5.2 6.4 1.7 8.1 2.4 3.2 1.6 0.0 12.9 15.2 0.0 0.0 5.8 11.8 0.0 0.6 0.0 0.2 0.8 0.0 0.6 0.0 0.0 2.2 0.0 0.4 3.9 1.6 440.5 0.9 1.7 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.9 18.6 49.6 19.6 3.2 5.0 20.4 37.0 27.0 45.2 43.6 43.6 43.3 44.9 14.4 10.1 16.6 30.5 33.7 21.5 47.1 31.9 24.6 23.5 18.4 25.3 0.6 36.0 24.3 0.9 2.1 29.2 28.5 10.3 27.1 29.6 35.9 55.3 50.2 13.0 45.3 25.9 21.8 29.6 39.3 39.4 46.2 22.0 17.2 16.3 23.3 20.4 24.9 37.8 19.2 28.1 40.8 22.1 11.1 19.3 41.2 20.3 50.6 21.7 34.8 40.5 16.6 40.4 23.9 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 0.0 2.7 2.2 3.6 35.3 1.0 0.5 0.0 14.7 7.9 17.4 0.0 11.0 3.3 0.7 8.8 4.5 1.7 280.4 0.0 116.8 5.1 1.0 0.0 0.8 46.3 0.0 2.9 9.8 15.3 6.3 2.0 8.8 1.7 1.8 4.0 1.0 0.3 0.0 0.7 2.1 0.5 0.0 1.4 104.2 29.6 16.3 18.4 7.0 5.6 6.0 CNR2 CB2 ENSG00000188822 "Cannabinoid receptor 2" P34972 1 23870526-23913362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 19.2;lymphoid tissue: 31.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 4.6;B-cells: 16.4;T-cells: 5.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 19.2;eosinophil: 16.2;memory B-cell: 14.9;naive B-cell: 15.1;NK-cell: 8.7" "Group enriched" "Detected in many" 7 "B-cells: 15.1;granulocytes: 19.2;NK-cells: 8.7" "Cell line enhanced" "Detected in some" "Daudi: 5.0;HEL: 4.2;HMC-1: 19.4;U-698: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB009719 Uncertain NA NA "CAB009719: AB_2082784" "unprognostic (9.45e-4)" "unprognostic (5.40e-3)" "unprognostic (8.50e-3)" "unprognostic (8.19e-3)" "unprognostic (3.55e-3)" "unprognostic (9.34e-6)" "unprognostic (5.58e-3)" "unprognostic (6.96e-3)" "unprognostic (1.74e-1)" "unprognostic (7.87e-2)" "unprognostic (1.53e-1)" "unprognostic (4.93e-2)" "unprognostic (1.04e-3)" "unprognostic (3.67e-1)" "unprognostic (1.80e-1)" "unprognostic (3.75e-2)" "unprognostic (4.91e-2)" 0.3 0.2 0.2 18.5 0.2 1.8 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.1 0.2 0.1 1.8 0.2 0.3 0.3 0.2 0.2 0.4 0.3 0.6 27.7 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.4 0.3 0.3 3.1 0.0 1.8 0.2 5.5 0.0 0.2 29.7 0.4 0.4 0.0 3.0 0.6 0.6 31.1 1.5 0.3 15.1 0.8 19.2 0.1 8.7 2.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.1 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 13.0 0.0 0.1 0.0 19.2 0.1 16.2 1.7 0.0 2.0 14.9 0.1 1.5 0.2 15.1 0.1 0.9 0.6 8.7 0.1 0.8 0.1 0.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 4.6 16.4 0.7 0.6 0.7 0.3 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 3.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.8 0.0 0.3 0.3 0.2 0.3 0.2 5.7 0.0 0.6 CRTAM CD355 ENSG00000109943 "Cytotoxic and regulatory T cell molecule" O95727 11 122838500-122872639 "CD markers, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 140.8" "Cell type enhanced" "Detected in some" 25 "Hofbauer cells: 6.2;Kupffer cells: 9.1;Macrophages: 7.2;T-cells: 34.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 24 "cerebellum: 140.8" "Cell type enhanced" "Detected in many" "NK-cell: 25.7" "Group enriched" "Detected in many" 5 "NK-cells: 25.7;T-cells: 16.7" "Cell line enriched" "Detected in single" 34 "SCLC-21H: 17.4" "Region enriched" "Detected in single" 44 "cerebellum: 115.2" "Low region specificity" "Detected in all" NA NA 3200000 "unprognostic (3.51e-3)" "unprognostic (6.73e-4)" "unprognostic (1.33e-2)" "unprognostic (3.73e-3)" "unprognostic (2.40e-2)" "unprognostic (5.25e-4)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (5.27e-2)" "unprognostic (1.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.32e-1)" "unprognostic (1.83e-4)" "unprognostic (6.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.87e-2)" "unprognostic (6.59e-2)" 0.4 0.3 0.3 2.7 0.4 1.9 0.4 140.8 0.4 0.3 0.4 0.2 0.1 0.4 0.8 0.4 0.3 0.3 1.8 0.3 0.3 0.3 0.3 1.0 2.2 10.6 0.4 0.1 0.3 0.3 0.0 0.3 0.2 5.8 0.3 0.5 0.3 0.7 0.1 0.3 0.3 1.3 0.2 1.2 4.4 0.7 0.3 0.1 3.3 0.3 0.2 4.3 1.1 0.3 0.1 1.7 0.6 4.4 25.7 16.7 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.2 6.7 2.7 6.5 0.0 0.7 13.5 1.7 0.1 2.2 16.7 0.6 25.7 4.4 0.1 0.0 2.8 0.3 0.4 140.8 0.4 0.3 0.3 0.4 0.1 5.8 0.1 0.0 1.4 0.0 0.4 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 1.1 0.0 6.2 0.0 0.0 0.6 9.1 0.6 0.0 7.2 3.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.6 0.1 34.1 0.0 0.3 ETNK2 "EKI2, FLJ10761" ENSG00000143845 "Ethanolamine kinase 2" Q9NVF9 1 204131062-204152003 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 65.9;liver: 80.5;testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 370.3;Late spermatids: 1080.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5" "Group enriched" "Detected in many" 11 "NK-cells: 1.5;T-cells: 4.8" "Cell line enhanced" "Detected in many" "hTCEpi: 26.4;MCF7: 25.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 8 "basal ganglia: 24.7" HPA057167 Enhanced NA NA "HPA057167: AB_2683358" "unprognostic (1.64e-1)" "unprognostic (4.17e-2)" "unprognostic (2.56e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-3)" "unprognostic (4.28e-2)" "unprognostic (6.54e-2)" "unprognostic (4.35e-2)" "prognostic favorable (6.50e-4)" "unprognostic (5.50e-3)" "unprognostic (4.69e-2)" "unprognostic (2.00e-2)" "unprognostic (1.20e-1)" 3.3 2.3 4.0 0.8 4.7 0.9 6.3 0.9 4.0 5.1 1.6 1.9 6.5 0.8 3.1 11.0 8.3 4.9 1.9 2.6 2.6 2.5 65.9 80.5 1.2 2.0 2.7 1.9 13.1 4.3 6.2 8.8 2.3 2.7 3.8 0.9 4.8 7.6 7.8 0.6 5.1 0.8 2.4 1.5 2.4 1.1 45.0 1.9 1.1 4.0 3.9 12.9 3.8 6.2 0.2 0.0 0.2 0.2 1.5 4.8 1.0 5.2 1.8 5.3 10.1 2.0 0.6 5.3 5.4 12.0 7.5 3.3 9.0 2.6 0.2 9.1 1.3 8.8 4.7 9.4 7.6 5.2 0.2 8.4 0.1 1.0 13.8 8.0 0.2 0.3 2.7 26.4 1.6 0.3 3.9 5.4 5.7 0.7 0.2 0.9 25.5 1.5 0.1 11.1 0.2 4.0 0.4 6.3 0.2 6.5 2.0 1.4 7.6 3.4 16.1 2.5 17.6 15.6 0.3 0.3 2.1 11.7 0.4 3.9 0.2 0.1 0.2 0.1 0.2 3.0 0.1 0.2 0.0 4.8 0.0 4.6 0.0 1.3 2.9 0.0 0.2 2.9 3.6 0.2 1.5 0.1 0.0 0.7 1.0 4.0 4.7 0.9 4.0 2.6 2.5 2.7 1.9 2.7 1.9 0.0 0.0 0.5 9.8 3.7 1.8 0.9 5.1 2.7 0.0 3.5 3.9 4.8 33.2 8.0 370.3 1.0 0.0 0.0 5.6 7.9 5.7 10.1 9.2 156.9 0.7 0.0 1.2 1.8 5.1 1080.2 27.0 0.6 10.1 0.0 0.0 2.6 4.6 0.0 39.6 120.8 0.8 0.0 3.8 9.3 5.9 2.0 7.9 0.9 0.0 8.3 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 200.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6" "Cell line enhanced" "Detected in some" "GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: AB_2685433" "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 3.5 1.5 2.4 4.9 5.1 0.8 13.2 1.0 3.8 5.6 31.1 8.9 14.4 2.6 25.3 5.8 8.1 15.8 16.6 26.1 2.9 2.1 1.5 1.0 1.7 4.1 10.2 2.5 9.5 2.0 0.9 5.6 4.9 7.3 19.7 8.0 4.2 8.0 23.1 200.5 3.7 6.5 36.9 8.8 1.7 10.8 3.5 7.6 0.2 9.0 15.1 3.1 24.8 16.1 0.6 0.2 2.9 0.3 4.4 7.6 1.4 1.7 0.3 0.0 0.0 3.8 0.9 0.6 0.3 3.9 0.2 0.4 0.0 1.0 0.0 1.1 2.9 17.4 0.1 0.0 0.3 0.3 59.1 1.3 0.0 2.0 0.0 5.2 0.0 0.2 7.6 2.6 0.9 1.1 20.6 0.2 0.8 0.1 0.5 0.2 0.4 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.5 0.1 0.3 0.4 6.7 6.8 0.4 6.6 0.1 0.2 1.1 0.3 0.3 17.7 6.1 0.8 0.1 4.5 0.0 0.8 2.9 0.3 0.0 3.7 0.2 3.6 0.6 5.1 5.4 0.2 0.6 6.0 7.6 0.2 4.4 0.2 0.1 4.5 1.4 2.4 5.1 1.0 3.8 2.9 2.1 10.2 2.5 7.3 7.6 0.0 3.0 0.9 172.4 10.2 7.9 242.3 2.5 2.7 20.5 7.0 33.4 13.8 8.3 11.6 2.6 7.7 43.7 23.3 26.4 10.2 11.3 165.2 0.0 1.5 4.9 20.6 98.1 0.6 3.2 2.7 36.8 2.9 42.2 1.0 40.8 51.7 39.4 23.2 57.7 3.3 92.8 19.4 73.6 5.4 1.3 5.5 91.3 21.0 19.3 65.2 FHL1 "bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA" ENSG00000022267 "Four and a half LIM domains 1" Q13642 X 136146702-136211359 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 557.6;tongue: 239.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 1067.5;Early spermatids: 313.2;Late spermatids: 886.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 20.6" "Group enriched" "Detected in many" 4 "dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 58.7;fHDF/TERT166: 53.1" "Low region specificity" "Detected in all" "HPA001040, HPA001391, CAB020817" Enhanced Supported "Plasma membrane,Cytosol" NA NA 18000000 Cytosol "Plasma membrane" "CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.61e-3)" "unprognostic (1.76e-2)" "unprognostic (2.51e-2)" "unprognostic (9.34e-2)" "unprognostic (7.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (1.72e-1)" "unprognostic (6.17e-3)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.05e-3)" "prognostic unfavorable (2.11e-4)" 61.9 4.1 7.6 11.0 9.5 0.7 30.6 6.3 7.2 31.5 30.6 3.9 10.0 5.0 25.5 27.7 43.2 14.2 11.7 79.0 6.1 8.1 3.3 2.5 13.7 2.5 5.5 8.1 6.7 2.4 13.4 5.0 13.5 4.4 23.4 10.0 13.5 16.5 30.1 557.6 4.9 11.4 77.7 4.3 2.5 22.1 5.7 3.0 0.6 18.2 239.4 22.1 47.0 14.3 3.4 12.5 0.7 0.4 20.6 11.4 6.2 0.0 9.6 13.3 12.5 29.0 11.7 0.2 37.3 58.7 7.5 18.1 0.0 2.7 0.1 13.0 53.1 21.0 0.1 25.8 31.8 6.3 0.1 29.7 0.1 7.9 0.0 27.2 0.0 6.2 21.7 5.2 9.0 28.6 3.1 7.8 7.3 0.0 5.6 17.5 0.4 5.2 0.3 4.1 0.0 11.3 14.6 0.5 7.9 0.2 0.0 9.4 14.1 1.4 0.0 2.7 5.6 0.0 0.5 22.0 34.7 16.1 1.3 9.3 1.5 3.2 0.2 2.6 0.3 3.8 0.0 0.4 0.0 3.2 0.0 8.6 3.4 11.4 4.5 1.8 2.3 7.6 2.3 0.7 20.6 0.0 12.5 1.2 6.2 7.6 9.5 6.3 7.2 6.1 8.1 5.5 8.1 4.4 3.0 44.7 16.0 6.4 17.4 50.3 30.5 1067.5 0.0 5.3 7.9 10.4 7.9 0.7 1.7 3.3 313.2 63.3 0.0 0.0 0.2 1.0 98.8 2.5 15.1 4.7 3.8 93.8 13.2 131.3 5.9 886.8 114.8 9.8 30.4 10.8 0.5 182.0 0.6 0.2 143.2 4.8 16.9 103.5 304.9 6.0 79.0 39.1 2.3 13.4 0.6 1.8 GZMA "CTLA3, HFSP" ENSG00000145649 "Granzyme A" P12544 5 55102648-55110252 "Enzymes, Predicted secreted proteins" "Apoptosis, Cytolysis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 92.3;intestine: 31.0;lymphoid tissue: 40.9" "Cell type enriched" "Detected in many" 28 "T-cells: 796.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "gdT-cell: 92.3;MAIT T-cell: 90.8;memory CD4 T-cell: 25.4;memory CD8 T-cell: 89.3;naive CD8 T-cell: 50.5;NK-cell: 61.9" "Group enriched" "Detected in many" 38 "NK-cells: 61.9;T-cells: 92.3" "Cell line enhanced" "Detected in some" "HL-60: 8.4;JURKAT: 6.3;REH: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA054134, HPA076751" Enhanced "Secreted to blood" NA NA "HPA054134: AB_2682395, HPA076751: " "prognostic favorable (7.27e-4)" "unprognostic (7.29e-3)" "unprognostic (1.50e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.96e-3)" "unprognostic (1.85e-3)" "unprognostic (8.30e-3)" "unprognostic (1.15e-2)" "unprognostic (5.15e-3)" "unprognostic (3.03e-2)" "unprognostic (1.77e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (1.26e-6)" "unprognostic (5.91e-2)" "unprognostic (5.57e-1)" "unprognostic (5.73e-3)" "unprognostic (3.33e-3)" 4.3 1.8 1.1 16.3 1.2 10.0 2.5 0.7 0.8 3.9 12.5 0.9 1.3 10.3 5.2 2.9 2.9 2.9 9.6 4.5 1.1 1.1 4.6 5.2 11.8 20.3 1.7 0.9 3.0 5.8 0.0 1.9 5.8 1.5 3.4 6.3 4.5 5.1 1.3 2.6 1.2 31.0 2.5 2.6 40.9 3.9 1.1 0.6 1.9 3.1 4.2 11.1 6.6 2.9 0.2 0.2 2.0 0.3 61.9 92.3 52.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 92.3 0.2 90.8 0.2 25.4 89.3 0.2 0.1 5.2 50.5 2.0 61.9 0.3 0.2 2.9 52.0 1.1 1.2 0.7 0.8 1.1 1.1 1.7 0.9 1.5 0.6 3.0 28.1 9.2 0.0 0.3 0.0 0.7 2.5 5.3 5.7 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.1 0.8 0.1 7.0 2.4 0.2 0.0 0.0 12.3 16.8 0.0 0.0 1.3 3.3 0.0 0.6 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.4 0.0 0.0 1.3 0.6 796.9 0.5 0.0 IL7R CD127 ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1" "Group enriched" "Detected in many" 5 "monocytes: 441.0;T-cells: 326.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1" "Group enriched" "Detected in many" 33 "NK-cells: 19.1;T-cells: 70.3" "Cell line enhanced" "Detected in many" "BJ: 22.2;BJ hTERT+ SV40 Large T+: 20.1;fHDF/TERT166: 41.6;HBF TERT88: 38.3;REH: 86.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB010215, HPA067550" Supported "Plasma membrane" "Intracellular and membrane" NA NA 180000 "Plasma membrane" "CAB010215: AB_673727, HPA067550: " "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 6.7 3.6 0.7 34.0 0.7 3.1 4.8 0.5 0.6 4.8 20.6 0.3 0.9 3.5 1.8 2.9 6.6 3.7 8.5 1.9 0.7 0.7 7.0 2.7 52.6 133.1 0.8 0.1 2.5 1.7 0.0 1.5 1.2 0.8 3.3 5.4 1.7 13.2 1.8 0.9 1.8 34.0 1.2 1.5 32.3 7.8 3.0 0.4 130.9 5.1 5.3 42.9 12.6 4.6 0.4 0.3 1.3 0.2 19.1 70.3 12.7 0.1 0.0 0.1 0.1 0.1 0.1 0.2 22.2 11.2 20.1 11.9 0.1 0.1 2.1 0.0 41.6 3.7 3.5 0.0 1.3 38.3 1.8 0.2 0.6 2.4 0.0 0.3 0.2 1.6 0.3 0.0 4.3 0.9 0.5 0.5 0.1 0.1 0.3 15.7 0.0 0.5 0.2 0.1 0.0 1.0 86.5 1.2 0.1 0.0 1.2 0.0 0.0 3.7 0.3 0.0 0.1 0.1 0.0 1.5 7.9 13.4 3.4 2.9 0.2 0.0 2.5 4.0 2.1 6.1 0.5 0.2 0.1 19.2 0.2 70.3 0.2 39.9 28.0 0.1 0.4 34.5 22.5 1.3 19.1 0.2 0.3 6.7 12.7 0.7 0.7 0.5 0.6 0.7 0.7 0.8 0.1 0.8 0.4 14.9 19.4 10.9 1.9 10.3 0.0 3.2 0.0 10.7 4.5 0.0 0.0 0.1 0.0 0.9 0.1 3.6 0.0 23.3 1.6 0.1 7.1 1.1 18.5 4.5 10.4 0.0 0.0 17.8 12.7 0.0 0.0 79.7 20.3 441.0 0.0 0.0 0.2 0.9 0.0 0.6 0.0 0.0 9.0 0.0 0.0 9.2 0.2 326.6 0.0 3.8 ITK "EMT, LYK, PSCTK2" ENSG00000113263 "IL2 inducible T cell kinase" Q08881 5 157142933-157255191 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.0;lymphoid tissue: 60.5" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 10.4;granulocytes: 32.2;T-cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 28 "gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1" "Group enriched" "Detected in many" 29 "NK-cells: 9.2;T-cells: 28.0" "Group enriched" "Detected in some" 9 "JURKAT: 36.5;MOLT-4: 13.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043670 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043670: " "unprognostic (2.08e-3)" "unprognostic (6.57e-4)" "unprognostic (5.06e-3)" "unprognostic (4.96e-5)" "unprognostic (1.52e-2)" "unprognostic (1.12e-4)" "unprognostic (8.45e-4)" "unprognostic (1.56e-2)" "unprognostic (1.87e-2)" "unprognostic (5.99e-3)" "unprognostic (1.76e-1)" "unprognostic (2.52e-1)" "unprognostic (4.52e-6)" "unprognostic (3.64e-1)" "unprognostic (4.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.26e-2)" 2.3 0.7 0.5 12.2 0.6 2.5 1.3 1.9 0.5 1.4 3.3 0.0 0.0 0.5 1.2 1.1 1.8 1.4 4.3 0.9 0.5 0.5 1.4 1.2 6.6 60.5 0.9 0.0 0.7 0.7 0.0 0.9 0.1 0.3 1.1 1.3 1.5 3.5 1.1 0.5 1.0 8.9 0.4 1.2 10.7 2.3 1.4 0.0 60.3 1.6 2.7 24.3 4.1 1.3 0.0 0.0 0.4 0.6 9.2 28.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 13.8 0.0 9.1 0.0 19.5 18.9 0.0 0.0 28.0 22.8 0.4 9.2 0.6 0.0 23.1 13.6 0.5 0.6 1.9 0.5 0.5 0.5 0.9 0.0 0.3 0.0 0.0 10.4 0.0 0.6 2.4 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 32.2 0.6 0.0 0.0 0.0 1.8 0.6 5.5 0.0 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 3.0 0.1 47.3 0.0 0.4 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 260.3" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2889.5" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 29.7;NK-cell: 57.8" "Group enriched" "Detected in all" 5 "granulocytes: 29.7;NK-cells: 57.8" "Cell line enhanced" "Detected in some" "Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 0.9 1.3 0.4 2.9 0.5 4.7 0.7 0.5 0.6 0.4 0.8 0.5 0.4 0.0 0.4 0.5 0.6 0.3 1.6 0.5 0.5 0.7 3.8 2.6 2.0 13.8 0.6 0.5 0.5 0.4 0.0 0.5 8.6 0.5 0.5 0.5 260.3 0.5 0.4 0.6 0.8 2.8 0.4 0.8 17.9 0.7 2.2 0.5 2.5 0.6 0.4 4.6 2.1 0.4 1.3 8.6 29.7 7.7 57.8 2.4 3.7 0.2 0.3 0.5 0.0 0.3 0.0 0.0 0.3 1.1 1.2 1.3 0.1 0.8 0.6 0.2 0.7 0.6 0.1 0.2 0.2 2.8 0.2 0.0 0.9 0.1 6.3 0.9 0.1 0.2 0.0 0.2 1.2 0.0 2.4 3.3 0.4 0.1 0.3 1.3 0.8 0.1 6.7 11.6 0.0 0.4 13.5 0.1 2.0 0.0 0.0 0.1 0.3 0.0 0.3 0.5 8.6 0.1 0.8 1.3 0.4 0.1 0.2 0.3 0.1 0.6 1.0 1.6 2.7 0.2 29.7 5.1 8.6 1.2 7.7 0.4 0.8 0.3 0.6 8.6 1.3 0.7 2.4 0.7 57.8 4.2 0.8 0.0 3.7 0.4 0.5 0.5 0.6 0.5 0.7 0.6 0.5 0.5 0.5 0.0 1.1 1.4 0.0 0.8 338.0 0.0 0.0 0.0 0.0 5.2 486.9 0.2 1.7 0.4 0.6 0.0 0.0 0.0 0.2 0.3 0.2 0.1 24.1 0.0 18.8 247.9 0.0 3.1 3.8 1.6 0.0 3.2 3.3 19.8 0.0 402.2 0.3 0.0 0.0 0.3 2889.5 0.0 0.0 0.7 0.2 1.3 0.2 2.1 0.0 0.0 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146581146-147084784 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 73.2" "Cell type enhanced" "Detected in many" 20 "Cone photoreceptor cells: 141.4;Early spermatids: 312.5;Late spermatids: 670.1;Rod photoreceptor cells: 261.9" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0" "Group enriched" "Detected in many" 33 "NK-cells: 9.5;T-cells: 16.1" "Cell line enriched" "Detected in some" 4 "HDLM-2: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Uncertain Cytosol NA NA Cytosol "HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 2.0 9.7 30.8 2.5 35.2 2.9 1.8 10.2 73.2 1.6 2.7 26.0 0.0 3.0 1.7 1.8 2.9 14.5 2.9 2.9 26.4 20.9 4.7 2.4 2.5 4.3 25.5 22.4 1.6 2.9 16.0 6.4 2.6 27.5 2.7 2.8 4.6 2.0 2.9 1.5 4.9 2.3 3.5 18.6 2.9 2.2 15.7 29.3 0.0 4.2 0.0 2.4 6.8 1.1 0.0 0.0 0.3 0.0 9.5 16.1 4.1 0.4 0.4 2.4 1.0 0.1 0.1 0.2 0.5 0.2 1.1 1.6 1.3 4.8 0.2 0.1 0.0 0.0 10.2 0.8 1.0 1.1 47.5 0.2 0.6 2.8 0.5 0.2 0.0 0.2 0.1 0.7 0.0 0.2 0.7 0.1 0.4 0.6 0.5 0.7 0.3 0.0 0.0 6.3 0.0 1.1 0.7 0.1 0.1 4.2 10.9 1.9 0.2 0.3 0.0 0.2 1.7 0.4 0.1 0.3 0.2 0.7 2.5 0.4 0.4 0.2 0.0 1.7 4.3 1.4 0.2 0.0 0.0 15.1 0.0 13.8 0.0 7.1 16.1 0.0 0.0 1.3 12.0 0.3 9.5 0.0 0.0 8.0 4.1 30.8 35.2 10.2 34.1 26.4 20.9 25.5 22.4 27.5 29.3 3.0 2.6 0.0 1.1 1.8 83.2 1.2 12.7 0.0 1.2 8.7 141.4 14.1 18.3 1.3 312.5 2.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.8 44.5 12.5 0.0 1.2 670.1 3.1 1.7 5.0 0.0 0.0 31.8 0.8 0.0 2.1 4.0 261.9 0.0 8.6 3.7 1.6 1.3 4.5 16.7 0.0 0.7 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 2384.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 17.9;U-266/84: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.7 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 1.3 2.8 1.0 2.8 0.8 3.6 1.8 1.8 5.4 2.6 9.3 0.7 0.6 17.9 4.1 3.2 6.4 10.5 4.8 0.9 2.7 4.6 6.2 5.4 1.1 1.5 0.5 1.1 3.3 1.1 1.8 12.8 3.4 1.2 2.3 3.4 3.5 4.1 1.6 0.3 5.6 0.9 5.4 5.1 1.9 6.0 1.6 2.1 18.8 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 0.0 4.1 0.0 4.4 3.3 268.3 2.4 0.0 2.7 1.2 5.2 559.6 0.8 1.7 1.3 2.1 8.0 1.6 0.0 2.7 0.2 3.5 2.6 1.1 0.6 1.0 162.1 4.1 11.1 1.8 5.9 17.5 1.0 3.3 1.0 2.8 315.6 1.7 3.4 5.3 4.0 2384.7 0.0 3.4 0.9 2.7 0.9 0.6 0.0 2.9 2.0 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 12.1 0.7 0.2 2.8 19.4 0.0 0.0 1.5 0.5 0.1 2.2 4.1 0.8 0.3 2.2 2.8 1.4 2.4 2.4 0.3 6.7 18.7 0.3 0.1 0.3 0.0 16.4 1.2 0.8 8.2 3.3 1.4 0.0 6.2 0.0 6.1 6.1 7.9 2.8 0.1 3.9 2.9 5.2 3.7 3.8 0.0 1.8 19.4 18.3 4.5 0.8 6.3 0.7 4.4 2.6 0.0 0.1 1.7 7.1 0.0 0.8 6.9 5.1 3.7 4.0 1.4 13.4 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 3.0 2.9 0.8 40.5 74.4 1.2 1.1 2.5 0.0 18.2 0.0 2.0 7.6 0.0 1.5 10.0 15.8 0.0 0.0 0.6 25.1 7.6 16.1 23.1 3.6 8.2 69.9 5.2 50.3 22.7 9.0 31.9 28.4 10.1 18.0 0.3 39.3 1.1 10.7 54.8 0.0 4.4 6.5 2.1 1.4 6.1 125.3 8.9 6.9 0.9 72.7 KLRD1 CD94 ENSG00000134539 "Killer cell lectin like receptor D1" Q13241 12 10226058-10329600 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 85.5;lymphoid tissue: 31.0;pituitary gland: 44.6" "Cell type enriched" "Detected in many" 26 "T-cells: 450.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 67.2;memory CD8 T-cell: 28.0;naive CD8 T-cell: 30.3;NK-cell: 85.5" "Group enriched" "Detected in many" 63 "NK-cells: 85.5;T-cells: 67.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA069688 Uncertain NA NA "HPA069688: AB_2686170" "unprognostic (3.75e-2)" "unprognostic (2.15e-3)" "unprognostic (4.95e-2)" "unprognostic (2.48e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-3)" "unprognostic (2.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.94e-3)" "unprognostic (4.53e-3)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.47e-3)" "unprognostic (1.78e-1)" "unprognostic (3.07e-1)" "unprognostic (3.06e-1)" "unprognostic (1.37e-2)" 5.2 1.3 0.9 6.4 1.1 6.9 1.7 0.8 0.9 1.4 2.7 0.6 0.2 1.5 3.3 1.9 2.0 1.1 1.5 1.7 1.0 1.0 1.5 3.7 12.3 10.2 3.8 0.7 0.9 1.9 0.0 44.6 2.3 0.8 2.0 0.9 2.1 1.2 0.5 1.1 0.8 10.6 0.5 2.6 31.0 1.8 1.4 0.4 2.2 1.3 0.3 3.6 6.3 1.3 0.1 0.2 1.2 0.2 85.5 67.2 16.2 0.9 0.7 1.1 1.5 1.5 0.6 0.9 2.3 0.1 0.2 0.7 1.4 1.0 1.3 1.1 1.9 0.8 1.1 0.5 1.3 0.2 2.2 2.8 1.7 2.6 0.6 2.7 1.1 2.2 0.7 1.7 0.4 1.2 1.3 0.3 1.2 1.0 4.9 0.3 1.9 1.0 1.3 1.8 0.8 1.4 0.6 1.6 1.2 0.7 2.1 2.4 1.2 1.1 2.2 0.5 3.1 0.8 2.1 1.7 1.8 3.1 1.5 0.7 2.0 1.8 1.1 2.6 1.6 1.6 0.1 0.1 0.1 67.2 0.2 7.6 0.1 0.4 28.0 0.2 0.1 0.1 30.3 1.2 85.5 0.1 0.2 0.1 16.2 0.9 1.1 0.8 0.9 1.0 1.0 3.8 0.7 0.8 0.4 0.0 14.6 0.8 1.0 0.5 0.7 2.0 5.1 2.7 3.4 0.0 5.9 1.2 0.0 0.2 5.9 3.4 0.0 0.0 0.0 0.8 1.9 1.2 2.3 2.1 0.7 1.6 0.0 13.5 17.1 9.8 0.3 1.7 5.0 0.0 0.0 0.6 0.0 0.0 0.7 1.0 0.9 0.0 0.9 1.2 3.4 0.5 0.7 450.1 0.0 1.0 PRKCQ ENSG00000065675 "Protein kinase C theta" Q04759 10 6427143-6580301 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 2: 6.5;Distal tubular cells: 6.6;T-cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7" "Group enriched" "Detected in many" 11 "NK-cells: 6.5;T-cells: 19.7" "Cell line enhanced" "Detected in some" "HEL: 29.8;JURKAT: 21.2;MOLT-4: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065279, HPA073098" Enhanced "Centriolar satellite" NA NA 200000 "Centriolar satellite" "HPA065279: AB_2685453, HPA073098: AB_2686571" "unprognostic (6.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.69e-3)" "unprognostic (2.46e-1)" "unprognostic (8.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.17e-1)" "unprognostic (3.22e-1)" "unprognostic (5.26e-2)" "unprognostic (7.74e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (3.51e-2)" 0.9 0.7 3.6 9.4 4.3 3.1 0.8 0.9 5.2 1.3 1.1 7.4 0.1 1.2 1.8 5.4 1.6 2.6 1.3 0.5 4.4 4.0 4.6 0.9 3.3 6.6 4.0 2.2 1.1 7.7 0.3 1.0 0.4 2.7 1.4 1.3 5.4 2.8 1.0 63.4 0.6 2.5 0.8 3.6 3.4 1.4 0.9 4.5 32.1 9.1 7.5 6.8 1.9 0.8 0.0 0.1 1.1 0.2 6.5 19.7 5.2 0.0 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.2 1.8 0.2 0.0 0.0 0.0 0.0 1.8 3.1 0.0 0.0 2.0 29.8 0.0 0.2 0.3 1.4 0.3 0.1 1.9 0.1 0.1 0.0 0.2 21.2 6.5 0.0 0.0 0.0 22.3 4.2 3.1 0.2 0.0 4.3 0.7 0.0 6.3 1.5 0.2 1.1 0.0 0.0 0.0 1.9 0.0 3.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.1 0.1 0.1 12.7 0.2 9.8 0.0 13.5 13.2 0.1 0.0 10.7 10.0 0.8 6.5 0.0 0.0 19.7 5.2 3.6 4.3 0.9 5.2 4.4 4.0 4.0 2.2 2.7 4.5 3.0 6.5 0.0 0.1 0.0 1.6 0.3 0.0 1.4 1.2 1.8 0.0 0.0 6.6 0.2 1.8 0.0 0.0 0.0 0.7 0.1 0.3 0.0 1.1 0.0 0.4 0.0 1.7 1.3 1.5 4.5 0.0 0.5 0.0 0.0 0.3 1.5 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.9 2.0 0.0 0.0 25.4 0.3 0.1 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 51.7;lymphoid tissue: 21.0" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8" "Group enriched" "Detected in many" 37 "B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7" "Group enriched" "Detected in some" 26 "Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9" "Low region specificity" "Detected in all" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" NA NA "Nucleoli, Endoplasmic reticulum" "HPA047497: AB_2680069" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.1 0.4 5.6 0.7 1.2 0.4 0.4 1.1 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.5 0.9 0.9 15.9 0.4 0.4 0.6 0.5 0.0 0.4 0.4 0.8 0.4 0.0 0.4 0.7 0.4 2.0 0.0 8.9 0.4 0.4 21.0 1.4 0.6 0.4 18.0 0.5 0.4 4.2 1.0 0.4 24.8 0.2 1.0 0.1 42.9 51.7 17.5 0.1 0.8 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 21.8 0.0 0.1 0.0 0.1 40.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.1 0.1 0.0 43.5 0.1 51.7 24.8 28.9 42.9 0.1 19.3 32.6 32.2 1.0 42.9 0.1 0.2 22.8 17.5 0.4 0.7 0.4 0.4 0.4 0.0 0.4 0.4 0.8 0.4 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 SH2D1A "DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD" ENSG00000183918 "SH2 domain containing 1A" O60880 X 124227868-124373197 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 163.1" "Cell type enriched" "Detected in some" 15 "T-cells: 101.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 53 "gdT-cell: 27.3;MAIT T-cell: 36.5;memory CD4 T-cell: 20.6;memory CD8 T-cell: 40.1;naive CD4 T-cell: 21.0;naive CD8 T-cell: 25.2;NK-cell: 31.7;T-reg: 25.3" "Group enriched" "Detected in many" 67 "NK-cells: 31.7;T-cells: 40.1" "Group enriched" "Detected in some" 5 "HDLM-2: 22.6;JURKAT: 48.8;Karpas-707: 50.8;MOLT-4: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "prognostic favorable (2.03e-4)" "unprognostic (1.18e-3)" "unprognostic (4.35e-3)" "unprognostic (9.66e-5)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (9.25e-3)" "unprognostic (3.34e-2)" "unprognostic (1.88e-2)" "unprognostic (2.80e-3)" "unprognostic (9.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.94e-6)" "unprognostic (1.27e-1)" "unprognostic (9.00e-2)" "unprognostic (2.36e-1)" "unprognostic (3.14e-3)" 2.5 0.5 0.4 5.8 0.6 2.5 1.0 0.2 0.3 0.8 1.0 0.4 0.5 0.6 0.7 0.8 0.9 0.6 2.6 0.6 0.5 0.4 1.1 1.7 4.1 21.3 0.6 0.2 0.6 0.3 0.0 0.4 0.4 0.3 1.0 0.7 0.7 1.9 0.3 0.3 0.4 4.0 0.3 1.0 12.2 1.3 0.4 0.3 163.1 1.3 0.7 10.2 4.2 1.1 0.2 0.1 0.5 0.2 31.7 40.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.8 0.0 50.8 0.0 0.0 60.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 7.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 27.3 0.1 36.5 0.2 20.6 40.1 0.1 0.0 21.0 25.2 0.5 31.7 0.2 0.1 25.3 17.2 0.4 0.6 0.2 0.3 0.5 0.4 0.6 0.2 0.3 0.3 3.0 6.6 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.5 0.5 0.1 0.0 0.0 4.9 4.6 0.0 0.0 1.9 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.9 0.1 101.4 0.0 0.0 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Group enriched" "Detected in some" 10 "Basal glandular cells: 246.2;Erythroid cells: 93.5;Glandular cells: 129.8;Urothelial cells: 212.7" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Group enriched" "Detected in some" 5 "GAMG: 79.4;RT4: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059570: AB_2684066, HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 79.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 1.1 0.0 0.0 0.7 0.3 0.3 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 0.0 1.1 1.3 246.2 0.2 0.3 6.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.0 93.5 0.2 0.0 0.1 129.8 0.0 0.0 0.1 0.0 0.0 17.8 1.2 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 5.7 0.0 212.7 SPINK2 HUSI-II ENSG00000128040 "Serine peptidase inhibitor, Kazal type 2" P20155 4 56809860-56821742 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "epididymis: 376.2" "Group enriched" "Detected in many" 9 "Early spermatids: 772.8;Late spermatids: 1064.2;Spermatocytes: 1687.5" "Group enriched" "Detected in some" 5 "lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 6 "NK-cell: 43.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.3" "Cell line enriched" "Detected in some" 4 "U-266/70: 44.5" "CAB020824, HPA026813" Enhanced "Secreted to blood" NA NA "CAB020824: , HPA026813: AB_1857446" "unprognostic (5.56e-3)" "unprognostic (3.60e-1)" "unprognostic (7.54e-2)" "unprognostic (2.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.60e-1)" "prognostic favorable (2.82e-4)" "unprognostic (9.83e-2)" "unprognostic (6.62e-2)" "unprognostic (9.40e-3)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (4.10e-3)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.87e-2)" 0.2 0.1 0.2 0.5 0.2 0.7 0.3 0.1 0.3 0.4 0.4 0.0 85.2 0.0 0.2 376.2 0.1 0.2 0.0 2.2 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.0 1.4 0.0 1.1 1.1 0.1 0.0 0.6 49.9 0.5 0.2 0.5 0.0 0.2 0.6 0.2 85.5 0.0 0.3 0.2 0.0 0.2 1.3 1.3 3.9 0.4 1.3 0.0 43.3 7.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 1.3 8.6 0.2 0.0 0.0 0.0 0.0 2.0 0.0 2.8 0.1 1.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 44.5 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.0 0.2 2.3 1.7 1.8 0.4 3.9 3.9 7.3 0.3 43.3 0.0 0.2 0.1 2.0 0.2 0.2 0.1 0.3 0.3 0.3 0.2 0.0 1.1 0.0 0.0 0.0 4.5 12.1 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 772.8 0.1 0.2 0.0 0.0 0.2 0.5 9.5 1.1 0.0 0.1 0.0 1.7 0.0 0.0 1064.2 35.1 0.2 11.8 0.0 5.3 1.4 0.0 9.3 23.0 0.0 0.0 12.9 1.0 1687.5 136.3 0.3 0.0 7.5 1.7 2.2 ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567137 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 22.6 3.5 4.9 6.0 3.2 5.4 21.6 2.9 4.1 3.8 8.8 4.2 4.4 8.5 4.2 3.1 4.1 4.3 7.8 6.6 2.1 1.9 8.4 21.2 5.6 12.7 2.7 3.9 2.8 10.9 8.8 8.5 3.2 4.3 4.0 5.0 3.6 4.5 4.6 2.1 3.4 12.7 5.5 3.3 9.1 6.3 1.4 4.6 1.6 5.2 2.7 6.0 5.6 9.1 2.0 17.0 11.1 0.4 7.2 5.0 0.7 3.8 15.0 1.9 5.3 20.6 9.0 7.9 5.3 5.9 5.3 4.9 3.4 2.0 5.7 3.9 5.7 9.4 10.6 6.6 2.3 2.9 17.7 5.0 2.3 7.4 4.3 6.3 5.9 10.7 6.7 6.2 5.1 0.9 3.9 3.8 3.4 3.0 5.5 2.8 5.2 5.6 6.9 0.4 13.0 4.5 13.1 7.3 13.2 9.5 5.9 1.3 2.2 8.0 3.6 2.0 2.1 9.1 13.7 4.7 3.1 3.9 7.7 4.6 9.3 6.2 3.0 6.1 3.7 6.5 11.1 0.4 1.8 1.9 0.2 5.0 1.0 1.0 1.7 1.0 2.0 0.3 1.0 0.5 7.2 0.2 17.0 0.9 0.7 4.9 3.2 2.9 4.1 2.1 1.9 2.7 3.9 4.3 4.6 3.0 5.5 5.6 1.1 1.1 0.0 2.0 5.1 5.3 4.5 7.0 0.0 0.9 0.0 2.8 0.2 1.4 8.3 0.0 6.6 1.0 3.8 1.2 2.3 25.3 6.6 1.6 6.9 3.7 6.7 0.2 4.4 8.2 5.0 3.6 6.3 0.9 4.8 0.0 4.2 5.4 0.7 0.0 2.0 0.5 0.4 2.0 0.2 14.4 6.3 1.1 AC011043.1 ENSG00000276256 "Homo sapiens uncharacterized LOC389831 (LOC389831), transcript variant 3, mRNA." Unmapped 42939-49164 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 17.4;Distal tubular cells: 16.6" "Cell type enhanced" "Detected in many" "NK-cell: 9.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 44.6" NA NA 0.0 1.0 0.0 0.0 1.7 1.2 0.8 1.8 3.2 1.6 2.4 0.9 2.1 1.2 1.1 10.3 6.8 0.0 0.0 2.8 6.3 5.9 2.7 6.3 2.7 0.3 5.4 0.0 0.7 1.3 2.3 0.5 2.1 0.1 0.4 0.0 1.6 1.9 3.2 0.0 0.6 9.8 4.4 1.5 44.6 23.8 26.6 25.8 13.5 14.6 7.7 4.8 3.6 4.3 6.2 27.2 8.2 3.6 15.8 3.4 28.2 17.3 4.8 14.8 7.0 22.5 17.7 8.0 7.1 15.4 3.0 4.3 7.4 5.4 6.0 5.4 13.6 14.3 5.1 6.5 17.7 6.9 16.8 2.6 6.3 20.6 2.6 22.2 2.5 0.0 11.1 1.9 4.0 6.5 9.9 25.0 0.8 9.0 25.1 4.9 8.7 4.6 3.0 11.4 4.8 0.5 10.2 0.3 0.7 0.1 6.2 1.6 6.8 0.0 0.6 0.0 2.0 0.1 3.2 1.9 1.0 2.7 3.2 0.4 0.7 2.3 0.0 9.8 0.2 2.2 4.4 1.5 11.9 7.3 0.0 2.7 1.6 2.2 0.0 2.5 14.7 6.8 17.4 0.0 3.1 16.6 10.8 1.1 1.3 1.6 0.0 5.2 3.1 1.9 0.5 3.5 0.9 0.6 0.0 8.2 1.3 0.0 0.5 0.9 0.9 0.0 2.8 5.2 10.5 8.8 9.0 3.2 9.8 1.1 6.5 1.4 0.0 0.4 1.5 3.4 0.0 6.9 1.4 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6394391 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Cell type enhanced" "Detected in many" 8 "granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 20.5;plasmacytoid DC: 19.4" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol No No 29000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 4.7 13.3 25.8 10.8 29.8 7.7 3.9 23.9 50.0 4.4 18.3 11.3 0.5 33.2 5.1 3.8 14.3 4.4 5.3 6.3 27.8 43.9 29.4 9.1 8.6 12.3 36.0 20.7 5.3 4.0 1.9 18.5 7.4 49.9 5.6 13.5 6.6 4.1 4.9 1.5 9.4 33.2 14.3 14.2 8.9 6.2 13.1 6.9 9.0 2.3 6.5 11.6 9.1 6.6 1.0 19.4 0.4 0.6 20.5 4.4 2.8 23.7 20.7 20.4 22.0 4.7 7.8 7.7 20.5 10.6 30.4 18.2 71.4 7.7 29.1 15.1 16.6 23.5 23.5 32.9 54.7 11.4 25.5 28.7 15.3 16.4 25.3 19.3 17.9 12.7 6.9 10.5 25.1 29.8 8.1 17.0 36.5 12.4 6.3 16.0 27.7 37.3 19.0 10.2 23.9 48.0 44.6 23.5 19.7 17.1 9.1 11.2 31.7 18.4 28.3 65.2 10.5 10.1 8.4 27.5 27.7 16.2 27.4 32.3 5.3 21.6 40.9 17.5 31.3 16.8 0.0 0.1 0.1 4.1 0.6 1.0 1.0 3.4 3.6 2.9 0.4 1.2 2.3 0.4 20.5 0.5 19.4 4.4 2.8 25.8 29.8 23.9 50.0 27.8 43.9 36.0 20.7 49.9 6.9 6.0 25.5 13.7 13.3 28.2 33.6 8.1 12.7 1.4 7.9 8.7 9.8 15.1 13.3 19.1 73.6 15.6 70.9 0.0 6.2 23.1 14.2 7.0 137.0 13.4 26.8 44.5 4.6 5.5 4.0 118.5 3.4 16.9 37.1 25.2 88.8 10.6 16.5 29.1 6.7 214.2 15.6 0.0 6.2 38.2 26.7 25.7 14.4 21.4 48.7 19.5 ADGRL1 "CIRL1, KIAA0821, LEC2, LPHN1" ENSG00000072071 "Adhesion G protein-coupled receptor L1" O94910 19 14147743-14206187 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 59.8;Horizontal cells: 33.4;Muller glia cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 31.8;HMC-1: 23.1;SCLC-21H: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037974 Uncertain NA NA 63000 "HPA037974: AB_10675623" "unprognostic (5.52e-2)" "unprognostic (3.89e-1)" "unprognostic (1.04e-1)" "unprognostic (5.52e-3)" "unprognostic (6.29e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (5.39e-2)" "unprognostic (2.73e-1)" "unprognostic (5.68e-2)" "prognostic favorable (1.14e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.45e-4)" "unprognostic (7.65e-3)" "unprognostic (1.32e-1)" "unprognostic (3.06e-2)" "unprognostic (2.18e-1)" 10.5 4.6 12.1 3.5 18.0 1.8 3.9 27.0 30.9 7.7 6.4 12.7 4.3 6.1 9.0 4.1 6.5 10.8 4.1 5.5 12.7 9.3 3.4 0.5 5.4 2.6 8.7 9.0 4.0 5.8 12.8 9.1 3.7 11.8 5.4 3.7 9.4 9.8 8.1 1.6 9.1 5.4 8.1 8.1 4.4 5.0 5.5 6.9 2.8 9.2 2.0 1.8 4.6 3.4 0.4 1.7 1.3 1.3 4.6 1.3 0.6 10.0 3.9 8.9 31.8 2.4 0.7 3.1 0.7 1.0 1.0 0.6 3.4 3.5 0.8 10.7 1.2 2.0 0.6 10.7 3.0 0.3 1.4 9.1 1.8 1.6 0.5 5.4 0.6 23.1 1.9 2.8 0.3 0.5 1.6 0.8 10.0 8.8 0.9 0.1 16.9 0.8 0.9 13.3 5.4 7.6 4.9 1.1 11.2 1.7 3.2 24.6 6.3 1.9 12.7 4.4 3.3 12.6 4.7 1.2 8.4 12.9 2.3 2.9 2.5 2.1 13.8 2.5 11.7 3.0 0.0 1.3 0.5 1.3 1.1 0.9 0.4 0.7 0.4 0.5 0.2 1.0 0.6 1.3 4.6 1.1 1.7 0.7 0.6 12.1 18.0 27.0 27.6 12.7 9.3 8.7 9.0 11.8 6.9 0.0 5.0 0.0 2.8 0.0 59.8 7.3 2.5 0.0 3.4 7.0 9.8 0.3 0.0 3.2 0.3 4.5 3.2 0.0 2.7 0.3 3.3 3.9 4.7 0.0 0.7 33.4 7.0 9.2 2.2 2.0 8.6 0.4 0.0 1.0 3.0 32.9 2.4 7.8 15.2 0.7 22.2 19.4 0.9 0.9 22.6 0.0 0.2 1.9 6.7 1.4 AGK "FLJ10842, MULK" ENSG00000006530 "Acylglycerol kinase" Q53H12 7 141551189-141655244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 37.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020959, HPA053471" Supported Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "HPA020959: AB_1854206, HPA053471: AB_2682164" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (9.47e-3)" "unprognostic (5.43e-2)" "unprognostic (2.15e-2)" "unprognostic (3.68e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (1.14e-1)" "unprognostic (6.24e-3)" "unprognostic (7.90e-2)" "unprognostic (9.29e-2)" "unprognostic (9.65e-2)" "unprognostic (3.30e-1)" "unprognostic (1.18e-1)" 8.7 12.0 11.9 8.0 19.0 5.9 10.6 21.3 23.7 8.8 8.9 10.2 8.8 6.4 16.8 17.1 9.5 11.9 6.8 24.5 16.1 12.3 16.0 10.5 8.4 10.0 11.8 18.8 10.8 8.0 15.7 13.3 9.9 14.2 10.1 13.4 10.6 13.5 10.7 8.4 6.8 8.8 15.0 13.9 12.2 9.0 12.9 9.0 7.8 9.8 8.4 15.6 8.4 8.5 4.6 6.4 0.4 5.5 37.9 10.3 5.7 12.4 13.5 13.4 11.0 10.6 13.2 9.1 13.2 12.9 21.2 21.2 10.5 9.6 14.0 11.8 12.6 20.0 9.3 18.7 15.4 22.9 16.5 16.6 13.0 6.4 10.4 15.8 9.0 7.0 14.7 13.6 18.6 18.2 9.9 16.2 16.1 19.3 20.0 10.2 12.5 24.3 4.1 14.2 9.6 15.2 15.7 2.3 41.9 13.6 10.6 11.7 16.1 13.7 16.6 13.6 14.1 8.9 9.9 9.1 9.8 7.7 13.1 19.0 15.2 15.0 6.7 16.2 4.2 27.0 0.0 2.6 0.4 9.1 5.5 6.5 4.6 7.4 10.3 6.4 2.5 5.5 9.6 0.2 37.9 3.2 2.5 7.2 5.7 11.9 19.0 21.3 23.7 16.1 12.3 11.8 18.8 14.2 9.0 0.0 5.9 3.7 5.1 2.7 10.7 16.8 5.1 6.7 5.7 12.2 7.9 13.4 8.3 6.3 10.0 5.8 2.0 0.0 6.1 6.7 5.4 2.6 8.1 4.5 6.1 14.3 0.0 3.1 4.7 8.5 6.4 4.7 6.8 18.0 2.9 9.8 4.6 0.0 9.9 6.1 16.4 0.0 6.2 4.6 4.9 2.4 7.7 11.4 5.6 2.7 AL139353.1 ENSG00000203546 14 31334312-31457441 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.2;Ciliated cells: 4.0;Cytotrophoblasts: 3.8;Distal tubular cells: 3.3;Proximal tubular cells: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 2.2;EFO-21: 2.2;HBEC3-KT: 1.6;U-2 OS: 1.4;U-266/70: 1.4" NA NA "unprognostic (2.86e-4)" "unprognostic (3.48e-1)" "unprognostic (3.52e-1)" "unprognostic (2.21e-1)" "unprognostic (2.52e-1)" "unprognostic (4.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.18e-2)" "unprognostic (3.91e-2)" "unprognostic (3.13e-2)" "unprognostic (5.79e-3)" "unprognostic (1.47e-2)" "unprognostic (2.63e-3)" "unprognostic (8.26e-3)" "unprognostic (3.56e-2)" "unprognostic (4.57e-2)" "unprognostic (5.10e-2)" 9.1 1.5 2.8 1.5 5.8 1.5 4.6 2.8 7.4 1.7 2.8 5.5 0.5 1.5 1.8 1.5 1.9 2.6 1.9 3.0 2.6 2.4 2.3 1.6 3.2 2.3 3.4 2.7 2.6 3.2 1.5 3.0 1.5 4.6 1.8 1.5 1.9 3.3 1.8 9.7 1.5 2.1 2.1 2.7 1.7 2.2 5.2 3.2 4.2 1.8 0.1 1.7 1.5 1.4 2.4 2.1 0.0 0.4 3.6 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.2 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 1.1 1.2 0.4 0.2 0.3 2.4 0.7 0.2 0.0 3.6 0.1 2.1 1.7 0.2 2.8 5.8 2.8 7.4 2.6 2.4 3.4 2.7 4.6 3.2 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.2 1.8 0.0 3.8 3.3 1.1 0.0 0.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 27.9;Rod photoreceptor cells: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.6;SK-BR-3: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046152: AB_2679559" "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.6 1.2 2.7 9.5 3.6 1.5 3.4 4.4 2.2 5.1 2.4 0.5 0.1 0.2 1.2 2.8 1.2 1.4 7.3 0.3 4.3 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.4 0.7 3.2 1.7 0.0 0.5 1.2 1.5 2.1 0.0 0.1 4.4 0.4 4.4 1.7 2.2 3.0 0.7 0.0 0.4 5.9 1.3 9.6 3.2 1.0 12.6 3.5 1.2 3.6 3.1 1.1 0.2 5.9 3.4 1.8 0.2 0.0 0.0 1.9 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 3.0 1.3 0.0 0.4 0.6 27.9 6.7 2.5 0.0 0.0 3.5 3.9 1.0 0.0 1.0 0.0 0.8 1.0 0.0 0.8 0.1 0.6 1.1 0.0 0.8 0.2 4.8 4.6 0.6 0.0 0.0 2.0 0.0 0.0 1.0 0.7 7.1 0.7 0.9 5.3 0.5 8.8 0.0 1.0 0.7 0.9 0.4 0.2 0.0 1.5 0.3 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416775-49422753 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 10.4;Hep G2: 29.9;NTERA-2: 5.4;SH-SY5Y: 7.9;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005566 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 10.9 6.6 8.0 8.8 6.0 6.6 16.7 10.4 8.4 10.0 7.4 21.3 10.9 9.2 11.1 3.4 9.7 13.0 16.6 7.4 2.0 21.4 41.2 5.6 2.3 7.6 8.3 14.5 18.5 16.3 10.4 2.5 10.7 9.1 10.1 12.2 9.8 20.0 3.8 5.4 11.0 7.1 5.8 7.9 8.1 2.6 7.4 1.7 8.7 0.4 1.8 6.2 8.1 0.7 5.4 4.7 3.2 8.9 1.6 2.3 0.1 0.5 0.7 0.1 0.4 0.0 10.4 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.2 0.1 0.4 0.1 0.2 0.2 0.0 0.3 29.9 1.1 0.0 0.1 0.3 0.7 0.0 0.4 1.1 0.1 0.2 0.0 0.0 0.1 0.3 0.2 0.2 5.4 0.0 0.1 0.0 0.1 0.2 0.7 0.2 0.0 7.9 0.1 0.0 0.6 7.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 3.2 4.7 0.0 1.9 0.1 0.6 0.0 0.0 5.4 0.7 1.6 1.5 0.3 8.9 0.7 0.5 0.0 2.3 6.6 8.8 16.7 10.4 7.4 2.0 7.6 8.3 10.7 7.4 3.0 11.6 3.7 11.4 2.5 17.2 18.3 17.8 6.7 7.9 0.0 19.6 22.7 0.0 0.7 1.7 2.7 19.7 0.0 0.6 6.5 4.7 10.1 7.0 37.3 4.4 7.9 12.2 3.1 2.7 1.6 9.8 3.5 5.0 0.0 16.2 21.5 0.5 14.0 6.0 0.7 17.7 6.5 4.3 1.4 0.4 2.4 8.6 5.7 31.1 8.6 APOBEC3H ARP10 ENSG00000100298 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3H" Q6NTF7 22 39097224-39104067 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.7;ductus deferens: 14.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 6.2;monocytes: 18.0;T-cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 15.7;MAIT T-cell: 6.6;memory CD4 T-cell: 8.6;memory CD8 T-cell: 13.2;naive CD8 T-cell: 6.4;NK-cell: 11.8;T-reg: 7.5" "Group enriched" "Detected in many" 14 "NK-cells: 11.8;T-cells: 15.7" "Cell line enhanced" "Detected in some" "Daudi: 4.4;HDLM-2: 4.3;Karpas-707: 11.3;U-266/70: 7.5" "HPA021492, HPA058565" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021492: AB_10964888, HPA058565: " "unprognostic (7.09e-3)" "prognostic favorable (1.20e-4)" "unprognostic (1.05e-1)" "unprognostic (6.81e-4)" "unprognostic (3.40e-1)" "unprognostic (1.54e-3)" "unprognostic (2.30e-2)" "unprognostic (1.36e-2)" "unprognostic (2.17e-1)" "unprognostic (3.83e-2)" "unprognostic (5.07e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.73e-12)" "unprognostic (1.05e-1)" "unprognostic (1.03e-1)" "unprognostic (6.55e-3)" "prognostic favorable (8.43e-7)" 1.7 2.2 0.7 6.2 1.2 4.9 1.0 0.8 0.9 1.5 2.3 0.9 14.1 0.4 1.7 6.4 1.5 1.9 2.7 5.9 0.7 0.7 2.3 1.3 4.2 5.3 2.0 1.0 0.9 3.8 0.8 2.0 1.3 1.2 1.6 5.6 1.1 3.3 3.6 2.7 0.5 2.7 1.6 2.1 7.5 2.0 4.0 0.3 3.7 1.8 1.2 5.5 3.1 1.5 1.0 0.1 0.0 1.0 11.8 15.7 2.9 0.0 0.7 0.1 0.0 0.0 0.4 3.2 0.0 0.2 0.3 0.1 0.0 0.4 4.4 1.7 0.4 0.0 0.2 0.0 0.9 0.0 4.3 0.5 1.0 0.2 0.1 0.4 0.0 3.3 2.9 2.5 0.3 0.4 0.3 0.0 0.2 0.0 11.3 1.3 1.3 2.0 0.4 0.0 0.1 0.0 2.4 0.0 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.2 0.0 0.0 7.5 1.0 0.2 0.3 1.9 0.1 0.0 0.2 0.0 15.7 0.3 6.6 1.0 8.6 13.2 0.1 0.3 0.5 6.4 0.0 11.8 1.0 0.0 7.5 2.9 0.7 1.2 0.8 0.9 0.7 0.7 2.0 1.0 1.2 0.3 0.0 6.2 0.8 0.5 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.5 0.0 3.8 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 23.2 0.0 0.6 ARHGAP26 "GRAF, KIAA0621, OPHN1L, OPHN1L1" ENSG00000145819 "Rho GTPase activating protein 26" Q9UNA1 5 142770377-143229011 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "neutrophil: 19.6;NK-cell: 5.8" "Group enriched" "Detected in many" 4 "granulocytes: 19.6;NK-cells: 5.8" "Cell line enhanced" "Detected in many" "Karpas-707: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035106, HPA035107" Enhanced Approved Cytosol NA NA Cytosol "HPA035106: AB_2674465, HPA035107: AB_10669855" "prognostic favorable (2.05e-4)" "prognostic favorable (1.36e-4)" "prognostic favorable (6.95e-4)" "prognostic favorable (5.93e-6)" "unprognostic (1.19e-1)" "unprognostic (1.93e-2)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.22e-1)" "unprognostic (9.43e-3)" "unprognostic (7.19e-3)" "unprognostic (8.65e-2)" "unprognostic (3.21e-3)" "unprognostic (5.67e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-2)" "prognostic favorable (2.88e-6)" 13.3 5.7 18.4 18.6 22.7 33.9 13.0 29.2 23.9 15.9 14.2 7.5 9.9 13.2 9.4 10.9 7.6 18.5 16.4 17.0 12.8 10.5 8.0 7.7 20.0 8.8 12.9 15.4 4.8 5.5 4.8 15.1 22.4 11.9 8.5 14.8 8.8 14.6 11.2 14.0 8.5 12.6 11.1 12.6 18.9 17.0 16.1 12.2 10.3 10.0 5.4 13.6 9.4 10.6 0.3 2.0 19.6 2.8 5.8 3.0 1.0 6.9 14.0 3.9 3.6 5.8 6.4 6.0 0.8 1.2 3.4 5.9 19.1 15.8 1.0 6.9 2.2 10.3 3.3 1.9 6.6 4.2 14.3 2.2 0.0 1.8 12.1 3.7 10.2 1.4 2.3 11.6 6.2 14.3 2.7 5.0 4.8 0.2 39.7 1.0 1.1 5.8 4.2 1.8 10.3 3.6 2.2 5.8 16.6 9.9 10.7 1.5 2.4 1.8 1.9 3.2 3.1 1.0 3.1 9.6 1.8 2.6 0.2 3.6 1.8 5.7 0.2 4.8 9.7 2.5 2.9 2.8 1.6 3.0 1.7 1.3 0.2 0.6 1.8 2.0 0.3 0.2 0.8 19.6 5.8 1.0 0.5 0.2 1.0 18.4 22.7 29.2 23.9 12.8 10.5 12.9 15.4 11.9 12.2 14.9 22.7 2.9 13.9 6.2 9.5 33.7 25.5 12.0 12.5 0.0 7.9 1.1 0.0 15.6 62.7 31.7 30.5 0.0 18.9 0.7 11.6 26.2 25.5 4.3 21.6 71.5 3.5 30.1 49.8 105.1 6.1 31.8 10.1 6.4 26.2 6.3 16.0 21.5 13.4 4.4 54.5 45.3 12.7 1.9 11.3 4.8 1.6 22.7 21.7 31.9 ATP1B1 ATP1B ENSG00000143153 "ATPase Na+/K+ transporting subunit beta 1" P05026 1 169105697-169132722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 239.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 1634.8;Proximal tubular cells: 927.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 127.3;RPTEC TERT1: 68.9;SH-SY5Y: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012911 Enhanced NA NA 4100000 "HPA012911: AB_1845173" "unprognostic (4.20e-2)" "unprognostic (3.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.85e-2)" "unprognostic (1.95e-1)" "unprognostic (5.34e-2)" "unprognostic (2.22e-1)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (6.80e-2)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "prognostic favorable (7.08e-7)" "unprognostic (1.11e-1)" "unprognostic (5.48e-2)" "unprognostic (1.97e-3)" "unprognostic (9.39e-2)" 3.9 26.3 48.7 8.6 45.1 1.3 14.9 39.4 92.1 8.7 43.8 34.5 11.3 61.3 19.8 11.2 28.7 9.4 50.1 36.0 86.3 68.2 239.7 30.6 16.9 1.9 82.3 52.6 11.5 33.0 130.6 16.7 8.3 111.5 9.8 34.8 15.5 55.7 15.4 55.1 11.2 51.2 17.8 64.0 9.6 69.5 8.4 25.9 0.9 60.1 23.7 13.9 12.3 9.0 1.4 8.4 10.5 3.0 5.6 9.1 1.4 12.3 30.2 9.8 7.5 2.3 0.4 3.4 6.1 5.0 6.4 6.7 36.8 25.0 0.0 23.1 4.8 7.2 14.6 5.4 11.6 6.6 0.1 2.4 0.7 22.8 17.1 3.7 0.5 1.1 1.3 2.9 4.7 6.1 11.2 5.8 0.9 0.1 0.1 7.3 4.7 1.0 1.9 3.9 127.3 6.5 0.1 11.9 2.1 68.9 15.4 7.8 57.2 36.1 36.4 1.6 12.5 7.5 1.2 12.3 4.9 13.2 8.3 21.8 0.7 0.9 0.2 5.9 1.8 6.6 10.5 1.0 0.1 2.9 3.0 1.5 1.4 3.4 1.1 8.4 0.2 1.0 1.1 0.3 5.6 0.9 0.4 9.1 1.4 48.7 45.1 39.4 92.1 86.3 68.2 82.3 52.6 111.5 25.9 223.4 199.8 17.7 144.1 46.6 22.3 136.8 749.1 187.4 257.0 1634.8 13.7 3.9 782.5 509.0 2.8 15.2 580.2 0.0 519.8 7.5 62.9 68.0 22.0 232.9 298.5 548.2 154.6 46.6 63.5 4.1 83.1 111.4 234.5 43.3 240.2 24.3 309.0 614.7 140.0 927.9 48.2 6.5 23.6 8.6 62.0 27.7 8.2 25.4 319.0 251.2 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395543-231401164 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.7;intestine: 41.2" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 19.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" NA NA 2100000 "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 3.0 10.3 5.3 2.3 4.9 5.5 1.9 0.9 3.2 1.2 28.0 3.8 0.8 12.2 1.6 3.5 1.9 3.6 93.7 26.8 4.2 4.4 1.4 1.3 17.7 1.8 4.0 2.0 13.0 18.9 6.7 8.9 10.7 3.2 1.6 35.5 2.0 4.0 2.3 0.4 2.4 41.2 1.1 1.9 6.7 17.1 1.6 2.2 1.2 4.2 1.7 3.9 1.2 0.6 7.1 4.2 0.4 0.3 19.9 2.0 0.5 0.5 2.1 0.2 0.4 0.1 0.2 0.8 0.2 0.8 0.1 0.1 1.0 15.0 1.7 4.6 0.2 0.1 3.9 0.2 0.0 0.1 0.2 0.4 11.8 0.3 0.7 0.1 0.1 0.6 0.1 1.1 0.1 0.2 0.8 0.2 0.3 0.3 0.3 0.1 0.6 0.1 0.5 4.9 5.8 2.6 0.2 0.0 0.2 0.5 1.3 0.4 0.6 0.2 1.3 0.5 5.7 0.5 10.5 0.2 0.3 0.3 0.2 0.1 1.8 0.6 0.5 0.3 0.1 18.2 0.3 0.0 0.4 2.0 0.3 0.4 7.1 0.0 0.2 4.2 5.1 0.1 0.5 0.1 19.9 0.3 2.1 0.1 0.5 5.3 4.9 0.9 3.2 4.2 4.4 4.0 2.0 3.2 2.2 38.7 24.6 2.2 1.2 2.1 0.2 0.8 84.1 75.0 33.0 1.8 2.0 0.4 0.0 13.5 0.3 0.7 75.7 0.0 73.7 52.0 2.2 11.2 9.2 0.0 9.0 0.0 99.1 3.7 7.0 0.9 1.4 13.6 3.3 4.6 119.1 0.5 58.2 46.0 7.8 0.1 1.6 0.0 1.4 0.7 1.3 2.4 1.7 6.9 275.6 13.2 BEX5 NGFRAP1L1 ENSG00000184515 "Brain expressed X-linked 5" Q5H9J7 X 102153708-102156057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 198.7;Distal tubular cells: 116.0" "Cancer enhanced" "Detected in all" "endometrial cancer: 45.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 11.2;memory CD4 T-cell: 8.5;memory CD8 T-cell: 5.9;naive CD4 T-cell: 12.4;naive CD8 T-cell: 7.4;NK-cell: 6.5;T-reg: 7.9" "Group enriched" "Detected in many" 6 "NK-cells: 6.5;T-cells: 12.4" "Group enriched" "Detected in some" 4 "HAP1: 9.0;Karpas-707: 34.8" "Low region specificity" "Detected in all" HPA059058 Enhanced NA NA "HPA059058: AB_2683894" "unprognostic (1.88e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (2.63e-3)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.25e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.23e-1)" "unprognostic (2.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.63e-2)" "prognostic favorable (1.97e-4)" "unprognostic (3.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.48e-2)" 2.7 12.1 35.4 2.9 28.1 1.8 6.0 18.7 49.7 3.6 4.0 3.5 2.9 3.3 4.8 24.8 1.8 4.1 9.5 2.4 31.2 41.7 13.4 2.6 5.7 3.6 22.5 26.1 10.5 13.0 15.3 25.1 0.5 26.1 5.1 4.8 3.7 7.8 3.5 0.8 2.2 2.7 3.0 15.7 3.0 5.8 9.2 3.7 0.0 15.6 0.0 5.6 1.9 1.2 1.6 0.6 0.0 0.0 6.5 12.4 2.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.1 0.8 9.0 0.2 0.0 0.0 0.4 2.9 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 1.4 0.2 0.1 3.3 1.3 34.8 0.1 3.8 0.2 0.0 4.1 0.0 1.4 0.0 0.0 0.1 3.2 0.0 5.0 0.5 0.0 0.0 0.0 0.7 0.8 0.0 3.3 0.2 2.4 0.3 0.0 4.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 11.2 1.6 8.5 5.9 0.0 0.7 12.4 7.4 0.0 6.5 0.0 0.6 7.9 2.3 35.4 28.1 18.7 47.2 31.2 41.7 22.5 26.1 26.1 3.7 3.0 3.5 10.4 20.3 13.3 53.8 17.5 198.7 12.0 12.5 36.6 0.0 0.0 116.0 15.2 1.1 18.5 0.7 0.0 19.4 0.0 6.6 16.6 22.0 11.5 0.2 54.0 34.4 30.1 0.6 4.7 2.3 2.4 28.7 10.0 18.9 32.2 8.8 0.0 0.4 16.5 22.1 0.0 4.1 2.1 1.1 9.8 0.0 10.1 5.6 9.1 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.1" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 11.3;Cone photoreceptor cells: 11.8;Muller glia cells: 11.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000887 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000887: AB_2666130" "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 2.8 6.4 8.6 1.6 13.0 2.7 3.7 15.3 20.6 5.5 3.4 8.7 2.3 2.1 7.5 5.8 2.9 4.5 3.0 4.9 8.9 12.5 6.3 3.8 2.6 1.5 7.2 12.7 9.9 3.6 9.1 7.1 4.8 21.1 7.2 2.9 3.9 3.6 8.2 4.8 3.4 2.5 7.2 6.3 2.7 2.5 4.4 7.3 1.7 6.6 1.2 2.0 4.1 3.4 0.7 0.3 0.9 0.2 5.3 2.0 0.5 0.5 4.0 13.1 3.9 4.2 2.5 5.3 3.5 4.7 5.8 11.1 3.4 2.4 0.0 3.7 3.9 3.8 2.8 7.2 3.8 6.5 0.0 4.3 1.0 3.3 0.7 6.7 0.7 1.3 4.4 3.4 2.6 0.3 5.3 5.8 0.2 3.0 3.6 5.0 2.2 2.6 0.4 7.6 1.4 3.0 1.4 3.8 0.0 3.8 5.8 5.8 5.5 3.8 1.1 0.4 4.9 3.3 1.8 5.9 1.5 4.0 2.2 3.3 1.9 4.8 0.0 3.6 0.9 2.4 0.9 0.2 0.2 1.0 0.1 0.9 0.4 1.1 2.0 0.1 0.7 1.3 1.7 0.7 5.3 0.1 0.3 1.6 0.5 8.6 13.0 15.3 20.6 8.9 12.5 7.2 12.7 21.1 7.3 6.0 1.0 0.0 1.0 1.5 11.3 7.0 2.5 0.0 1.2 3.5 11.8 3.3 6.6 1.2 0.0 2.1 0.5 0.0 0.7 0.8 2.5 1.7 0.0 1.0 1.1 3.2 4.6 3.7 2.1 0.4 2.6 0.0 0.0 1.0 0.6 11.0 0.2 0.0 2.5 1.7 6.0 6.5 1.0 3.9 6.5 1.0 1.1 0.0 1.1 0.6 C1orf21 PIG13 ENSG00000116667 "Chromosome 1 open reading frame 21" Q9H246 1 184387058-184629020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 238.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5" "Group enriched" "Detected in many" 12 "NK-cells: 7.5;T-cells: 11.4" "Cell line enhanced" "Detected in many" "HDLM-2: 23.3;Karpas-707: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026831 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026831: AB_1845636" "unprognostic (8.27e-2)" "unprognostic (7.45e-2)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (5.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (3.35e-8)" "unprognostic (1.81e-2)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (3.60e-2)" 12.0 15.9 16.8 7.5 9.5 2.1 25.2 17.5 18.8 20.2 18.5 4.4 16.7 8.7 17.3 14.2 14.1 10.1 9.2 20.0 12.5 8.8 4.1 7.5 12.2 3.5 8.3 13.3 13.9 4.7 12.6 7.6 5.7 11.8 17.8 13.1 10.7 5.1 18.9 51.7 30.1 15.8 25.2 7.6 8.2 10.7 4.1 5.4 1.5 4.4 13.6 3.9 22.0 23.5 0.0 0.7 0.2 0.1 7.5 11.4 2.1 0.6 0.1 3.6 0.3 11.4 9.4 6.1 3.2 3.1 2.0 1.8 0.0 0.3 0.0 0.0 3.6 0.7 2.0 2.3 2.6 1.9 23.3 3.7 0.1 1.0 0.0 4.5 2.0 1.0 11.3 7.7 2.3 2.0 8.2 2.4 3.5 0.0 17.7 3.1 2.4 2.3 0.6 5.4 4.8 0.6 3.0 3.8 3.5 0.0 1.2 2.1 5.4 1.6 1.4 6.6 3.4 0.2 0.2 2.3 4.1 2.1 6.2 3.9 11.0 5.1 0.0 4.1 3.3 4.7 0.0 0.1 0.0 11.4 0.0 1.1 0.0 1.9 5.9 0.7 0.0 0.6 5.9 0.2 7.5 0.0 0.2 0.0 2.1 16.8 9.5 17.5 15.9 12.5 8.8 8.3 13.3 11.8 5.4 35.7 88.4 1.5 208.9 135.5 27.4 78.1 28.1 17.4 53.4 1.8 0.0 92.1 6.6 5.0 34.6 101.3 150.2 0.0 16.6 76.1 45.1 118.1 9.3 55.0 34.1 25.4 18.4 81.6 6.3 26.6 70.8 10.1 60.8 32.5 59.7 30.7 19.0 164.9 18.0 5.7 8.7 19.4 53.8 2.3 16.6 127.2 238.0 44.5 61.0 172.9 C1R ENSG00000159403 "Complement C1r" P00736 12 7080209-7092607 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 370.2" "Group enriched" "Detected in many" 5 "Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4" "Low region specificity" "Detected in all" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol "Secreted to blood" NA NA 14000000000 "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 45.8 17.4 2.6 18.1 3.8 0.0 82.0 1.4 2.8 36.7 24.5 2.4 11.2 5.0 27.2 66.8 38.1 33.3 46.7 49.5 1.9 1.8 27.5 370.2 25.3 46.8 3.5 2.0 103.5 11.4 1.4 6.3 10.3 4.6 47.8 15.3 17.7 12.8 13.2 16.0 10.7 14.4 53.2 6.2 35.1 19.8 39.3 1.9 2.3 30.6 20.7 15.1 46.8 83.8 0.4 0.0 2.5 0.4 3.2 3.4 0.8 0.1 1.5 0.1 1.3 181.7 92.7 0.1 20.4 80.0 24.2 49.3 0.2 0.3 0.0 0.6 15.9 1.6 0.3 1.7 0.8 3.4 1.9 0.1 0.0 0.6 0.6 34.9 0.1 0.2 107.4 0.5 11.0 0.8 18.4 0.4 0.1 0.0 2.5 3.1 0.0 0.9 0.1 0.8 0.0 0.1 1.1 0.5 0.1 0.1 0.9 0.0 0.3 14.7 0.4 0.4 0.2 0.0 0.0 0.0 5.8 0.9 26.7 0.1 0.1 0.4 0.0 8.3 0.1 0.8 0.0 0.4 2.0 1.6 0.1 2.0 0.0 1.4 3.4 0.0 0.4 2.8 2.9 2.5 3.2 0.0 0.0 1.4 0.8 2.6 3.8 1.4 2.8 1.9 1.8 3.5 2.0 4.6 1.9 20.8 84.7 28.4 53.6 48.5 0.2 14.6 168.2 6.7 34.2 17.4 2.0 2.9 3.3 164.2 3.5 51.3 0.3 23.3 39.1 4.8 462.9 14.1 9.3 1385.8 10.3 0.0 0.0 128.9 25.4 9.4 1057.9 10.1 50.6 2.8 0.6 15.1 74.1 0.6 364.9 5.0 0.9 168.1 97.8 5.7 4.1 35.0 4.3 13.1 0.7 9.8 C8orf88 ENSG00000253250 "Chromosome 8 open reading frame 88" P0DMB2 8 90958637-90985257 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.2" "Cell type enhanced" "Detected in many" 25 "Early spermatids: 490.5;Late spermatids: 116.9;Spermatocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 28.1" "Low region specificity" "Detected in all" HPA078486 Enhanced NA NA "HPA078486: " "unprognostic (2.17e-1)" "unprognostic (7.00e-2)" "unprognostic (2.51e-2)" "unprognostic (2.95e-4)" "unprognostic (4.07e-2)" "unprognostic (1.19e-1)" "unprognostic (8.44e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.71e-2)" "unprognostic (9.89e-2)" "unprognostic (7.18e-2)" "unprognostic (6.04e-2)" "unprognostic (2.59e-3)" "unprognostic (1.17e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (6.23e-6)" 7.2 2.6 4.7 6.0 5.1 6.0 7.6 1.3 3.0 12.7 15.4 2.1 17.3 1.6 11.8 14.3 11.5 5.9 11.3 28.2 4.0 3.2 4.9 0.8 4.0 2.8 2.8 1.3 10.4 1.2 0.5 3.0 2.2 3.6 15.2 3.8 9.3 1.5 15.6 2.1 3.6 3.8 39.6 4.1 2.0 8.3 55.2 2.5 8.7 12.1 2.2 1.1 25.8 8.0 2.0 5.6 0.1 0.0 7.6 2.7 0.8 0.0 1.1 6.1 0.5 6.6 6.5 0.1 6.8 10.3 9.1 13.6 0.1 1.8 0.1 0.6 6.6 9.8 0.0 0.1 0.4 17.2 0.0 17.8 19.0 5.6 0.0 28.1 0.0 0.6 6.3 0.0 10.4 16.9 12.9 0.8 6.1 11.4 11.0 13.5 0.0 17.4 6.7 1.4 0.0 0.1 0.0 12.4 0.0 6.7 0.0 5.3 9.3 0.3 0.0 8.9 7.3 0.0 0.9 3.8 11.1 18.8 0.1 7.2 15.5 15.2 9.7 10.9 0.0 4.8 0.0 0.0 0.1 1.8 0.0 2.5 1.7 1.6 1.8 0.5 2.0 1.3 2.7 0.0 7.6 0.0 5.6 1.0 0.8 4.7 5.1 1.3 3.0 4.0 3.2 2.8 1.3 3.6 2.5 0.0 0.6 0.5 6.7 16.8 0.0 10.3 2.5 0.0 0.0 3.5 0.0 0.1 5.0 0.6 490.5 5.6 0.0 23.3 0.0 0.7 7.0 3.1 2.3 0.0 0.6 0.0 0.0 6.2 0.6 116.9 17.5 1.5 10.1 1.0 0.0 0.4 2.3 0.0 20.5 1.4 0.0 19.4 13.9 171.9 14.3 23.2 0.0 1.8 0.0 1.0 CAPN12 ENSG00000182472 "Calpain 12" Q6ZSI9 19 38730187-38769904 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Group enriched" "Detected in many" 7 "basophil: 24.5;NK-cell: 12.7" "Group enriched" "Detected in many" 7 "granulocytes: 24.5;NK-cells: 12.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 17.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "hippocampal formation: 3.6" HPA053322 Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA053322: AB_2682111" "unprognostic (1.81e-1)" "unprognostic (4.48e-2)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.45e-2)" "unprognostic (1.29e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (5.90e-6)" "unprognostic (7.04e-2)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (4.59e-2)" 0.6 0.4 0.2 4.7 0.2 0.2 0.7 0.2 0.3 4.2 4.1 0.1 5.6 1.2 1.1 1.0 1.2 3.6 21.0 0.7 1.0 0.4 7.1 21.8 2.0 1.8 0.2 0.1 0.4 5.0 0.2 0.7 0.5 2.4 2.2 0.7 0.4 34.3 3.0 0.3 4.5 1.9 0.5 0.4 4.9 1.6 0.6 0.1 0.4 0.4 1.6 5.2 1.5 1.0 1.7 0.0 24.5 0.0 12.7 2.6 0.7 0.2 1.8 0.1 0.0 0.3 0.1 2.2 0.1 0.0 0.0 0.1 3.2 0.1 0.7 0.1 0.0 0.3 1.3 0.0 0.8 0.0 0.1 0.0 0.3 0.7 0.9 0.0 0.0 17.6 0.8 2.5 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.2 1.9 0.0 0.1 0.0 0.1 0.4 0.1 0.4 0.1 1.4 0.0 0.0 0.1 0.0 0.4 0.9 0.7 0.0 0.1 0.0 0.7 24.5 0.0 1.8 2.6 0.0 2.5 1.5 0.7 1.3 0.0 1.7 0.0 0.6 0.4 12.7 0.0 0.0 0.5 0.7 0.2 0.2 0.2 0.3 1.0 0.4 0.2 0.1 2.4 0.1 11.9 27.1 15.9 8.0 8.4 1.2 0.6 50.9 5.3 5.7 5.2 0.0 1.5 0.0 9.1 0.4 1.8 4.2 0.0 6.3 8.2 1.1 2.3 4.7 12.7 0.9 0.0 3.5 1.3 1.0 0.2 0.6 2.0 3.3 0.0 18.8 1.7 4.0 3.5 0.4 16.5 0.6 0.0 1.7 0.3 2.4 8.3 2.4 25.4 16.4 4.3 CD160 "BY55, NK1, NK28" ENSG00000117281 "CD160 molecule" O95971 1 145719471-145739288 "CD markers, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.9;brain: 15.2;intestine: 19.9;lymphoid tissue: 17.4" "Cell type enriched" "Detected in some" 5 "T-cells: 48.4" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 15.2" "Group enriched" "Detected in many" 9 "gdT-cell: 33.9;MAIT T-cell: 14.4;memory CD8 T-cell: 22.9;naive CD8 T-cell: 27.3;NK-cell: 23.2" "Group enriched" "Detected in many" 11 "NK-cells: 23.2;T-cells: 33.9" "Cell line enhanced" "Detected in many" "HeLa: 4.7" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (6.54e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.33e-1)" "unprognostic (3.40e-2)" "unprognostic (1.35e-1)" "unprognostic (8.25e-3)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.24e-2)" "unprognostic (7.49e-3)" "unprognostic (3.48e-5)" "unprognostic (4.05e-2)" "unprognostic (2.03e-1)" "unprognostic (2.89e-2)" "unprognostic (2.92e-4)" 0.6 0.2 2.2 3.6 2.6 5.1 0.6 15.2 3.1 0.8 9.3 0.4 0.3 5.6 0.8 1.4 0.9 0.6 1.2 0.6 1.6 2.2 0.5 5.9 3.8 6.0 1.6 0.3 1.1 2.2 0.0 0.4 1.8 0.6 1.3 1.0 0.9 3.0 0.4 1.0 1.1 19.9 1.4 1.0 17.4 0.8 0.8 0.3 2.9 0.4 0.3 3.1 0.7 0.3 0.2 0.3 2.7 0.4 23.2 33.9 20.2 1.4 1.0 1.6 0.9 0.0 0.3 0.3 0.1 0.0 0.2 0.1 0.6 0.1 1.7 1.3 0.2 0.1 1.7 0.2 0.2 0.1 3.5 1.7 3.1 4.7 1.3 0.1 2.1 3.2 0.2 0.4 0.1 0.3 0.7 0.0 1.7 0.8 1.5 0.1 1.5 1.2 4.0 1.2 0.8 2.9 0.3 0.2 1.1 0.0 0.6 1.2 1.6 0.9 1.3 0.6 1.2 1.5 2.0 1.8 1.4 0.6 0.8 3.0 2.4 1.6 0.6 0.7 2.4 0.2 2.7 0.1 0.1 33.9 0.1 14.4 0.2 0.4 22.9 0.0 0.2 0.2 27.3 1.7 23.2 0.4 0.3 0.0 20.2 2.2 2.6 15.2 3.1 1.6 2.2 1.6 0.3 0.6 0.3 0.0 0.0 0.0 0.2 0.1 2.1 0.2 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 2.8 0.1 0.5 0.0 0.4 0.0 0.0 0.3 2.3 0.5 0.0 6.4 0.0 1.8 3.1 6.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 2.6 0.0 0.2 0.0 0.1 0.1 0.1 48.4 0.0 0.1 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;parathyroid gland: 82.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 12.8;Kupffer cells: 11.2;monocytes: 21.6;T-cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5" "Group enriched" "Detected in many" 11 "NK-cells: 14.0;T-cells: 19.4" "Group enriched" "Detected in some" 6 "HEL: 45.3;HMC-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 27000000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.2 0.6 1.0 7.5 2.0 1.7 0.8 0.7 0.9 1.5 2.9 0.3 0.1 1.1 1.0 1.4 0.8 0.8 1.4 0.9 1.9 1.3 1.3 3.1 5.2 14.0 1.7 0.0 1.0 0.6 82.5 2.4 0.6 1.3 0.9 1.2 2.4 5.4 0.6 1.1 0.4 6.0 1.3 4.2 31.9 1.4 1.8 0.5 6.4 1.8 2.6 10.1 2.0 1.6 0.4 1.5 0.9 0.6 14.0 19.4 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 2.4 0.0 45.3 0.1 0.0 0.0 0.3 20.2 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 4.7 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.1 5.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.5 19.4 0.4 7.3 0.4 16.1 11.8 1.5 0.1 9.0 9.7 0.9 14.0 0.6 0.1 5.5 6.6 1.0 2.0 0.7 0.9 1.9 1.3 1.7 0.0 1.3 0.5 3.0 5.1 0.8 0.3 0.0 2.4 1.6 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 6.6 0.1 0.0 0.0 0.3 0.0 0.4 0.2 12.8 0.5 1.4 0.0 0.0 2.5 11.2 7.5 0.9 7.8 0.0 21.6 0.0 1.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 0.3 0.5 0.4 0.0 25.4 0.0 0.1 CDK20 "CCRK, p42" ENSG00000156345 "Cyclin dependent kinase 20" Q8IZL9 9 87966441-87974753 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 25.4;Spermatocytes: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.2" "Group enriched" "Detected in many" 7 "NK-cells: 7.2;T-cells: 5.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.4;THP-1: 21.7" "Low region specificity" "Detected in all" "HPA007666, HPA027379, HPA027401" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA007666: AB_10600002, HPA027379: AB_10599939, HPA027401: AB_10601553" "unprognostic (4.60e-2)" "unprognostic (6.48e-2)" "unprognostic (1.69e-2)" "prognostic favorable (2.59e-4)" "unprognostic (2.32e-1)" "unprognostic (4.33e-3)" "unprognostic (2.81e-4)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "unprognostic (2.83e-3)" "unprognostic (4.04e-2)" "prognostic favorable (2.12e-5)" "unprognostic (8.24e-3)" "unprognostic (5.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.42e-2)" 2.6 16.2 10.8 2.4 13.0 1.6 4.1 8.7 17.1 8.7 5.0 6.1 5.1 5.3 7.2 6.0 2.8 19.5 5.6 3.0 8.6 10.7 8.2 3.2 4.0 2.0 5.8 14.3 9.5 4.8 7.6 10.8 3.1 9.3 6.1 3.4 7.7 3.6 8.6 2.1 3.6 7.6 5.5 3.1 1.6 3.7 17.7 5.2 0.8 6.8 1.2 1.1 6.3 3.0 0.1 0.8 0.4 0.8 7.2 5.0 1.3 2.4 3.0 2.4 7.6 1.7 2.4 1.0 2.2 4.2 5.9 5.5 0.7 3.6 0.0 3.3 3.6 10.3 3.1 0.0 2.1 2.4 5.9 2.5 0.0 1.9 0.0 7.4 2.8 3.4 1.9 4.4 9.3 3.8 4.6 0.0 5.3 0.3 0.0 1.7 7.1 1.9 0.8 1.9 5.3 1.1 0.0 0.0 0.1 7.4 2.0 14.4 4.1 2.5 3.0 3.6 0.8 3.3 21.7 0.0 2.6 1.0 0.5 2.4 3.8 3.6 0.0 9.3 1.9 2.8 0.0 0.7 0.4 1.3 0.8 0.5 0.0 3.0 1.9 0.7 0.1 5.0 3.2 0.1 7.2 0.7 0.8 2.7 1.3 10.8 13.0 8.7 17.1 8.6 10.7 5.8 14.3 9.3 5.2 3.0 4.1 0.0 1.5 1.9 5.2 2.0 2.5 25.4 5.7 1.8 2.0 3.6 1.7 4.2 4.7 0.5 5.4 0.0 1.3 1.9 3.3 2.5 1.1 0.9 0.9 7.9 0.0 0.6 0.0 1.7 4.0 1.1 0.0 0.0 2.0 4.8 1.5 0.0 6.3 5.3 13.5 6.5 2.3 25.0 2.9 1.9 3.3 0.5 2.9 0.7 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.4;Late spermatids: 214.6;Spermatocytes: 140.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0" "Group enriched" "Detected in many" 8 "B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favorable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavorable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 5.5 8.3 11.0 5.7 15.8 3.5 9.0 14.7 15.6 20.8 12.2 7.1 22.8 35.7 14.0 14.8 10.2 20.3 8.9 11.3 10.9 15.9 17.0 18.8 11.5 4.2 12.6 10.2 14.4 17.4 16.6 27.8 2.7 14.4 14.3 12.1 12.6 6.1 28.7 10.6 4.6 11.5 14.0 19.1 3.9 8.6 41.5 15.3 24.2 26.2 6.7 4.5 13.3 9.1 2.9 0.2 0.5 0.1 3.6 6.4 2.0 21.6 4.5 10.7 13.0 6.7 7.5 10.0 4.3 8.1 6.0 8.9 6.3 11.8 5.1 10.3 8.0 22.8 9.6 9.7 8.6 13.5 9.0 6.4 14.6 10.5 8.2 10.5 0.7 5.4 40.3 5.0 4.5 11.2 16.0 8.6 16.8 10.6 17.1 9.8 8.2 15.3 0.8 6.3 5.7 10.2 16.9 13.9 13.1 11.4 9.7 13.0 8.5 22.5 5.4 25.5 12.8 27.1 7.1 5.0 4.4 8.4 9.0 5.2 15.9 8.7 17.4 9.8 1.4 15.0 0.4 0.1 0.2 4.2 0.1 5.0 2.9 3.4 3.7 0.1 2.0 5.9 6.4 0.5 3.6 0.0 0.2 2.0 2.0 11.0 15.8 14.7 15.6 10.9 15.9 12.6 10.2 14.4 15.3 29.8 54.7 0.8 31.2 8.7 15.6 23.2 17.8 48.2 38.7 19.2 33.4 5.9 61.3 18.3 163.4 7.1 4.6 0.0 15.5 3.6 6.2 27.5 19.7 12.4 2.2 20.6 15.0 4.9 0.8 214.6 9.2 3.3 10.1 1.0 9.5 19.7 13.7 7.0 12.0 17.0 29.1 6.5 11.8 140.5 9.1 7.0 8.0 4.9 22.3 24.8 CEP78 "C9orf81, FLJ12643" ENSG00000148019 "Centrosomal protein 78" Q5JTW2 9 78236062-78279690 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Cone-rod dystrophy, Deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 51.9;Spermatocytes: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 23.0" "Group enriched" "Detected in many" 5 "NK-cells: 23.0;T-cells: 12.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048846 Approved NA NA "HPA048846: AB_2680537" "unprognostic (4.62e-1)" "unprognostic (6.33e-3)" "unprognostic (2.87e-2)" "unprognostic (1.36e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-2)" "unprognostic (5.13e-4)" "unprognostic (6.75e-2)" "unprognostic (8.48e-3)" "unprognostic (2.10e-1)" "unprognostic (1.38e-2)" "unprognostic (7.03e-2)" "unprognostic (1.25e-2)" "unprognostic (2.27e-3)" "unprognostic (4.93e-1)" "unprognostic (1.18e-3)" "unprognostic (3.34e-1)" 4.2 6.0 9.6 7.1 10.8 16.5 7.5 12.7 9.9 7.3 6.0 10.0 3.2 4.7 9.7 5.8 6.5 6.6 4.2 3.5 9.6 7.2 7.0 6.8 5.5 9.3 10.3 8.7 8.3 5.2 10.2 7.7 6.6 8.2 6.0 7.1 8.1 5.5 6.0 3.2 6.1 5.4 8.1 9.0 8.0 5.5 22.5 10.6 22.2 7.4 3.0 12.2 6.4 6.8 3.2 2.5 0.4 3.0 23.0 12.0 4.9 16.6 8.0 17.5 10.8 3.2 5.5 12.2 13.9 6.0 9.0 10.9 1.4 4.7 14.9 6.9 4.9 12.5 19.6 27.4 8.2 12.9 13.3 8.8 8.0 9.2 5.9 2.8 13.5 7.8 2.9 1.8 9.6 6.5 4.1 12.9 15.9 6.3 12.4 11.4 10.3 16.9 6.5 18.8 18.5 7.5 16.7 21.0 4.4 5.0 7.1 16.4 11.4 18.1 5.5 4.5 14.2 6.8 3.6 6.9 7.6 12.6 14.8 13.1 7.3 9.1 9.8 6.4 9.2 12.4 0.4 0.5 0.4 12.0 2.0 5.8 3.2 5.2 10.7 1.4 2.3 2.6 8.5 0.3 23.0 3.0 2.5 7.7 4.9 9.6 10.8 12.7 9.9 9.6 7.2 10.3 8.7 8.2 10.6 23.8 8.6 9.3 7.9 4.5 24.7 7.9 7.6 30.8 7.9 1.8 104.1 8.4 5.0 7.4 7.7 7.1 1.1 0.0 5.6 17.6 5.6 4.1 4.7 8.3 8.2 3.2 7.5 5.5 3.2 4.9 13.8 6.4 1.7 7.2 5.9 14.5 4.6 5.1 14.2 4.1 51.9 0.0 9.9 70.7 23.2 4.3 3.3 33.0 8.3 4.2 CLSTN3 "CDHR14, CSTN3, KIAA0726" ENSG00000139182 "Calsyntenin 3" Q9BQT9 12 7129698-7158945 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 150.4;Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 50000 "prognostic favorable (5.08e-4)" "unprognostic (2.84e-2)" "unprognostic (1.06e-3)" "unprognostic (1.33e-2)" "unprognostic (6.73e-3)" "unprognostic (6.35e-2)" "unprognostic (9.52e-2)" "unprognostic (2.58e-1)" "unprognostic (2.94e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.19e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (2.19e-2)" "unprognostic (6.14e-2)" "unprognostic (1.91e-1)" "prognostic favorable (8.07e-4)" 11.0 16.2 22.1 14.9 37.1 14.4 6.8 51.4 64.0 5.9 6.0 5.7 1.7 8.1 8.1 4.2 4.9 7.2 12.2 4.1 19.2 33.3 14.1 14.6 7.8 15.4 13.3 31.6 13.2 6.9 14.4 15.0 4.1 37.6 5.8 6.0 7.6 8.1 5.7 1.4 11.1 7.1 8.9 6.0 14.1 6.1 3.5 4.0 6.7 6.5 1.0 11.3 12.0 5.6 0.3 0.2 2.6 0.0 12.4 7.2 1.9 6.6 11.1 3.8 9.2 4.6 6.7 17.2 3.9 9.2 6.8 11.2 16.1 10.5 10.7 2.9 7.7 7.9 8.7 6.9 7.6 4.0 10.8 6.6 17.7 17.4 15.1 6.3 2.7 32.2 20.1 7.6 8.7 10.7 32.6 8.2 10.2 16.5 6.6 1.6 2.0 6.9 2.9 10.9 0.4 0.7 4.6 0.0 3.1 10.4 12.4 5.0 8.2 9.4 2.3 1.5 9.8 4.5 6.4 4.9 4.3 13.0 9.8 2.1 8.1 1.9 1.4 7.6 3.7 2.6 2.6 0.0 0.0 7.2 0.0 4.1 0.3 3.2 6.1 0.2 0.3 1.1 2.5 0.5 12.4 0.0 0.1 3.3 1.9 22.1 37.1 51.4 64.0 19.2 33.3 13.3 31.6 37.6 4.0 0.0 3.8 0.0 2.3 3.7 150.4 1.2 7.6 0.0 1.2 14.0 58.9 4.9 0.0 8.1 0.8 7.7 1.7 0.0 6.4 6.3 4.3 1.9 5.7 23.1 1.0 25.4 28.2 4.3 3.5 0.6 11.8 1.7 5.0 1.0 3.4 9.5 6.3 2.9 6.0 28.2 36.4 6.5 2.5 0.7 1.1 5.0 2.7 13.6 2.8 1.6 CTSW ENSG00000172543 "Cathepsin W" P56202 11 65879809-65883741 "Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.2;bone marrow: 41.4" "Group enriched" "Detected in many" 10 "granulocytes: 70.4;T-cells: 273.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 106.6;MAIT T-cell: 67.7;memory CD8 T-cell: 68.3;naive CD8 T-cell: 51.4;NK-cell: 157.2" "Group enriched" "Detected in many" 48 "NK-cells: 157.2;T-cells: 106.6" "Group enriched" "Detected in some" 23 "HEL: 38.8;NB-4: 88.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" CAB016345 Enhanced "Secreted to blood" NA NA 340000 "CAB016345: AB_626813" "prognostic favorable (3.06e-4)" "unprognostic (2.06e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.36e-6)" "unprognostic (1.21e-1)" "prognostic favorable (9.89e-4)" "unprognostic (5.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (5.14e-3)" "unprognostic (2.83e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (8.84e-6)" "unprognostic (3.86e-2)" "unprognostic (3.78e-1)" "unprognostic (1.26e-1)" "unprognostic (4.01e-3)" 5.2 1.2 0.9 4.9 1.0 41.4 2.3 0.6 0.7 3.9 4.9 0.8 0.5 2.4 8.4 4.0 2.1 2.1 2.5 9.0 0.9 1.0 2.5 6.8 12.7 36.0 1.1 0.6 3.0 1.1 0.0 1.4 10.7 1.4 7.4 2.5 6.3 10.9 1.5 1.9 1.5 5.9 1.7 2.1 33.1 3.3 3.4 0.4 11.1 3.1 1.3 18.2 4.5 2.6 0.4 2.7 2.3 0.3 157.2 106.6 45.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 38.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.2 0.0 0.0 0.4 88.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 2.4 0.0 2.3 0.2 0.3 106.6 0.2 67.7 0.4 11.7 68.3 2.7 0.3 7.0 51.4 2.0 157.2 0.3 1.7 1.6 45.7 0.9 1.0 0.6 0.7 0.9 1.0 1.1 0.6 1.4 0.4 0.0 6.2 3.7 0.4 4.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.2 1.8 0.6 0.0 0.0 0.0 0.1 3.2 0.3 70.4 1.7 1.9 0.0 0.0 5.5 5.3 8.8 0.0 7.3 16.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.8 0.2 0.9 5.5 0.2 273.8 0.0 0.3 CXorf57 "FLJ10178, FLJ14191" ENSG00000147231 "Chromosome X open reading frame 57" Q6NSI4 X 106611930-106679442 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;pituitary gland: 32.3" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 26.8;Intestinal endocrine cells: 14.9;Syncytiotrophoblasts: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 3.5;MAIT T-cell: 2.6;memory B-cell: 3.9;memory CD4 T-cell: 3.0;memory CD8 T-cell: 2.4;naive B-cell: 2.9;naive CD4 T-cell: 3.7;naive CD8 T-cell: 3.0;NK-cell: 2.1;T-reg: 1.1" "Group enriched" "Detected in many" 11 "B-cells: 3.9;NK-cells: 2.1;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HEK 293: 22.6;RT4: 23.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000896, HPA001010, HPA001374" Uncertain Supported "Nuclear speckles" NA No "Nuclear speckles" "HPA000896: AB_1078880, HPA001010: , HPA001374: AB_2666288" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (4.85e-2)" "unprognostic (8.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-1)" "unprognostic (5.49e-2)" "unprognostic (3.81e-3)" "unprognostic (1.17e-1)" "unprognostic (4.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.23e-3)" 1.4 12.0 5.2 2.1 23.0 0.8 2.3 0.9 8.5 2.9 1.3 6.8 1.0 1.8 5.1 3.7 1.3 6.3 1.0 1.5 5.9 25.8 4.2 2.2 3.8 4.8 4.7 5.3 11.3 2.5 0.1 32.3 5.7 6.3 2.3 1.3 2.6 1.1 2.2 2.2 4.0 2.0 1.5 4.5 2.9 4.2 6.0 5.4 1.9 5.2 0.4 3.3 5.9 2.0 3.9 0.2 0.2 0.0 2.1 3.7 1.2 4.2 0.0 4.4 6.1 2.5 2.1 6.6 0.1 0.8 0.0 0.0 0.9 0.9 8.8 0.0 0.5 4.7 1.2 11.2 1.9 0.0 0.0 22.6 2.9 0.0 0.2 0.1 0.0 2.0 1.2 1.3 0.3 0.8 1.2 0.0 7.9 0.1 11.6 1.0 0.0 8.0 0.0 4.0 2.8 0.7 0.0 4.0 0.0 1.9 23.8 7.2 0.0 0.4 0.1 2.5 3.5 1.0 0.1 0.0 1.9 1.6 0.0 2.6 4.2 1.7 10.9 3.4 0.0 3.1 0.0 0.0 0.0 3.5 0.0 2.6 3.9 3.0 2.4 0.0 2.9 3.7 3.0 0.2 2.1 0.0 0.2 1.1 1.2 5.2 23.0 0.9 6.8 5.9 25.8 4.7 5.3 6.3 5.4 8.9 2.6 0.0 0.8 2.3 3.2 0.8 2.5 26.8 7.9 1.8 0.0 10.7 3.3 0.3 1.0 0.0 0.3 0.0 0.5 3.6 0.7 0.2 0.0 1.9 1.1 0.0 14.9 0.0 0.0 0.9 0.6 0.0 5.0 0.0 0.0 2.3 0.3 0.0 0.4 0.8 0.2 6.5 0.6 2.9 11.5 1.4 18.9 2.5 0.1 0.5 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 68.2" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 594.9;Horizontal cells: 511.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: AB_2683621" "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favorable (2.40e-4)" "prognostic unfavorable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 12.3 9.5 22.4 9.3 19.9 22.2 9.2 68.2 38.8 17.5 10.2 39.3 5.1 6.0 9.9 18.0 10.1 18.1 11.4 15.8 23.9 16.7 25.6 33.8 9.0 15.5 30.9 21.7 5.4 24.9 18.2 18.6 10.4 25.4 8.1 7.9 14.2 30.0 11.7 39.7 9.8 9.1 8.4 36.7 18.1 11.4 19.0 27.5 20.5 12.5 7.7 13.5 9.6 9.9 29.3 19.1 0.7 2.1 21.8 10.2 3.4 9.4 8.0 8.8 3.3 12.4 17.0 3.4 6.2 9.5 2.7 5.4 17.6 9.6 12.5 27.6 16.5 16.3 10.9 1.8 4.8 1.3 1.3 3.1 18.6 7.1 12.3 5.3 4.1 0.6 6.1 1.1 4.5 1.3 26.2 0.7 0.4 17.4 2.0 19.5 24.7 4.4 13.2 10.7 10.3 2.2 8.0 18.1 19.1 20.3 6.9 28.2 29.1 2.2 57.1 4.6 20.4 31.2 19.5 3.9 22.2 4.4 10.5 5.5 7.5 15.6 23.6 33.4 1.4 12.2 0.3 2.1 0.1 3.2 0.4 10.2 27.7 0.3 2.3 1.8 29.3 0.2 0.9 0.7 21.8 0.1 19.1 0.4 3.4 22.4 19.9 68.2 38.8 23.9 16.7 30.9 21.7 25.4 27.5 44.7 16.8 79.0 14.3 23.4 189.2 39.2 91.7 25.4 18.2 139.6 23.6 2.7 268.5 104.4 594.9 41.3 10.1 23.3 127.1 18.5 63.9 34.4 20.8 98.7 39.4 511.7 17.9 26.4 25.4 156.4 36.2 34.8 57.3 50.5 49.6 220.2 83.9 5.8 28.7 146.6 42.7 12.9 77.3 5.4 7.8 18.2 31.5 24.5 24.3 15.8 DENND2D "FLJ22457, RP5-1180E21.2" ENSG00000162777 "DENN domain containing 2D" Q9H6A0 1 111187174-111204535 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 51.0;lymphoid tissue: 67.6" "Cell type enhanced" "Detected in many" 8 "T-cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7" "Group enriched" "Detected in all" 6 "NK-cells: 45.1;T-cells: 51.0" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;MOLT-4: 52.9;SK-BR-3: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043630, HPA048642" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043630: AB_2678589, HPA048642: AB_2680474" "unprognostic (1.72e-3)" "prognostic favorable (1.67e-4)" "unprognostic (2.60e-2)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.70e-4)" "unprognostic (5.09e-2)" "unprognostic (8.10e-2)" "unprognostic (1.35e-1)" "unprognostic (4.66e-3)" "unprognostic (3.09e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-2)" "unprognostic (3.80e-3)" "unprognostic (5.45e-2)" "unprognostic (2.75e-2)" "prognostic favorable (8.66e-5)" 8.9 11.1 0.9 42.9 2.6 3.5 6.5 0.8 1.6 4.9 10.4 1.4 4.9 6.4 2.4 5.9 19.5 6.4 9.9 2.5 1.0 1.0 11.4 9.3 11.5 42.0 2.6 0.8 3.0 7.5 8.8 8.0 20.2 1.9 9.2 6.9 3.7 21.1 4.7 1.3 7.9 13.8 1.3 3.2 33.8 9.0 5.1 1.8 39.2 8.0 7.0 67.6 15.7 8.2 8.2 3.2 3.5 3.5 45.1 51.0 29.6 10.4 0.4 0.0 0.0 2.6 1.0 0.1 0.6 0.0 1.1 0.2 3.1 5.1 11.1 3.7 1.6 0.0 3.3 0.0 0.5 1.1 21.0 0.0 3.3 0.7 0.0 3.9 0.0 3.4 3.1 2.3 0.3 0.0 3.5 0.1 4.2 0.0 3.5 0.3 8.9 52.9 0.3 0.0 13.2 1.4 1.3 0.0 16.1 3.7 11.3 3.7 0.0 3.7 34.3 1.2 0.0 10.1 10.5 0.0 0.0 0.0 0.0 0.0 3.2 1.3 8.3 0.0 9.3 0.0 0.8 3.5 2.3 44.8 2.5 38.2 7.2 32.5 45.6 3.2 8.2 51.0 48.4 3.5 45.1 1.8 2.4 13.7 29.6 0.9 2.6 0.8 1.6 1.0 1.0 2.6 0.8 1.9 1.8 6.0 15.6 29.2 15.0 4.4 0.0 0.9 7.6 18.7 18.2 19.2 0.0 1.2 16.6 23.6 26.8 2.9 16.1 0.0 14.1 2.1 4.1 21.1 17.3 4.9 46.9 0.0 5.8 9.2 28.5 38.6 1.1 9.9 6.8 1.0 23.6 0.0 13.8 14.0 0.4 21.0 0.5 0.0 0.7 13.0 0.7 3.4 9.6 105.1 20.4 26.5 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12617731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8" "Group enriched" "Detected in many" 9 "dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5" "Cell line enhanced" "Detected in many" "A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favorable (2.65e-4)" "unprognostic (5.48e-2)" 22.7 4.4 6.3 6.2 8.6 2.5 30.6 4.0 7.9 16.7 16.3 3.4 9.2 13.6 7.6 15.5 19.0 12.2 11.2 16.1 6.8 8.6 12.3 45.6 11.6 8.3 9.0 4.5 11.8 20.3 0.5 8.9 11.5 9.8 16.3 5.6 20.3 11.8 14.3 10.2 5.6 18.9 11.1 9.8 4.2 12.3 5.2 4.2 3.1 40.5 5.4 5.2 21.0 9.4 0.2 8.6 2.1 0.3 13.8 33.5 15.6 4.8 27.6 0.0 12.2 16.0 1.3 3.2 1.6 0.0 0.0 0.1 3.3 56.6 0.0 1.3 16.2 4.9 22.3 6.0 3.1 0.0 0.0 9.9 4.3 2.8 15.4 2.4 0.0 0.0 8.1 3.7 0.0 0.1 55.9 5.2 0.1 6.5 0.0 0.1 0.8 1.1 0.2 1.8 5.2 11.2 0.1 0.0 5.6 0.0 9.5 0.3 0.5 9.3 30.4 1.7 3.9 2.9 1.2 3.8 0.1 0.6 8.5 0.1 0.8 0.0 0.0 6.4 0.3 52.5 2.1 0.2 0.0 33.5 0.1 24.2 0.2 18.3 15.7 8.6 0.2 31.6 19.7 1.7 13.8 0.3 1.0 0.5 15.6 6.3 8.6 4.0 7.9 6.8 8.6 9.0 4.5 9.8 4.2 89.3 49.3 3.7 141.7 22.8 0.8 31.9 38.2 58.9 55.7 19.2 17.7 22.8 19.9 81.6 86.2 36.5 70.9 23.3 142.3 39.4 26.7 66.3 15.1 157.8 60.3 0.0 24.1 62.0 40.2 235.9 21.0 19.3 6.8 17.2 30.8 13.7 112.0 49.1 9.2 39.4 2.0 0.0 30.1 1.4 1.4 23.6 22.0 22.3 29.9 124.6 DLG3 "KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102" ENSG00000082458 "Discs large MAGUK scaffold protein 3" Q92796 X 70444861-70505490 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 2.4" "Cell line enhanced" "Detected in many" "OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001733, HPA078130" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA001733: AB_1078675, HPA078130: AB_2686879" "prognostic unfavorable (1.69e-4)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (2.77e-1)" "unprognostic (4.65e-2)" "unprognostic (3.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.20e-2)" "unprognostic (7.79e-2)" "unprognostic (7.92e-2)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" "prognostic favorable (1.72e-10)" "unprognostic (3.36e-2)" "unprognostic (5.45e-2)" "unprognostic (1.51e-2)" "unprognostic (1.97e-3)" 2.7 3.3 12.5 6.5 17.6 0.7 10.8 16.4 25.2 9.2 16.0 4.3 14.7 11.7 7.6 23.7 14.5 17.4 16.3 6.0 15.2 10.0 10.8 1.4 7.8 3.1 6.5 10.2 11.2 27.1 21.2 8.9 5.5 8.0 9.6 17.1 10.2 21.0 10.4 1.1 8.4 20.8 11.3 3.4 14.6 13.8 1.9 3.5 3.2 13.8 2.6 8.0 11.2 9.9 0.4 0.0 0.0 0.0 1.7 2.4 0.3 3.4 1.6 9.9 4.2 2.6 3.1 6.9 2.0 2.3 1.1 1.1 9.8 8.1 0.0 4.8 2.0 0.8 7.5 19.2 4.5 0.7 4.0 5.8 0.0 8.8 5.3 5.0 0.1 1.3 3.2 3.0 1.4 3.2 10.2 0.4 6.6 1.8 13.8 1.1 12.1 7.8 0.0 16.7 28.0 11.6 7.3 4.9 1.4 6.7 10.6 4.7 0.3 1.6 19.2 3.7 8.6 10.1 0.0 0.7 1.3 1.3 1.2 1.5 9.1 6.8 4.3 1.9 0.0 1.9 0.0 0.0 0.0 2.1 0.0 1.8 0.4 1.7 2.4 0.0 0.0 1.1 1.8 0.0 1.7 0.0 0.0 2.4 0.3 12.5 17.6 16.4 25.2 15.2 10.0 6.5 10.2 8.0 3.5 17.9 16.1 3.2 4.8 0.7 15.6 16.7 25.5 32.1 12.5 8.7 0.0 5.5 10.0 11.9 0.0 0.3 27.4 0.0 21.3 2.0 5.0 15.9 1.1 0.0 0.6 4.8 24.6 1.8 0.3 0.0 1.4 1.3 1.7 2.8 22.3 10.3 21.5 17.3 6.0 3.7 5.8 6.5 5.1 0.4 1.7 1.8 1.4 3.8 17.2 9.0 DOCK9 "KIAA1058, ZIZ1" ENSG00000088387 "Dedicator of cytokinesis 9" Q9BZ29 13 98793429-99086625 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 47.1;Endothelial cells: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 2.4;MAIT T-cell: 5.7;memory CD4 T-cell: 6.3;memory CD8 T-cell: 2.6;naive CD4 T-cell: 7.6;naive CD8 T-cell: 4.7;NK-cell: 8.5;T-reg: 2.7" "Group enriched" "Detected in many" 11 "NK-cells: 8.5;T-cells: 7.6" "Cell line enhanced" "Detected in many" "BEWO: 41.6;hTERT-HME1: 92.6;HUVEC TERT2: 37.4;TIME: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034061, CAB034065, HPA043940" Uncertain NA NA "CAB034061: AB_2277513, CAB034065: AB_2094798, HPA043940: AB_2678741" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (8.76e-2)" "unprognostic (4.24e-2)" "unprognostic (1.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.62e-2)" "unprognostic (2.96e-1)" "unprognostic (2.47e-1)" "unprognostic (1.16e-1)" "unprognostic (6.38e-3)" "unprognostic (2.79e-1)" "unprognostic (7.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.36e-2)" "unprognostic (3.31e-2)" 48.8 8.7 24.7 10.1 42.0 2.9 26.4 20.0 33.4 17.2 15.1 54.5 10.5 8.0 13.7 19.3 41.7 15.5 18.5 19.3 29.1 19.9 12.0 8.0 37.1 15.7 40.9 18.2 13.1 10.5 20.8 8.8 49.1 40.5 12.2 11.0 17.7 20.1 12.3 10.2 38.5 12.8 19.0 34.0 8.2 9.7 7.9 43.5 2.2 31.9 13.1 19.8 14.3 23.2 0.7 0.0 0.1 0.0 8.5 7.6 1.8 12.5 4.0 2.2 3.0 2.3 1.8 41.6 3.5 2.9 2.5 2.3 25.9 9.8 10.7 8.4 3.4 4.6 12.5 5.7 11.3 4.6 10.5 3.1 0.0 7.7 0.4 3.0 0.0 0.6 2.0 7.9 2.6 92.6 5.9 37.4 6.9 2.1 2.4 10.9 4.1 7.2 0.0 1.0 17.2 2.9 0.4 8.2 0.5 8.1 10.4 5.0 5.6 5.4 13.6 3.3 19.0 3.7 0.0 36.8 2.2 2.4 1.4 5.7 3.7 2.9 1.7 3.5 0.0 3.3 0.0 0.0 0.0 2.4 0.0 5.7 0.7 6.3 2.6 0.0 0.4 7.6 4.7 0.1 8.5 0.0 0.0 2.7 1.8 24.7 42.0 20.0 33.4 29.1 19.9 40.9 18.2 40.5 43.5 14.9 26.6 0.8 6.3 13.6 38.8 9.3 10.2 1.4 6.8 8.7 47.1 29.6 1.7 4.7 1.5 62.5 8.4 0.0 5.8 8.1 8.7 7.6 2.3 7.2 4.1 23.8 6.4 30.1 1.8 2.3 7.2 1.4 1.7 0.0 6.8 11.0 9.9 5.8 13.8 3.9 24.8 0.0 9.5 7.2 4.4 28.0 14.4 4.5 4.6 9.7 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 35.4" "Cell type enhanced" "Detected in many" 9 "granulocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;HaCaT: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 7.4 4.7 6.0 7.1 11.2 23.2 8.2 5.9 11.1 5.7 10.8 21.1 0.3 2.1 4.9 2.7 7.0 8.5 7.6 3.8 7.2 4.0 2.8 35.4 8.0 9.0 14.0 5.6 2.8 18.3 1.8 2.5 4.5 8.4 3.6 4.9 8.5 9.5 1.7 21.0 8.0 6.2 9.7 10.1 6.4 4.5 3.9 14.1 5.6 5.3 10.6 8.6 8.5 4.1 0.8 5.4 4.6 4.2 15.1 12.7 1.6 6.1 2.6 0.2 0.2 19.2 9.9 0.2 4.1 10.8 6.9 5.3 0.1 1.7 4.8 1.4 10.7 5.0 42.3 0.9 4.0 6.0 12.3 0.5 8.2 1.2 0.7 4.5 3.6 5.6 13.8 2.9 7.4 7.5 3.2 0.2 1.2 0.8 1.7 6.5 0.1 0.7 2.8 0.6 1.3 0.3 0.4 11.7 0.3 2.3 3.7 15.8 1.2 0.5 0.5 17.5 2.5 0.9 2.1 1.5 3.5 0.9 5.3 5.1 2.9 2.0 2.6 5.4 1.6 3.6 4.6 4.2 0.2 3.6 3.7 3.3 0.7 2.5 2.5 5.4 0.8 0.8 1.5 0.3 15.1 1.4 0.2 12.7 1.6 6.0 11.2 5.9 11.1 7.2 4.0 14.0 5.6 8.4 14.1 0.0 1.7 1.9 12.6 45.2 4.5 3.3 10.2 8.1 6.8 3.5 19.6 2.2 0.0 27.3 29.1 6.3 1.0 0.0 7.8 2.7 8.3 10.9 135.7 50.4 22.0 1.6 42.1 1.8 11.0 2.7 23.0 23.9 21.9 13.6 9.9 13.5 21.9 0.0 12.0 0.7 32.3 0.0 5.1 3.8 2.0 36.1 2.9 29.9 2.2 14.4 ELOVL6 "FLJ23378, LCE, MGC5487" ENSG00000170522 "ELOVL fatty acid elongase 6" Q9H5J4 4 110045846-110199199 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.9" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 35.3;Hepatocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6" "Group enriched" "Detected in many" 20 "NK-cells: 5.6;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042355 Uncertain NA NA "HPA042355: AB_10796577" "unprognostic (3.92e-2)" "unprognostic (9.47e-2)" "prognostic favorable (6.74e-4)" "unprognostic (8.09e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-3)" "unprognostic (4.16e-1)" "unprognostic (3.01e-3)" "unprognostic (4.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.33e-1)" "unprognostic (1.90e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (5.32e-2)" 7.6 9.8 7.7 7.9 9.4 3.7 7.9 10.9 12.3 4.0 14.5 8.6 0.9 11.8 3.4 2.7 16.6 2.9 11.1 8.1 6.6 5.9 6.4 43.9 3.3 2.2 7.5 9.4 2.0 2.5 10.6 7.1 2.6 15.7 3.0 14.1 4.3 6.9 3.2 1.4 12.3 10.2 5.7 20.0 1.9 16.9 1.3 7.3 1.1 2.3 7.9 4.0 6.0 5.0 0.1 0.0 0.2 0.1 5.6 4.9 0.8 13.4 8.0 29.3 7.3 19.7 20.7 15.0 9.4 4.6 3.3 7.4 3.9 23.7 1.1 0.8 7.2 11.3 12.6 22.2 27.5 7.7 4.6 6.4 15.2 8.7 10.2 12.2 14.8 9.9 18.0 6.4 16.8 8.0 10.9 6.5 1.6 18.1 31.5 7.3 7.1 3.4 1.5 13.4 8.2 4.8 2.3 11.5 3.9 21.4 10.1 5.2 11.2 4.8 32.0 4.1 13.9 5.4 0.1 2.4 6.7 7.9 11.2 11.4 1.5 4.9 24.9 10.2 0.0 1.7 0.2 0.1 0.1 4.8 0.0 4.9 0.1 2.1 3.2 0.0 0.1 0.7 2.3 0.2 5.6 0.0 0.0 0.2 0.8 7.7 9.4 10.9 12.3 6.6 5.9 7.5 9.4 15.7 7.3 0.0 5.6 0.0 2.3 1.5 22.3 2.4 7.6 1.4 6.8 10.4 35.3 1.2 5.0 6.1 3.7 1.1 16.0 0.0 7.3 21.6 3.9 2.4 5.8 43.3 1.6 25.4 2.9 4.3 2.7 2.7 1.1 0.7 0.0 0.0 12.4 4.4 12.1 24.6 1.1 5.6 15.9 6.5 3.8 0.2 1.2 6.0 1.7 12.8 12.4 4.4 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815012-127854756 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 336.5;Ito cells: 724.3;Leydig cells: 451.1;Peritubular cells: 1336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.6;HUVEC TERT2: 68.4;TIME: 139.4;U-138 MG: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" NA NA 260000000 "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favorable (6.61e-4)" "prognostic favorable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 40.3 19.3 6.4 26.6 10.5 5.5 52.7 3.9 8.6 26.3 14.0 7.6 18.5 11.2 27.0 25.2 17.2 23.2 28.3 105.4 8.0 5.0 40.8 26.8 66.7 44.1 10.6 7.0 66.4 9.6 8.6 12.5 60.2 10.1 23.1 6.4 35.5 9.9 51.7 24.1 10.1 14.5 23.1 8.7 52.4 11.6 37.2 7.7 6.7 35.4 19.3 11.0 20.3 44.8 1.1 6.4 0.3 17.7 4.6 2.3 4.6 0.1 0.1 1.0 0.0 17.2 11.8 30.3 19.9 14.3 10.6 6.2 0.0 0.1 0.1 9.7 36.6 8.0 0.3 0.0 3.2 3.5 0.0 0.0 5.6 11.3 0.6 13.3 2.6 0.0 20.1 0.7 13.8 5.0 0.1 68.4 0.1 0.0 0.1 12.4 0.1 0.0 0.2 0.2 0.0 0.5 8.8 1.7 0.1 0.0 0.0 0.1 0.2 10.5 9.2 2.7 0.7 1.8 4.0 139.4 34.9 1.9 22.7 0.0 0.7 0.1 0.1 9.4 7.0 11.4 0.0 12.2 0.3 1.3 17.7 0.4 0.4 2.1 2.3 6.4 1.1 1.3 2.0 0.3 4.6 13.0 2.4 0.8 4.6 6.4 10.5 3.9 8.6 8.0 5.0 10.6 7.0 10.1 7.7 3.0 23.1 25.1 2.3 10.6 2.5 16.5 22.9 8.1 3.4 3.5 3.9 24.4 0.0 8.3 7.0 336.5 0.0 23.3 1.0 249.8 36.6 1.4 15.0 5.1 119.5 0.0 2.4 724.3 66.8 29.3 451.1 50.7 23.6 46.9 1.1 3.1 2.0 0.0 1336.5 0.0 4.1 71.1 20.8 3.7 4.9 7.3 314.8 5.7 0.2 1.1 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.9;brain: 22.6;lymphoid tissue: 21.4" "Group enriched" "Detected in some" 8 "Erythroid cells: 23.3;T-cells: 32.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 20 "cerebellum: 22.6" "Group enriched" "Detected in many" 7 "gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9" "Group enriched" "Detected in many" 102 "NK-cells: 17.9;T-cells: 16.5" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7" "Region enriched" "Detected in some" 8 "olfactory region: 95.2" "Group enriched" "Detected in many" 13 "cerebellum: 44.2;olfactory region: 21.9" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.4 0.7 0.5 6.8 0.4 1.6 1.6 22.6 0.4 1.8 0.8 0.0 0.0 0.3 3.2 0.9 1.4 0.6 5.0 0.7 0.4 0.7 1.0 4.9 10.1 15.6 0.5 0.3 1.3 0.9 0.0 0.6 1.6 1.1 2.1 0.9 3.3 2.2 0.1 0.4 0.4 1.8 0.7 0.9 21.4 1.4 0.5 0.0 1.8 1.1 0.9 11.2 3.3 0.8 0.0 0.0 0.1 0.0 17.9 16.5 1.4 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 2.6 2.0 0.0 10.2 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.1 1.2 0.0 1.4 0.5 0.0 12.3 0.3 0.0 0.0 3.0 2.7 0.0 0.3 0.2 1.2 1.9 0.0 0.0 1.0 0.0 5.7 0.0 0.0 0.0 1.2 0.5 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 10.0 0.0 16.5 0.0 1.9 12.0 0.0 0.0 0.1 7.5 0.1 17.9 0.0 0.0 0.0 1.4 0.5 0.4 22.6 0.4 0.4 0.7 0.5 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 3.7 3.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 32.6 0.0 0.0 EPHA4 "Hek8, TYRO1" ENSG00000116106 "EPH receptor A4" P54764 2 221418027-221574202 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 25.0;Pancreatic endocrine cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 35.8;ASC diff: 15.8;CACO-2: 26.2;U-2197: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB028368 Enhanced NA NA 8400000 "CAB028368: AB_2099353" "unprognostic (1.28e-1)" "unprognostic (5.87e-2)" "unprognostic (2.28e-1)" "unprognostic (2.46e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (7.05e-4)" "unprognostic (1.80e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (1.12e-1)" "unprognostic (2.85e-2)" "prognostic favorable (5.67e-4)" "unprognostic (3.12e-2)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (8.66e-2)" 7.1 1.8 8.1 1.9 18.3 3.5 5.2 14.7 29.6 4.9 5.9 3.1 3.2 1.1 6.5 3.1 5.0 6.6 3.3 16.7 19.9 4.4 5.2 0.9 3.7 2.5 2.4 16.4 11.7 1.2 2.0 1.2 1.7 4.9 5.9 4.7 0.8 3.7 6.7 3.1 12.8 4.1 8.2 2.1 3.3 4.0 11.4 2.6 0.5 9.8 3.7 3.2 4.6 4.9 2.5 0.2 3.0 0.0 6.0 5.0 0.7 1.1 1.1 35.8 0.0 15.8 9.8 0.0 8.5 3.7 7.7 2.8 26.2 0.4 0.0 0.0 11.8 0.0 3.1 5.5 0.0 3.2 4.2 3.0 0.0 0.3 0.0 0.4 0.0 0.6 3.9 1.9 2.4 0.0 4.8 7.2 0.0 0.0 0.0 2.0 4.2 0.1 0.0 2.5 2.6 0.8 0.0 3.9 0.0 12.0 1.9 6.3 0.0 2.8 0.6 0.6 3.0 1.3 0.0 0.0 0.8 1.5 17.5 0.4 0.0 0.0 0.0 3.2 0.0 1.6 3.0 0.0 0.0 3.4 0.0 3.4 2.5 5.0 3.3 0.0 1.8 1.9 0.3 0.2 6.0 0.0 0.2 2.1 0.7 8.1 18.3 14.7 29.6 19.9 4.4 2.4 16.4 4.9 2.6 0.0 5.4 0.8 0.4 5.5 10.2 25.0 7.6 1.4 3.4 8.7 0.0 0.0 6.6 0.2 2.0 11.7 0.1 0.0 0.2 0.0 3.9 1.2 1.1 0.0 0.3 1.6 3.4 12.3 0.0 4.3 1.1 0.2 6.8 0.0 14.0 6.3 18.0 0.0 8.1 1.5 2.7 0.0 7.2 6.7 1.3 10.9 0.0 1.0 6.8 1.8 EPM2A "LD, LDE" ENSG00000112425 "EPM2A, laforin glucan phosphatase" O95278 6 145382535-145736023 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation, Epilepsy, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 20.3" "Low region specificity" "Detected in all" "HPA053643, HPA055468" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053643: AB_2797247, HPA055468: AB_2797252" "unprognostic (2.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.34e-3)" "unprognostic (2.92e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (1.52e-4)" "unprognostic (2.28e-1)" "prognostic favorable (4.08e-7)" "unprognostic (4.12e-4)" "unprognostic (2.17e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" 5.4 6.0 8.8 1.9 9.0 2.2 3.6 4.0 8.9 3.9 11.1 8.6 2.5 3.4 4.8 4.8 8.9 4.3 3.9 19.4 9.6 8.7 8.0 5.7 3.5 3.4 11.9 5.5 5.9 2.9 5.5 3.3 2.0 9.6 6.2 3.4 5.6 3.1 9.2 60.9 2.4 3.3 13.9 13.6 2.5 4.6 3.3 7.1 3.7 4.2 15.7 2.9 10.4 6.0 1.4 1.0 0.3 1.4 5.4 2.4 1.0 1.1 1.7 3.3 6.3 8.2 2.5 1.4 3.0 3.5 2.8 3.4 1.5 1.7 20.3 2.5 3.5 3.4 1.8 1.2 1.3 2.5 7.9 1.7 3.3 2.4 2.5 5.0 11.3 2.0 2.1 6.8 1.7 0.6 3.7 2.0 4.8 1.4 5.2 3.5 2.6 7.5 2.4 3.4 3.0 1.7 4.3 3.0 5.9 2.5 1.7 6.1 6.1 5.3 3.2 7.0 3.1 1.8 6.5 4.3 2.8 1.4 2.6 2.3 3.8 3.8 8.2 2.4 2.7 4.4 0.0 0.1 0.1 0.4 1.4 1.1 1.3 1.1 0.9 1.0 1.4 1.2 2.4 0.3 5.4 0.3 0.9 0.2 1.0 8.8 9.0 4.0 8.9 9.6 8.7 11.9 5.5 9.6 7.1 6.0 1.0 3.2 0.8 0.8 7.9 23.5 5.1 2.7 3.4 1.8 5.9 0.7 10.0 0.9 28.2 1.5 0.3 0.0 2.0 0.6 1.2 1.3 2.3 5.8 2.0 28.6 1.2 1.3 1.5 14.1 2.8 3.1 6.8 0.0 1.5 7.5 1.1 1.1 2.1 6.3 6.7 0.0 2.0 1.6 1.3 0.4 0.3 0.0 1.0 0.3 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 45.5;pituitary gland: 30.8" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 7.5;Ciliated cells: 12.0;Club cells: 9.1;Early spermatids: 3.9;Late spermatids: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "NK-cell: 9.8" "Lineage enriched" "Detected in many" 4 "NK-cells: 9.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;RH-30: 13.0;SH-SY5Y: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028917 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA028917: AB_2672826" "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 1.0 1.1 2.8 0.6 16.8 0.5 0.6 0.2 6.8 4.0 0.6 1.9 0.0 0.7 0.6 2.2 1.0 2.5 0.8 4.6 2.8 2.2 0.6 0.5 1.0 0.6 2.9 2.8 0.8 0.6 45.5 30.8 0.6 4.2 12.4 0.7 15.3 1.2 4.6 3.2 0.6 0.7 3.9 0.4 0.7 0.9 1.3 5.1 4.4 0.9 2.9 0.6 3.5 5.7 0.8 1.9 1.8 2.3 9.8 2.3 0.2 0.1 0.0 3.8 16.8 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 1.2 0.0 0.9 0.0 13.0 5.5 0.0 0.0 1.3 31.6 0.0 0.0 1.0 3.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.2 1.8 0.3 0.6 0.9 0.9 1.9 0.8 0.7 1.9 0.7 0.8 1.3 1.4 1.6 9.8 2.3 1.9 2.3 0.2 2.8 16.8 0.2 2.8 2.8 2.2 2.9 2.8 4.2 5.1 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 12.0 9.1 0.0 0.0 0.6 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 1.0 0.1 0.5 0.0 0.0 0.0 FCRL6 "FcRH6, FLJ16056, IFGP6" ENSG00000181036 "Fc receptor like 6" Q6DN72 1 159800511-159816251 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.4;lymphoid tissue: 15.5" "Cell type enriched" "Detected in some" 37 "T-cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 39.4;memory CD8 T-cell: 36.0;naive CD8 T-cell: 29.2;NK-cell: 13.2" "Group enriched" "Detected in many" 27 "NK-cells: 13.2;T-cells: 39.4" "Cell line enhanced" "Detected in some" "HSkMC: 2.4;hTCEpi: 2.6;Karpas-707: 1.8;U-937: 1.7" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-3)" "unprognostic (1.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.62e-3)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.79e-3)" "unprognostic (6.65e-3)" "unprognostic (2.76e-2)" "unprognostic (3.91e-1)" "unprognostic (1.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.52e-5)" "unprognostic (3.98e-1)" "unprognostic (1.13e-1)" "unprognostic (8.78e-2)" "unprognostic (9.18e-2)" 2.2 1.5 0.6 7.0 0.6 6.8 1.6 1.1 0.8 1.3 0.7 0.7 0.0 0.8 4.6 2.4 0.8 1.2 7.2 3.6 0.6 0.6 1.5 4.0 7.5 9.0 0.7 2.4 1.4 0.9 0.0 0.9 1.3 1.0 3.2 0.3 2.7 2.8 0.1 1.1 0.9 2.5 0.7 1.8 15.5 1.1 1.2 0.0 3.2 1.3 1.2 3.4 2.0 1.0 0.0 0.9 0.3 0.3 13.2 39.4 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.4 0.0 0.0 2.4 2.6 0.0 0.5 0.0 0.1 0.3 0.0 1.8 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.3 0.0 0.5 0.2 0.0 0.2 1.7 0.9 0.0 0.0 0.0 39.4 0.0 0.8 0.0 7.3 36.0 0.9 0.0 3.3 29.2 0.3 13.2 0.3 0.0 0.0 11.1 0.6 0.6 1.1 0.8 0.6 0.6 0.7 2.4 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 FZD6 Hfz6 ENSG00000164930 "Frizzled class receptor 6" O60353 8 103298433-103332866 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 41.7;Suprabasal keratinocytes: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017991 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA017991: AB_1849138" "unprognostic (8.22e-3)" "unprognostic (2.64e-1)" "unprognostic (4.75e-2)" "unprognostic (2.57e-1)" "unprognostic (1.22e-2)" "unprognostic (6.99e-2)" "unprognostic (4.01e-2)" "unprognostic (2.74e-1)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.20e-6)" "unprognostic (3.62e-2)" "unprognostic (1.83e-1)" "unprognostic (2.86e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (7.54e-2)" 13.1 9.2 3.4 5.2 3.8 0.5 13.3 4.3 5.9 12.1 10.7 3.5 8.6 4.0 12.0 16.4 17.9 17.8 12.3 9.6 3.7 3.8 17.4 5.8 17.1 4.7 4.2 2.9 11.6 14.4 21.3 27.2 14.1 10.0 12.4 4.9 11.6 15.3 8.8 4.3 16.9 7.7 12.7 4.2 6.1 8.0 7.2 1.5 10.9 21.2 18.7 14.7 15.9 11.3 1.7 1.0 0.2 0.0 7.9 2.2 0.5 19.6 4.0 9.5 0.0 2.2 7.0 5.9 10.5 11.5 9.3 6.1 2.1 15.1 0.0 17.9 9.2 2.9 29.1 5.3 21.7 16.6 4.4 6.5 10.4 4.6 2.6 31.3 0.0 0.0 7.9 41.8 9.9 30.6 22.2 19.1 2.2 1.0 8.6 10.0 8.1 9.2 0.8 2.2 1.4 6.9 0.7 4.5 0.0 19.0 12.4 3.3 2.7 14.6 7.7 19.0 5.3 0.0 3.5 1.5 2.2 11.0 8.4 10.6 2.2 1.1 4.2 6.1 0.0 13.5 0.0 0.0 0.2 0.6 0.0 0.0 0.9 2.1 0.9 1.0 1.7 2.2 1.0 0.0 7.9 0.0 0.2 0.6 0.5 3.4 3.8 4.3 5.9 3.7 3.8 4.2 2.9 10.0 1.5 23.8 16.1 0.8 13.5 41.7 3.7 4.7 7.6 26.8 25.0 12.2 2.0 17.8 0.0 10.9 7.8 28.9 3.2 0.0 7.2 6.6 6.9 11.0 0.0 3.2 2.1 6.4 5.1 11.1 0.6 2.1 1.1 1.7 13.5 1.0 6.9 15.5 8.1 3.5 1.4 8.2 4.4 0.0 4.1 7.2 0.7 39.0 12.2 2.5 5.2 19.2 GAB1 ENSG00000109458 "GRB2 associated binding protein 1" Q13480 4 143336762-143474568 "Predicted intracellular proteins, RAS pathway related proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 38.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034333, HPA066404" Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB034333: AB_2107855, HPA066404: " "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (1.79e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-1)" "unprognostic (1.35e-2)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.20e-1)" "prognostic favorable (3.91e-5)" "unprognostic (4.99e-2)" "unprognostic (2.70e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" 9.2 8.4 15.0 7.3 33.3 8.8 9.7 5.8 22.0 10.1 17.0 64.0 10.2 10.4 17.7 13.1 18.2 8.6 11.1 26.2 19.5 11.4 12.9 7.9 15.6 5.0 35.7 19.0 18.1 7.0 17.2 6.3 18.0 30.5 7.8 20.3 15.4 11.7 13.9 11.2 11.1 10.4 15.9 32.3 6.2 11.0 7.9 41.7 1.0 7.8 6.0 7.3 9.9 11.9 3.1 3.4 5.9 2.3 7.4 0.4 0.4 3.4 0.7 8.9 6.4 4.5 4.3 11.6 2.4 8.0 2.9 5.1 6.6 5.9 0.1 0.7 3.3 2.0 1.9 8.5 2.8 3.3 0.5 2.0 6.2 1.9 3.1 3.1 0.8 1.2 5.3 5.0 3.5 2.3 6.2 3.8 0.1 2.0 11.5 2.0 4.9 0.5 0.0 2.5 1.8 2.8 38.0 4.3 4.4 4.5 4.2 2.1 6.3 1.6 7.0 3.0 6.2 4.5 0.8 2.8 3.7 2.9 1.7 1.8 18.5 9.0 13.7 2.5 2.5 3.0 5.9 0.6 0.7 0.0 0.8 0.4 1.3 0.1 0.0 0.8 3.1 0.0 0.0 4.0 7.4 2.3 3.4 0.0 0.4 15.0 33.3 5.8 22.0 19.5 11.4 35.7 19.0 30.5 41.7 26.8 14.7 6.7 7.6 18.0 1.9 27.8 7.6 2.7 5.7 12.2 0.0 18.0 0.0 5.0 0.9 16.5 11.2 0.0 2.2 8.5 11.5 6.2 2.3 5.8 5.3 3.2 21.4 11.6 9.7 2.1 19.2 5.7 15.1 2.8 25.0 14.1 4.1 8.6 17.7 5.0 0.7 12.9 16.5 1.8 5.2 21.8 8.7 1.3 13.5 11.1 GATA3 HDR ENSG00000107485 "GATA binding protein 3" P23771 10 8045378-8075203 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 97.8;skin 1: 61.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 243.8;Extravillous trophoblasts: 651.3;Syncytiotrophoblasts: 949.1" "Group enriched" "Detected in many" 24 "breast cancer: 190.0;urothelial cancer: 87.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 42 "gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9" "Group enriched" "Detected in many" 54 "NK-cells: 16.6;T-cells: 18.9" "Cell line enhanced" "Detected in some" "BEWO: 33.3;MCF7: 79.6;RT4: 32.6;SH-SY5Y: 28.0;T-47d: 103.7" "Region enriched" "Detected in single" 6 "midbrain: 7.3" "Group enriched" "Detected in some" 38 "midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0" "CAB016217, HPA029730" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016217: AB_2108591, HPA029730: AB_10601907" "unprognostic (1.70e-1)" "unprognostic (7.23e-2)" "unprognostic (3.58e-2)" "unprognostic (2.00e-1)" "unprognostic (7.03e-3)" "unprognostic (4.68e-3)" "unprognostic (4.23e-2)" "unprognostic (9.65e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (3.83e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (6.31e-2)" "unprognostic (1.82e-3)" 2.0 2.0 0.3 3.4 0.3 0.9 17.8 0.3 0.3 1.8 0.5 0.1 44.4 0.1 0.4 13.5 0.8 0.4 0.4 0.9 0.3 0.4 12.9 0.7 1.6 2.7 0.8 0.0 0.3 0.4 55.0 3.8 53.4 1.4 8.1 0.0 1.8 8.9 97.8 0.8 61.7 1.2 3.4 0.4 2.7 0.5 0.8 0.1 42.4 3.3 0.6 3.4 26.9 16.4 0.2 0.0 0.3 0.0 16.6 18.9 3.0 5.5 1.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 2.0 5.0 0.0 0.0 0.0 0.0 4.9 0.5 0.1 0.0 16.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.3 0.1 2.6 7.8 0.0 0.0 0.0 79.6 8.7 0.0 0.6 1.0 0.7 0.4 0.4 0.1 0.0 32.6 1.6 28.0 0.0 4.5 0.0 6.1 103.7 0.0 0.0 0.4 1.0 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 9.7 0.0 13.3 0.2 18.2 14.1 0.0 0.0 10.0 9.0 0.3 16.6 0.0 0.0 18.9 3.0 0.3 0.3 0.3 0.3 0.3 0.4 0.8 0.0 1.4 0.1 0.0 8.9 0.5 60.9 84.1 0.0 1.2 0.0 0.0 1.2 169.3 0.0 243.8 0.0 0.2 0.0 4.9 0.0 0.0 0.3 651.3 6.9 27.0 2.3 0.5 27.7 0.0 0.0 9.8 4.0 0.0 0.0 2.2 8.5 1.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 173.9 949.1 56.1 0.0 68.0 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 102.4;Intestinal endocrine cells: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 7.3 49.2 4.0 9.5 4.8 2.2 5.4 3.7 6.0 2.8 3.3 7.2 17.1 14.0 7.1 3.3 21.5 10.5 12.3 27.1 3.8 11.0 7.6 9.3 9.5 42.0 5.5 12.3 5.8 3.4 11.5 3.1 14.1 3.7 4.2 12.3 5.1 4.4 1.3 7.7 10.5 4.9 7.5 68.1 4.6 3.5 2.5 12.3 9.1 45.4 11.7 5.7 6.2 10.0 6.5 6.1 6.8 5.8 5.9 2.5 8.8 6.4 5.5 5.9 9.1 8.1 6.3 8.8 4.2 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 0.0 3.7 7.8 42.9 30.9 12.8 17.8 25.5 48.2 47.8 0.0 23.6 5.2 10.0 12.8 1.4 13.5 19.9 46.7 11.0 6.5 8.7 44.8 2.3 102.4 19.8 7.9 212.1 9.2 60.1 1.0 6.1 16.4 8.5 6.4 16.3 13.8 17.1 8.5 8.9 19.8 4.0 12.9 10.3 3.3 8.1 21.8 6.5 10.7 13.8 89.1 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 36.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 158.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 11.2" "Cell type enhanced" "Detected in many" "gdT-cell: 5.8;NK-cell: 5.8" "Group enriched" "Detected in many" 23 "NK-cells: 5.8;T-cells: 5.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 0.8 1.2 1.6 4.4 4.2 0.1 4.5 0.3 2.5 6.0 13.5 4.5 8.7 3.6 20.5 6.6 3.0 17.1 15.7 0.8 2.2 2.7 13.8 0.3 4.1 1.3 0.9 1.4 9.5 6.5 22.7 8.6 5.4 11.2 23.5 7.8 36.2 5.2 17.4 0.8 5.9 2.7 5.6 0.7 0.2 5.7 7.0 0.3 1.4 15.0 5.2 2.6 5.1 2.9 0.2 0.0 0.0 0.0 5.8 5.8 0.8 6.0 0.6 3.3 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 5.1 19.6 0.0 6.5 0.0 2.7 20.7 9.9 0.1 0.0 0.0 9.4 0.0 2.6 0.2 0.9 0.0 11.4 0.1 0.3 0.0 0.0 0.0 0.0 3.0 9.9 0.0 0.0 5.8 1.6 1.1 1.8 47.6 7.2 0.0 0.0 0.5 5.6 4.3 14.0 5.2 4.4 5.6 0.0 0.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 5.8 0.0 2.3 0.0 1.3 2.3 0.0 0.2 1.6 2.6 0.0 5.8 0.0 0.0 0.0 0.8 1.6 4.2 0.3 2.5 2.2 2.7 0.9 1.4 11.2 0.3 0.0 2.6 0.0 4.2 1.9 6.1 1.0 2.5 8.1 3.4 0.0 39.3 0.2 0.0 2.0 1.7 0.6 9.7 0.0 2.1 0.9 1.5 7.6 0.0 0.0 0.2 4.8 8.6 0.0 0.0 4.9 1.1 0.0 5.0 0.0 5.8 8.1 1.7 8.2 0.7 8.1 158.9 0.0 1.9 2.3 4.2 0.6 0.1 1.3 10.7 2.6 GMPR ENSG00000137198 "Guanosine monophosphate reductase" P36959 6 16238580-16295549 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 103.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 72.9;Erythroid cells: 186.9;Glandular cells: 74.5;Melanocytes: 87.7;Peritubular cells: 76.0" "Cancer enhanced" "Detected in all" "melanoma: 95.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.8;NK-cell: 8.3" "Group enriched" "Detected in many" 5 "granulocytes: 7.8;monocytes: 4.2;NK-cells: 8.3" "Cell line enhanced" "Detected in many" "HEL: 46.2;HMC-1: 78.9;SK-MEL-30: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA021476" Uncertain NA NA 3800000 "HPA000904: AB_1078998, HPA021476: AB_1849858" "unprognostic (2.74e-1)" "unprognostic (1.05e-1)" "unprognostic (2.14e-1)" "unprognostic (4.97e-3)" "unprognostic (3.52e-2)" "unprognostic (1.05e-1)" "unprognostic (3.06e-1)" "prognostic favorable (8.07e-4)" "unprognostic (4.12e-1)" "prognostic favorable (2.06e-4)" "unprognostic (3.15e-1)" "unprognostic (2.86e-1)" "prognostic favorable (2.94e-5)" "unprognostic (3.01e-1)" "unprognostic (1.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.17e-1)" 2.8 7.3 14.6 1.4 11.0 9.6 6.5 3.8 6.9 2.7 3.7 9.1 2.0 1.5 4.2 7.9 2.5 22.4 1.9 31.5 13.3 11.5 10.3 2.7 3.7 2.5 14.0 5.7 15.7 7.4 4.4 6.8 3.4 21.3 25.5 1.8 22.0 5.2 4.2 103.3 4.3 1.5 4.3 11.8 3.3 8.3 25.1 10.9 1.4 2.7 16.2 1.5 2.0 1.2 0.7 1.3 7.8 4.2 8.3 1.0 14.1 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.9 3.8 6.8 13.9 0.3 0.1 0.0 2.2 1.4 4.8 0.0 1.6 0.2 1.1 0.0 1.2 46.2 0.0 0.0 3.0 0.2 78.9 0.9 0.7 2.1 0.0 5.6 12.2 0.1 10.3 0.0 1.2 0.9 0.0 0.9 0.4 0.0 1.8 0.0 10.4 0.0 9.0 1.3 2.3 0.3 0.4 0.8 17.6 3.1 0.7 0.3 3.0 0.1 0.0 0.3 1.8 0.5 0.0 0.0 0.2 4.9 5.3 7.8 2.9 0.4 0.6 4.2 1.0 0.2 0.1 0.4 1.3 0.7 0.0 0.2 3.0 8.3 1.3 1.2 0.0 14.1 14.6 11.0 3.8 6.9 13.3 11.5 14.0 5.7 21.3 10.9 0.0 0.0 0.5 29.7 4.5 0.9 50.8 22.9 8.1 2.3 19.2 0.0 23.1 72.9 10.6 10.2 5.8 0.8 186.9 4.4 2.8 6.1 74.5 56.3 2.9 8.0 0.0 7.5 11.1 2.2 8.5 31.9 4.3 87.7 10.8 2.3 7.3 3.2 0.3 76.0 10.4 0.4 0.0 8.5 4.7 17.0 1.6 5.7 1.3 2.5 5.8 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 89.7;Club cells: 84.2;Collecting duct cells: 38.4;Extravillous trophoblasts: 38.4;Syncytiotrophoblasts: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 39.4;CAPAN-2: 26.5;fHDF/TERT166: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.4 1.2 1.0 4.8 21.7 7.5 6.5 22.5 39.4 10.7 14.6 1.0 26.5 0.0 9.7 25.2 0.2 5.5 0.3 9.1 11.4 1.8 1.6 1.0 2.5 1.3 5.1 0.0 0.7 12.6 4.1 9.8 3.3 13.5 0.0 0.0 0.0 0.0 18.5 2.2 0.0 0.3 1.1 4.9 1.5 0.4 6.4 5.0 14.4 23.8 0.4 0.0 4.1 2.3 7.0 5.1 8.1 1.3 1.9 2.1 0.7 3.9 4.2 1.4 1.1 0.0 0.4 0.0 6.4 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 14.9 17.1 0.0 0.0 0.0 0.0 0.0 0.0 89.7 84.2 38.4 0.0 23.4 19.9 13.1 0.0 0.0 0.0 0.0 7.5 38.4 0.0 0.0 3.5 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.8 0.0 0.0 18.5 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 HAVCR2 "CD366, FLJ14428, Tim-3, TIM3, TIMD3" ENSG00000135077 "Hepatitis A virus cellular receptor 2" Q8TDQ0 5 157085832-157142869 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.6" "Cell type enhanced" "Detected in many" 12 "granulocytes: 80.6;Hofbauer cells: 135.6;Kupffer cells: 75.1;Macrophages: 74.2;monocytes: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.2;intermediate monocyte: 14.5;myeloid DC: 34.6;NK-cell: 24.1;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 6 "dendritic cells: 34.6;monocytes: 14.5;NK-cells: 24.1" "Cell line enhanced" "Detected in some" "ASC diff: 5.9;Daudi: 3.9;HDLM-2: 17.4;HMC-1: 4.3;RPMI-8226: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB026003 Enhanced NA NA 2900000 "CAB026003: " "unprognostic (2.50e-2)" "unprognostic (1.11e-2)" "unprognostic (5.18e-2)" "unprognostic (2.04e-3)" "unprognostic (3.79e-2)" "unprognostic (1.14e-1)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (8.48e-2)" "unprognostic (5.13e-2)" "unprognostic (7.83e-2)" "unprognostic (1.89e-1)" "unprognostic (1.83e-2)" "unprognostic (2.13e-1)" "unprognostic (1.34e-1)" 16.8 8.6 9.3 16.0 12.3 10.3 6.5 8.4 10.7 5.1 5.3 15.5 1.8 4.1 3.9 5.9 4.2 5.3 11.4 4.8 9.8 9.3 23.3 8.9 19.8 21.7 15.5 7.5 4.4 3.8 2.4 5.5 14.3 11.3 4.2 6.5 4.1 6.2 3.1 3.3 3.1 6.0 7.2 24.8 23.1 4.2 5.8 12.1 4.7 3.8 2.9 11.1 10.3 2.9 0.3 34.6 3.1 14.5 24.1 3.8 9.7 0.0 0.1 0.1 0.1 5.9 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 3.9 0.3 0.0 0.1 0.1 0.0 0.0 0.0 17.4 0.0 0.8 0.0 0.0 0.0 0.0 4.3 0.2 0.3 0.0 0.1 0.0 0.0 0.4 0.1 2.1 0.0 0.0 0.1 2.8 0.2 0.0 0.0 0.1 2.2 14.2 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.1 0.2 0.0 0.7 0.3 0.2 0.0 0.3 1.2 0.2 0.1 0.4 0.1 3.1 13.2 0.0 3.8 14.5 0.8 0.3 1.6 2.0 34.6 0.1 2.0 2.9 0.7 24.1 8.6 4.1 3.1 9.7 9.3 12.3 8.4 10.7 9.8 9.3 15.5 7.5 11.3 12.1 6.0 9.2 10.3 0.1 0.9 1.0 0.8 0.0 0.0 3.4 0.0 0.0 0.6 6.6 0.0 10.7 0.9 0.0 0.0 0.0 0.7 1.3 0.5 80.6 0.0 135.6 0.0 0.0 1.3 75.1 6.0 0.3 74.2 3.3 60.5 0.0 0.1 0.1 0.0 0.0 38.9 0.0 6.5 0.7 0.2 0.5 1.1 0.9 28.7 0.1 0.4 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.8;skin 1: 154.6" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 696.8;Alveolar cells type 2: 414.3;Basal keratinocytes: 368.4;Suprabasal keratinocytes: 329.7;Syncytiotrophoblasts: 269.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 68.6;NK-cell: 90.9" "Group enriched" "Detected in many" 14 "NK-cells: 90.9;T-cells: 68.6" "Cell line enhanced" "Detected in some" "HDLM-2: 13.4;HUVEC TERT2: 29.7;RT4: 22.1;TIME: 33.6;U-266/70: 11.7" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 1.7 5.0 24.1 5.2 13.0 2.0 23.1 4.0 28.2 26.4 3.1 3.6 3.0 3.4 2.5 106.2 90.3 2.3 6.7 5.7 20.0 8.2 2.3 0.7 112.4 3.4 12.1 12.9 1.4 1.1 2.3 1.2 128.8 15.0 4.5 1.6 1.0 19.0 12.9 3.4 154.6 3.4 20.9 11.2 2.3 3.2 9.6 1.9 1.8 65.9 93.2 66.3 6.8 37.8 5.6 0.4 1.5 0.5 90.9 68.6 38.2 0.0 0.0 0.0 0.0 2.3 7.3 2.6 0.0 0.0 0.6 0.4 0.0 0.0 5.4 0.3 0.1 1.0 1.0 0.6 0.0 0.8 13.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 5.4 1.6 0.0 1.5 29.7 0.0 0.0 0.2 1.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.1 0.0 22.1 0.4 0.2 0.0 0.0 0.0 2.1 0.0 0.0 33.6 0.0 0.1 0.2 0.0 11.7 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.2 68.6 0.4 37.4 5.6 17.1 30.1 0.3 4.3 3.1 21.0 1.5 90.9 0.5 0.4 1.0 38.2 24.1 13.0 4.0 28.2 20.0 8.2 12.1 12.9 15.0 1.9 696.8 414.3 13.2 36.1 368.4 1.6 11.3 0.0 20.1 221.8 1.8 0.0 1.7 1.7 0.0 27.8 9.0 0.5 0.0 0.2 4.7 21.3 17.3 9.3 0.8 3.5 0.0 8.1 5.5 16.3 34.5 2.8 8.0 33.7 62.3 1.9 104.0 2.3 0.0 2.8 0.2 4.3 32.3 77.3 2.6 10.4 329.7 269.1 177.7 0.3 25.7 HOXA1 "HOX1, HOX1F" ENSG00000105991 "Homeobox A1" P49639 7 27092993-27095996 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 12.9" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 2.1;granulocytes: 2.3;Intestinal endocrine cells: 2.9;Ito cells: 3.1;Kupffer cells: 1.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "pons and medulla: 5.0" "Group enriched" "Detected in many" 5 "intermediate monocyte: 6.0;NK-cell: 6.8;non-classical monocyte: 8.7" "Group enriched" "Detected in many" 6 "monocytes: 8.7;NK-cells: 6.8" "Cell line enhanced" "Detected in many" "HMC-1: 12.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" "Group enriched" "Detected in some" 5 "midbrain: 1.3;pons and medulla: 1.9" NA NA "unprognostic (7.39e-2)" "unprognostic (1.26e-3)" "unprognostic (1.05e-1)" "unprognostic (2.17e-4)" "unprognostic (2.79e-2)" "prognostic unfavorable (6.73e-5)" "unprognostic (4.70e-2)" "unprognostic (2.72e-2)" "unprognostic (6.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-4)" "unprognostic (2.03e-1)" "unprognostic (2.82e-1)" "unprognostic (5.77e-3)" "unprognostic (1.17e-1)" 1.5 1.2 0.2 3.7 0.4 0.4 2.9 0.2 0.3 1.1 1.9 0.4 0.0 0.4 1.2 3.6 8.2 2.2 2.9 0.9 0.2 0.2 2.9 0.5 0.8 2.1 0.4 0.0 3.8 0.4 3.2 0.3 0.9 5.0 3.7 1.9 0.3 0.3 5.3 0.7 4.1 3.0 2.6 4.9 8.0 1.2 0.8 0.0 3.1 0.4 1.3 5.2 12.9 10.6 0.4 1.2 1.0 8.7 6.8 1.3 0.6 5.4 2.4 0.2 3.1 0.0 0.0 5.0 0.7 3.2 2.1 2.5 12.2 3.5 3.8 7.3 1.9 7.8 11.9 4.3 3.5 1.5 0.3 12.6 4.9 0.2 0.1 0.6 4.1 12.8 2.3 3.5 2.5 5.1 0.0 3.1 3.9 5.3 0.0 4.2 0.1 0.0 6.7 0.0 2.2 0.5 4.7 1.4 0.0 7.0 5.3 0.4 0.0 2.7 0.0 3.3 4.3 0.0 1.9 2.3 0.5 5.0 3.7 0.9 0.0 0.0 1.7 1.9 7.3 5.2 1.0 0.3 0.6 1.2 6.0 1.2 0.4 1.3 1.2 1.2 0.0 0.6 1.2 0.3 6.8 8.7 0.0 1.2 0.6 0.2 0.4 0.2 0.3 0.2 0.2 0.4 0.0 5.0 0.0 0.0 0.0 0.0 1.2 2.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.2 0.2 2.3 0.0 0.1 0.0 2.9 3.1 1.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.1 1.0 0.0 1.0 0.9 1.1 HOXA9 "HOX1, HOX1G" ENSG00000078399 "Homeobox A9" P31269 7 27162435-27175180 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7" "Cell line enhanced" "Detected in some" "HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5" "HPA061982, HPA076200" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061982: AB_2684651, HPA076200: " "unprognostic (4.72e-1)" "unprognostic (1.23e-2)" "unprognostic (2.86e-1)" "unprognostic (5.24e-3)" "unprognostic (2.36e-1)" "unprognostic (2.02e-1)" "unprognostic (8.35e-2)" "unprognostic (8.44e-3)" "unprognostic (5.50e-2)" "unprognostic (5.71e-2)" "unprognostic (9.87e-3)" "unprognostic (4.42e-2)" "unprognostic (2.80e-3)" "unprognostic (6.45e-2)" "unprognostic (7.58e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" 3.2 3.4 0.2 8.8 0.1 2.4 8.7 0.1 0.2 15.5 12.8 0.2 4.1 0.0 10.4 16.8 1.4 12.2 0.3 0.1 0.1 0.0 35.1 0.1 0.8 0.7 0.1 0.1 2.0 0.1 0.0 0.1 1.4 0.4 16.6 4.5 0.2 0.5 5.6 21.0 13.3 8.2 13.1 0.7 1.0 0.0 2.4 0.1 2.6 0.3 0.3 0.3 16.2 11.4 0.5 6.0 5.4 1.0 11.7 1.5 0.5 12.7 0.0 0.0 6.4 2.1 1.6 0.0 5.1 4.1 0.4 0.4 0.8 0.5 0.1 0.5 2.7 0.0 11.9 8.2 0.0 0.4 0.0 43.6 0.1 0.3 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 15.2 2.7 0.0 0.0 15.0 0.2 40.5 0.0 5.4 0.0 0.1 0.2 0.0 10.7 0.4 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.0 14.5 0.0 5.4 1.0 0.0 1.5 0.2 0.2 0.2 0.0 0.1 6.0 0.5 0.3 0.1 0.9 11.7 0.4 1.9 0.2 0.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 10.6 22.2 0.0 0.6 0.0 0.0 0.0 17.4 0.0 0.3 46.4 0.0 0.0 0.2 7.9 0.0 0.0 0.3 10.8 14.2 0.0 0.0 0.3 0.0 37.7 0.0 4.8 0.0 0.0 1.6 5.0 0.0 19.1 0.0 0.0 18.4 0.0 60.8 0.0 0.0 3.6 0.0 0.6 24.1 0.2 4.4 19.4 11.5 IFNL1 "IL-29, IL29" ENSG00000182393 "Interferon lambda 1" Q8IU54 19 39296325-39298673 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.1" "Cell type enriched" "Detected in single" 24 "T-cells: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "gdT-cell: 4.4;MAIT T-cell: 4.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 4.1;myeloid DC: 3.3;naive CD8 T-cell: 2.3;NK-cell: 6.1" "Group enriched" "Detected in many" 46 "dendritic cells: 3.3;NK-cells: 6.1;T-cells: 4.4" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;GAMG: 2.5;SK-MEL-30: 1.0;U-266/84: 1.9" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 97000 "unprognostic (3.08e-2)" "unprognostic (8.74e-2)" "unprognostic (2.46e-4)" "unprognostic (5.76e-2)" "unprognostic (6.91e-3)" "unprognostic (5.73e-3)" "unprognostic (3.94e-2)" "unprognostic (4.80e-2)" "unprognostic (2.96e-5)" "unprognostic (7.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" 0.1 0.0 0.1 0.9 0.1 0.6 0.1 0.1 0.1 0.3 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.2 0.3 0.9 0.4 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.5 0.3 0.1 0.1 1.6 0.1 0.6 0.1 1.8 1.6 0.1 0.1 0.1 0.1 0.0 3.3 0.0 0.0 6.1 4.4 0.9 0.0 0.9 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.9 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.8 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 4.4 0.0 2.1 4.1 3.3 0.0 0.2 2.3 0.0 6.1 0.0 0.0 0.3 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.0 IGFBP4 "BP-4, HT29-IGFBP, IBP4, IGFBP-4" ENSG00000141753 "Insulin like growth factor binding protein 4" P22692 17 40443461-40457731 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 370.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 472.5;Ito cells: 497.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.6;NK-cell: 20.5" "Group enriched" "Detected in many" 5 "NK-cells: 20.5;T-cells: 12.6" "Cell line enhanced" "Detected in many" "A549: 111.6;ASC diff: 84.3;ASC TERT1: 82.6;BJ: 89.6;BJ hTERT+: 92.2;HSkMC: 175.6;U-2197: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066240 Supported "Secreted to blood" NA NA 227000000 500000000 "HPA066240: AB_2685643" "unprognostic (1.03e-3)" "unprognostic (1.61e-1)" "unprognostic (1.85e-1)" "prognostic favorable (3.54e-4)" "unprognostic (7.44e-3)" "unprognostic (1.00e-1)" "prognostic favorable (5.49e-4)" "unprognostic (4.55e-2)" "unprognostic (1.19e-2)" "unprognostic (2.28e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (2.36e-1)" "unprognostic (3.81e-2)" 79.7 23.3 2.5 36.8 5.2 0.0 198.7 1.8 3.1 115.0 57.1 3.2 41.1 9.9 88.8 126.5 67.7 67.4 117.5 119.1 2.2 1.8 72.3 255.6 88.2 101.4 3.7 2.3 370.8 21.5 6.5 19.4 99.8 5.1 66.7 17.0 46.2 24.4 38.6 36.3 22.3 36.8 80.4 6.4 68.1 38.7 53.2 2.3 4.2 81.0 50.4 22.5 89.9 123.9 3.6 0.1 0.0 0.0 20.5 12.6 0.9 0.0 111.6 5.7 0.0 84.3 82.6 0.1 89.6 92.2 17.1 13.4 4.9 1.4 0.0 48.6 42.6 2.3 0.9 1.9 0.5 7.8 0.3 0.1 0.3 8.1 7.3 52.9 0.2 0.0 175.6 0.4 22.9 3.2 2.0 29.7 0.0 1.7 0.0 24.6 3.3 0.0 20.6 3.1 4.8 15.1 5.5 0.1 0.1 0.7 3.5 1.5 4.5 40.4 0.1 1.3 5.7 41.3 2.0 44.7 23.9 1.2 75.4 0.0 0.0 0.0 0.1 14.2 0.8 6.1 0.0 0.0 0.0 1.8 0.0 12.6 0.4 3.3 4.4 0.0 3.6 0.2 0.4 0.0 20.5 0.0 0.1 0.0 0.9 2.5 5.2 1.8 3.1 2.2 1.8 3.7 2.3 5.1 2.3 8.9 44.4 38.9 76.3 50.0 1.2 15.1 99.3 8.1 12.5 7.0 0.0 4.9 14.9 3.0 5.5 236.2 69.3 0.0 2.2 4.7 103.0 15.8 2.3 472.5 206.0 1.6 8.1 497.8 43.5 7.0 228.1 14.8 69.2 5.4 77.9 3.8 23.2 69.1 111.4 154.4 1.0 187.5 232.9 2.3 6.4 41.8 6.3 14.4 110.8 67.4 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67396900 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;pancreas: 15.0" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 2.9;Hofbauer cells: 2.9;Melanocytes: 1.7;T-cells: 6.4" "Cancer enhanced" "Detected in many" "melanoma: 5.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 18.2" "Group enriched" "Detected in many" 42 "NK-cells: 18.2;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;SCLC-21H: 8.9;SK-MEL-30: 22.4;THP-1: 13.0" "Region enhanced" "Detected in single" "olfactory region: 1.8" "Low region specificity" "Detected in all" HPA024168 Uncertain Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 3.8 1.0 1.8 3.1 3.6 1.5 3.7 0.6 7.7 2.4 1.0 0.0 0.0 0.7 0.8 1.1 3.2 0.9 1.1 5.2 9.6 1.1 1.5 1.4 1.8 4.3 1.0 6.0 0.8 15.0 0.9 0.8 14.1 1.6 1.2 0.9 1.3 7.2 1.7 11.4 2.1 1.4 1.0 1.0 2.5 1.0 2.3 0.0 1.1 1.1 3.2 1.6 1.4 1.2 0.0 0.0 0.2 0.0 18.2 6.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 2.1 1.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.4 0.0 0.0 22.4 0.0 0.0 13.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 2.7 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 3.9 1.0 1.8 3.6 0.6 7.7 9.6 1.1 1.0 6.0 1.6 0.0 0.0 2.9 0.0 0.2 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.4 0.0 0.1 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell type enriched" "Detected in many" 5 "granulocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Yes No Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.9 0.3 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.5 0.0 1.9 0.0 13.8 0.8 2.5 0.6 0.1 29.8 5.2 20.0 6.8 1.1 2.2 3.6 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.7 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.4 2.4 0.4 0.0 0.0 0.0 0.1 32.0 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 0.0 13.3 0.0 1.0 0.7 0.0 1.5 0.0 5.3 3.4 1.8 0.0 0.0 1.7 0.8 0.0 7.1 0.0 0.0 0.5 0.7 2.2 0.8 104.4 6.2 0.1 0.0 0.0 13.5 3.1 0.0 0.3 19.4 3.3 0.0 0.0 0.3 0.7 0.0 0.0 0.8 0.0 6.5 0.9 0.2 0.4 0.9 0.0 22.4 0.0 0.7 IL18RAP "AcPL, CD218b" ENSG00000115607 "Interleukin 18 receptor accessory protein" O95256 2 102418689-102452565 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6;bone marrow: 50.2;lymphoid tissue: 29.8" "Cell type enriched" "Detected in some" 8 "T-cells: 24.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 34.6" "Group enriched" "Detected in many" 108 "granulocytes: 22.5;NK-cells: 34.6;T-cells: 22.1" "Cell line enriched" "Detected in some" 10 "U-937: 34.8" "Not detected" "Not detected" "Not detected" "Not detected" CAB025270 Enhanced NA NA "CAB025270: " "unprognostic (1.73e-3)" "unprognostic (6.27e-3)" "unprognostic (5.07e-3)" "unprognostic (4.64e-6)" "unprognostic (2.90e-1)" "unprognostic (1.18e-2)" "unprognostic (5.86e-5)" "unprognostic (5.09e-3)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (4.78e-2)" "unprognostic (5.31e-2)" "unprognostic (1.51e-2)" "unprognostic (2.71e-1)" "unprognostic (6.35e-2)" "unprognostic (8.56e-2)" "unprognostic (2.73e-2)" 3.6 0.3 0.2 6.1 0.5 50.2 0.9 0.3 0.4 1.2 4.8 0.5 0.0 1.2 1.2 2.1 0.8 3.8 3.0 2.1 0.2 0.2 0.9 2.6 9.6 16.4 0.9 0.0 1.1 0.4 0.0 0.9 0.8 0.2 0.6 0.9 1.5 0.8 0.3 0.6 0.2 8.1 1.0 1.0 29.8 1.5 1.3 0.0 1.3 0.8 0.9 3.5 2.5 1.3 0.0 0.2 22.5 0.0 34.6 22.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 1.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.2 0.0 0.0 6.1 15.7 0.0 22.1 0.0 2.0 4.2 0.1 0.0 0.0 0.5 22.5 34.6 0.0 0.2 0.1 2.0 0.2 0.5 0.3 0.4 0.2 0.2 0.9 0.0 0.2 0.0 3.0 0.6 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 IL2RB "CD122, IL15RB" ENSG00000100385 "Interleukin 2 receptor subunit beta" P14784 22 37125838-37175054 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5" "Group enriched" "Detected in many" 8 "Extravillous trophoblasts: 80.1;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 14.7;NK-cell: 51.6" "Group enriched" "Detected in many" 32 "NK-cells: 51.6;T-cells: 14.7" "Cell line enriched" "Detected in some" 8 "HDLM-2: 106.6" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Low region specificity" "Detected in single" HPA062657 Enhanced NA NA "HPA062657: AB_2684822" "unprognostic (3.38e-3)" "unprognostic (1.21e-2)" "prognostic favorable (6.76e-4)" "prognostic favorable (3.18e-5)" "unprognostic (2.44e-2)" "unprognostic (9.69e-3)" "unprognostic (2.60e-1)" "unprognostic (5.22e-2)" "unprognostic (1.03e-3)" "unprognostic (5.37e-2)" "unprognostic (1.09e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (4.63e-2)" "unprognostic (7.96e-2)" "unprognostic (3.94e-3)" "unprognostic (2.46e-2)" 2.2 1.0 0.8 20.5 0.8 12.3 1.6 0.6 0.7 1.3 5.5 0.6 1.4 1.8 4.3 2.8 2.6 1.8 5.8 3.7 0.7 0.8 1.9 6.0 7.4 20.8 0.8 0.2 1.5 1.0 0.0 1.1 58.5 0.7 3.5 1.8 2.9 3.7 2.1 0.9 4.0 7.3 0.6 1.1 35.0 2.3 1.1 0.2 21.0 2.1 1.8 28.7 4.0 1.5 0.3 0.0 1.0 0.1 51.6 14.7 7.9 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.1 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 2.8 0.0 0.1 7.7 13.2 0.0 0.1 0.0 0.1 1.0 0.0 0.1 14.7 0.1 8.1 0.1 3.3 8.2 0.0 0.3 1.1 4.3 0.3 51.6 0.1 0.0 6.8 7.9 0.8 0.8 0.6 0.7 0.7 0.8 0.8 0.2 0.7 0.2 3.0 11.6 1.5 0.8 2.9 0.0 1.1 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.2 80.1 1.1 0.1 9.3 1.0 2.1 0.0 0.0 8.6 1.6 0.9 0.3 0.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.0 97.0 0.0 0.0 ITGAM "CD11b, CR3A, MAC-1" ENSG00000169896 "Integrin subunit alpha M" P11215 16 31259990-31332892 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Innate immunity" "Integrin, Receptor" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 93.7" "Cell type enhanced" "Detected in many" 22 "granulocytes: 34.6;Hofbauer cells: 42.4;Kupffer cells: 152.2;Macrophages: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.4;classical monocyte: 19.1;eosinophil: 23.8;gdT-cell: 12.2;intermediate monocyte: 7.6;neutrophil: 21.0;NK-cell: 18.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HMC-1: 33.5;NB-4: 11.8;U-937: 14.3" "HPA002274, CAB025091, CAB072870" Enhanced NA NA 900000 "CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435" "unprognostic (1.82e-2)" "unprognostic (1.70e-2)" "unprognostic (8.78e-2)" "unprognostic (2.54e-2)" "unprognostic (2.40e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.86e-1)" "unprognostic (1.73e-1)" "unprognostic (3.29e-3)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.93e-5)" "unprognostic (9.89e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (3.99e-2)" "unprognostic (5.03e-2)" 19.7 5.0 6.0 14.0 7.2 93.7 6.0 2.0 4.5 2.9 3.2 9.4 0.5 1.8 2.5 3.5 2.2 4.8 4.0 6.5 4.3 3.9 3.0 3.3 14.6 22.8 10.5 1.6 2.5 2.9 1.6 1.8 4.9 5.3 3.6 2.7 3.3 3.2 2.0 1.6 1.5 4.4 6.9 8.6 29.9 2.8 1.5 7.4 2.3 2.1 1.7 6.6 4.9 4.5 1.9 3.4 29.4 19.1 18.8 12.2 8.0 0.5 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.5 0.9 0.6 0.0 0.2 0.1 0.0 0.2 0.0 4.8 0.0 0.6 0.0 0.0 0.0 1.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 14.3 0.0 29.4 19.1 23.8 12.2 7.6 0.7 1.9 1.3 3.6 3.4 0.3 0.3 3.0 21.0 18.8 1.1 0.2 0.5 8.0 6.0 7.2 2.0 4.5 4.3 3.9 10.5 1.6 5.3 7.4 3.0 15.6 5.1 0.1 1.0 0.0 1.5 2.5 0.0 2.3 0.0 0.0 0.3 0.0 1.1 0.3 0.6 0.0 0.0 0.0 0.4 1.0 0.5 34.6 0.8 42.4 0.0 3.5 1.8 152.2 1.5 0.3 53.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.9 0.0 0.4 0.7 0.9 0.7 5.4 0.0 0.1 ITGAX CD11c ENSG00000140678 "Integrin subunit alpha X" P20702 16 31355134-31382997 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 80.7;granulocytes: 70.6;Hofbauer cells: 46.3;Kupffer cells: 28.3;Macrophages: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HMC-1: 49.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004458, HPA004723, CAB072871" Enhanced NA NA "CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231" "unprognostic (9.75e-3)" "unprognostic (2.49e-2)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (1.89e-1)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (9.59e-2)" "unprognostic (8.06e-3)" "unprognostic (3.20e-1)" "unprognostic (7.75e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.82e-1)" "unprognostic (2.95e-2)" 47.9 1.9 4.4 28.1 5.7 28.6 2.9 1.4 4.4 1.8 2.1 17.1 0.6 1.7 2.1 2.5 1.9 4.3 7.7 2.5 5.3 4.6 2.3 4.6 33.2 24.4 13.6 3.8 3.0 2.1 0.8 2.4 3.3 8.1 2.5 3.2 2.5 4.3 1.3 1.1 1.6 3.8 3.3 15.6 46.3 3.3 0.9 7.5 3.8 2.2 0.9 9.7 5.1 1.9 0.8 12.4 31.7 20.3 14.9 1.8 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.0 0.0 0.1 0.1 0.0 0.5 49.2 0.0 0.0 0.8 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.5 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.1 3.9 10.1 9.2 1.8 18.1 0.1 0.8 0.0 0.3 12.4 0.4 0.0 0.2 31.7 14.9 20.3 0.2 0.0 3.2 4.4 5.7 1.4 4.4 5.3 4.6 13.6 3.8 8.1 7.5 11.9 80.7 2.9 0.2 2.5 0.0 1.4 0.0 2.7 19.4 0.0 0.0 0.3 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.2 2.1 0.2 70.6 0.0 46.3 0.0 0.0 0.0 28.3 0.0 0.0 71.4 1.7 2.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.1 1.0 0.3 5.0 0.0 0.0 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 252.4;granulocytes: 190.5;Leydig cells: 310.7;Muller glia cells: 153.0;T-cells: 187.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4" "Group enriched" "Detected in many" 7 "granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0" "Cell line enriched" "Detected in some" 5 "MOLT-4: 191.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favorable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 27.2 4.1 27.0 9.1 37.8 13.6 27.4 7.8 25.8 21.8 11.0 16.1 6.5 5.4 16.4 19.4 14.8 15.3 10.6 42.1 33.6 22.5 7.7 2.2 19.0 28.5 34.8 19.5 69.6 6.3 2.7 9.3 10.6 25.8 16.7 11.9 16.2 28.2 8.8 13.2 10.3 8.8 20.9 33.9 8.4 9.6 8.0 12.5 100.7 31.1 14.1 16.5 14.7 16.6 4.7 1.1 26.5 0.2 25.2 48.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.3 0.0 0.5 0.0 7.8 0.0 0.0 0.0 12.4 14.4 2.3 0.0 0.0 0.0 0.0 0.0 37.7 8.8 0.0 0.0 0.0 191.0 8.6 2.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.2 0.0 0.1 0.0 2.1 0.2 0.2 0.3 0.0 0.2 0.0 0.1 24.1 0.0 0.0 0.0 0.0 0.9 26.5 0.1 16.8 23.2 0.2 17.0 4.6 44.6 36.5 0.1 4.7 48.0 22.6 0.8 25.2 0.2 1.1 32.4 22.6 27.0 37.8 7.8 25.8 33.6 22.5 34.8 19.5 25.8 12.5 3.0 20.8 15.9 13.6 59.9 2.3 25.4 5.1 1.4 7.9 1.8 0.0 0.4 5.0 0.2 2.4 252.4 0.0 0.0 46.7 0.1 64.7 9.2 190.5 0.8 1.0 1.6 2.4 119.7 10.6 4.7 310.7 4.2 59.1 1.0 66.9 153.0 0.9 0.0 110.7 1.1 5.8 0.0 20.2 0.4 1.1 41.0 0.2 187.1 2.3 2.3 JAKMIP2 "JAMIP2, KIAA0555" ENSG00000176049 "Janus kinase and microtubule interacting protein 2" Q96AA8 5 147585439-147782848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0" "Cell type enhanced" "Detected in many" 20 "Bipolar cells: 19.5;granulocytes: 27.8;Horizontal cells: 81.0;Muller glia cells: 21.8" "Cancer enriched" "Detected in some" 6 "glioma: 4.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.9;MAIT T-cell: 6.3;memory CD4 T-cell: 3.5;memory CD8 T-cell: 6.4;naive CD8 T-cell: 5.6;NK-cell: 7.4" "Group enriched" "Detected in many" 6 "NK-cells: 7.4;T-cells: 8.9" "Cell line enhanced" "Detected in many" "AF22: 11.1;Karpas-707: 26.4;RH-30: 26.7;RPMI-8226: 8.5;SCLC-21H: 12.5;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046929, HPA065023" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA046929: AB_2679867, HPA065023: AB_2685407" "unprognostic (3.69e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (3.58e-2)" "unprognostic (1.63e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.21e-4)" "unprognostic (1.28e-1)" "unprognostic (5.20e-8)" "unprognostic (1.54e-3)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 1.3 6.5 12.0 2.5 10.4 1.7 1.1 44.0 35.0 1.8 1.7 8.7 0.0 1.6 2.6 1.4 3.1 1.1 3.2 1.2 12.4 10.0 1.3 5.1 4.2 2.3 11.4 9.0 1.2 2.2 0.9 14.8 1.0 10.2 1.7 1.9 1.0 1.4 1.6 1.0 1.3 1.9 3.4 10.8 2.1 1.9 5.3 16.5 8.7 1.0 0.0 2.3 1.6 0.3 0.8 1.2 0.7 0.2 7.4 8.9 1.6 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.6 3.8 1.1 0.0 0.0 0.2 0.0 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 26.4 0.0 0.0 2.6 0.0 6.3 0.0 0.1 1.0 26.7 8.5 0.0 0.0 12.5 8.7 0.0 0.2 0.0 1.5 0.0 0.0 0.0 2.0 2.3 0.0 0.6 1.8 1.0 2.5 5.0 0.0 0.0 0.0 0.0 0.4 8.9 0.0 6.3 0.8 3.5 6.4 0.2 0.4 0.9 5.6 0.7 7.4 0.2 1.2 1.5 1.6 12.0 10.4 44.0 16.4 12.4 10.0 11.4 9.0 10.2 16.5 0.0 1.0 0.0 0.0 0.0 19.5 0.6 0.0 2.7 2.3 0.0 2.0 0.0 0.0 0.4 8.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 27.8 2.6 1.3 81.0 1.2 0.6 1.6 4.6 0.0 1.1 0.0 0.0 0.3 21.8 0.3 0.0 0.0 0.0 7.9 0.0 0.0 1.5 1.1 0.1 0.2 9.6 0.0 0.0 KDELC1 "EP58, MGC5302" ENSG00000134901 "KDEL motif containing 1" Q6UW63 13 102784281-102799007 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 20.1;Peritubular cells: 10.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.5" "Group enriched" "Detected in many" 4 "NK-cells: 6.5;T-cells: 4.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020780, HPA043946, HPA064398" Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 7400 Nucleoplasm "CAB020780: , HPA043946: AB_2678743, HPA064398: AB_2685256" "unprognostic (1.97e-2)" "unprognostic (2.34e-1)" "unprognostic (3.21e-1)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (6.68e-3)" "prognostic unfavorable (4.81e-4)" "unprognostic (4.34e-3)" "unprognostic (2.75e-2)" "unprognostic (7.26e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.73e-4)" "unprognostic (1.11e-2)" "unprognostic (1.17e-1)" "unprognostic (2.46e-1)" "unprognostic (2.60e-3)" 7.0 4.6 6.7 4.0 8.2 1.9 7.1 14.8 8.6 8.8 5.6 4.5 6.1 1.8 18.8 5.9 4.9 7.0 10.9 8.4 6.1 2.6 10.0 10.1 5.8 2.9 8.4 3.2 9.8 3.2 2.5 10.5 15.8 5.7 6.0 3.9 5.7 3.4 7.1 1.7 3.3 3.5 16.4 6.3 4.7 4.4 2.6 7.1 3.0 5.2 1.9 2.5 9.0 6.2 0.4 1.2 0.0 0.0 6.5 4.5 0.5 3.8 2.8 18.2 17.4 18.7 14.5 4.4 10.3 8.0 9.7 16.8 8.2 5.5 0.0 8.3 8.5 4.9 6.4 12.9 5.3 9.8 1.6 10.8 4.7 8.7 8.8 16.3 11.9 17.1 13.7 6.1 7.3 7.1 14.5 21.0 5.9 7.6 0.0 5.1 4.2 5.3 9.6 11.6 5.5 8.7 0.0 13.0 4.5 26.5 0.3 2.7 16.8 10.2 2.7 5.7 15.8 7.9 5.2 6.4 6.4 4.7 7.2 10.3 3.6 6.6 0.0 12.5 0.0 11.0 0.0 0.0 0.0 2.7 0.0 4.5 0.4 1.5 2.2 1.2 0.0 0.5 1.4 0.0 6.5 0.0 0.0 1.7 0.5 6.7 8.2 14.8 8.6 6.1 2.6 8.4 3.2 5.7 7.1 3.0 0.3 0.0 0.6 1.0 0.6 0.8 2.5 0.0 0.0 0.0 2.0 4.8 0.0 2.1 0.0 3.4 0.0 0.0 0.3 20.1 7.0 0.2 6.9 2.8 2.7 0.0 1.2 6.2 0.6 0.0 4.6 0.2 0.0 0.0 0.3 0.9 0.5 0.0 10.3 1.0 0.7 6.5 3.1 0.0 1.1 0.9 3.1 1.5 0.5 0.1 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 235.9;Ciliated cells: 303.8;Cone photoreceptor cells: 290.6;Rod photoreceptor cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 3.1;T-cells: 8.5" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB022079: , HPA058432: AB_2683717" "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favorable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 3.4 10.1 17.7 3.1 18.5 0.8 5.1 22.1 36.7 8.4 9.2 7.7 2.9 7.1 7.7 4.7 16.0 26.8 5.1 13.4 18.0 28.7 20.9 15.6 4.8 2.2 26.4 18.0 3.2 10.1 17.4 12.3 6.4 41.5 9.3 10.6 5.9 16.4 3.5 8.0 8.5 7.9 7.2 29.2 5.0 9.6 9.5 9.6 0.0 7.1 2.5 4.1 3.6 6.0 0.7 0.0 0.1 0.0 3.1 8.5 1.1 5.9 7.6 10.7 4.5 2.0 1.0 8.6 1.5 0.7 2.0 1.4 13.7 7.4 0.0 4.8 0.6 3.2 5.3 6.1 3.7 1.8 11.7 4.9 0.0 13.4 12.5 1.6 9.9 0.0 0.6 8.2 2.5 12.0 4.6 2.6 2.6 11.2 12.3 1.6 3.5 1.2 0.0 14.4 0.0 6.7 0.0 0.0 6.8 7.6 9.9 14.7 63.8 5.8 9.3 3.5 11.4 10.8 1.2 1.8 1.1 4.7 0.3 4.2 5.6 1.9 0.0 2.8 1.4 0.9 0.0 0.0 0.0 8.4 0.0 4.1 0.7 5.2 8.5 0.0 0.0 1.3 5.9 0.1 3.1 0.0 0.0 2.3 1.1 17.7 18.5 22.1 31.6 18.0 28.7 26.4 18.0 41.5 9.6 35.7 17.4 0.8 18.1 16.5 235.9 106.3 17.8 303.8 69.4 12.2 290.6 12.6 8.3 23.9 92.2 5.8 23.8 0.0 35.7 84.3 10.0 29.0 13.8 39.9 3.5 130.3 23.1 8.0 2.4 60.6 2.8 2.1 13.5 12.6 25.5 106.4 33.2 20.1 2.5 41.7 184.9 0.0 9.8 22.7 7.2 26.8 49.4 20.8 23.4 14.6 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.4 25.1 12.2 7.3 7.4 6.0 9.5 14.5 10.4 14.9 11.5 13.6 6.1 9.3 14.0 10.7 19.2 17.3 12.5 14.0 5.0 14.8 15.8 1.8 19.8 9.2 14.3 4.1 9.9 6.0 18.6 17.4 14.2 9.6 6.9 11.2 9.9 12.5 11.8 28.8 23.2 6.2 12.1 5.9 20.9 8.9 6.3 12.6 11.6 11.5 33.4 16.1 10.6 9.5 17.3 7.1 15.7 2.8 11.3 24.5 21.9 29.6 19.0 13.1 10.9 5.0 17.3 2.8 9.8 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 3.0 1.0 5.6 8.0 7.9 32.1 1.4 0.0 5.3 1.2 12.2 11.8 8.8 11.6 15.0 8.9 4.5 2.9 0.0 7.2 16.4 4.8 12.0 0.0 2.1 2.7 52.4 35.6 4.3 4.6 3.4 8.1 2.8 11.8 10.0 5.8 14.1 13.4 3.6 13.1 9.1 26.5 0.0 16.2 24.4 25.6 8.4 10.6 3.3 3.7 7.1 KLHL23 "FLJ37812, MGC22679, MGC2610" ENSG00000213160 "Kelch like family member 23" Q8NBE8 2 169694488-169776989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 108.6;Cone photoreceptor cells: 84.4;Sertoli cells: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.6" "Group enriched" "Detected in many" 4 "dendritic cells: 2.0;NK-cells: 6.6;T-cells: 2.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047593 Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA047593: " "unprognostic (4.77e-2)" "unprognostic (2.65e-2)" "unprognostic (7.48e-2)" "unprognostic (4.12e-3)" "unprognostic (1.66e-2)" "unprognostic (2.13e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (4.19e-2)" "unprognostic (3.64e-3)" "unprognostic (1.05e-2)" "unprognostic (4.09e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.43e-5)" "unprognostic (2.61e-1)" "unprognostic (1.45e-1)" "unprognostic (2.70e-1)" "unprognostic (4.87e-3)" 6.8 2.5 14.1 6.1 13.6 1.8 8.3 16.4 16.4 11.9 26.0 6.9 7.5 11.3 26.7 5.8 12.7 11.4 8.7 10.8 12.7 10.7 7.1 6.3 7.8 3.2 8.9 14.3 19.3 7.9 8.8 17.2 13.0 8.1 14.6 14.7 8.6 8.1 13.8 11.0 2.5 11.8 25.4 8.7 2.9 8.6 20.1 7.9 9.1 10.3 4.5 3.3 11.0 6.2 0.8 2.0 0.1 0.1 6.6 2.3 0.7 6.2 3.2 24.6 6.9 1.4 0.5 16.8 3.0 2.3 5.5 6.1 6.8 5.4 3.9 2.5 0.3 8.0 1.0 25.5 2.1 8.4 13.7 12.5 11.5 6.5 11.0 2.1 16.0 1.8 1.0 1.8 2.3 3.9 3.6 4.2 14.4 15.6 0.5 1.8 3.0 23.4 6.5 20.1 3.3 2.5 7.5 21.0 0.4 5.0 18.6 32.0 22.0 4.7 0.4 2.8 8.1 4.0 5.2 1.5 2.2 7.2 2.1 5.0 1.8 1.7 17.5 1.7 4.8 3.4 0.0 0.1 0.0 1.6 0.0 2.2 0.6 1.4 1.2 0.2 0.8 2.3 2.2 0.1 6.6 0.0 2.0 1.6 0.7 14.1 13.6 16.4 13.1 12.7 10.7 8.9 14.3 8.1 7.9 3.0 5.4 0.0 5.8 1.3 108.6 41.9 17.8 6.7 6.8 0.0 84.4 3.7 3.3 15.1 3.0 5.6 8.0 0.0 27.4 7.4 3.9 14.9 0.0 10.2 0.8 38.1 30.6 8.6 1.0 2.7 2.3 1.0 0.0 0.0 19.5 12.9 16.7 14.1 8.1 13.4 35.6 168.1 38.7 3.2 9.8 0.9 1.0 4.3 20.2 3.9 KLRK1 "CD314, D12S2489E, KLR, NKG2-D, NKG2D" ENSG00000213809 "Killer cell lectin like receptor K1" P26718 12 10372353-10391874 "Cancer-related genes, CD markers, Predicted membrane proteins, Transporters" "Adaptive immunity, Differentiation, Immunity, Innate immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;lymphoid tissue: 30.7" "Cell type enriched" "Detected in some" 9 "T-cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 39 "gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8" "Group enriched" "Detected in many" 47 "NK-cells: 50.8;T-cells: 49.4" "Cell line enriched" "Detected in some" 8 "U-698: 36.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB021896, HPA068877" Enhanced Supported "Plasma membrane" NA NA 33000 "Plasma membrane" "CAB021896: , HPA068877: AB_2686052" "unprognostic (3.34e-4)" "unprognostic (2.65e-4)" "unprognostic (3.25e-1)" "unprognostic (2.59e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-5)" "unprognostic (5.61e-4)" "unprognostic (1.00e-3)" "unprognostic (1.33e-1)" "unprognostic (9.22e-2)" "unprognostic (1.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-10)" "unprognostic (1.24e-2)" "unprognostic (6.32e-2)" "unprognostic (7.59e-2)" "unprognostic (7.08e-10)" 4.1 0.9 1.3 18.3 1.1 10.6 2.1 0.4 0.8 2.8 4.5 1.2 0.6 2.0 2.4 2.7 3.1 2.0 7.7 1.3 1.3 1.1 2.4 3.6 13.6 22.2 2.1 0.1 1.5 3.3 0.0 1.2 1.6 1.2 2.2 2.1 2.4 7.0 0.6 0.5 1.1 13.1 1.3 2.1 30.7 3.3 1.9 0.6 6.0 2.9 2.8 11.4 11.3 2.5 1.0 0.2 0.8 0.1 50.8 49.4 16.7 0.2 0.0 0.4 1.9 0.1 4.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.2 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.2 0.0 0.0 0.0 49.4 0.1 18.5 0.8 0.3 44.0 0.1 1.0 0.4 44.3 0.8 50.8 0.1 0.2 0.1 16.7 1.3 1.1 0.4 0.8 1.3 1.1 2.1 0.1 1.2 0.6 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.3 0.0 0.0 L3MBTL4 "FLJ35936, HsT1031" ENSG00000154655 "L3MBTL4, histone methyl-lysine binding protein" Q8NA19 18 5954706-6415237 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 50.7;Late spermatids: 66.8;monocytes: 45.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 5.3;NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.3;Karpas-707: 5.9;RPMI-8226: 13.8;SCLC-21H: 6.7;SH-SY5Y: 7.3;U-2 OS: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA064194, HPA069042" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064194: AB_2685208, HPA069042: AB_2686071" "unprognostic (1.33e-3)" "unprognostic (8.98e-2)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.70e-2)" "unprognostic (1.73e-1)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-2)" "unprognostic (5.08e-2)" "unprognostic (1.00e-1)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" 6.3 6.9 8.4 3.7 12.8 2.1 6.8 0.8 8.1 6.2 3.4 12.3 4.8 4.2 4.9 5.4 5.9 6.2 4.3 8.6 9.6 3.5 9.9 12.0 5.9 2.7 13.7 5.5 12.3 14.2 18.8 8.2 1.1 4.6 3.4 3.0 6.0 5.9 9.6 1.4 9.9 4.8 2.0 3.6 4.0 4.4 17.0 13.4 0.6 8.2 2.5 2.3 3.1 7.1 5.3 1.3 0.4 2.2 6.4 1.4 0.8 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.6 0.0 0.0 4.3 0.2 0.0 0.0 0.1 0.0 2.0 0.1 0.2 2.9 2.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.3 0.0 1.8 3.8 0.0 13.8 0.0 2.4 6.7 7.3 0.0 0.1 0.3 0.5 0.0 0.0 0.1 0.1 4.4 0.1 1.7 0.2 0.0 0.1 1.7 0.1 2.1 0.4 2.2 0.1 1.4 0.6 0.1 1.1 0.2 0.2 1.3 5.3 0.3 0.4 0.3 6.4 1.4 0.3 0.1 0.8 8.4 12.8 0.8 8.1 9.6 3.5 13.7 5.5 4.6 13.4 3.0 9.8 0.0 5.5 6.9 0.8 4.5 12.7 1.4 6.8 5.2 15.7 0.1 3.3 7.1 50.7 3.6 0.9 0.0 4.5 0.0 2.8 4.9 1.1 8.5 3.3 0.0 10.9 1.3 2.5 66.8 9.5 2.6 1.7 45.1 1.3 1.0 3.8 1.9 12.0 6.0 0.3 6.5 6.2 11.8 1.3 7.2 0.1 1.0 3.8 3.9 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765176-203776233 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.7" "Group enriched" "Detected in some" 5 "granulocytes: 78.7;T-cells: 27.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0" "Group enriched" "Detected in many" 19 "B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9" "Group enriched" "Detected in some" 4 "Karpas-707: 11.7;U-266/70: 14.4;U-266/84: 32.4;U-698: 12.3" "Low region specificity" "Detected in all" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 1.6 0.6 0.4 19.9 0.4 1.3 1.3 0.4 0.4 1.8 3.4 0.0 0.2 2.1 1.2 1.1 4.5 1.1 3.8 0.6 0.4 0.4 1.0 0.8 6.3 17.4 0.4 0.0 0.7 0.6 0.0 0.5 0.1 0.0 2.2 2.6 1.1 5.7 1.5 0.5 1.0 5.5 1.1 0.5 11.7 3.4 1.0 0.0 22.7 1.1 0.7 26.7 6.3 2.8 6.5 0.0 0.3 0.0 4.6 9.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 11.7 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 32.4 12.3 0.0 0.9 0.0 0.0 0.0 0.3 9.9 0.0 7.4 6.5 5.7 7.3 0.0 1.5 4.5 5.9 0.0 4.6 0.0 0.0 6.0 2.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 3.4 11.5 0.3 1.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 78.7 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.9 10.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 27.9 0.0 0.4 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1, regulator of NFKB signaling" O95751 X 141175745-141177125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 36.5;Peritubular cells: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 29.8;MCF7: 40.1;PC-3: 50.3;U-251 MG: 29.9" "Region enriched" "Detected in many" 5 "cerebellum: 21.5" "Low region specificity" "Detected in all" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 21.1 24.2 24.4 5.9 31.8 2.0 9.9 18.3 51.2 24.2 5.5 21.0 11.0 5.1 17.3 12.1 10.0 30.3 10.4 6.7 27.3 25.6 15.6 3.1 9.7 5.5 23.2 23.3 31.8 18.3 13.0 54.9 1.8 30.2 23.1 3.5 13.5 47.9 36.4 3.8 17.9 5.2 12.5 19.5 9.3 7.8 6.6 16.6 1.8 22.6 3.7 5.7 11.2 9.9 8.2 4.8 8.2 0.0 19.2 8.9 3.0 0.0 29.8 4.6 12.8 8.0 9.8 0.0 7.1 8.8 9.7 13.6 0.0 11.7 0.0 5.6 11.6 9.6 14.0 5.0 10.4 6.9 0.0 9.2 0.0 16.1 0.0 3.1 0.0 2.8 17.3 5.4 8.4 4.5 7.8 8.2 0.0 0.2 0.0 8.7 40.1 0.0 0.0 4.8 0.0 50.3 0.0 4.1 0.0 11.9 7.0 0.0 4.0 0.0 6.2 0.0 2.6 7.9 0.0 14.8 0.0 9.6 0.0 29.9 0.0 0.0 0.0 5.0 0.0 0.0 8.2 0.0 0.1 4.3 0.0 3.1 3.3 8.9 3.3 0.8 8.2 7.9 5.1 0.2 19.2 0.0 4.8 8.1 3.0 24.4 31.8 18.3 47.4 27.3 25.6 23.2 23.3 30.2 16.6 0.0 4.0 0.0 15.7 5.4 25.2 1.6 22.9 5.3 10.3 22.7 7.9 1.9 36.5 12.0 0.5 11.3 0.0 0.0 12.3 1.6 11.7 14.6 2.3 0.0 0.8 19.1 5.2 11.1 0.8 0.9 20.4 1.6 3.3 0.0 0.2 20.6 11.6 0.0 36.4 26.8 9.6 12.9 19.4 0.9 7.7 5.9 1.3 5.7 0.0 14.0 LRRC1 "dJ523E19.1, FLJ10775, FLJ11834, LANO" ENSG00000137269 "Leucine rich repeat containing 1" Q9BTT6 6 53794497-53924121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 81.7;Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031603, HPA031604" Enhanced Supported Cytosol NA NA Cytosol "HPA031603: AB_10601753, HPA031604: AB_10601224" "unprognostic (2.90e-1)" "unprognostic (8.01e-2)" "unprognostic (9.59e-3)" "unprognostic (2.46e-2)" "unprognostic (7.04e-3)" "unprognostic (1.55e-2)" "unprognostic (2.19e-3)" "unprognostic (6.37e-2)" "unprognostic (7.02e-2)" "unprognostic (7.12e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.97e-1)" "prognostic favorable (2.21e-7)" "unprognostic (1.74e-1)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-3)" 13.1 2.3 8.6 7.6 17.0 2.5 12.4 4.0 13.4 12.1 22.6 17.5 7.3 15.3 5.3 8.9 17.2 7.9 12.0 3.8 9.4 6.1 7.3 1.1 7.0 2.4 21.8 6.1 5.7 8.3 24.8 8.0 26.1 11.2 8.3 23.2 7.8 14.9 7.0 1.9 20.2 20.7 6.1 11.9 1.8 13.2 12.3 20.6 8.3 16.3 8.4 9.3 12.3 16.1 1.8 1.4 0.4 0.2 3.3 1.1 0.1 20.1 2.6 2.8 5.0 0.7 0.4 20.1 2.8 5.7 2.4 3.3 22.4 10.0 2.9 2.3 1.7 4.5 10.0 22.1 8.9 3.1 3.5 6.4 1.7 2.0 15.0 7.3 2.2 1.3 0.7 7.4 0.2 5.4 3.8 4.3 10.6 0.4 2.7 1.3 8.8 14.7 0.3 2.2 15.1 2.0 3.0 4.7 1.5 6.5 26.1 7.4 0.7 3.3 14.7 4.3 7.4 9.6 2.2 2.0 1.8 6.0 0.1 2.5 2.7 2.1 2.0 2.1 3.0 2.2 0.0 0.2 0.4 1.0 0.0 0.4 0.3 0.9 1.1 1.4 1.8 0.8 0.6 0.0 3.3 0.0 1.2 0.1 0.1 8.6 17.0 4.0 13.4 9.4 6.1 21.8 6.1 11.2 20.6 38.7 3.8 2.7 22.4 46.8 33.1 3.3 5.1 9.4 20.5 15.7 3.9 42.9 6.6 17.3 75.0 17.5 33.2 0.0 13.8 43.0 5.2 14.6 5.7 0.0 4.5 7.9 17.2 7.4 0.3 81.7 8.6 1.5 10.1 3.6 22.1 38.2 21.5 36.6 9.6 10.1 2.7 6.5 2.5 6.1 6.9 46.0 89.7 3.8 18.4 26.7 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "CAB025341: , HPA055371: AB_2682797" "prognostic favorable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.5 1.2 1.7 2.6 2.7 8.7 7.9 15.3 21.2 7.8 8.4 2.2 6.2 0.2 1.5 6.5 11.8 5.1 0.4 6.1 13.3 1.4 0.2 0.8 0.8 1.9 7.3 0.5 2.7 3.7 10.2 31.3 17.4 7.0 16.4 0.8 1.5 7.3 6.1 1.7 0.3 2.0 1.2 8.4 6.2 0.5 1.4 1.5 7.9 11.6 0.9 1.4 2.3 6.1 37.2 4.4 1.3 0.6 21.4 9.9 7.3 7.3 5.1 2.7 2.8 0.3 15.0 0.6 6.2 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 50.6 43.7 7.5 289.5 111.8 2.2 13.7 33.1 29.4 33.0 10.4 0.0 30.6 6.6 37.6 0.4 35.0 98.6 0.0 21.5 52.9 80.2 257.7 21.9 5.0 23.2 0.0 100.5 14.7 7.8 0.0 9.2 26.4 55.6 17.2 43.3 16.8 51.3 62.0 3.5 2.4 2.0 19.4 116.4 0.9 1.0 90.2 400.7 27.7 35.7 321.4 MATK "CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101" ENSG00000007264 "Megakaryocyte-associated tyrosine kinase" P42679 19 3777970-3802129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.3;bone marrow: 19.1;brain: 27.4" "Group enriched" "Detected in many" 6 "granulocytes: 44.9;Hofbauer cells: 58.6;T-cells: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 19.4;NK-cell: 29.3" "Group enriched" "Detected in many" 54 "NK-cells: 29.3;T-cells: 19.4" "Cell line enhanced" "Detected in some" "HL-60: 41.6;HMC-1: 12.8;K-562: 18.5;MCF7: 13.5;NB-4: 29.0;SCLC-21H: 12.7;THP-1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004847, HPA066547" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol" "HPA004847: AB_1079316, HPA066547: " "prognostic favorable (5.27e-4)" "unprognostic (1.28e-2)" "unprognostic (1.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.36e-1)" "unprognostic (3.39e-2)" "unprognostic (9.50e-2)" "unprognostic (1.23e-1)" "unprognostic (7.91e-2)" "unprognostic (3.19e-3)" "unprognostic (2.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.16e-2)" "unprognostic (7.59e-2)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (2.33e-2)" 11.2 1.6 22.1 6.8 18.1 19.1 2.2 1.5 27.4 1.5 2.3 1.7 0.0 7.0 1.2 0.4 1.1 4.7 5.1 1.7 25.1 10.0 1.1 2.8 7.3 9.6 7.0 11.0 1.0 1.6 0.1 1.4 1.4 6.1 1.2 1.4 0.6 3.8 1.0 0.8 1.6 6.7 1.1 2.8 14.8 4.1 2.1 1.3 3.5 0.9 0.0 4.5 2.4 0.7 0.4 0.3 0.4 0.0 29.3 19.4 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.4 4.2 5.5 0.1 0.0 0.0 7.2 4.6 0.5 1.1 0.0 41.6 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 13.5 0.1 29.0 3.4 3.5 0.1 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.4 0.0 10.9 1.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 13.2 0.0 2.5 12.2 0.3 0.4 1.2 7.1 0.4 29.3 0.0 0.1 0.1 2.7 22.1 18.1 1.5 27.4 25.1 10.0 7.0 11.0 6.1 1.3 0.0 1.4 2.4 0.0 0.3 1.7 1.1 0.0 1.4 0.0 0.0 11.8 0.2 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.3 0.5 0.1 44.9 0.8 58.6 0.0 6.8 11.6 3.5 4.0 0.0 7.2 1.7 1.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.3 2.7 1.0 0.2 105.8 0.1 0.0 MDC1 "Em:AB023051.5, KIAA0170, NFBD1" ENSG00000137337 "Mediator of DNA damage checkpoint 1" Q14676 6 30699807-30717889 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 15.7;AN3-CA: 12.3;HEK 293: 29.8" "Low region specificity" "Detected in all" HPA006915 Enhanced Supported "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA006915: AB_1853669" "unprognostic (8.52e-2)" "unprognostic (4.32e-1)" "unprognostic (4.11e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-2)" "unprognostic (9.44e-2)" "unprognostic (2.74e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.99e-1)" "unprognostic (4.39e-3)" "unprognostic (3.23e-1)" 10.8 3.6 5.7 9.5 5.9 4.9 5.5 10.2 8.0 6.9 6.3 8.5 3.8 3.8 9.9 5.1 3.7 8.3 5.0 5.0 5.2 2.4 5.1 6.2 5.1 5.4 4.9 3.7 11.3 5.7 3.1 12.5 3.1 6.0 6.4 2.9 9.4 5.5 3.5 11.1 11.7 6.4 6.1 5.5 7.1 7.7 26.7 5.3 11.4 11.9 2.4 13.0 5.2 5.4 2.0 1.8 0.4 0.2 3.8 1.2 0.3 15.7 1.1 1.2 12.3 3.9 3.9 1.0 1.3 0.7 2.7 1.1 1.0 1.7 2.6 6.7 7.8 6.4 1.6 2.4 4.5 2.5 2.2 29.8 1.9 3.0 0.7 0.5 1.1 1.4 1.0 0.9 4.2 2.0 0.3 0.4 6.4 3.9 2.9 0.4 1.5 0.7 0.2 0.9 0.8 0.8 2.2 1.3 2.9 4.5 3.4 2.6 1.3 0.6 3.2 0.5 2.2 2.9 2.2 1.0 1.0 1.5 2.0 1.5 1.9 7.3 6.8 0.3 4.4 2.1 0.4 0.1 0.3 1.1 0.2 0.9 0.8 0.9 1.2 0.2 2.0 1.0 0.8 0.1 3.8 0.1 1.8 0.0 0.3 5.7 5.9 10.2 8.0 5.2 2.4 4.9 3.7 6.0 5.3 14.9 15.4 9.7 4.8 3.9 10.7 6.3 7.6 8.1 6.8 5.2 7.9 4.4 3.3 3.8 3.4 5.6 1.0 0.0 5.4 9.5 7.3 2.5 16.2 11.4 5.6 4.8 6.4 5.5 5.9 2.1 7.2 4.5 1.7 8.2 2.6 10.0 4.8 0.0 5.6 2.8 17.0 12.9 5.0 75.3 17.2 3.1 1.6 6.9 4.4 0.8 MLC1 "KIAA0027, LVM, MLC, VL" ENSG00000100427 "Megalencephalic leukoencephalopathy with subcortical cysts 1" Q15049 22 50059391-50085902 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.0;brain: 95.3" "Cell type enhanced" "Detected in some" 23 "Hofbauer cells: 2.6;Muller glia cells: 12.6;T-cells: 4.5" "Cancer enriched" "Detected in some" 69 "glioma: 122.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 46.8;NB-4: 43.3;THP-1: 82.0;U-266/70: 28.7;U-266/84: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003040 Enhanced Supported Cytosol NA NA Cytosol "HPA003040: AB_1079387" "unprognostic (2.68e-2)" "unprognostic (5.46e-6)" "unprognostic (5.41e-3)" "unprognostic (1.51e-1)" "unprognostic (1.47e-1)" "unprognostic (2.42e-3)" "unprognostic (9.54e-3)" "unprognostic (7.21e-2)" "unprognostic (2.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.31e-1)" "unprognostic (1.51e-3)" "unprognostic (8.39e-4)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (3.66e-2)" "unprognostic (2.92e-1)" 1.6 1.4 42.3 1.9 45.4 27.0 1.4 17.6 95.3 2.5 1.5 25.9 0.0 1.8 1.5 2.3 1.4 2.8 2.1 1.6 30.9 19.6 1.4 1.6 2.3 1.6 22.5 28.9 1.4 1.4 1.4 0.1 3.2 18.4 2.9 1.4 0.0 1.5 2.6 1.4 2.2 1.5 1.6 18.9 2.8 1.5 2.8 17.3 0.0 1.4 0.0 1.8 1.8 2.6 0.1 0.7 0.1 7.1 15.8 3.3 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 46.8 15.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 43.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 82.0 0.0 0.0 0.0 0.0 0.0 28.7 24.5 0.0 0.0 7.2 0.4 0.0 0.7 0.0 3.3 5.7 0.1 0.1 0.2 1.4 0.7 0.0 0.1 1.6 0.1 15.8 7.1 0.1 0.1 2.7 42.3 45.4 17.6 29.8 30.9 19.6 22.5 28.9 18.4 17.3 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.2 4.5 0.0 0.0 MOK "RAGE, RAGE1, STK30" ENSG00000080823 "MOK protein kinase" Q9UQ07 14 102224500-102305200 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 214.2;Cone photoreceptor cells: 174.7;Early spermatids: 171.0;Rod photoreceptor cells: 441.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 28.6;hTEC/SVTERT24-B: 72.8;NB-4: 90.6;U-138 MG: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027292 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA027292: AB_10600989" "unprognostic (8.16e-2)" "unprognostic (1.82e-1)" "unprognostic (6.68e-2)" "unprognostic (6.05e-3)" "unprognostic (1.34e-2)" "unprognostic (1.81e-2)" "unprognostic (4.43e-2)" "unprognostic (3.49e-4)" "unprognostic (2.19e-1)" "unprognostic (2.03e-2)" "unprognostic (2.93e-1)" "unprognostic (3.01e-3)" "unprognostic (5.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.48e-1)" 5.9 6.8 12.9 2.7 17.3 3.7 7.8 9.7 15.9 7.6 3.6 8.7 6.2 4.7 7.6 10.2 3.9 26.4 6.4 8.3 13.5 10.2 7.7 3.6 6.1 2.5 6.0 13.7 12.4 8.6 9.4 22.1 3.6 16.6 5.1 3.0 15.2 6.1 5.4 1.9 8.6 4.1 5.9 6.2 3.8 11.7 45.0 6.2 0.4 11.7 2.3 2.2 6.2 3.9 0.7 3.9 0.9 1.1 10.6 2.4 1.3 3.4 3.0 0.4 1.7 0.7 2.5 0.7 7.0 2.0 10.1 12.2 0.2 8.4 2.6 0.5 1.3 2.2 0.7 0.6 3.6 28.6 2.9 2.6 0.6 0.4 2.3 3.1 0.3 3.4 2.1 0.9 72.8 6.7 7.9 0.3 0.5 0.6 0.1 6.6 2.3 0.2 90.6 0.1 1.5 7.4 0.4 0.2 0.0 4.1 0.1 1.1 0.7 1.2 0.4 19.6 0.1 2.1 0.2 0.2 38.5 1.9 1.4 2.2 0.2 0.4 0.2 7.7 0.2 17.4 0.0 1.1 0.0 0.7 0.7 1.2 0.0 0.5 1.9 3.9 0.7 1.1 2.4 0.9 10.6 0.1 0.0 0.0 1.3 12.9 17.3 9.7 15.9 13.5 10.2 6.0 13.7 16.6 6.2 17.9 17.4 0.5 6.5 9.5 36.2 12.2 10.2 214.2 43.3 12.2 174.7 1.0 5.0 7.0 171.0 6.7 3.8 0.0 14.2 2.1 7.6 3.6 3.5 1.7 2.0 15.9 4.6 7.4 1.8 130.3 28.1 4.2 75.9 0.0 2.0 58.0 5.6 0.0 15.2 8.1 441.5 25.8 12.1 81.9 27.2 5.1 1.0 6.7 3.8 3.0 MYO6 "DFNA22, DFNB37, KIAA0389" ENSG00000196586 "Myosin VI" Q9UM54 6 75749192-75919537 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Hearing, Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 333.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3" "Group enriched" "Detected in many" 20 "NK-cells: 3.3;T-cells: 8.6" "Cell line enhanced" "Detected in many" "RT4: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010762, HPA035482, HPA035483" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647" "unprognostic (6.29e-2)" "unprognostic (6.34e-2)" "unprognostic (3.63e-3)" "unprognostic (1.30e-1)" "unprognostic (8.98e-2)" "unprognostic (2.73e-2)" "unprognostic (3.41e-3)" "unprognostic (1.23e-2)" "unprognostic (1.23e-2)" "unprognostic (2.66e-2)" "unprognostic (7.78e-2)" "unprognostic (2.78e-2)" "prognostic favorable (1.27e-12)" "unprognostic (1.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.49e-2)" 8.4 9.1 18.2 9.0 27.0 0.9 26.9 17.1 24.1 16.2 18.9 26.8 28.7 30.0 7.5 25.9 28.1 10.0 23.1 4.9 19.1 12.2 44.0 13.8 20.5 4.5 24.0 17.9 4.6 18.5 42.2 24.2 7.1 19.0 16.0 17.3 11.9 23.3 33.7 4.2 14.1 27.7 8.0 21.2 6.7 23.9 14.3 28.2 0.9 13.4 9.1 10.9 16.1 13.1 0.2 0.0 0.1 0.1 3.3 8.6 1.2 22.7 6.1 4.9 3.5 11.9 9.6 19.6 8.1 8.6 6.0 7.8 9.2 20.5 0.0 7.9 9.1 6.9 18.0 5.8 11.6 6.9 9.6 11.9 6.5 2.0 5.6 10.2 0.0 9.5 6.8 8.4 8.1 6.4 10.0 16.6 3.3 8.5 3.3 6.1 21.9 0.0 0.2 3.3 17.1 1.6 0.4 11.8 0.4 22.3 43.4 10.2 6.7 2.0 20.4 3.5 11.6 8.7 13.3 24.3 6.6 5.7 0.3 7.3 6.9 7.0 0.0 4.1 0.0 2.3 0.1 0.0 0.0 8.6 0.0 4.0 0.2 2.7 4.9 0.0 0.0 0.6 4.8 0.1 3.3 0.1 0.0 0.1 1.2 18.2 27.0 17.1 24.1 19.1 12.2 24.0 17.9 19.0 28.2 131.0 218.3 7.6 88.9 26.8 74.9 7.3 35.7 75.0 79.6 143.1 113.9 27.1 46.4 104.1 3.9 45.8 95.7 0.0 104.0 18.4 24.2 142.1 25.4 28.2 5.5 90.6 81.6 42.4 3.8 5.6 27.9 6.0 28.7 4.6 66.2 333.7 145.6 80.7 40.7 83.4 184.9 12.9 16.9 10.9 13.8 29.7 65.6 12.1 54.2 164.0 NCALD ENSG00000104490 "Neurocalcin delta" P61601 8 101686543-102124907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;salivary gland: 48.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 37.5;Melanocytes: 97.8;Muller glia cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 32.8" "Group enriched" "Detected in many" 13 "NK-cells: 32.8;T-cells: 17.1" "Group enriched" "Detected in some" 4 "AF22: 44.4;HDLM-2: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043245 Approved NA NA "HPA043245: AB_2678385" "unprognostic (3.49e-1)" "unprognostic (1.55e-1)" "unprognostic (4.85e-2)" "unprognostic (4.97e-2)" "unprognostic (5.48e-3)" "unprognostic (2.60e-3)" "unprognostic (1.25e-1)" "unprognostic (5.63e-3)" "unprognostic (1.54e-1)" "unprognostic (2.48e-1)" "prognostic favorable (5.30e-4)" "unprognostic (2.79e-1)" "unprognostic (6.24e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-1)" "unprognostic (7.87e-2)" "unprognostic (1.00e-2)" 9.6 3.4 21.2 5.6 26.8 0.7 21.2 2.7 57.2 6.9 8.8 7.3 1.3 2.7 3.7 2.0 6.1 18.6 5.8 5.1 25.1 16.4 7.0 7.0 9.4 5.6 7.2 18.4 18.2 4.3 0.6 6.6 4.6 7.8 5.9 4.2 20.8 48.5 7.4 6.4 7.3 4.6 5.7 4.4 3.6 5.7 3.4 2.8 0.3 2.6 3.1 4.9 5.4 2.1 0.3 1.9 0.5 0.1 32.8 17.1 4.6 2.1 3.2 44.4 0.2 0.4 7.8 0.0 0.7 0.1 0.0 0.0 0.0 0.0 2.8 1.0 3.3 0.1 0.0 0.3 0.0 0.0 54.8 0.3 0.2 0.0 0.1 0.0 1.8 0.3 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.3 0.7 0.5 0.0 0.0 1.0 0.0 0.0 7.3 0.1 0.2 4.3 0.0 1.0 1.8 7.7 0.3 1.5 0.0 0.7 0.1 0.0 0.1 12.1 1.7 0.0 0.1 0.0 0.7 0.1 0.1 0.1 17.1 0.1 15.4 0.3 6.6 10.1 1.9 0.2 1.6 8.5 0.5 32.8 0.1 0.1 6.5 4.6 21.2 26.8 2.7 57.2 25.1 16.4 7.2 18.4 7.8 2.8 0.0 1.6 0.0 0.4 3.8 13.0 3.6 7.6 37.5 4.5 0.0 23.6 2.6 6.6 4.8 9.8 6.4 0.0 0.0 1.0 7.7 16.2 1.7 2.3 13.1 1.6 12.7 20.2 14.7 2.7 5.0 2.6 2.4 97.8 0.0 2.7 42.7 2.3 0.0 1.4 14.6 4.4 25.8 10.3 0.5 0.9 2.8 2.5 22.3 0.4 0.9 NEIL1 "FLJ22402, FPG1, hFPG1, NEI1" ENSG00000140398 "Nei like DNA glycosylase 1" Q96FI4 15 75346955-75357114 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.7;memory B-cell: 4.0;naive B-cell: 6.5;NK-cell: 14.1" "Group enriched" "Detected in many" 12 "B-cells: 6.5;NK-cells: 14.1;T-cells: 4.7" "Cell line enhanced" "Detected in many" "Daudi: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054084 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA054084: AB_2682372" "unprognostic (9.84e-3)" "unprognostic (1.19e-1)" "unprognostic (1.15e-2)" "unprognostic (4.62e-3)" "unprognostic (3.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.24e-2)" "unprognostic (1.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.50e-3)" "unprognostic (8.60e-2)" "unprognostic (9.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.03e-1)" "unprognostic (2.27e-3)" 7.1 14.8 12.9 28.2 14.5 6.8 9.3 24.4 15.4 10.8 8.3 4.9 23.2 10.1 8.4 11.6 6.4 10.0 10.2 5.3 12.8 5.7 7.9 9.1 9.3 9.8 6.0 9.8 11.0 10.8 9.1 9.0 4.6 8.0 10.4 2.4 7.1 25.0 24.2 13.6 11.7 9.5 4.3 5.9 6.8 9.9 3.8 7.0 15.4 8.2 5.2 13.3 7.5 8.5 6.5 0.2 0.7 0.5 14.1 4.7 1.0 2.2 3.7 2.4 1.5 0.7 0.8 4.6 1.3 0.0 0.5 0.1 0.6 4.0 11.6 2.2 0.2 1.1 6.4 1.4 0.4 0.0 5.6 9.5 1.9 10.0 1.8 1.0 2.2 2.7 0.3 1.8 0.6 0.0 6.0 1.5 1.1 1.2 3.4 0.4 2.9 0.4 6.3 2.1 0.4 0.9 2.2 1.5 0.5 2.2 2.4 1.4 2.8 2.3 1.0 3.2 1.3 4.3 3.3 6.3 1.3 2.5 1.9 1.1 5.4 5.2 9.4 1.2 9.4 1.2 0.0 0.5 0.0 4.7 0.1 1.3 4.0 0.8 1.0 0.2 6.5 1.4 1.4 0.7 14.1 0.1 0.2 0.2 1.0 12.9 14.5 24.4 15.4 12.8 5.7 6.0 9.8 8.0 7.0 20.8 19.2 9.3 14.9 5.7 20.2 2.5 2.5 38.8 23.9 14.0 9.8 8.7 1.7 7.2 21.8 13.4 15.5 0.0 7.4 3.1 7.8 12.0 10.5 10.5 2.8 9.5 20.7 24.5 6.9 1.1 17.5 5.8 8.5 0.0 18.2 21.4 6.1 14.7 12.7 5.8 5.9 6.5 4.1 1.4 0.7 5.1 4.0 13.1 11.3 5.8 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372715 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 270.6;bone marrow: 108.2" "Cell type enriched" "Detected in many" 16 "T-cells: 1698.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7" "Group enriched" "Detected in all" 46 "NK-cells: 166.7;T-cells: 270.6" "Group enriched" "Detected in some" 5 "NB-4: 60.2;THP-1: 17.9;U-937: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles NA NA Vesicles "HPA071454: AB_2686399" "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favorable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 7.4 1.8 1.3 11.2 1.7 108.2 3.3 0.7 1.0 2.9 2.2 0.8 0.4 2.2 5.4 6.3 3.8 1.8 10.6 6.0 1.2 1.2 3.2 9.4 26.1 31.0 2.3 0.7 4.1 2.6 0.0 1.8 9.3 1.3 6.8 1.6 6.2 3.5 0.9 5.6 1.0 7.6 2.5 2.8 63.3 2.5 1.9 0.2 7.3 3.1 2.0 16.0 5.1 2.3 1.1 3.2 4.5 4.7 166.7 270.6 141.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.6 0.2 0.0 0.0 6.4 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.2 0.0 0.0 0.7 60.2 0.0 0.0 0.1 1.4 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 17.9 0.1 0.0 0.0 0.2 0.0 0.9 0.2 0.3 0.0 15.6 0.0 2.2 1.3 0.5 270.6 4.7 113.5 1.1 34.1 168.7 3.2 0.5 11.5 130.3 4.5 166.7 3.6 2.5 0.6 141.5 1.3 1.7 0.7 1.0 1.2 1.2 2.3 0.7 1.3 0.2 3.0 10.1 16.0 0.0 4.4 0.0 0.4 10.2 1.4 2.3 5.2 0.0 0.4 3.3 0.0 0.0 2.8 0.3 0.0 0.0 0.4 2.3 0.0 24.2 3.4 12.4 0.0 0.0 45.4 103.5 0.0 0.0 26.0 16.9 1.8 0.0 0.0 0.0 0.3 0.0 6.9 0.0 0.0 0.5 0.0 0.2 5.6 0.9 1698.3 0.0 0.1 NMT2 ENSG00000152465 "N-myristoyltransferase 2" O60551 10 15102584-15168693 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 89.2;Hepatocytes: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 33.8;TIME: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001303 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA001303: AB_1079494" "unprognostic (1.08e-1)" "unprognostic (7.65e-2)" "unprognostic (8.78e-2)" "unprognostic (1.15e-3)" "unprognostic (6.97e-2)" "unprognostic (2.24e-1)" "unprognostic (7.11e-2)" "unprognostic (5.13e-2)" "unprognostic (3.20e-1)" "unprognostic (4.01e-3)" "unprognostic (3.31e-1)" "unprognostic (2.00e-1)" "unprognostic (7.06e-2)" "unprognostic (3.79e-3)" "unprognostic (2.00e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" 29.3 5.4 18.9 6.5 17.3 3.8 19.2 35.6 25.3 12.0 9.9 6.0 4.7 7.4 14.5 5.0 8.2 8.9 8.1 9.6 12.8 9.2 10.8 18.5 7.2 9.0 8.8 15.0 18.2 7.1 28.5 7.9 5.1 10.3 10.7 10.7 8.3 5.8 9.4 18.8 11.5 11.9 12.5 10.3 10.1 8.8 14.5 9.9 23.7 6.9 4.5 8.9 10.1 20.1 1.9 0.3 8.7 0.5 12.9 17.5 3.9 2.8 3.6 4.2 3.1 11.5 12.4 0.8 6.2 5.0 5.7 7.8 3.5 12.7 0.1 4.3 33.8 15.7 3.5 3.7 3.5 9.6 3.7 4.8 7.6 1.8 4.8 7.7 0.5 28.3 11.0 3.6 8.1 2.4 20.9 22.0 5.3 3.6 0.5 21.2 3.5 5.8 1.4 3.1 3.2 3.5 4.3 6.2 0.5 4.2 0.6 1.2 4.8 7.5 1.2 2.0 3.7 3.8 2.3 49.0 5.7 8.4 25.0 4.4 4.3 4.5 0.3 7.0 2.0 4.1 8.7 0.3 7.9 7.2 0.4 12.9 1.4 11.5 8.3 0.3 1.9 14.7 9.3 1.2 12.9 0.5 0.2 17.5 3.9 18.9 17.3 35.6 25.3 12.8 9.2 8.8 15.0 10.3 9.9 8.9 9.1 18.2 17.3 14.7 21.8 11.1 76.5 5.3 14.8 26.2 3.9 0.8 8.3 23.8 6.4 20.4 30.1 46.7 16.8 2.1 11.6 13.9 89.2 122.4 2.4 19.1 17.2 24.5 6.9 9.6 20.1 6.5 11.8 13.6 9.9 12.0 21.3 12.2 19.4 44.1 14.9 0.0 15.3 7.4 50.5 12.9 2.2 38.3 16.9 13.4 NMUR1 "FM-3, GPC-R, GPR66, NMU1R" ENSG00000171596 "Neuromedin U receptor 1" Q9HB89 2 231523160-231530495 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 12 "Ito cells: 8.0;Peritubular cells: 7.1;Rod photoreceptor cells: 15.5;T-cells: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 15.2;MAIT T-cell: 3.9;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.6;NK-cell: 8.1" "Group enriched" "Detected in many" 18 "NK-cells: 8.1;T-cells: 15.2" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA027895 Uncertain NA NA "HPA027895: AB_10602713" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (6.74e-3)" "unprognostic (9.44e-3)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.22e-2)" "unprognostic (2.07e-1)" "unprognostic (4.08e-4)" "unprognostic (3.76e-3)" "unprognostic (2.26e-1)" "unprognostic (2.61e-1)" "unprognostic (5.25e-2)" 13.6 2.2 0.6 1.2 0.9 3.5 3.2 2.1 0.8 2.5 3.5 0.4 4.4 4.4 1.8 3.8 3.3 3.0 4.6 12.6 0.3 0.3 2.1 2.0 6.4 0.5 0.3 0.1 2.8 7.7 0.2 0.6 4.8 0.6 4.0 1.2 8.4 4.6 3.6 0.3 0.8 7.3 8.4 0.6 7.3 1.7 3.0 0.7 0.2 1.8 0.6 0.8 4.4 1.4 0.0 0.3 0.6 0.1 8.1 15.2 3.6 0.3 1.2 1.5 1.5 0.1 0.4 1.3 0.5 0.0 0.0 0.1 0.4 0.5 0.8 0.4 0.4 0.7 0.7 2.6 0.5 0.1 0.5 0.9 0.8 1.1 0.4 0.1 0.8 1.3 0.7 0.3 0.4 0.0 1.2 0.6 0.6 2.5 1.4 0.1 0.8 0.6 1.1 0.7 0.6 0.3 0.4 0.8 0.7 0.1 0.9 0.6 0.7 1.0 0.6 0.3 1.1 1.3 1.6 1.6 1.7 1.3 0.8 0.4 2.0 0.1 0.6 0.5 0.8 0.6 0.4 0.1 0.0 15.2 0.0 3.9 0.0 1.2 7.3 0.0 0.0 0.1 4.6 0.6 8.1 0.1 0.3 0.5 3.6 0.6 0.9 2.1 0.8 0.3 0.3 0.3 0.1 0.6 0.7 0.0 0.0 0.0 0.1 0.9 1.4 2.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.8 0.4 0.0 0.0 0.2 0.1 1.4 0.0 1.1 0.0 0.2 1.6 0.0 8.0 1.9 0.2 2.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 7.1 0.0 15.5 0.0 0.3 1.5 3.2 0.4 0.6 10.9 0.0 0.1 NREP "C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17" ENSG00000134986 "Neuronal regeneration related protein" Q16612 5 111662621-111997464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 82.5;Cytotrophoblasts: 84.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 149.5" "Group enriched" "Detected in many" 5 "myeloid DC: 16.0;NK-cell: 4.1;plasmacytoid DC: 16.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 70.3;SH-SY5Y: 76.1" HPA000545 Approved Approved Vesicles NA NA Vesicles "HPA000545: AB_1845721" "unprognostic (2.85e-2)" "unprognostic (1.00e-2)" "unprognostic (2.30e-1)" "unprognostic (1.48e-3)" "unprognostic (4.37e-1)" "unprognostic (2.26e-1)" "unprognostic (8.16e-3)" "unprognostic (1.58e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (3.76e-2)" "unprognostic (2.02e-1)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (5.76e-3)" 4.2 14.4 14.1 5.0 21.9 7.1 6.4 149.5 45.5 8.2 8.5 6.7 4.3 3.5 21.7 4.1 5.2 4.6 16.0 17.2 15.7 10.5 11.7 11.7 6.3 3.3 11.0 21.5 10.4 2.9 1.7 5.0 28.2 27.8 13.1 5.9 16.1 8.3 18.2 39.6 4.7 3.9 13.1 8.0 8.3 5.6 3.0 4.3 34.1 4.7 8.6 3.8 7.4 6.4 0.9 16.2 0.0 2.6 4.1 1.1 1.4 0.1 1.1 70.3 14.9 3.3 7.9 3.3 23.4 13.9 22.2 36.9 0.1 0.4 11.5 7.3 11.3 3.1 0.0 14.6 0.8 11.5 4.6 2.1 9.0 5.9 12.4 4.7 11.9 0.1 7.6 3.7 21.5 7.4 52.5 25.1 13.1 0.1 1.2 23.1 0.2 47.4 8.4 39.8 0.0 5.4 51.0 28.4 3.1 8.5 0.2 16.0 76.1 5.1 0.3 0.5 38.6 2.9 33.1 4.9 27.1 9.1 13.2 2.5 5.6 4.5 14.6 6.0 25.3 5.3 0.0 2.6 0.0 0.0 1.3 0.0 0.9 0.1 0.1 16.0 0.8 0.8 1.1 0.0 4.1 0.6 16.2 0.0 1.4 14.1 21.9 149.5 45.5 15.7 10.5 11.0 21.5 27.8 4.3 6.0 25.0 2.7 1.4 16.1 66.2 29.9 10.2 0.0 9.1 12.2 82.5 84.9 28.2 13.3 2.0 15.7 1.1 0.0 4.9 16.2 34.0 0.8 4.7 8.5 30.5 19.1 20.7 33.7 14.5 0.8 7.8 6.9 13.5 1.8 7.6 12.1 7.6 0.0 21.9 42.5 28.6 12.9 22.3 0.9 11.3 11.0 26.3 4.9 10.7 0.1 NUDT11 "DIPP3b, FLJ10628, hDIPP3beta" ENSG00000196368 "Nudix hydrolase 11" Q96G61 X 51490011-51496596 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;testis: 35.5" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9" "Cancer enhanced" "Detected in many" "testis cancer: 17.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HAP1: 33.6;NTERA-2: 21.0" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.01e-1)" "unprognostic (2.57e-1)" "unprognostic (8.21e-2)" "unprognostic (1.93e-3)" "unprognostic (6.61e-2)" "unprognostic (1.13e-3)" "unprognostic (5.52e-3)" "unprognostic (1.25e-1)" "unprognostic (2.25e-2)" "unprognostic (2.18e-1)" "unprognostic (8.41e-2)" "unprognostic (1.33e-1)" "unprognostic (7.80e-12)" "unprognostic (4.34e-4)" "unprognostic (1.17e-2)" "unprognostic (2.78e-1)" "unprognostic (3.94e-4)" 1.2 5.4 11.2 1.4 21.9 1.6 2.8 7.4 26.1 3.8 2.6 0.8 4.4 1.7 5.9 4.3 1.9 1.6 2.2 0.8 7.0 17.9 0.9 0.6 0.8 1.1 5.3 12.7 10.0 3.8 0.5 2.8 0.6 5.3 10.1 1.4 0.5 1.3 11.9 0.6 1.7 1.5 5.0 1.8 0.9 0.9 35.5 1.1 3.6 1.0 0.2 1.1 1.7 1.6 0.5 0.4 0.0 0.2 1.9 3.7 1.0 0.0 0.5 10.1 0.0 8.8 11.2 0.0 4.7 1.3 0.2 0.2 0.0 0.0 0.0 0.2 5.7 5.6 0.7 33.6 11.5 0.1 0.0 2.2 0.0 0.0 0.0 4.1 0.0 2.2 6.8 4.6 3.0 11.1 1.9 7.9 10.4 0.0 0.0 9.5 0.2 12.7 0.0 21.0 0.0 8.5 0.0 7.1 0.0 2.1 0.0 0.0 6.6 2.0 0.0 1.8 5.2 0.0 0.0 4.6 2.4 11.1 0.7 0.0 4.4 2.0 7.2 1.5 0.0 0.9 0.0 0.0 0.0 3.7 0.0 1.4 0.5 1.2 1.9 0.4 0.3 0.2 3.1 0.0 1.9 0.2 0.2 0.0 1.0 11.2 21.9 7.4 14.9 7.0 17.9 5.3 12.7 5.3 1.1 0.0 0.0 0.0 4.8 13.6 1.5 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 9.4 0.0 0.0 0.0 1.3 0.9 4.1 9.3 0.0 0.0 0.1 0.0 0.0 0.0 0.8 10.2 8.1 0.6 5.0 0.0 0.0 0.9 2.2 0.0 19.4 0.0 0.1 0.0 12.7 13.4 11.9 8.0 0.2 0.0 0.0 1.1 OSBPL5 "KIAA1534, ORP5" ENSG00000021762 "Oxysterol binding protein like 5" Q9H0X9 11 3087116-3166739 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038335, HPA038712, HPA058727" Approved Enhanced Vesicles NA NA Vesicles "HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (3.69e-2)" "unprognostic (8.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (4.03e-3)" "unprognostic (1.29e-1)" "unprognostic (3.49e-3)" "unprognostic (2.16e-3)" "unprognostic (9.44e-2)" "unprognostic (2.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.50e-2)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" 17.6 7.0 4.2 10.3 6.2 17.8 20.7 4.4 8.8 24.7 15.6 7.5 24.0 9.0 17.1 15.9 8.1 12.6 13.8 10.0 4.6 6.5 8.1 2.7 12.9 10.5 6.9 6.4 9.6 8.4 2.4 6.5 7.8 9.8 15.9 5.2 9.0 17.1 17.5 28.0 17.8 9.6 20.1 11.9 20.3 10.2 4.4 6.3 36.5 9.3 9.6 3.8 14.3 17.7 0.0 2.7 1.0 10.1 10.0 9.3 3.9 1.7 2.7 3.3 3.8 9.9 4.6 0.0 8.9 4.3 3.6 2.5 0.0 5.1 0.0 2.7 5.0 2.5 6.6 0.6 2.5 0.5 1.7 2.5 7.4 8.8 0.0 8.0 6.6 1.1 7.1 2.9 1.3 1.3 2.7 2.4 13.4 2.6 0.0 1.8 4.9 14.4 36.7 2.4 1.1 5.8 7.5 4.5 1.0 1.4 1.6 5.5 0.6 3.6 13.1 3.4 2.0 5.4 17.5 8.1 4.5 6.2 10.7 1.5 1.8 0.0 0.2 4.8 12.4 5.7 0.2 3.1 1.0 9.3 4.4 1.2 0.0 1.0 3.4 2.7 0.0 0.6 3.6 0.4 10.0 10.1 1.2 0.1 3.9 4.2 6.2 4.4 8.8 4.6 6.5 6.9 6.4 9.8 6.3 0.0 5.6 0.5 2.3 4.2 12.7 2.8 2.5 5.3 3.4 3.5 7.9 0.3 1.7 2.9 0.0 7.5 7.7 0.0 1.7 0.4 7.8 2.9 1.1 0.0 1.7 58.8 0.0 3.7 5.9 1.0 8.3 2.5 3.3 0.0 5.4 3.5 2.4 7.0 15.9 1.7 0.6 12.9 8.5 0.0 0.6 5.9 0.0 7.7 6.8 2.2 P2RY11 P2Y11 ENSG00000244165 "Purinergic receptor P2Y11" Q96G91 19 10111538-10115372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Hofbauer cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 6.8;MAIT T-cell: 16.4;memory CD8 T-cell: 6.9;naive CD8 T-cell: 5.4;NK-cell: 10.7" "Group enriched" "Detected in all" 6 "NK-cells: 10.7;T-cells: 16.4" "Cell line enhanced" "Detected in many" "HEK 293: 20.5;NB-4: 21.3" HPA014232 Approved NA NA "HPA014232: AB_1854883" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (2.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.82e-1)" "unprognostic (2.79e-2)" "unprognostic (2.34e-1)" "unprognostic (5.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.93e-1)" "unprognostic (2.04e-3)" "unprognostic (2.22e-2)" "unprognostic (4.32e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (1.58e-1)" "prognostic favorable (1.77e-4)" 9.0 3.6 4.8 21.7 6.7 8.5 4.9 5.5 6.5 3.1 9.4 6.0 3.4 7.8 3.2 3.2 4.4 5.3 3.5 3.8 5.1 4.6 2.9 4.9 13.6 11.1 3.2 2.3 4.3 6.3 1.5 4.2 3.4 4.0 5.0 1.8 5.0 7.6 2.5 6.6 9.0 9.2 2.8 4.9 13.4 5.1 4.9 2.5 7.5 5.2 2.6 22.8 2.9 3.1 1.5 1.2 2.1 2.1 10.7 16.4 4.3 3.6 3.4 1.2 3.9 1.6 1.3 6.7 1.5 0.6 0.7 1.2 4.0 1.8 6.4 2.3 0.3 0.6 5.3 1.0 3.0 0.1 3.1 20.5 5.7 5.1 2.4 2.3 3.0 9.6 2.2 2.5 1.2 1.7 1.4 0.4 4.1 2.8 8.5 0.7 5.3 4.5 21.3 7.6 3.1 4.2 6.8 2.4 3.7 1.2 4.6 4.7 7.8 1.0 2.7 8.4 0.5 2.1 8.5 1.4 4.3 2.1 7.7 2.8 17.3 12.4 2.3 3.1 12.7 3.8 2.1 1.9 0.3 6.8 2.1 16.4 1.5 1.5 6.9 1.2 1.0 1.2 5.4 0.4 10.7 1.4 0.7 1.8 4.3 4.8 6.7 5.5 5.2 5.1 4.6 3.2 2.3 4.0 2.5 6.0 3.0 0.0 2.5 4.2 7.7 1.4 5.1 2.7 2.3 1.8 2.0 1.4 1.7 1.3 0.2 2.1 1.3 23.3 1.0 1.0 1.2 1.6 3.5 3.0 39.3 6.4 3.5 2.5 1.3 0.0 3.1 6.7 1.7 0.0 4.6 1.6 1.1 1.5 1.1 1.0 5.3 0.0 1.7 1.7 3.6 3.4 1.1 12.7 3.4 1.1 P3H4 "LEPREL4, NO55, SC65" ENSG00000141696 "Prolyl 3-hydroxylase family member 4 (non-enzymatic)" Q92791 17 41801947-41812604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 4.4;MAIT T-cell: 5.9;memory CD4 T-cell: 2.9;memory CD8 T-cell: 2.8;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 9.5" "Group enriched" "Detected in many" 9 "NK-cells: 9.5;T-cells: 5.9" "Cell line enriched" "Detected in many" 12 "OE19: 144.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022520 Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Vesicles" "HPA022520: " "unprognostic (9.11e-2)" "unprognostic (3.72e-3)" "unprognostic (3.66e-2)" "unprognostic (3.72e-2)" "unprognostic (8.69e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-3)" "unprognostic (1.94e-1)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (4.48e-6)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (8.96e-2)" "unprognostic (1.96e-3)" 5.0 13.6 5.4 6.0 5.0 0.5 12.7 7.8 6.2 11.5 8.9 2.9 17.9 8.6 11.9 10.4 5.3 8.3 11.2 9.7 4.3 5.0 7.9 2.7 6.4 6.7 5.5 6.0 12.2 34.5 11.5 11.8 12.8 4.4 10.0 4.3 7.3 10.9 9.5 3.9 7.7 7.6 10.5 3.7 4.4 5.4 3.5 5.9 0.9 20.9 4.5 4.4 7.6 7.1 0.8 0.3 0.0 0.2 9.5 5.9 1.5 1.2 6.6 4.0 10.4 4.3 4.2 3.9 9.7 4.9 3.8 5.2 3.2 1.8 0.2 4.1 8.4 2.9 2.2 3.4 4.7 1.3 2.6 5.4 1.6 6.4 4.3 5.3 0.3 0.5 4.4 1.3 3.3 2.9 8.9 4.7 0.4 0.2 1.6 2.3 4.4 0.0 0.8 2.5 144.7 3.6 3.3 4.4 4.3 2.3 0.3 2.0 4.1 1.8 11.8 4.0 2.6 6.8 1.1 4.9 3.7 5.4 6.7 4.8 1.5 0.3 0.0 5.6 1.5 5.6 0.0 0.2 0.0 4.4 0.0 5.9 0.6 2.9 2.8 0.3 0.8 3.5 4.2 0.0 9.5 0.0 0.0 0.7 1.5 5.4 5.0 7.8 6.2 4.3 5.0 5.5 6.0 4.4 5.9 0.0 8.5 0.0 4.7 0.0 3.4 8.3 7.6 1.4 3.4 5.2 7.9 8.8 6.6 19.2 0.4 6.0 9.1 23.3 5.8 23.2 10.0 7.7 1.1 2.4 2.5 25.4 2.4 12.3 0.6 0.4 19.5 1.0 0.0 1.0 13.6 11.6 8.0 10.5 19.4 4.8 2.5 19.4 3.4 2.5 8.3 0.0 4.5 2.9 11.8 1.8 PARP15 "FLJ40597, pART7" ENSG00000173200 "Poly(ADP-ribose) polymerase family member 15" Q460N3 3 122577602-122639047 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.9;lymphoid tissue: 40.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5" "Group enriched" "Detected in many" 6 "B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3" "Cell line enhanced" "Detected in some" "HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6" "Not detected" "Not detected" HPA035757 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035757: AB_10669656" "unprognostic (8.19e-3)" "unprognostic (2.88e-3)" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (9.01e-5)" "unprognostic (4.79e-2)" "unprognostic (1.83e-2)" "unprognostic (3.91e-2)" "unprognostic (5.40e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "unprognostic (9.24e-7)" "unprognostic (9.03e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (1.22e-2)" 2.4 0.9 0.5 24.5 0.4 9.8 1.3 0.3 0.8 1.2 2.8 1.2 0.5 1.0 1.5 2.3 1.9 1.4 2.8 1.5 0.6 0.5 1.5 1.9 5.6 20.3 0.6 0.6 1.1 2.7 0.0 1.0 1.0 0.6 1.3 2.1 1.8 5.5 0.2 2.6 0.7 22.9 0.9 0.9 40.4 1.7 1.7 0.4 9.4 1.9 1.7 34.8 3.6 1.2 11.9 1.2 1.3 0.6 5.2 9.3 2.7 0.6 0.2 0.5 0.5 0.2 0.3 0.6 0.3 0.2 0.1 0.1 0.3 1.0 0.8 0.6 0.2 0.3 0.6 0.1 0.0 0.0 1.9 0.2 10.6 0.8 0.5 0.2 0.7 0.5 2.2 0.1 0.4 0.2 0.4 2.4 6.6 0.3 2.1 0.0 0.5 3.2 0.7 0.7 0.2 0.3 4.9 0.4 0.6 0.0 1.0 0.8 0.5 0.3 0.2 0.3 0.6 0.8 5.1 12.6 0.4 1.1 0.5 0.4 1.0 0.7 2.4 0.7 0.3 0.2 1.3 0.2 0.1 9.3 0.5 6.5 11.2 5.0 6.4 0.9 11.9 4.3 5.9 0.7 5.2 0.6 1.2 4.5 2.7 0.5 0.4 0.3 0.8 0.6 0.5 0.6 0.6 0.6 0.4 17.9 12.8 22.9 0.0 0.5 0.0 0.4 0.0 18.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 18.5 0.5 6.6 0.0 0.0 2.5 3.5 0.0 0.0 3.2 1.7 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 12.9 0.0 0.0 PCSK6 "PACE4, SPC4" ENSG00000140479 "Proprotein convertase subtilisin/kexin type 6" P29122 15 101297142-101525202 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.3;liver: 76.0;lymphoid tissue: 37.4" "Group enriched" "Detected in many" 9 "Hepatocytes: 210.8;Horizontal cells: 185.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 24.9;CACO-2: 17.4;HEK 293: 26.1;Hep G2: 23.3;OE19: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004774 Uncertain "Secreted to extracellular matrix" NA NA 38000 "HPA004774: AB_1079583" "prognostic favorable (9.99e-4)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (2.46e-2)" "unprognostic (9.83e-2)" "unprognostic (8.14e-2)" "unprognostic (2.20e-3)" "unprognostic (8.56e-2)" "unprognostic (2.16e-1)" "unprognostic (2.39e-2)" "unprognostic (3.85e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.06e-7)" "unprognostic (2.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 3.0 1.5 5.1 1.5 25.1 0.9 6.1 4.5 11.5 1.5 8.4 41.9 0.0 3.6 1.4 2.5 4.8 1.9 1.9 10.1 8.9 5.7 1.7 76.0 2.3 4.6 38.8 8.4 4.0 1.7 0.5 3.1 16.5 29.0 1.9 8.2 0.7 1.5 0.7 3.5 4.0 4.8 1.9 69.3 37.4 5.3 6.6 24.5 3.7 1.4 3.5 1.3 1.6 1.6 2.6 0.7 1.9 2.4 7.5 1.4 2.5 8.1 6.7 1.2 0.8 0.0 0.1 24.9 0.5 1.3 0.0 0.1 17.4 3.8 0.1 1.1 0.2 0.5 5.6 6.7 0.7 0.1 1.2 26.1 14.3 3.4 23.3 0.8 2.0 0.3 0.4 4.6 0.1 0.2 0.1 0.0 1.8 11.0 0.2 0.0 3.9 0.1 1.8 3.5 31.6 2.9 0.1 0.2 1.8 2.2 11.6 3.4 3.6 11.5 0.8 3.7 3.8 0.9 9.1 0.1 0.1 0.7 0.2 0.0 0.3 0.3 0.3 0.1 0.3 3.3 1.3 0.6 1.9 0.6 0.8 0.7 1.1 1.0 0.5 0.2 2.6 1.4 1.3 1.1 7.5 2.4 0.7 0.2 2.5 5.1 25.1 4.5 10.4 8.9 5.7 38.8 8.4 29.0 24.5 3.0 1.1 0.8 0.2 0.3 1.9 1.5 7.6 1.4 1.2 1.8 19.6 5.6 0.0 0.4 1.3 4.3 5.1 0.0 0.7 21.0 2.8 0.8 0.0 210.8 1.3 185.9 0.0 19.6 6.3 2.2 9.8 0.3 0.0 0.0 4.1 1.5 5.2 7.0 0.0 0.0 1.5 0.0 0.9 4.2 2.1 0.1 2.7 1.5 4.5 0.1 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907186-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 48.2" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 30.6;Ductal cells: 17.7;Horizontal cells: 25.4;T-cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6" "Group enriched" "Detected in many" 27 "granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6" "Group enriched" "Detected in some" 6 "ASC diff: 56.8;HHSteC: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 24000 "Golgi apparatus, Vesicles" "HPA046183: AB_2679573, HPA066271: AB_2685645" "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 26.1 48.2 1.1 10.1 1.5 0.1 21.2 0.6 1.8 13.8 5.6 1.1 15.0 1.5 9.8 10.2 2.7 5.3 20.6 13.9 0.9 1.9 4.3 1.8 2.3 3.5 0.8 1.6 33.4 32.8 5.0 14.4 8.5 6.4 8.5 4.0 16.7 6.0 16.2 9.8 5.1 2.2 4.0 2.1 2.3 8.6 5.4 0.0 1.1 11.5 4.4 4.6 13.5 10.0 0.4 0.0 7.1 0.0 12.6 13.6 2.9 0.0 3.0 1.6 0.0 56.8 1.7 0.0 0.3 0.3 0.2 0.3 0.0 0.5 2.8 0.5 2.8 2.0 0.1 0.0 0.1 0.1 0.0 1.2 0.0 0.6 0.1 17.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.8 0.0 2.6 0.0 0.0 3.8 0.0 5.4 1.2 0.7 0.0 0.7 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 7.1 13.6 0.0 1.1 0.4 1.5 5.8 0.0 0.0 0.1 5.1 0.2 12.6 0.0 0.0 0.1 2.9 1.1 1.5 0.6 1.8 0.9 1.9 0.8 1.6 6.4 0.0 0.0 0.0 1.7 5.5 2.7 1.0 3.1 30.6 0.0 1.2 5.2 0.0 0.1 0.0 17.7 7.6 7.1 0.0 0.0 3.8 0.1 7.6 1.2 0.0 0.0 0.3 25.4 1.7 3.7 0.3 9.4 0.3 0.0 0.0 1.0 0.7 1.1 3.7 0.0 2.1 0.1 0.3 6.5 2.1 0.3 1.7 1.8 0.0 18.5 0.6 3.1 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 758.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 43.1;T-47d: 112.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favorable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.3 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.9 0.1 0.1 0.2 1.1 0.0 0.6 0.0 0.1 0.1 1.8 0.3 0.1 0.4 7.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.1 0.1 0.2 0.2 0.2 0.5 0.0 1.3 0.2 43.1 0.0 0.1 1.2 0.3 0.3 0.0 1.2 112.0 0.1 0.1 0.2 0.2 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.9 0.0 0.1 0.4 0.4 61.1 0.0 0.0 54.1 0.0 0.0 117.7 1.7 8.9 0.0 18.0 0.0 1.6 0.1 0.2 0.1 0.0 45.6 0.2 0.0 6.3 1.8 1.2 5.2 0.0 0.0 0.0 0.0 0.5 0.0 1.8 2.9 0.0 758.4 0.3 0.0 0.3 0.2 0.2 0.0 0.1 0.0 1.0 0.0 PLCG1 "NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1" ENSG00000124181 "Phospholipase C gamma 1" P19174 20 41136960-41196801 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4" "Group enriched" "Detected in many" 8 "NK-cells: 4.0;T-cells: 8.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004277, HPA036681, HPA036682" Approved Enhanced Cytosol NA NA Cytosol "CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246" "unprognostic (2.77e-1)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (4.31e-2)" "unprognostic (5.82e-2)" "unprognostic (2.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "prognostic favorable (4.72e-4)" "unprognostic (3.32e-1)" "unprognostic (2.73e-3)" "unprognostic (1.82e-1)" "unprognostic (2.65e-1)" "unprognostic (9.27e-2)" "unprognostic (2.79e-2)" 20.2 15.1 25.1 20.9 22.1 8.3 34.9 52.6 26.8 19.9 13.9 23.4 12.5 16.5 27.6 13.9 13.5 17.0 18.7 20.9 25.4 13.6 15.3 6.8 19.3 30.7 18.5 20.5 28.7 9.1 16.9 14.2 22.2 18.7 18.4 13.2 20.0 13.2 20.6 13.4 22.3 17.1 22.2 15.4 20.1 12.4 19.9 23.9 48.1 28.5 11.9 21.9 17.1 21.1 0.7 0.0 0.0 0.0 4.0 8.0 3.3 5.4 6.9 33.2 24.3 13.3 9.3 10.6 8.9 11.5 18.0 15.3 16.6 1.8 12.1 11.0 9.7 18.9 10.1 14.4 16.0 10.5 3.4 7.7 0.8 11.5 19.5 10.1 4.7 3.3 11.9 9.0 13.3 10.4 16.3 20.0 26.0 9.0 8.0 16.2 40.4 29.2 3.7 12.3 7.0 12.7 23.3 24.2 5.9 9.9 10.0 11.8 22.5 16.0 7.5 16.0 19.4 8.7 5.6 21.6 43.1 14.0 13.7 10.8 8.9 3.9 10.0 10.2 5.2 17.8 0.0 0.0 0.0 5.9 0.0 8.0 0.3 5.2 4.9 0.0 0.7 5.7 5.4 0.0 4.0 0.0 0.0 4.4 3.3 25.1 22.1 52.6 26.8 25.4 13.6 18.5 20.5 18.7 23.9 14.9 6.5 0.8 1.8 4.9 3.7 9.2 0.0 1.4 3.4 3.5 9.8 1.3 0.0 2.7 5.1 15.8 6.4 0.0 1.4 1.6 6.1 1.9 1.1 2.5 3.2 3.2 1.7 13.5 2.2 5.3 14.1 1.7 3.3 1.0 9.8 7.2 2.8 3.7 17.3 2.4 4.6 12.9 5.1 11.6 11.5 6.0 0.7 6.9 5.1 0.9 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 147.8;T-47d: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 16.4 14.9 5.2 0.4 2.7 4.5 2.0 3.5 5.9 11.7 6.8 1.1 14.6 0.0 23.2 12.6 28.5 20.7 0.2 8.1 10.7 0.0 0.4 0.0 6.7 1.2 14.8 0.0 0.4 2.6 11.3 4.5 12.7 147.8 23.5 0.0 0.0 0.5 23.1 6.0 0.0 0.0 0.9 1.6 2.4 0.8 14.3 0.0 30.8 3.3 0.3 0.7 10.8 2.1 9.5 9.7 51.9 0.2 30.0 3.2 8.7 1.4 28.1 0.0 0.0 0.0 2.5 0.0 14.4 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 17.9 18.6 2.7 128.0 125.8 2.8 105.2 22.9 18.7 68.2 17.4 3.9 55.6 8.3 96.4 5.7 109.7 37.3 0.0 69.2 180.6 32.4 45.1 9.2 6.0 13.5 0.0 80.9 51.5 8.9 2.3 11.8 11.2 23.6 5.4 25.3 3.5 71.6 40.7 10.3 2.5 2.7 0.0 79.3 72.4 10.4 90.5 108.6 6.4 24.3 54.0 PRF1 "HPLH2, P1, PFP" ENSG00000180644 "Perforin 1" P14222 10 70597348-70602775 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Cytolysis "Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 100.3;lymphoid tissue: 38.7" "Cell type enriched" "Detected in some" 9 "T-cells: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1" "Group enriched" "Detected in many" 48 "NK-cells: 65.1;T-cells: 100.3" "Cell line enriched" "Detected in some" 11 "HDLM-2: 72.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002436, HPA037940" Approved Approved Cytosol "Intracellular and membrane" NA NA 960000 Cytosol "CAB002436: AB_563955, HPA037940: AB_2675747" "unprognostic (6.11e-3)" "unprognostic (1.26e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.09e-4)" "unprognostic (1.87e-2)" "prognostic favorable (3.54e-4)" "unprognostic (6.98e-3)" "unprognostic (2.62e-1)" "unprognostic (1.44e-3)" "unprognostic (1.69e-2)" "unprognostic (5.22e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (7.38e-2)" "unprognostic (2.70e-1)" "unprognostic (7.97e-3)" "unprognostic (5.22e-3)" 8.8 1.3 0.9 5.5 1.1 15.3 2.4 0.5 0.7 1.7 3.8 0.4 0.2 1.4 4.4 2.9 2.7 1.7 5.3 4.1 0.8 0.9 1.8 6.5 19.6 11.3 2.5 0.3 2.1 1.6 0.0 1.1 3.1 1.2 3.3 0.8 3.9 2.5 3.3 2.6 0.9 5.1 1.2 1.4 38.7 3.1 1.6 0.2 12.7 2.8 1.0 10.3 3.2 1.7 0.4 0.3 1.7 0.2 65.1 100.3 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 0.4 0.0 2.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 100.3 0.1 70.9 0.4 14.6 54.9 0.2 0.2 6.2 36.1 1.7 65.1 0.2 0.3 11.1 46.7 0.9 1.1 0.5 0.7 0.8 0.9 2.5 0.3 1.2 0.2 3.0 22.3 6.5 0.0 0.3 0.0 0.8 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.1 8.1 2.1 0.1 0.0 0.0 8.6 5.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.6 0.6 203.1 0.0 0.0 PRKCH "PKC-L, PKCL, PRKCL" ENSG00000027075 "Protein kinase C eta" P24723 14 61187559-61550976 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 56.0;Erythroid cells: 70.0;Ito cells: 55.9;T-cells: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6" "Group enriched" "Detected in many" 14 "NK-cells: 27.3;T-cells: 35.3" "Cell line enhanced" "Detected in many" "BEWO: 30.4;HUVEC TERT2: 39.9;MOLT-4: 26.5;RT4: 16.8;TIME: 26.1" "Group enriched" "Detected in many" 6 "basal ganglia: 25.0;thalamus: 19.5" "Low region specificity" "Detected in many" "HPA026294, HPA053709" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026294: AB_10603988, HPA053709: AB_2682237" "unprognostic (1.42e-1)" "unprognostic (3.89e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.55e-6)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (4.14e-1)" "unprognostic (1.94e-1)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (6.98e-2)" "unprognostic (4.73e-3)" 17.5 5.4 5.0 21.6 22.0 11.2 14.7 2.8 6.1 13.6 10.3 6.2 6.9 5.1 19.1 7.0 20.1 8.6 12.7 10.1 6.8 4.4 8.1 5.5 24.1 27.6 5.9 2.5 7.1 5.9 8.8 15.5 22.7 7.2 9.8 5.0 9.1 24.7 10.8 9.1 15.9 16.0 10.5 5.7 25.9 6.0 4.3 6.4 54.6 15.1 10.6 34.6 13.2 14.4 0.4 2.2 1.5 0.7 27.3 35.3 17.9 6.4 2.2 0.3 1.7 1.0 0.2 30.4 0.1 0.5 0.3 0.3 0.7 3.8 0.1 4.6 0.0 0.6 4.4 0.2 4.9 0.5 0.8 2.9 0.0 0.7 0.2 0.4 0.0 0.9 0.8 5.1 0.2 3.5 0.4 39.9 12.9 0.0 0.1 2.3 11.7 26.5 0.2 0.5 4.6 3.1 2.2 1.1 0.0 0.0 16.8 1.1 1.9 0.7 5.9 3.6 5.6 5.8 0.5 26.1 0.7 5.2 0.8 0.3 0.5 0.1 0.2 1.1 0.4 1.3 0.1 0.7 0.5 30.0 0.4 23.9 0.4 23.0 35.3 2.2 0.3 28.5 27.6 1.5 27.3 0.2 0.7 18.6 17.9 5.0 22.0 2.8 6.1 6.8 4.4 5.9 2.5 7.2 6.4 6.0 10.7 4.6 15.8 16.7 0.2 3.9 10.2 10.7 18.2 0.0 0.0 23.4 3.3 4.6 25.5 56.0 1.7 70.0 5.9 16.9 3.7 13.1 1.1 1.0 5.6 0.0 11.3 55.9 11.1 3.6 1.7 9.0 15.1 5.4 2.6 9.3 4.4 2.9 6.3 0.8 0.3 0.0 4.1 0.0 2.1 23.3 40.4 137.1 0.7 24.4 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267713-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.1" "Group enriched" "Detected in some" 5 "T-cells: 31.9;Undifferentiated cells: 11.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons and medulla: 13.9" "Group enriched" "Detected in many" 5 "gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1" "Group enriched" "Detected in many" 30 "NK-cells: 30.1;T-cells: 25.4" "Group enriched" "Detected in some" 4 "ASC diff: 1.4;HSkMC: 1.6;REH: 2.4;U-138 MG: 1.8" "Low region specificity" "Detected in many" HPA049668 Enhanced NA NA "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 3.9 0.9 0.7 9.6 2.5 1.8 9.3 1.4 1.4 5.5 10.0 0.7 0.9 1.1 4.1 2.2 2.1 2.5 4.9 2.3 0.8 0.8 1.5 1.8 3.4 8.9 1.0 3.5 2.3 0.8 0.8 4.5 0.4 13.9 2.1 12.8 11.2 2.6 3.5 0.9 1.3 2.4 2.0 3.6 10.9 2.0 0.9 0.8 1.8 2.5 0.1 3.1 3.3 3.2 0.0 0.0 0.9 0.1 30.1 25.4 4.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 25.4 0.0 12.7 0.0 3.5 15.2 0.0 0.0 0.6 8.9 0.9 30.1 0.1 0.0 0.0 4.1 0.7 2.5 1.4 1.4 0.8 0.8 1.0 3.5 13.9 0.8 3.0 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 1.2 3.1 2.1 0.0 0.0 0.2 1.7 0.0 4.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 31.9 11.2 0.0 PYHIN1 "IFIX, MGC23885" ENSG00000163564 "Pyrin and HIN domain family member 1" Q6K0P9 1 158930796-158977054 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.4;lymphoid tissue: 23.3" "Cell type enriched" "Detected in some" 11 "T-cells: 126.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0" "Group enriched" "Detected in many" 5 "NK-cells: 11.4;T-cells: 33.4" "Cell line enriched" "Detected in some" 6 "U-698: 33.1" "HPA051224, HPA055373" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA051224: AB_2681394, HPA055373: " "unprognostic (1.64e-3)" "unprognostic (1.75e-3)" "unprognostic (2.93e-3)" "unprognostic (2.64e-3)" "unprognostic (3.99e-2)" "unprognostic (3.57e-3)" "unprognostic (2.44e-3)" "unprognostic (2.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.47e-3)" "unprognostic (3.94e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-6)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-2)" "unprognostic (4.45e-3)" 4.0 0.6 0.5 20.1 0.5 3.9 2.1 0.4 0.4 2.0 2.7 0.2 0.3 1.2 2.2 1.4 1.7 1.6 3.2 1.2 0.6 0.5 1.8 2.6 11.7 18.8 0.7 0.0 1.6 0.8 0.0 0.8 1.7 0.4 2.6 1.8 1.2 3.4 1.2 0.7 0.9 7.8 0.4 1.3 20.7 2.0 1.0 0.0 6.6 2.5 1.9 23.3 5.7 1.6 4.9 0.1 1.2 0.1 11.4 33.4 6.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 33.1 0.0 5.1 0.0 0.4 0.1 0.1 33.4 0.1 19.1 4.9 14.2 25.2 0.1 2.4 4.8 16.0 1.2 11.4 0.1 0.1 21.0 6.0 0.5 0.5 0.4 0.4 0.6 0.5 0.7 0.0 0.4 0.0 11.9 3.2 9.5 0.7 0.3 0.2 0.3 0.0 9.4 3.4 3.5 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.4 2.3 1.3 2.1 0.0 0.0 3.1 4.3 0.0 0.0 1.4 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.1 0.5 0.1 126.8 0.0 0.3 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0;stomach 1: 36.6" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 200.3;granulocytes: 234.0;Late spermatids: 149.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 4.6;NK-cell: 5.0" "Group enriched" "Detected in many" 4 "NK-cells: 5.0;T-cells: 4.6" "Cell line enhanced" "Detected in many" "HEL: 20.9;hTCEpi: 16.0;hTERT-HME1: 19.4;U-87 MG: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 37000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 1.1 2.4 13.8 2.3 11.3 1.0 10.8 0.8 30.0 4.5 4.4 0.3 0.0 4.5 1.1 0.7 17.0 1.3 9.8 0.9 12.0 7.9 0.8 1.4 6.2 0.7 4.6 18.4 0.7 5.3 1.3 3.6 2.4 8.6 18.0 4.8 0.0 12.8 3.3 0.6 13.2 4.3 1.1 2.1 1.8 36.6 4.8 0.4 0.1 0.7 13.9 5.9 6.8 7.1 0.0 0.0 1.1 0.0 5.0 4.6 3.4 2.5 7.4 0.2 0.0 0.5 6.8 0.0 0.5 4.5 0.6 0.4 0.0 2.9 0.4 0.0 1.3 5.8 4.9 0.0 3.0 0.1 0.0 0.2 20.9 1.8 0.0 0.9 1.1 2.3 5.4 16.0 8.8 19.4 7.3 0.2 0.1 0.0 1.3 5.5 2.5 0.0 2.4 0.1 4.6 5.0 0.0 0.0 0.1 1.4 9.6 0.0 3.6 0.7 4.5 0.0 0.0 2.8 0.1 0.1 6.5 0.2 3.3 0.6 0.1 0.0 0.0 56.8 11.9 0.3 1.1 0.0 0.2 4.6 0.0 1.1 0.0 1.5 2.3 0.0 0.0 0.6 2.3 0.5 5.0 0.0 0.0 0.0 3.4 13.8 11.3 0.8 30.0 12.0 7.9 4.6 18.4 8.6 0.4 44.7 32.8 0.0 6.7 22.8 1.7 0.4 15.3 6.7 21.6 5.2 2.0 5.4 1.7 5.2 200.3 0.7 3.1 0.0 35.6 4.0 2.5 73.1 234.0 0.8 0.6 6.4 4.1 3.1 0.8 149.0 2.0 2.4 6.8 1.8 17.2 1.3 24.0 17.5 0.4 0.0 0.4 6.5 1.3 2.2 1.2 43.0 2.4 20.1 8.1 27.8 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113242-88175467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.5;tongue: 38.1" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 41.2;Cytotrophoblasts: 78.5;Melanocytes: 124.9;Suprabasal keratinocytes: 86.1;Syncytiotrophoblasts: 45.8" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Region enriched" "Detected in single" 5 "pons and medulla: 3.2" "Group enriched" "Detected in many" 5 "NK-cell: 15.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 5 "dendritic cells: 4.2;NK-cells: 15.3" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.4;hTCEpi: 69.6;hTERT-HME1: 62.0;SK-MEL-30: 37.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071701 Uncertain "Nuclear bodies,Mitochondria" NA NA "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favorable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 1.8 15.6 0.4 1.2 0.4 0.4 4.6 0.3 0.6 10.8 1.6 1.2 2.8 1.0 7.0 8.7 29.9 2.8 8.2 1.7 0.6 0.5 2.6 0.8 5.3 0.4 0.5 0.2 3.0 2.3 0.9 4.6 7.7 3.2 4.0 0.4 35.5 4.9 5.2 0.5 24.9 2.4 2.7 0.7 1.3 0.9 5.3 0.1 1.6 6.6 38.1 21.0 4.2 13.3 0.0 4.2 0.5 1.3 15.3 1.8 0.6 2.3 0.3 0.0 0.1 0.0 0.5 0.1 1.4 5.8 2.3 4.3 1.0 1.0 0.1 1.4 1.5 0.2 15.9 1.2 19.4 3.2 0.2 1.1 11.7 1.5 0.0 0.2 0.1 0.1 0.5 69.6 0.3 62.0 2.9 2.7 0.2 0.0 0.2 0.0 0.0 0.1 3.9 1.8 0.1 0.0 0.1 0.0 0.1 4.5 8.9 0.4 0.2 0.0 0.0 37.4 1.4 3.5 1.0 1.5 0.0 1.0 0.0 0.2 0.3 1.4 0.0 0.3 0.4 0.2 0.0 0.6 0.1 1.6 0.6 0.9 0.0 0.5 1.8 1.5 0.0 0.1 0.9 0.5 15.3 1.3 4.2 0.9 0.6 0.4 0.4 0.3 0.6 0.6 0.5 0.5 0.2 3.2 0.1 0.0 4.1 0.0 12.1 41.2 0.0 0.1 0.0 4.0 7.9 0.0 0.0 78.5 3.3 1.3 0.0 1.5 1.1 0.0 1.0 6.8 6.7 2.1 16.1 0.0 14.7 0.0 0.0 0.0 1.0 0.0 3.1 4.9 124.9 10.8 0.0 0.5 1.8 1.1 1.1 3.2 5.9 0.0 2.8 0.0 3.2 86.1 45.8 1.5 2.1 22.8 RALGDS "RalGEF, RGDS, RGF" ENSG00000160271 "Ral guanine nucleotide dissociation stimulator" Q12967 9 133097720-133149334 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 88.7;Urothelial cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 16.7;MAIT T-cell: 6.6;memory CD4 T-cell: 7.6;memory CD8 T-cell: 12.0;naive CD8 T-cell: 6.5;NK-cell: 5.7;T-reg: 13.1" "Group enriched" "Detected in many" 9 "NK-cells: 5.7;T-cells: 16.7" "Cell line enhanced" "Detected in all" "HDLM-2: 53.1;SH-SY5Y: 33.7" "HPA025961, CAB032582" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB032582: AB_2238105, HPA025961: AB_2671795" "unprognostic (1.01e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.35e-2)" "unprognostic (7.92e-3)" "unprognostic (8.20e-2)" "unprognostic (7.95e-2)" "unprognostic (5.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.91e-2)" "unprognostic (2.88e-1)" "unprognostic (2.69e-3)" "unprognostic (5.03e-2)" "unprognostic (9.54e-3)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" 18.9 19.8 28.2 14.5 43.2 26.3 16.8 33.1 38.1 14.8 11.1 43.6 12.8 13.0 10.3 10.4 28.7 18.8 23.9 18.7 30.4 23.0 6.3 5.7 19.9 18.8 45.6 19.2 26.6 17.4 11.5 31.8 8.2 38.0 11.8 8.0 8.0 21.6 16.7 13.1 24.8 15.3 10.6 44.3 13.4 13.3 3.8 48.0 5.5 12.2 14.5 13.6 17.1 12.7 1.1 0.5 1.3 0.4 5.7 16.7 3.5 2.6 3.8 8.1 10.0 3.1 4.5 6.8 3.1 4.7 3.2 2.1 3.3 5.7 3.9 2.9 5.3 4.9 12.4 8.2 5.7 1.1 53.1 5.8 3.4 7.6 4.7 4.0 5.3 6.2 5.3 8.1 1.7 3.6 8.8 6.6 7.8 6.6 24.8 2.9 8.5 7.6 5.1 5.5 11.7 10.0 7.8 1.9 6.6 3.9 4.5 25.6 33.7 3.7 5.5 4.9 3.3 5.7 5.6 3.5 3.6 3.8 2.7 2.1 1.1 3.0 4.7 3.2 6.1 4.0 1.3 0.4 0.5 16.7 0.2 6.6 1.1 7.6 12.0 0.5 0.3 1.7 6.5 0.2 5.7 0.1 0.5 13.1 3.5 28.2 43.2 33.1 38.1 30.4 23.0 45.6 19.2 38.0 48.0 29.8 13.7 6.9 42.4 49.2 12.3 5.9 12.7 12.0 17.0 8.7 11.8 3.6 3.3 9.9 0.4 26.3 24.7 0.0 5.8 3.4 9.1 38.3 15.1 3.0 11.6 58.8 35.5 37.4 8.3 1.5 12.4 18.0 21.9 1.8 13.4 20.5 10.0 13.5 8.5 2.2 8.5 0.0 11.2 2.3 3.8 88.7 4.9 23.0 15.8 86.8 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Group enriched" "Detected in some" 4 "HDLM-2: 23.2;HEL: 9.5" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in all" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: AB_2668943" "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favorable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.1 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.0 0.1 0.0 0.1 0.2 23.2 0.5 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 3.6 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 3.0 1.0 0.0 0.9 0.3 21.5 0.4 0.0 1.4 2.3 1.8 306.3 0.0 3.3 6.8 0.6 0.3 0.0 0.0 2.8 0.1 2.3 0.2 0.0 0.0 0.1 49.3 57.3 1.8 0.0 1.7 0.9 3.2 1.7 33.3 2.2 27.8 3.9 0.0 4.6 8.1 472.2 0.0 0.9 0.0 0.4 0.1 0.1 9.2 0.4 0.1 RUNX2 "AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1" ENSG00000124813 "Runt related transcription factor 2" Q13950 6 45328157-45664349 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 67.7;monocytes: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 16.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.6;Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB008374, HPA022040, CAB062561, CAB068226, HPA070715" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: " "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (3.99e-2)" "unprognostic (2.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-1)" "unprognostic (1.23e-1)" "unprognostic (3.70e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (3.97e-9)" "prognostic unfavorable (2.24e-4)" "unprognostic (5.52e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (6.66e-5)" 3.7 2.1 4.9 13.7 7.0 15.5 5.7 1.0 7.2 13.5 6.0 5.6 7.4 4.1 3.5 2.3 3.4 2.4 6.8 1.8 7.4 3.5 3.9 1.8 5.3 8.6 6.3 3.4 5.0 1.9 1.3 3.8 3.3 7.2 9.5 7.8 5.4 19.8 14.9 2.2 4.9 10.8 3.4 10.5 6.6 6.0 2.1 7.3 6.5 4.2 4.5 11.7 7.3 8.9 0.1 11.4 5.3 0.6 16.0 10.2 0.7 1.6 0.5 0.3 0.0 1.5 4.0 0.0 1.5 3.6 5.1 7.2 0.0 0.9 0.0 1.8 2.1 2.3 2.0 0.0 1.4 9.4 6.1 0.7 0.0 1.1 0.0 8.0 6.3 0.0 10.8 1.1 4.5 5.1 18.6 0.0 2.5 0.0 29.1 9.1 0.4 0.2 11.0 0.3 1.4 0.2 0.0 24.3 0.0 5.0 3.2 0.0 0.0 1.1 0.0 1.8 4.5 1.7 0.5 0.2 5.2 4.2 8.0 5.5 9.2 0.0 25.4 5.9 2.4 2.3 5.3 0.6 3.2 1.2 0.1 10.2 0.1 2.8 3.2 1.8 0.1 0.5 1.5 4.8 16.0 0.1 11.4 2.3 0.7 4.9 7.0 1.0 7.2 7.4 3.5 6.3 3.4 7.2 7.3 0.0 2.4 3.7 14.8 2.5 0.0 1.7 0.0 4.0 4.5 3.5 0.0 0.0 0.0 0.6 67.7 0.3 0.0 0.0 0.2 0.0 2.7 15.7 2.3 0.5 3.8 0.0 0.0 1.8 4.5 13.2 1.1 7.9 6.8 20.8 0.7 0.0 0.4 0.0 2.1 2.2 0.0 6.5 2.5 0.9 0.4 1.4 0.1 17.3 0.0 18.2 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.4" "Group enriched" "Detected in many" 5 "dendritic cells: 8.4;NK-cells: 19.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 94.7;SuSa: 111.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 38.2 20.9 49.6 13.8 48.3 1.2 61.8 11.5 28.2 39.1 32.3 25.0 13.9 9.4 23.5 25.0 19.9 34.5 32.0 56.3 30.3 32.0 28.0 20.2 23.3 12.7 54.2 32.7 29.9 13.9 45.9 9.7 21.6 37.7 23.0 19.3 21.1 19.8 21.7 73.8 14.1 13.7 27.2 38.9 13.7 11.9 10.3 28.5 2.4 79.0 28.2 14.6 21.1 16.0 2.6 8.4 3.0 1.5 19.4 0.9 0.8 21.1 17.7 20.5 13.0 18.1 53.1 7.4 29.4 46.6 17.8 20.5 17.2 23.6 0.5 55.9 49.8 2.6 20.2 8.5 18.2 15.8 0.0 7.9 1.3 22.2 14.6 12.0 0.6 4.6 42.7 6.9 15.9 17.2 52.5 40.2 0.1 6.8 0.0 55.3 74.9 0.0 0.3 16.5 18.2 53.5 3.3 21.2 0.1 94.7 16.2 6.3 0.2 62.8 32.4 63.5 111.1 26.4 0.7 56.9 12.3 6.9 16.4 35.3 0.2 0.5 0.9 22.0 0.3 7.2 3.0 1.5 0.1 0.3 0.7 0.6 2.6 0.3 0.2 5.0 1.6 0.5 0.3 0.2 19.4 0.9 8.4 0.9 0.8 49.6 48.3 11.5 28.2 30.3 32.0 54.2 32.7 37.7 28.5 26.8 88.4 17.1 154.8 98.1 2.0 108.1 175.8 60.2 93.3 441.4 0.0 118.0 210.5 277.9 6.5 300.3 126.3 46.7 281.2 170.7 294.9 188.4 23.1 34.1 128.8 0.0 119.8 371.4 32.4 21.5 714.6 43.9 226.0 20.8 107.7 97.5 336.0 115.8 295.2 330.9 5.7 0.0 84.3 7.5 18.3 66.1 62.5 8.6 64.8 157.7 SAMD3 "bA73O6.2, FLJ34032" ENSG00000164483 "Sterile alpha motif domain containing 3" Q8N6K7 6 130144315-130365425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8" "Cell type enriched" "Detected in some" 7 "T-cells: 87.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 31 "gdT-cell: 32.8;MAIT T-cell: 25.7;memory CD4 T-cell: 11.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 8.4;naive CD8 T-cell: 20.4;NK-cell: 31.9;T-reg: 10.8" "Group enriched" "Detected in many" 47 "NK-cells: 31.9;T-cells: 32.8" "Cell line enhanced" "Detected in some" "HBF TERT88: 4.0;HDLM-2: 7.1;hTEC/SVTERT24-B: 4.7;hTERT-RPE1: 4.3;NTERA-2: 3.7;PC-3: 2.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 2.7" "HPA028992, HPA028993" Uncertain NA NA "HPA028992: AB_10598914, HPA028993: AB_10601891" "unprognostic (2.91e-3)" "unprognostic (5.35e-3)" "unprognostic (4.15e-2)" "unprognostic (2.70e-2)" "unprognostic (1.50e-2)" "unprognostic (2.48e-4)" "unprognostic (1.20e-2)" "unprognostic (2.42e-3)" "unprognostic (2.39e-2)" "unprognostic (2.46e-2)" "unprognostic (5.61e-2)" "unprognostic (1.98e-1)" "unprognostic (5.07e-6)" "unprognostic (7.09e-2)" "unprognostic (1.14e-1)" "unprognostic (6.62e-2)" "unprognostic (3.45e-2)" 3.3 4.1 3.2 11.4 0.9 4.6 2.1 1.8 1.0 2.8 1.4 0.6 0.5 0.6 11.7 3.6 1.2 2.4 4.1 1.4 4.4 3.1 2.0 3.0 9.8 12.0 1.2 0.7 3.3 1.4 0.0 8.0 3.0 1.6 4.1 3.0 4.8 5.3 1.2 0.9 0.6 2.2 2.3 1.4 13.9 2.0 4.4 0.4 16.4 1.5 2.7 12.6 3.8 1.5 0.6 0.1 0.6 0.1 31.9 32.8 10.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.8 0.3 0.8 0.9 0.1 0.0 0.1 0.7 0.4 0.0 0.0 0.0 4.0 7.1 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.5 0.0 4.7 0.3 4.3 0.2 0.9 0.3 0.0 0.2 0.0 0.2 0.0 3.7 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.8 0.1 25.7 0.6 11.7 28.9 0.1 0.0 8.4 20.4 0.6 31.9 0.1 0.1 10.8 10.0 3.2 0.9 1.8 1.0 4.4 3.1 1.2 0.7 1.6 0.4 0.0 2.9 0.0 0.0 0.3 2.3 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 3.5 2.5 3.4 5.6 0.6 0.6 5.0 0.0 0.1 0.0 0.0 1.1 1.8 0.5 0.1 0.0 0.4 0.5 0.6 0.4 0.0 87.3 0.7 0.0 SCML4 dJ47M23.1 ENSG00000146285 "Scm polycomb group protein like 4" Q8N228 6 107704104-107824317 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;lymphoid tissue: 24.6" "Group enriched" "Detected in many" 21 "Early spermatids: 71.9;Late spermatids: 104.1;T-cells: 35.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "gdT-cell: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6" "Group enriched" "Detected in many" 5 "NK-cells: 17.6;T-cells: 27.3" "Cell line enriched" "Detected in some" 5 "HDLM-2: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA063326, HPA065958" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA063326: AB_2684986, HPA065958: AB_2685587" "unprognostic (4.00e-5)" "unprognostic (2.10e-3)" "unprognostic (4.71e-2)" "unprognostic (4.24e-3)" "unprognostic (1.38e-3)" "unprognostic (4.75e-4)" "unprognostic (3.84e-3)" "unprognostic (6.65e-3)" "unprognostic (4.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.13e-4)" "unprognostic (3.68e-1)" "unprognostic (3.77e-4)" "unprognostic (8.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.52e-3)" "unprognostic (5.09e-3)" 1.3 0.6 0.5 13.9 0.6 2.7 1.4 0.3 0.5 1.2 5.4 0.3 0.3 10.1 0.9 4.9 1.3 1.2 2.4 0.6 1.7 0.9 1.7 2.7 3.2 24.6 0.4 0.0 0.7 1.4 0.0 3.9 0.3 0.5 1.2 2.1 1.6 5.7 0.0 0.3 0.9 12.4 0.4 0.9 11.5 2.4 10.4 0.2 23.9 1.5 1.3 24.5 2.3 1.3 4.5 0.3 3.6 0.1 17.6 27.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 2.1 19.5 0.0 18.0 4.5 27.3 24.3 0.0 3.5 26.9 23.9 3.6 17.6 0.1 0.3 2.6 9.4 0.5 0.6 0.3 0.5 1.7 0.9 0.4 0.0 0.5 0.2 0.0 0.0 0.9 0.0 1.3 0.0 0.8 0.0 1.4 0.0 0.0 0.0 1.0 0.0 0.6 71.9 0.3 1.0 0.0 0.0 0.0 0.6 0.0 1.1 1.7 0.2 1.6 0.0 1.3 0.0 104.1 0.9 0.8 3.3 1.0 1.6 0.0 0.1 0.3 0.7 0.0 0.0 0.0 1.0 1.1 0.5 0.1 0.1 35.9 2.9 0.0 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646216 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.7;lymphoid tissue: 36.5" "Cell type enriched" "Detected in some" 8 "T-cells: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9" "Group enriched" "Detected in many" 8 "dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9" "Group enriched" "Detected in some" 7 "HEL: 41.9;JURKAT: 24.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: AB_2682246, HPA058217: AB_2683641" "unprognostic (4.16e-3)" "prognostic favorable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 2.3 0.8 0.7 15.1 0.8 11.3 1.3 1.5 0.5 1.5 3.9 0.2 2.3 2.8 2.0 1.1 1.7 1.4 4.8 1.6 0.7 0.7 1.5 1.9 6.9 17.1 0.7 0.0 1.6 0.8 0.0 1.1 1.6 0.8 1.5 1.8 1.8 6.3 0.4 0.9 0.7 7.5 1.5 1.1 15.9 2.5 1.0 0.3 36.5 1.5 1.1 18.4 3.8 1.3 0.2 21.7 2.3 0.3 16.5 14.9 11.6 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.2 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.1 4.9 3.5 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.5 0.0 0.8 0.2 1.6 13.9 0.3 11.7 0.2 11.5 12.9 0.1 0.1 10.8 14.5 2.3 16.5 0.0 21.7 14.9 11.6 0.7 0.8 1.5 0.5 0.7 0.7 0.7 0.0 0.8 0.3 0.0 3.8 0.0 0.1 0.3 0.2 0.3 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.1 0.0 0.2 0.0 0.0 1.3 1.5 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.1 0.1 31.9 0.1 0.3 SLC17A9 "C20orf59, FLJ23412, VNUT" ENSG00000101194 "Solute carrier family 17 member 9" Q9BYT1 20 62952647-62969585 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Exocytosis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 28.5;Hepatocytes: 35.4;Hofbauer cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 16.0;CACO-2: 14.8;Hep G2: 30.7;NB-4: 16.5;RPMI-8226: 15.9;U-937: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA047470 Approved Nucleoplasm NA NA Nucleoplasm "HPA047470: AB_2680060" "unprognostic (2.65e-3)" "unprognostic (2.13e-1)" "unprognostic (7.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-3)" "unprognostic (5.33e-2)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (1.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (2.78e-15)" "unprognostic (6.06e-3)" "unprognostic (5.51e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 4.2 1.3 1.6 11.4 3.4 11.9 2.2 0.4 1.4 1.9 4.8 0.6 0.1 6.4 1.7 1.2 1.5 2.1 7.3 1.5 1.5 0.7 1.5 42.7 5.7 6.6 4.8 0.0 1.9 3.4 0.0 2.5 1.9 3.4 1.6 3.8 1.1 3.6 1.2 3.4 0.9 3.9 1.4 3.9 10.5 10.7 0.8 2.9 0.5 1.4 0.5 11.8 5.6 2.4 4.0 4.2 0.0 2.7 7.3 1.3 1.2 0.0 0.0 0.0 0.1 0.1 1.3 0.0 16.0 4.6 5.3 8.4 14.8 0.0 11.5 0.0 12.8 0.0 0.0 2.3 0.0 1.2 0.0 0.0 5.0 0.4 30.7 3.6 9.0 0.0 1.2 0.0 6.3 0.0 0.0 3.4 0.0 0.0 6.7 0.0 0.0 0.3 16.5 0.0 5.7 0.0 11.9 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 1.1 0.0 0.0 0.5 0.0 2.3 0.1 6.2 0.0 19.4 0.0 0.0 1.6 0.0 1.3 2.7 0.9 4.0 0.0 0.6 4.2 3.2 0.0 0.6 0.0 7.3 0.6 0.0 0.1 1.2 1.6 3.4 0.4 1.4 1.5 0.7 4.8 0.0 3.4 2.9 0.0 0.6 28.5 0.0 0.8 0.2 1.2 12.7 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.6 0.7 1.6 0.0 0.3 0.6 5.8 0.5 4.7 35.4 16.2 0.0 2.9 2.5 4.0 0.0 1.1 9.1 5.0 1.0 7.7 0.0 1.1 0.0 0.7 0.0 0.0 0.0 3.1 0.3 0.9 1.0 0.7 4.1 9.1 0.4 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063999-19112888 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9" "Group enriched" "Detected in many" 6 "B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Yes No Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favorable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favorable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 4.8 5.7 13.8 4.5 12.2 7.5 4.9 22.5 15.4 7.0 4.8 5.9 4.5 5.7 6.8 4.4 4.5 7.4 4.7 8.9 9.7 7.8 26.7 42.3 5.4 8.5 5.9 7.8 13.8 7.4 6.5 9.6 3.2 7.9 7.6 3.0 12.2 11.0 6.3 26.7 5.2 5.6 5.7 6.1 7.3 4.6 4.5 8.1 6.6 17.1 7.3 12.2 5.5 5.4 6.2 0.7 0.2 0.6 2.8 5.1 1.5 6.2 0.8 1.6 2.8 6.1 5.1 2.5 3.0 4.6 4.7 5.4 1.2 12.5 4.5 7.1 2.8 4.7 1.1 3.2 2.5 2.7 1.1 6.2 1.5 1.7 10.0 4.9 0.7 3.2 5.1 1.8 3.6 2.2 3.8 2.1 14.7 17.5 8.1 2.5 5.6 7.5 7.1 0.9 1.7 6.5 5.8 2.8 8.6 1.8 1.1 1.8 1.3 3.2 0.1 1.3 2.2 5.7 3.5 1.9 3.5 2.0 7.3 2.9 9.4 5.1 3.5 3.7 9.6 1.8 0.0 0.2 0.2 5.1 0.5 2.8 6.2 2.9 4.3 0.3 5.1 1.9 2.8 0.0 2.8 0.6 0.7 2.9 1.5 13.8 12.2 22.5 15.4 9.7 7.8 5.9 7.8 7.9 8.1 0.0 9.6 8.9 2.4 2.9 68.0 8.9 2.5 1.4 3.4 8.7 17.7 5.7 11.6 1.4 1.2 3.5 5.4 0.0 2.7 2.7 3.6 2.6 3.5 44.5 1.5 3.2 8.1 4.3 0.3 0.6 4.6 1.1 3.3 0.0 4.0 11.9 1.9 2.9 6.0 27.0 42.5 6.5 5.7 7.9 6.4 2.5 3.9 11.4 2.9 1.3 SLFN12L ENSG00000205045 "Schlafen family member 12 like" Q6IEE8 17 35464249-35537861 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.4" "Cell type enriched" "Detected in some" 7 "T-cells: 20.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 9.5;MAIT T-cell: 8.8;memory CD4 T-cell: 6.3;memory CD8 T-cell: 8.0;naive CD4 T-cell: 4.8;naive CD8 T-cell: 5.2;NK-cell: 6.8;T-reg: 4.7" "Group enriched" "Detected in many" 7 "NK-cells: 6.8;T-cells: 9.5" "Cell line enhanced" "Detected in some" "HDLM-2: 19.9;Karpas-707: 14.1;U-266/70: 5.0;U-266/84: 4.4" HPA024447 Uncertain NA NA "HPA024447: AB_1856614" "unprognostic (1.93e-3)" "unprognostic (2.10e-4)" "unprognostic (3.77e-2)" "unprognostic (2.67e-2)" "unprognostic (8.18e-3)" "unprognostic (2.98e-5)" "unprognostic (4.59e-3)" "unprognostic (2.75e-2)" "unprognostic (6.82e-2)" "unprognostic (1.67e-2)" "unprognostic (9.51e-2)" "unprognostic (1.78e-1)" "unprognostic (2.25e-6)" "unprognostic (2.30e-1)" "unprognostic (3.88e-2)" "unprognostic (7.02e-2)" "unprognostic (8.88e-3)" 7.2 0.9 1.0 11.2 1.2 6.6 2.7 0.8 1.4 1.6 3.0 0.9 1.2 3.9 3.6 3.0 2.3 2.0 3.8 1.4 1.1 1.1 1.8 1.8 9.1 10.6 1.7 0.5 1.3 1.2 0.5 1.0 0.6 2.9 1.8 2.0 2.1 6.2 1.3 0.9 1.2 7.0 1.1 1.9 18.4 3.0 0.8 1.1 5.8 2.8 2.1 16.3 2.3 2.0 0.4 0.3 1.1 0.4 6.8 9.5 1.9 0.5 0.2 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.6 1.5 0.1 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.8 19.9 0.1 1.2 0.7 0.1 0.0 0.4 0.2 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.3 14.1 0.1 0.0 0.4 0.3 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.1 0.1 0.2 0.1 1.9 0.5 0.3 1.2 0.5 0.2 5.0 4.4 0.1 0.2 0.3 0.6 0.8 0.4 0.9 9.5 0.1 8.8 0.3 6.3 8.0 0.3 0.4 4.8 5.2 1.1 6.8 0.1 0.3 4.7 1.9 1.0 1.2 0.8 1.4 1.1 1.1 1.7 0.5 2.9 1.1 3.0 2.4 0.0 0.5 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 20.6 0.0 0.2 SLFN13 FLJ31952 ENSG00000154760 "Schlafen family member 13" Q68D06 17 35435096-35448837 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 50.6" "Cell type enhanced" "Detected in many" 22 "Cholangiocytes: 22.9;Ciliated cells: 81.7;Club cells: 18.2;T-cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 8.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 14.7;HL-60: 46.9;Karpas-707: 13.7;REH: 26.9;U-266/70: 23.7" "HPA022532, HPA023064" Uncertain Approved "Cytokinetic bridge" Yes No "Cytokinetic bridge" "HPA022532: AB_1856615, HPA023064: AB_1856616" "unprognostic (1.11e-1)" "prognostic favorable (3.82e-4)" "unprognostic (4.73e-2)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (5.74e-2)" "unprognostic (9.38e-3)" "unprognostic (1.32e-2)" "unprognostic (3.34e-1)" "unprognostic (3.55e-1)" "unprognostic (5.06e-3)" "unprognostic (2.33e-1)" "unprognostic (1.33e-1)" "unprognostic (3.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 3.0 1.0 1.1 6.4 1.7 11.8 4.8 0.5 1.0 5.2 6.5 2.6 4.8 4.0 5.6 6.0 6.5 12.4 6.1 1.8 1.3 0.7 5.1 1.7 5.2 4.8 0.9 0.5 2.7 2.0 14.3 3.2 1.2 2.0 2.4 3.1 0.9 50.6 2.0 1.4 1.5 5.7 1.8 1.5 11.3 5.7 1.5 1.1 24.8 12.7 5.4 12.9 2.0 2.0 1.4 0.4 6.5 0.5 8.1 1.9 0.5 0.0 2.5 5.1 0.0 0.1 0.5 0.0 0.6 0.1 2.5 4.0 0.0 0.0 0.0 14.7 0.4 0.1 4.3 0.5 1.8 2.8 1.4 0.8 13.4 2.2 0.0 0.2 46.9 0.4 0.1 0.2 1.3 0.0 0.0 0.8 0.1 0.0 13.7 0.0 0.0 0.3 10.2 2.5 0.0 0.0 26.9 0.1 1.3 4.3 12.4 0.0 0.0 0.0 2.3 0.1 0.3 3.6 7.5 0.1 0.0 0.7 3.8 0.2 23.7 3.2 0.0 0.0 7.5 0.3 5.0 0.4 6.5 1.9 0.5 1.5 1.4 0.9 1.0 0.4 1.3 0.8 0.6 1.4 8.1 0.2 0.1 0.7 0.5 1.1 1.7 0.5 1.0 1.3 0.7 0.9 0.5 2.0 1.1 0.0 3.0 2.2 3.1 0.9 0.0 0.6 22.9 81.7 18.2 5.2 0.0 0.4 1.7 1.1 0.1 0.7 0.5 0.0 0.3 0.2 0.8 1.0 3.5 0.4 1.3 0.0 2.9 3.1 0.6 0.0 0.9 1.6 0.0 1.8 2.7 0.2 1.1 0.0 0.4 0.8 0.1 0.0 0.6 0.2 0.1 1.0 0.0 15.7 3.9 1.0 SLFN5 MGC19764 ENSG00000166750 "Schlafen family member 5" Q08AF3 17 35243036-35273655 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 96.4;T-cells: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 11.1;MAIT T-cell: 13.7;memory CD4 T-cell: 13.6;memory CD8 T-cell: 12.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 13.7;NK-cell: 16.8;T-reg: 27.8" "Group enriched" "Detected in many" 7 "NK-cells: 16.8;T-cells: 27.8" "Cell line enhanced" "Detected in many" "HHSteC: 33.8;hTERT-HME1: 45.1" "Low region specificity" "Detected in all" HPA017760 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA017760: AB_2189993" "unprognostic (3.43e-1)" "unprognostic (3.26e-1)" "unprognostic (4.66e-2)" "unprognostic (1.60e-1)" "unprognostic (8.35e-2)" "unprognostic (1.15e-3)" "unprognostic (1.70e-2)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (7.01e-2)" "unprognostic (2.41e-3)" "unprognostic (2.39e-1)" "unprognostic (6.05e-3)" "unprognostic (3.27e-1)" "unprognostic (7.77e-2)" "unprognostic (3.92e-1)" "unprognostic (1.48e-1)" 32.9 12.8 2.8 21.2 2.6 2.8 11.5 1.7 3.0 18.9 7.7 6.6 25.3 4.0 13.6 7.7 10.0 9.3 8.3 6.4 3.6 2.8 5.9 4.0 18.6 20.9 4.8 1.2 10.7 5.0 4.5 3.2 9.9 6.0 15.9 5.0 7.9 15.4 43.1 27.5 5.0 8.5 10.9 6.1 25.3 7.6 3.8 2.2 51.4 7.6 7.2 22.3 17.0 8.5 0.7 1.4 1.9 3.0 16.8 27.8 7.1 6.1 3.2 0.4 0.5 9.2 16.3 1.2 16.1 25.5 13.5 15.1 0.0 4.0 0.7 10.4 15.9 3.6 26.0 0.3 7.2 9.5 0.1 0.5 0.1 3.3 0.3 33.8 0.4 0.1 18.5 18.4 10.3 45.1 8.1 6.1 6.4 0.0 9.3 9.4 0.5 7.5 0.3 0.5 1.3 2.4 0.0 5.4 0.0 3.5 15.3 1.0 0.0 1.8 1.7 28.7 1.9 10.7 0.2 24.1 5.4 2.1 3.9 3.6 1.7 0.1 0.1 15.9 0.0 7.7 1.9 1.7 1.1 11.1 2.7 13.7 0.4 13.6 12.6 1.4 0.7 17.0 13.7 0.7 16.8 3.0 0.5 27.8 7.1 2.8 2.6 1.7 3.0 3.6 2.8 4.8 1.2 6.0 2.2 56.6 61.3 2.2 22.6 4.0 0.9 7.8 25.5 96.4 69.4 17.4 0.0 0.2 1.7 58.0 1.5 67.1 1.4 0.0 33.7 1.5 15.3 77.2 57.9 3.9 12.1 6.4 1.2 57.1 21.5 0.0 6.9 15.8 11.8 45.1 4.5 5.8 62.6 2.9 1.4 1.3 4.3 12.9 17.3 0.4 1.9 3.4 0.2 91.8 0.4 70.5 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 1384.0" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 42.4 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.2 31.7 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 30.2 4.2 0.0 50.3 0.0 16.6 0.0 1.1 0.4 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 23.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 0.0 0.0 1.7 0.1 0.0 12.1 0.2 229.3 0.0 0.0 55.8 25.5 0.0 202.2 3.9 5.0 0.0 64.6 23.3 11.3 0.1 0.0 0.3 1.1 8.5 0.1 0.0 133.5 0.6 0.8 11.2 0.3 0.0 0.0 1.0 34.7 2.7 11.1 51.8 0.0 1384.0 32.6 0.0 0.0 0.7 0.4 0.0 0.0 1.0 35.7 0.2 SOX13 "ICA12, MGC117216, Sox-13" ENSG00000143842 "SRY-box 13" Q9UN79 1 204073115-204127743 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.1" "Group enriched" "Detected in many" 6 "NK-cells: 4.1;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 24.0;SK-BR-3: 50.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051790, HPA054843" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051790: AB_2681610, HPA054843: AB_2682622" "unprognostic (4.88e-3)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (4.74e-2)" "unprognostic (2.65e-1)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.75e-1)" "unprognostic (2.95e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (1.04e-1)" "unprognostic (8.20e-2)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 22.2 10.7 11.0 6.9 8.6 0.8 18.4 9.2 9.9 37.0 17.2 14.4 16.1 13.5 30.3 12.4 10.9 22.3 16.4 9.7 11.0 6.9 19.0 12.3 20.5 4.3 13.7 7.0 13.5 12.8 34.2 5.6 27.3 14.3 23.5 8.3 13.7 13.1 18.7 14.2 9.9 16.8 18.2 12.1 8.4 8.2 8.7 13.3 0.1 10.4 7.5 7.0 19.5 19.2 0.0 0.0 0.5 0.0 4.1 2.6 0.3 8.5 5.5 11.9 0.8 11.4 3.4 24.0 3.3 2.0 5.3 3.3 4.6 6.4 0.0 11.0 2.1 1.4 13.9 4.5 4.3 2.5 3.9 2.2 0.0 3.7 5.1 2.6 0.0 5.0 3.5 2.2 3.3 2.9 2.6 7.6 0.1 0.0 0.0 1.1 10.5 0.0 0.0 15.7 13.9 6.7 0.1 4.0 5.2 4.0 19.8 1.8 0.9 3.4 50.1 15.0 11.1 22.3 1.0 4.4 1.2 3.2 5.1 2.3 0.0 0.0 0.0 1.9 0.1 3.1 0.2 0.0 0.5 2.5 0.0 2.6 0.0 1.2 1.4 0.0 0.0 0.0 1.0 0.3 4.1 0.0 0.0 0.0 0.3 11.0 8.6 9.2 9.9 11.0 6.9 13.7 7.0 14.3 13.3 6.0 11.4 0.8 7.9 1.9 0.5 24.3 10.2 1.4 4.5 8.7 0.0 4.3 1.7 2.7 8.5 12.7 12.6 0.0 1.3 5.0 5.0 6.6 16.2 5.9 1.2 0.0 7.5 8.0 0.0 20.2 19.2 0.7 1.7 0.0 5.5 6.3 2.9 7.6 18.4 3.5 0.9 38.8 15.5 0.2 0.7 1.4 1.6 1.9 5.4 5.7 SPEF2 "CT122, FLJ23577, KPL2" ENSG00000152582 "Sperm flagellar 2" Q9C093 5 35617844-35814611 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 327.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 5.2;MAIT T-cell: 6.5;memory CD4 T-cell: 3.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 4.1" "Group enriched" "Detected in many" 8 "NK-cells: 4.1;T-cells: 6.5" "Cell line enhanced" "Detected in many" "HDLM-2: 14.2;T-47d: 8.4" "Low region specificity" "Detected in many" "HPA039606, HPA040343" Enhanced NA NA "HPA039606: AB_10671044, HPA040343: AB_2676930" "unprognostic (3.81e-2)" "unprognostic (3.17e-1)" "unprognostic (6.23e-2)" "unprognostic (8.71e-2)" "unprognostic (4.55e-2)" "unprognostic (8.23e-2)" "unprognostic (8.11e-4)" "unprognostic (1.23e-1)" "unprognostic (2.35e-1)" "unprognostic (9.96e-2)" "unprognostic (1.01e-4)" "unprognostic (4.50e-2)" "unprognostic (6.34e-3)" "unprognostic (1.53e-2)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (2.12e-2)" 2.4 5.4 5.9 4.1 14.5 2.1 7.6 3.6 10.3 15.8 2.6 5.3 8.8 1.5 17.3 19.1 1.8 21.7 4.5 2.8 4.7 7.0 10.9 2.1 6.8 2.7 3.0 6.1 9.1 6.4 13.3 22.5 6.5 12.9 8.3 3.1 4.9 4.7 9.4 1.0 1.9 2.3 6.4 3.0 3.6 3.3 9.0 3.1 2.3 11.9 0.6 1.5 3.7 7.9 0.6 0.6 0.4 0.5 4.1 6.5 1.3 0.9 1.4 1.7 4.7 1.2 1.4 0.2 2.2 1.4 5.3 3.5 0.0 2.5 0.0 1.2 3.1 5.9 0.1 1.5 2.1 5.3 14.2 0.5 0.0 6.2 0.5 1.6 3.7 0.0 2.1 3.8 2.9 1.6 6.4 0.1 0.9 1.7 0.9 0.8 2.4 0.0 0.0 0.1 3.4 1.3 3.2 0.0 0.0 3.7 0.4 0.1 1.3 0.0 2.6 0.4 1.0 8.4 7.2 0.0 1.5 2.0 3.0 0.8 0.0 0.0 0.3 4.3 0.1 0.0 0.0 0.5 0.0 5.2 0.5 6.5 0.2 3.1 5.4 0.6 0.6 3.5 4.2 0.4 4.1 0.2 0.2 0.7 1.3 5.9 14.5 3.6 10.3 4.7 7.0 3.0 6.1 12.9 3.1 8.9 5.4 0.0 2.5 1.4 15.0 5.3 5.1 327.9 46.6 5.2 35.3 1.3 5.0 3.1 59.7 3.2 0.4 0.0 1.5 0.7 6.8 2.4 5.7 0.9 1.0 19.1 2.4 6.2 0.6 15.5 9.5 2.4 1.7 34.3 3.4 14.6 1.3 0.0 6.7 9.9 39.9 0.0 1.9 18.2 9.1 0.9 0.7 7.5 2.6 0.2 SPRED2 "FLJ21897, FLJ31917, Spred-2" ENSG00000198369 "Sprouty related EVH1 domain containing 2" Q7Z698 2 65310851-65432637 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 3.2;plasmacytoid DC: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.7;NK-cells: 3.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038256, HPA064394" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038256: , HPA064394: AB_2732712" "unprognostic (1.49e-1)" "unprognostic (5.95e-3)" "unprognostic (3.46e-2)" "unprognostic (4.40e-3)" "unprognostic (8.94e-2)" "unprognostic (1.63e-1)" "unprognostic (2.90e-2)" "unprognostic (9.94e-2)" "unprognostic (9.07e-2)" "unprognostic (4.25e-1)" "unprognostic (5.05e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (7.21e-3)" "unprognostic (5.43e-2)" 25.1 13.5 21.0 19.3 17.8 6.7 26.2 26.2 28.9 16.9 18.9 9.0 5.8 17.2 20.1 12.3 12.8 13.8 18.3 17.5 19.0 14.3 16.1 28.1 22.0 14.8 15.3 19.0 18.3 20.6 29.5 15.1 18.1 20.5 15.1 18.7 15.1 17.9 13.6 9.6 13.6 20.7 13.7 16.5 11.0 22.6 8.1 12.9 40.3 22.1 10.4 17.1 21.2 30.5 0.1 7.7 1.2 1.2 3.2 1.2 1.5 27.0 14.3 15.6 15.9 20.4 20.4 11.3 8.1 12.0 5.2 7.2 18.8 7.7 20.9 4.3 10.0 15.1 9.1 8.9 18.2 10.7 23.9 6.5 4.3 3.8 20.3 10.3 13.3 8.9 16.3 10.8 18.7 17.9 11.4 3.3 11.7 18.6 8.2 8.4 18.3 10.3 12.4 7.8 21.1 16.8 8.2 14.1 10.8 16.3 22.9 6.7 23.8 8.5 7.3 21.7 10.1 6.9 11.3 5.1 13.3 17.9 11.8 12.9 16.2 6.5 34.1 21.6 12.8 25.6 0.0 0.4 0.0 1.2 1.2 0.1 0.0 0.2 1.0 0.8 0.1 0.2 0.3 1.2 3.2 0.6 7.7 0.0 1.5 21.0 17.8 26.2 26.7 19.0 14.3 15.3 19.0 20.5 12.9 17.9 16.5 2.2 27.6 35.4 14.1 6.5 17.8 6.7 4.5 8.7 5.9 10.2 11.6 10.1 1.3 9.8 16.0 0.0 7.4 7.2 13.1 21.2 1.1 12.7 5.9 23.8 10.9 15.4 6.5 2.5 15.8 7.8 18.6 44.1 19.7 8.9 9.7 15.8 11.7 5.7 10.7 25.8 15.4 2.8 9.8 14.6 2.5 0.7 10.1 22.0 STAP2 "BKS, STAP-2" ENSG00000178078 "Signal transducing adaptor family member 2" Q9UGK3 19 4324043-4342786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 281.0;Paneth cells: 282.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "NK-cell: 10.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;NK-cells: 10.8;T-cells: 3.4" "Cell line enhanced" "Detected in many" "A-431: 27.3;HaCaT: 22.7;MCF7: 32.5;RT4: 43.8" "Region enriched" "Detected in single" 13 "cerebellum: 32.8" "Low region specificity" "Detected in single" "HPA002375, HPA027761" Approved NA NA "HPA002375: AB_1078285, HPA027761: AB_1845364" "unprognostic (1.42e-1)" "prognostic favorable (2.76e-4)" "unprognostic (3.52e-1)" "prognostic favorable (3.03e-5)" "unprognostic (4.35e-2)" "unprognostic (9.35e-3)" "unprognostic (4.52e-1)" "unprognostic (7.81e-2)" "unprognostic (3.43e-1)" "unprognostic (2.00e-2)" "unprognostic (1.93e-2)" "unprognostic (9.05e-2)" "unprognostic (1.43e-3)" "unprognostic (1.38e-2)" "unprognostic (1.72e-1)" "unprognostic (3.00e-2)" "prognostic favorable (4.13e-4)" 2.5 6.6 0.7 12.6 1.1 0.0 5.8 0.9 1.0 8.8 26.0 0.7 23.3 28.4 4.9 12.0 31.6 5.4 10.9 1.7 0.7 0.4 12.9 24.7 6.8 4.0 0.7 0.6 7.0 12.5 6.4 2.5 7.6 1.5 12.8 21.7 3.3 23.9 19.4 1.6 24.0 54.9 2.5 0.7 1.2 8.3 1.7 0.8 5.1 13.3 28.1 21.9 7.6 12.8 0.9 2.9 0.3 0.2 10.8 3.4 1.2 27.3 0.1 2.1 2.0 0.1 1.5 11.8 0.5 3.0 0.9 0.8 16.4 11.4 0.0 4.6 0.9 6.2 22.7 0.3 16.2 0.5 4.8 0.2 0.0 0.1 11.4 3.9 0.0 0.2 1.2 14.0 1.6 4.2 2.4 3.0 0.7 1.0 6.3 0.5 32.5 0.4 0.2 1.6 17.6 6.8 1.1 0.2 0.7 9.6 43.8 0.7 1.2 0.0 8.8 4.7 0.8 19.9 0.1 4.3 0.0 0.4 0.2 0.6 0.0 0.4 0.4 0.1 0.1 2.0 0.3 0.2 0.0 0.8 0.0 3.4 0.9 1.1 0.1 0.9 0.2 3.4 1.9 0.2 10.8 0.0 2.9 3.3 1.2 0.7 1.1 0.9 1.0 0.7 0.4 0.7 0.6 1.5 0.8 8.9 15.6 5.6 42.4 35.9 0.4 5.3 38.2 14.7 17.0 27.9 0.0 13.4 21.6 117.7 0.9 7.4 281.0 0.0 89.4 1.7 3.8 76.9 9.2 28.4 1.6 0.0 82.5 3.1 3.3 0.5 4.4 2.3 18.6 21.6 127.6 1.0 113.4 282.0 1.8 66.6 0.7 0.0 4.0 0.5 1.5 54.1 10.4 4.9 144.6 95.3 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.5" "Cell type enhanced" "Detected in many" 6 "B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" No NA 1000000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.2 3.3 6.0 38.1 9.6 18.2 6.7 1.1 4.5 3.7 10.3 6.7 1.5 12.3 2.3 6.7 16.2 6.9 6.6 5.5 7.2 3.2 8.6 2.5 13.7 36.4 9.1 2.5 2.1 8.9 25.9 3.1 5.0 6.1 4.1 8.3 2.8 8.9 1.8 1.4 8.3 22.2 3.5 11.3 38.5 7.4 5.5 7.9 30.5 18.1 7.8 32.2 8.6 7.5 23.1 24.9 32.8 21.4 8.7 0.1 10.2 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 39.4 1.1 0.0 1.3 6.1 0.8 3.2 0.0 0.0 5.4 22.7 0.0 0.0 0.0 31.3 20.9 0.0 4.5 0.0 0.4 0.0 0.0 4.9 0.6 3.2 0.0 4.8 0.0 13.7 0.2 14.8 0.0 26.2 0.0 10.8 0.8 5.9 2.1 1.8 0.0 2.8 0.0 0.1 2.5 24.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.6 0.0 22.1 0.0 1.4 21.4 23.3 0.1 19.0 0.1 23.1 0.0 0.0 24.9 17.5 0.0 0.0 32.8 8.7 16.4 18.5 0.0 10.2 6.0 9.6 1.1 4.5 7.2 3.2 9.1 2.5 6.1 7.9 11.9 22.7 53.8 3.7 3.1 0.9 1.6 12.7 12.0 17.0 14.0 0.0 1.2 13.3 12.6 5.5 1.1 18.4 0.0 10.9 1.3 1.1 1.8 40.6 0.9 63.0 0.0 9.9 4.9 79.3 4.7 0.6 66.0 11.8 24.4 23.8 0.0 15.3 28.1 0.0 0.3 0.1 6.5 1.0 0.7 0.7 5.0 1.1 5.3 24.7 6.5 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 and MAP3K7 binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: AB_2674394" "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favorable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 6.1 8.0 5.9 6.6 6.9 10.1 6.5 9.1 9.2 7.6 6.5 4.2 17.9 5.2 40.3 7.4 13.2 9.2 10.6 6.9 6.1 5.3 16.9 23.3 8.0 8.1 6.7 6.6 11.3 17.3 25.0 9.4 39.3 9.1 12.9 6.7 9.3 11.5 15.0 8.8 8.1 7.4 9.6 5.2 7.1 8.4 26.7 3.6 8.3 7.7 14.5 15.6 6.6 7.9 1.0 0.6 0.8 1.1 3.9 1.0 0.4 23.2 5.6 5.8 5.9 4.5 6.9 6.1 7.2 9.1 4.9 5.5 6.3 20.0 10.5 4.4 8.3 9.4 12.1 8.9 18.4 7.1 18.1 8.5 9.8 6.6 15.4 3.9 10.3 7.7 4.9 11.1 8.3 21.4 8.5 8.0 8.1 11.2 8.6 6.3 11.2 8.2 5.2 6.9 4.2 9.5 5.3 10.2 7.8 8.2 6.8 4.8 6.9 8.1 12.3 15.6 11.3 10.5 4.1 7.7 5.4 8.0 27.1 6.6 11.3 8.6 10.4 8.5 4.9 7.6 0.2 0.5 0.8 0.7 1.1 0.9 0.8 1.0 0.4 0.6 1.0 1.0 1.0 0.8 3.9 0.8 0.3 0.6 0.4 5.9 6.9 9.1 9.2 6.1 5.3 6.7 6.6 9.1 3.6 11.9 10.4 5.4 6.5 8.0 6.5 10.6 17.8 16.0 7.9 10.4 11.8 12.7 3.3 8.3 0.8 7.7 7.4 23.3 5.9 4.2 5.1 13.1 13.9 24.2 6.8 11.1 6.9 8.6 13.8 0.9 10.0 10.2 5.0 7.2 12.3 6.0 7.7 8.7 15.2 10.2 19.1 0.0 3.1 3.7 1.7 8.8 18.8 6.9 9.3 9.9 TBX21 "T-bet, TBLYM" ENSG00000073861 "T-box 21" Q9UL17 17 47733244-47746119 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.5;bone marrow: 12.2;lymphoid tissue: 17.7" "Cell type enriched" "Detected in some" 9 "T-cells: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "gdT-cell: 13.5;NK-cell: 10.8" "Group enriched" "Detected in many" 8 "NK-cells: 10.8;T-cells: 13.5" "Cell line enriched" "Detected in single" 113 "HDLM-2: 19.1" "Region enriched" "Detected in single" 27 "olfactory region: 27.1" "Low region specificity" "Detected in all" "CAB009524, CAB030043" Enhanced NA NA "CAB009524: AB_2200557, CAB030043: AB_1595503" "unprognostic (3.31e-3)" "unprognostic (3.17e-3)" "unprognostic (1.17e-2)" "unprognostic (5.35e-6)" "unprognostic (3.93e-1)" "unprognostic (2.56e-4)" "unprognostic (5.86e-4)" "unprognostic (6.90e-2)" "unprognostic (3.63e-3)" "unprognostic (6.26e-4)" "unprognostic (1.43e-1)" "unprognostic (1.93e-2)" "unprognostic (3.04e-4)" "unprognostic (7.92e-2)" "unprognostic (2.67e-1)" "unprognostic (9.19e-3)" "unprognostic (4.43e-3)" 2.9 0.6 0.5 5.7 0.5 12.2 0.9 0.4 0.4 2.3 4.3 0.9 0.4 1.3 2.0 1.7 1.4 1.0 1.8 0.9 0.5 0.5 1.3 1.9 11.1 9.3 2.6 0.3 1.2 0.6 0.0 0.6 0.2 0.7 3.3 0.7 2.2 3.0 0.4 1.5 0.5 2.7 1.4 0.8 17.7 1.6 0.7 0.4 4.1 1.4 1.6 8.1 2.6 1.8 1.5 0.0 0.2 0.0 10.8 13.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 3.1 1.5 2.8 7.4 0.0 0.4 0.4 7.1 0.2 10.8 0.0 0.0 0.1 1.6 0.5 0.5 0.4 0.4 0.5 0.5 2.6 0.3 0.7 0.4 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.2 0.1 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.0 20.3 0.0 0.0 TGFBR3 "betaglycan, BGCAN" ENSG00000069702 "Transforming growth factor beta receptor 3" Q03167 1 91680343-91906335 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 105.0;Ito cells: 311.2;Leydig cells: 135.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 22 "NK-cells: 9.0;T-cells: 21.3" "Cell line enhanced" "Detected in many" "ASC diff: 67.2;ASC TERT1: 32.8;U-2197: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008257, CAB018971" Supported Approved Cytosol "Secreted to blood" NA NA 29000000 Cytosol "CAB018971: , HPA008257: AB_1080258" "unprognostic (7.57e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.36e-4)" "unprognostic (9.39e-3)" "prognostic favorable (4.84e-4)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (9.32e-2)" "unprognostic (1.07e-1)" "prognostic favorable (4.99e-4)" "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.08e-2)" 40.1 15.9 3.2 6.8 3.1 1.6 63.5 1.8 4.4 30.1 15.2 3.5 30.0 3.4 17.6 21.0 22.2 17.6 23.3 16.3 3.9 1.9 12.5 11.9 18.4 18.1 2.6 2.0 62.4 8.9 4.4 4.4 25.1 4.5 21.7 5.6 8.8 14.7 46.5 19.2 13.4 9.8 34.4 4.1 27.1 11.1 14.0 3.0 1.1 7.5 6.5 3.1 39.2 42.1 0.0 0.6 0.6 0.6 9.0 21.3 3.9 2.7 2.7 4.1 0.7 67.2 32.8 13.0 2.0 10.2 2.4 2.9 1.2 0.4 0.0 0.5 3.7 1.9 0.4 1.0 0.3 1.8 9.5 2.2 0.0 3.4 11.3 1.4 0.1 0.0 7.9 1.3 5.2 1.2 0.3 1.2 0.0 6.5 0.2 0.7 0.0 0.0 0.0 1.7 1.2 0.9 0.1 1.4 0.5 0.9 16.4 0.1 0.0 1.0 0.0 5.7 1.7 0.3 1.0 3.6 4.0 1.0 22.8 0.4 10.1 0.9 0.0 0.8 0.5 0.5 0.6 0.0 0.0 21.3 0.1 11.6 0.0 5.4 11.4 0.0 0.0 1.7 8.0 0.3 9.0 0.6 0.6 2.4 3.9 3.2 3.1 1.8 4.4 3.9 1.9 2.6 2.0 4.5 3.0 8.9 11.9 3.0 10.4 33.4 0.2 17.3 28.1 6.7 6.8 29.6 2.0 23.5 3.3 1.7 48.3 64.2 0.7 23.3 4.2 9.3 105.0 7.3 2.3 17.8 9.7 0.0 23.1 311.2 19.6 18.5 135.4 3.8 33.7 0.0 0.5 2.2 3.5 0.0 70.0 15.9 0.2 12.9 35.4 0.7 1.7 29.7 48.5 30.5 2.3 5.4 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 9.5;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Cell line enhanced" "Detected in some" "EFO-21: 9.5;MCF7: 8.9;PC-3: 11.7;REH: 7.5;SCLC-21H: 6.1;WM-115: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.5 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.5 0.0 0.0 1.5 1.3 9.5 0.0 0.8 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.9 0.2 0.0 1.4 0.1 11.7 7.5 0.0 0.1 0.1 0.0 6.1 2.3 0.5 0.0 2.2 0.1 2.7 0.3 1.6 1.3 2.4 0.2 0.5 0.7 0.0 0.0 0.1 0.5 6.2 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 0.0 0.3 0.5 2.4 4.0 4.3 1.2 0.0 1.4 1.2 5.2 0.0 0.2 0.0 1.0 1.3 7.1 0.0 0.0 0.2 1.2 3.8 1.7 0.0 1.7 0.3 9.5 0.0 7.4 0.3 1.5 4.0 0.0 6.8 0.0 0.0 17.0 0.0 0.0 6.0 0.0 1.1 0.0 1.7 0.5 3.1 2.3 0.2 0.0 0.0 0.6 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA029489: AB_2673067, HPA059922: AB_2684164" "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavorable (5.80e-4)" 5.8 3.6 6.4 4.3 11.3 2.6 6.3 2.0 11.9 6.0 4.3 4.2 2.2 4.1 5.7 5.0 5.2 4.6 4.5 4.0 3.9 4.0 3.1 5.4 4.3 3.6 3.1 5.2 4.9 6.5 7.0 6.5 6.1 5.2 2.7 6.3 3.5 4.8 2.6 3.4 3.9 2.9 7.6 3.5 4.1 3.7 2.1 2.6 1.9 6.8 4.9 5.1 5.4 4.7 3.0 2.3 1.3 3.1 8.4 2.2 1.4 3.1 6.2 1.2 4.1 6.5 5.8 3.7 1.5 1.9 1.5 3.5 1.2 7.4 11.9 3.4 2.9 6.8 6.0 3.2 5.5 5.2 1.4 0.4 2.5 4.5 2.6 3.6 2.6 2.0 6.6 6.1 6.2 7.4 4.0 6.7 5.4 5.2 4.2 5.4 3.4 2.7 0.5 1.4 10.6 1.2 2.0 5.6 11.4 2.6 2.3 4.4 4.2 7.3 3.9 4.7 5.5 4.1 1.2 2.5 10.6 2.5 3.7 4.2 8.4 6.4 5.0 3.4 8.0 6.7 1.3 0.7 0.0 1.3 3.1 2.2 1.8 0.2 1.2 2.3 3.0 1.1 1.9 0.0 8.4 1.2 0.7 1.5 1.4 6.4 11.3 2.0 11.9 3.9 4.0 3.1 5.2 5.2 2.6 0.0 5.8 0.0 2.4 2.5 1.0 1.4 0.0 9.4 5.7 3.5 3.9 6.8 0.0 2.0 0.0 1.6 2.0 0.0 1.9 8.0 2.7 3.0 2.3 3.4 2.8 9.5 1.2 3.7 0.3 0.0 1.7 2.1 1.7 0.0 2.9 1.0 2.5 2.5 1.1 3.0 1.1 0.0 2.2 0.5 5.3 3.9 3.9 1.5 2.3 2.6 TNFRSF18 "AITR, CD357, GITR" ENSG00000186891 "TNF receptor superfamily member 18" Q9Y5U5 1 1203508-1206691 "CD markers, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 46.6;skin 1: 28.9" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 167.9;granulocytes: 46.0;Melanocytes: 47.2;Suprabasal keratinocytes: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 46.6" "Group enriched" "Detected in many" 11 "NK-cells: 46.6;T-cells: 19.0" "Group enriched" "Detected in some" 11 "RPMI-8226: 62.6;SCLC-21H: 45.0" HPA008025 Approved "Secreted to blood" NA NA "HPA008025: AB_1849696" "unprognostic (1.20e-3)" "unprognostic (4.61e-2)" "unprognostic (4.59e-2)" "prognostic favorable (7.72e-6)" "unprognostic (2.73e-4)" "prognostic favorable (4.12e-4)" "unprognostic (3.43e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.01e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.40e-11)" "unprognostic (1.02e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-1)" "unprognostic (2.08e-1)" 1.4 0.5 1.0 8.9 1.0 1.9 4.2 4.9 2.5 14.3 8.3 0.3 0.1 5.7 2.1 1.1 4.7 1.0 3.7 0.2 0.5 0.3 1.1 1.7 3.0 9.1 0.4 2.4 0.3 2.7 9.4 3.8 1.3 1.7 1.9 1.2 0.5 9.0 2.6 1.0 28.9 5.0 0.2 0.3 6.7 3.8 0.8 0.1 4.4 0.9 2.7 8.2 1.5 2.2 2.9 0.0 0.2 0.0 46.6 19.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 4.7 0.0 0.0 62.6 0.1 0.0 45.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.6 1.3 8.5 1.2 0.0 2.9 0.3 0.4 0.2 46.6 0.0 0.0 19.0 2.1 1.0 1.0 4.9 2.5 0.5 0.3 0.4 2.4 1.7 0.1 0.0 2.2 7.5 10.8 167.9 0.0 2.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.5 0.9 11.2 7.3 46.0 0.0 0.8 0.0 3.4 1.3 0.8 0.0 0.0 1.8 47.2 21.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 131.6 0.0 20.8 0.0 3.3 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171061339-171460408 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell type enhanced" "Detected in many" 7 "granulocytes: 79.9;Muller glia cells: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3" "Group enriched" "Detected in many" 29 "granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol NA NA 9100 Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 2.2 5.4 29.0 7.4 30.9 4.9 3.6 21.1 26.1 1.9 10.9 12.2 4.1 25.8 4.3 2.1 5.6 4.3 7.1 11.2 30.9 14.8 5.6 4.6 11.3 7.9 11.4 18.3 2.6 5.2 0.7 9.0 3.1 13.6 5.6 9.5 3.5 2.9 7.3 23.2 1.6 25.6 6.0 14.5 5.8 9.2 10.7 21.1 3.7 7.1 2.2 6.9 6.4 2.6 0.2 0.0 10.5 0.1 2.7 6.7 1.1 0.3 0.5 19.9 2.1 0.3 0.0 4.7 4.1 1.2 3.3 2.2 17.8 7.4 0.0 1.5 3.8 3.0 6.1 2.8 1.1 3.6 0.1 4.4 27.0 1.5 0.0 9.5 5.3 30.8 2.9 3.0 1.9 0.4 7.7 19.8 4.5 9.7 0.0 0.5 0.4 1.7 6.8 8.2 14.2 7.7 0.0 5.1 7.1 6.4 0.0 0.9 1.0 2.5 0.2 4.4 2.2 9.0 1.3 0.2 0.0 3.5 9.0 3.0 0.0 0.0 0.0 0.9 6.0 23.0 4.4 0.1 10.5 4.2 0.0 5.2 0.0 5.0 3.7 0.0 0.2 6.7 3.8 0.1 2.7 0.1 0.0 5.3 1.1 29.0 30.9 21.1 22.2 30.9 14.8 11.4 18.3 13.6 21.1 6.0 37.9 0.5 1.4 2.3 9.3 25.7 25.5 2.7 12.5 8.7 13.7 4.7 5.0 9.2 29.5 1.6 26.2 0.0 6.8 1.8 4.4 0.6 79.9 6.8 2.5 0.0 12.7 1.3 5.6 33.0 2.3 3.3 1.7 0.0 9.4 79.4 4.8 16.5 6.0 14.9 27.7 0.0 7.6 2.8 1.0 1.4 2.1 31.2 15.3 2.4 TRAF3IP1 "DKFZP434F124, IFT54, MIP-T3, MIPT3" ENSG00000204104 "TRAF3 interacting protein 1" Q8TDR0 2 238320441-238400900 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 143.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037857, HPA037858" Approved NA NA "HPA037857: AB_2675706, HPA037858: AB_10671724" "unprognostic (1.25e-1)" "unprognostic (9.08e-2)" "unprognostic (2.50e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (3.38e-2)" "unprognostic (1.80e-3)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (9.04e-2)" "unprognostic (6.38e-3)" "unprognostic (7.44e-2)" "unprognostic (4.78e-3)" "unprognostic (7.48e-3)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.07e-1)" 10.4 7.8 10.5 8.8 15.5 3.0 10.0 11.6 17.3 11.2 12.2 11.1 11.0 7.6 13.2 18.4 9.8 27.8 12.0 7.6 11.5 12.3 10.4 8.2 9.8 6.4 13.1 8.7 11.2 7.9 23.3 11.7 7.3 17.6 10.6 9.1 8.2 9.5 12.6 16.2 8.1 7.0 13.9 12.8 6.9 8.7 21.5 12.5 4.4 15.6 5.0 7.6 10.7 8.5 1.0 1.1 0.9 3.3 5.7 1.6 0.5 7.7 9.5 8.8 10.6 8.9 11.0 6.5 6.4 9.7 8.4 7.9 3.4 6.1 0.1 3.4 9.0 9.8 7.9 9.7 7.2 13.1 4.6 9.9 2.0 8.9 11.4 9.4 9.3 5.4 8.5 11.6 10.6 8.6 7.9 8.4 7.1 9.3 1.8 8.9 9.7 7.4 5.1 9.8 6.1 5.0 11.8 16.1 3.1 11.3 3.6 12.1 6.6 10.8 8.5 8.2 5.7 7.1 7.1 9.5 10.3 8.1 10.4 8.2 4.7 2.5 3.1 10.1 3.4 6.7 0.5 0.8 0.3 0.8 0.4 1.6 1.0 0.8 1.1 0.4 0.6 1.0 1.0 0.9 5.7 3.3 1.1 0.0 0.5 10.5 15.5 11.6 17.3 11.5 12.3 13.1 8.7 17.6 12.5 29.8 14.9 3.7 6.7 7.0 18.8 11.5 5.1 143.2 33.0 1.8 35.3 5.9 0.0 7.4 52.7 8.3 6.1 0.0 7.9 5.3 6.7 6.9 5.8 13.7 4.0 44.5 10.3 8.0 1.8 51.6 10.3 5.3 3.3 1.8 8.7 15.1 6.7 6.5 15.9 6.7 36.7 6.5 9.7 40.5 39.9 6.9 3.1 3.5 9.7 4.8 TTC39B "C9orf52, FLJ33868" ENSG00000155158 "Tetratricopeptide repeat domain 39B" Q5VTQ0 9 15163622-15307360 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 2.0;gdT-cell: 4.1;MAIT T-cell: 5.4;memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.1;NK-cell: 7.6;T-reg: 4.9" "Group enriched" "Detected in many" 5 "granulocytes: 2.0;NK-cells: 7.6;T-cells: 6.7" "Cell line enhanced" "Detected in many" "HEL: 27.2;RT4: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063162 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA063162: AB_2684952" "unprognostic (1.64e-1)" "unprognostic (9.32e-3)" "unprognostic (1.47e-2)" "unprognostic (7.89e-2)" "unprognostic (7.47e-2)" "unprognostic (1.06e-1)" "unprognostic (4.12e-2)" "prognostic favorable (9.64e-6)" "unprognostic (5.99e-2)" "unprognostic (4.77e-2)" "unprognostic (1.59e-1)" "unprognostic (6.89e-2)" "prognostic favorable (4.08e-7)" "unprognostic (3.31e-3)" "unprognostic (2.12e-2)" "unprognostic (5.19e-2)" "unprognostic (1.48e-1)" 7.3 4.9 3.6 7.2 7.9 2.3 7.7 35.9 12.9 8.2 10.5 1.7 1.8 9.0 10.0 4.4 14.2 6.1 11.2 3.0 3.6 5.6 14.6 8.5 8.6 8.9 5.3 6.4 6.6 6.3 3.7 13.5 2.2 20.8 4.6 9.3 3.8 6.3 3.4 3.7 15.1 15.2 6.9 5.9 6.8 8.8 8.5 2.9 1.3 4.7 4.7 9.3 6.2 8.1 1.0 0.6 2.0 0.9 7.6 6.7 3.4 2.6 0.5 0.8 3.9 3.8 7.0 0.8 3.4 6.2 2.7 6.5 0.5 1.1 0.0 0.4 4.2 3.2 2.3 0.6 4.2 2.3 2.9 0.5 27.2 1.2 4.9 6.2 0.0 0.6 6.8 3.3 5.6 6.3 1.9 3.8 2.3 0.1 6.2 6.8 0.8 1.4 0.1 1.0 8.2 0.8 0.3 2.1 1.2 5.8 15.5 2.0 0.4 0.8 2.0 0.6 1.3 8.7 1.7 2.8 1.5 1.3 2.1 0.9 0.1 0.0 0.0 1.4 0.3 0.7 2.0 0.9 1.2 4.1 0.7 5.4 0.3 5.6 6.3 0.6 1.0 6.7 4.1 0.7 7.6 0.9 0.1 4.9 3.4 3.6 7.9 35.9 12.9 3.6 5.6 5.3 6.4 20.8 2.9 11.9 17.5 2.7 6.0 15.3 23.4 2.7 7.6 16.0 9.1 7.0 0.0 2.7 14.9 5.3 30.6 6.3 28.8 0.0 19.0 0.9 8.9 7.4 27.8 10.4 4.2 12.7 12.2 6.2 3.7 25.3 6.6 5.6 6.8 2.8 14.3 16.0 10.1 44.2 12.0 32.1 3.9 0.0 10.3 2.3 1.9 18.7 3.4 20.1 12.6 13.2 TXK "BTKL, PSCTK5, PTK4, RLK, TKL" ENSG00000074966 "TXK tyrosine kinase" P42681 4 48066393-48134256 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4" "Cell type enriched" "Detected in some" 9 "T-cells: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 43.5" "Group enriched" "Detected in many" 26 "NK-cells: 43.5;T-cells: 17.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062482 Approved Vesicles NA NA Vesicles "HPA062482: AB_2684778" "unprognostic (1.04e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (9.24e-3)" "unprognostic (1.09e-2)" "unprognostic (2.58e-4)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (1.50e-1)" "unprognostic (6.39e-3)" "unprognostic (8.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (2.59e-1)" "unprognostic (2.04e-2)" 1.8 1.5 0.3 15.3 0.4 3.9 1.5 0.2 0.6 0.8 2.1 0.3 0.2 1.3 1.3 11.6 2.4 2.6 1.7 0.7 0.2 0.4 2.1 2.8 4.0 49.1 0.5 0.5 0.5 1.0 0.4 1.3 28.4 0.6 0.9 1.0 1.0 6.1 0.2 0.5 1.7 7.9 0.4 0.4 17.8 1.0 1.7 0.2 14.0 1.9 0.2 19.3 2.4 1.4 0.0 0.1 1.1 0.0 43.5 17.5 10.6 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.8 0.0 1.4 0.0 0.2 0.2 0.0 0.0 0.4 0.2 0.1 2.4 0.0 0.0 0.0 0.3 11.3 0.0 0.0 0.1 0.0 0.8 0.1 0.4 0.2 0.0 0.7 0.0 0.0 2.1 0.0 0.6 0.8 0.3 0.0 0.0 1.4 1.3 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.1 5.5 6.8 0.4 0.0 0.4 25.4 1.1 0.0 0.3 13.2 0.0 17.4 0.0 6.8 6.4 0.0 0.0 17.5 11.9 0.8 43.5 0.0 0.1 5.1 10.6 0.3 0.4 0.2 0.6 0.2 0.4 0.5 0.5 0.6 0.2 0.0 2.6 0.8 0.5 0.3 0.0 0.2 2.5 0.0 0.0 0.0 3.9 0.2 1.7 1.3 4.3 0.1 0.0 0.0 0.0 0.1 0.5 0.4 1.1 1.0 1.2 0.0 0.0 4.3 5.1 1.3 0.3 0.5 1.7 0.0 0.0 2.3 0.2 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.2 1.0 0.5 43.1 0.2 0.6 UBN2 "FLJ25778, KIAA2030" ENSG00000157741 "Ubinuclein 2" Q6ZU65 7 139230356-139308236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 109.8;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 9.0;NK-cell: 3.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.0;NK-cells: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019743, HPA020122, HPA020124" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202" "unprognostic (1.96e-1)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-2)" "unprognostic (2.41e-1)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-3)" "unprognostic (9.88e-2)" "unprognostic (1.65e-1)" "unprognostic (4.96e-2)" "unprognostic (3.65e-2)" "unprognostic (4.54e-3)" "unprognostic (2.95e-1)" "unprognostic (2.91e-2)" "unprognostic (1.05e-2)" 5.4 7.8 11.9 5.3 13.0 10.4 9.7 20.8 13.7 7.6 5.9 8.7 12.6 5.0 10.0 14.1 7.0 7.3 5.7 5.8 11.5 6.9 6.3 7.0 6.0 5.1 10.2 7.6 11.5 10.7 10.5 16.9 6.2 8.6 8.2 6.9 8.1 8.1 12.7 11.1 18.6 5.9 7.9 8.4 6.3 6.3 25.5 9.7 6.9 10.4 3.1 5.2 6.4 13.6 1.2 1.2 9.0 1.0 3.4 0.8 0.1 3.9 3.7 6.1 7.6 4.9 4.5 4.7 2.3 3.4 2.1 2.5 4.5 3.9 6.7 4.3 2.8 5.2 3.7 7.8 1.9 3.7 3.4 4.5 5.0 6.7 4.9 2.8 9.7 3.9 3.1 5.5 2.7 4.4 3.8 4.0 3.6 11.6 5.2 2.7 6.0 7.0 11.3 8.7 4.0 2.7 4.0 5.7 4.7 2.9 2.9 10.1 7.3 7.0 4.9 3.3 6.0 3.1 6.5 4.5 2.6 3.0 3.8 2.9 6.0 6.6 11.8 4.2 5.9 3.8 9.0 1.0 0.1 0.5 0.5 0.4 1.0 0.5 0.6 0.3 1.2 0.8 0.5 1.0 3.4 0.4 1.2 0.3 0.1 11.9 13.0 20.8 13.7 11.5 6.9 10.2 7.6 8.6 9.7 6.0 20.5 7.1 15.7 20.7 52.5 24.3 15.3 29.4 15.9 21.0 88.4 7.1 6.6 6.4 109.8 13.8 13.1 23.3 6.1 7.6 17.4 29.6 11.5 16.8 6.2 42.9 22.4 16.5 14.0 132.0 20.8 13.4 8.5 4.6 16.7 25.5 8.4 14.7 20.1 7.9 57.3 19.4 21.5 26.9 30.1 25.2 12.2 8.7 12.1 18.6 UBXN10 "FLJ25429, UBXD3" ENSG00000162543 "UBX domain protein 10" Q96LJ8 1 20186085-20196048 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 44.3;testis: 30.4" "Group enriched" "Detected in many" 7 "Ciliated cells: 120.5;Early spermatids: 95.0;Late spermatids: 125.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 9.9;K-562: 11.0;SCLC-21H: 7.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028555, HPA028564" Uncertain NA NA "HPA028555: AB_10600417, HPA028564: AB_10601897" "unprognostic (3.00e-3)" "unprognostic (3.30e-2)" "unprognostic (4.31e-2)" "prognostic favorable (2.02e-4)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.43e-1)" "unprognostic (3.43e-2)" "unprognostic (2.37e-1)" "unprognostic (6.76e-2)" "unprognostic (4.60e-1)" "unprognostic (8.79e-2)" "unprognostic (5.78e-2)" "unprognostic (1.65e-3)" "unprognostic (7.11e-2)" "unprognostic (4.47e-2)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" 0.9 1.7 2.4 0.8 4.3 1.8 3.1 2.6 8.5 6.8 10.3 6.8 5.3 1.1 6.0 8.4 4.0 44.3 2.1 3.3 3.5 4.2 2.9 6.0 7.6 0.6 2.8 2.7 7.1 1.7 2.8 8.8 1.2 9.0 2.6 4.7 1.7 1.3 2.9 0.5 0.9 2.5 3.4 2.1 0.4 3.8 30.4 1.9 0.0 11.3 0.1 0.8 3.0 0.7 0.8 1.5 0.8 0.9 6.6 4.9 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 1.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 2.5 11.0 0.0 0.0 0.0 0.4 0.4 1.1 0.3 0.0 0.0 0.0 0.0 0.8 0.5 7.8 0.0 0.0 0.2 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 4.8 0.1 4.9 0.8 1.4 1.7 1.5 0.2 1.1 1.6 0.8 6.6 0.0 0.0 0.6 0.8 2.4 4.3 2.6 8.5 3.5 4.2 2.8 2.7 9.0 1.9 0.0 6.7 0.0 0.0 0.1 0.0 4.5 2.5 120.5 15.9 3.5 0.0 0.1 5.0 2.2 95.0 0.3 1.1 0.0 1.6 0.4 0.8 0.2 12.8 3.9 0.8 0.0 1.2 1.3 1.9 125.2 2.6 0.0 0.0 1.0 9.2 1.2 1.1 0.0 1.1 2.2 2.9 0.0 0.4 17.3 1.9 0.0 0.2 0.0 2.9 0.1 UST 2OST ENSG00000111962 "Uronyl 2-sulfotransferase" Q9Y2C2 6 148747328-149076990 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 17.0;Muller glia cells: 13.3;Peritubular cells: 10.6;Suprabasal keratinocytes: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032022 Approved NA NA "HPA032022: AB_10603326" "unprognostic (3.43e-1)" "unprognostic (1.90e-1)" "unprognostic (7.87e-3)" "unprognostic (3.22e-5)" "unprognostic (1.83e-3)" "unprognostic (1.50e-1)" "unprognostic (5.71e-2)" "unprognostic (1.96e-2)" "unprognostic (8.31e-3)" "unprognostic (2.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.11e-1)" "unprognostic (9.25e-3)" "unprognostic (9.48e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (3.02e-2)" 8.6 16.0 4.8 7.1 9.3 0.8 8.5 20.9 10.8 12.8 8.6 6.0 6.6 2.6 10.8 8.1 8.2 10.4 12.2 4.5 6.3 12.6 5.2 2.2 8.6 4.9 14.1 4.5 15.6 19.0 0.7 2.3 6.1 13.0 9.8 4.0 10.7 4.3 6.9 3.7 8.6 5.6 11.5 9.1 8.0 5.7 12.1 6.5 3.1 37.5 5.7 4.9 10.6 21.0 1.5 1.3 0.1 0.9 6.2 1.7 0.4 0.0 2.1 12.0 9.2 14.6 12.2 0.1 5.1 13.4 2.5 6.5 0.0 0.8 4.2 1.1 7.9 6.3 3.7 8.5 4.3 5.1 5.6 6.4 0.1 6.8 0.1 5.4 0.2 1.8 6.2 9.7 6.5 12.1 5.1 0.1 7.1 0.0 0.0 2.0 5.3 0.0 0.0 7.0 20.7 2.7 2.0 1.6 4.9 0.1 9.6 6.2 0.0 17.0 4.2 3.1 9.0 3.1 0.2 0.2 7.3 0.8 1.6 4.5 0.0 0.0 0.0 8.1 3.4 4.1 0.0 0.2 0.0 1.7 0.7 1.4 0.8 1.3 1.5 1.1 1.5 0.1 0.7 0.1 6.2 0.9 1.3 0.4 0.4 4.8 9.3 20.9 7.4 6.3 12.6 14.1 4.5 13.0 6.5 3.0 2.7 0.5 4.2 8.4 0.0 1.2 0.0 1.4 1.2 1.8 0.0 1.4 0.0 0.1 0.6 0.1 0.0 0.0 1.7 0.2 8.1 4.2 0.0 0.0 1.4 0.0 0.0 2.5 1.3 2.6 17.0 1.1 5.0 1.0 1.4 13.3 1.5 0.0 10.6 0.4 0.4 0.0 2.2 1.7 3.2 10.2 1.1 1.5 0.6 6.8 UVSSA KIAA1530 ENSG00000163945 "UV stimulated scaffold protein A" "Q2YD98, Q8N1N5" 4 1347266-1395992 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050824, HPA053496" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA050824: AB_2681251, HPA053496: AB_2682170" "unprognostic (6.40e-3)" "unprognostic (4.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-2)" "unprognostic (1.67e-1)" "unprognostic (3.85e-4)" "unprognostic (1.89e-1)" "unprognostic (4.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.88e-2)" "unprognostic (2.12e-3)" "unprognostic (3.92e-3)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.76e-3)" "unprognostic (5.19e-2)" "unprognostic (1.02e-2)" "prognostic favorable (6.87e-4)" 6.5 7.1 5.7 8.0 10.8 11.8 8.1 7.2 7.1 6.1 7.6 10.6 10.9 9.7 10.0 11.4 6.8 10.7 5.5 4.8 8.0 3.4 5.8 6.3 9.4 7.6 7.8 4.3 9.5 13.4 6.7 19.0 9.4 7.0 6.7 5.6 9.6 11.1 6.7 8.7 19.6 8.7 7.2 8.4 9.9 8.9 22.2 7.6 7.1 11.5 3.1 7.3 9.3 7.0 1.5 2.4 3.6 2.1 8.2 1.6 1.5 4.3 6.8 6.3 6.6 9.8 9.7 5.9 3.9 3.0 3.1 2.5 4.6 7.3 2.6 7.5 3.3 7.5 4.6 3.6 4.6 2.6 4.5 2.2 6.4 8.7 7.0 2.6 3.9 8.5 2.9 8.8 3.3 3.8 3.7 5.1 6.1 6.5 8.9 3.8 3.1 6.3 9.1 6.7 2.6 6.1 5.7 3.1 3.8 2.7 5.9 4.8 6.3 2.7 3.5 4.7 5.9 9.1 2.2 10.8 11.9 3.0 4.5 6.4 15.8 9.0 5.8 9.0 4.9 7.3 0.2 1.8 1.7 1.6 1.1 1.0 1.2 1.3 1.5 2.4 1.5 1.3 0.9 3.6 8.2 2.1 1.4 0.6 1.5 5.7 10.8 7.2 7.1 8.0 3.4 7.8 4.3 7.0 7.6 6.0 25.8 3.7 4.3 4.8 13.8 3.1 7.6 21.4 9.1 15.7 39.3 2.6 3.3 6.5 3.9 5.3 8.8 0.0 7.4 2.5 4.8 4.7 8.1 9.0 5.7 28.6 5.8 6.2 5.9 5.1 4.9 8.5 5.0 6.4 8.0 12.9 7.5 5.7 3.5 3.6 28.3 0.0 4.7 22.1 8.3 5.4 3.1 5.9 5.5 3.1 VANGL1 STB2 ENSG00000173218 "VANGL planar cell polarity protein 1" Q8TAA9 1 115641953-115698224 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Ito cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025235, CAB076375" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB076375: AB_2665604, HPA025235: AB_1858718" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "prognostic favorable (7.53e-4)" "unprognostic (9.94e-2)" "unprognostic (1.71e-2)" "unprognostic (5.18e-2)" "unprognostic (2.18e-3)" "unprognostic (5.11e-3)" "unprognostic (2.11e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.88e-2)" "unprognostic (1.74e-2)" "unprognostic (7.71e-3)" "unprognostic (1.21e-1)" "unprognostic (4.50e-3)" "unprognostic (9.06e-3)" 7.0 8.6 2.2 5.8 3.1 2.0 16.4 1.2 2.5 14.0 9.3 5.3 8.3 4.0 13.2 8.8 14.4 13.7 5.3 12.7 3.2 2.3 11.8 7.1 12.1 7.4 2.1 1.9 8.9 11.5 5.5 2.2 5.3 2.4 9.4 7.1 6.6 9.5 11.0 2.1 9.8 6.6 15.9 2.0 4.7 6.6 7.9 2.6 18.0 11.8 10.0 10.0 10.2 9.4 0.3 3.5 0.0 0.8 8.9 4.3 1.4 21.5 9.2 3.0 4.0 11.2 10.1 6.0 8.4 6.1 11.0 8.8 5.3 10.8 0.0 14.5 9.7 10.4 27.3 5.0 14.9 7.3 25.2 6.1 12.0 8.5 4.3 4.1 3.5 5.2 5.3 10.5 7.8 8.4 5.8 10.9 20.6 7.2 6.7 11.0 28.8 17.6 1.4 7.5 12.6 8.8 0.0 8.7 6.2 5.1 14.5 2.7 3.6 15.1 10.0 7.2 5.9 5.1 3.9 11.6 7.6 12.0 16.5 15.2 0.9 1.0 0.0 10.2 6.3 18.5 0.0 0.8 0.0 3.0 0.5 0.8 0.3 1.9 2.9 3.5 0.0 0.7 3.3 0.0 8.9 0.8 3.0 4.3 1.4 2.2 3.1 1.2 2.5 3.2 2.3 2.1 1.9 2.4 2.6 3.0 2.7 1.9 6.3 6.5 4.0 6.3 2.5 6.7 1.2 8.7 37.3 3.7 0.0 14.9 4.6 7.7 7.7 0.0 12.1 5.8 6.4 7.0 0.0 2.4 3.8 0.0 6.4 31.9 1.5 1.9 5.5 1.8 0.0 19.0 7.9 4.2 16.1 5.8 7.8 5.7 0.7 6.5 5.7 1.0 9.4 5.6 0.3 1.8 8.3 6.5 ZFP69 "FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A" ENSG00000187815 "ZFP69 zinc finger protein" Q49AA0 1 40477215-40496343 "Predicted intracellular proteins, Transcription factors" "Lipid metabolism, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Early spermatids: 5.9;Spermatogonia: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "THP-1: 36.3" "Low region specificity" "Detected in many" "HPA027808, HPA054942" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027808: AB_10601031, HPA054942: AB_2682644" "unprognostic (1.07e-2)" "unprognostic (6.00e-2)" "unprognostic (7.58e-3)" "unprognostic (4.15e-2)" "unprognostic (1.52e-1)" "prognostic favorable (9.31e-4)" "unprognostic (7.21e-3)" "unprognostic (1.72e-1)" "unprognostic (8.40e-3)" "unprognostic (6.34e-3)" "unprognostic (2.31e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.00e-6)" "unprognostic (1.05e-1)" "unprognostic (3.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.81e-1)" 5.1 3.4 8.3 5.8 8.5 4.1 5.1 6.8 5.8 4.7 5.3 7.5 5.1 4.4 5.6 5.6 4.4 5.2 8.9 7.3 6.7 5.6 3.7 4.7 5.6 6.3 9.0 2.4 6.8 6.7 8.1 3.1 5.3 8.6 5.6 4.9 3.9 4.9 6.0 1.2 6.7 4.9 9.7 8.7 6.9 4.8 8.4 8.4 9.4 5.2 2.9 6.8 6.1 14.3 1.1 0.6 0.1 0.5 4.8 2.0 0.6 3.3 0.0 2.0 2.6 2.5 2.6 3.4 1.8 2.1 2.8 3.3 1.8 2.6 6.0 2.4 2.9 3.7 2.7 3.8 1.6 3.3 5.4 2.6 4.4 3.0 2.9 2.0 0.1 4.8 2.6 4.0 1.9 2.9 0.9 1.6 0.1 2.5 0.0 1.6 1.7 4.5 5.6 3.8 0.3 0.0 2.5 7.1 2.8 1.5 2.5 2.6 4.2 3.1 2.9 5.1 3.2 0.0 36.3 0.7 1.3 2.6 3.6 0.2 0.1 4.6 3.8 2.4 0.9 3.5 0.0 0.5 0.1 1.6 0.2 2.0 1.1 1.2 1.9 0.6 0.6 0.6 2.0 0.1 4.8 0.4 0.0 0.6 0.6 8.3 8.5 6.8 5.8 6.7 5.6 9.0 2.4 8.6 8.4 6.0 0.0 0.9 0.3 0.9 1.3 1.2 0.0 1.4 0.0 0.0 0.0 1.0 1.7 1.3 5.9 1.8 0.3 0.0 1.2 1.2 0.7 0.2 0.0 0.9 1.1 0.0 0.0 0.6 1.5 2.5 1.1 1.4 1.7 1.8 1.4 1.6 0.8 0.0 1.8 0.5 0.8 0.0 0.5 2.7 4.6 0.4 0.2 0.7 1.4 0.1 ZNF324B FLJ45850 ENSG00000249471 "Zinc finger protein 324B" Q6AW86 19 58451604-58457833 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "NK-cell: 8.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 8.3" "Cell line enhanced" "Detected in many" "HEK 293: 29.4" HPA023400 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023400: AB_1859195" "unprognostic (2.75e-1)" "unprognostic (2.36e-2)" "unprognostic (2.27e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-1)" "unprognostic (5.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.47e-3)" "unprognostic (2.65e-1)" "unprognostic (3.21e-1)" "prognostic favorable (2.83e-4)" "unprognostic (5.58e-2)" "unprognostic (2.43e-1)" "unprognostic (9.50e-2)" "unprognostic (1.40e-1)" "unprognostic (1.56e-3)" "unprognostic (2.94e-2)" 7.4 6.2 6.9 8.3 12.4 5.0 9.0 11.4 12.6 8.7 5.9 7.6 9.8 5.9 8.5 5.0 8.4 9.0 6.8 4.7 6.6 5.5 6.2 6.6 7.3 6.8 9.1 7.0 10.2 10.1 8.0 8.4 4.8 8.8 7.5 6.1 8.4 8.9 8.5 8.2 11.2 6.0 7.4 5.3 10.3 8.0 11.3 9.3 9.4 8.0 6.0 6.4 9.3 6.9 1.1 0.6 1.3 1.0 8.3 1.3 0.7 4.3 7.2 4.0 6.6 2.8 2.5 2.9 3.9 2.9 3.2 2.3 2.5 1.9 5.9 2.5 2.3 3.3 3.6 5.2 3.6 2.5 6.0 29.4 5.1 5.4 1.0 2.9 8.3 7.6 2.5 3.6 3.6 3.1 2.1 2.3 5.3 7.3 3.6 3.3 2.8 6.1 2.0 2.2 5.1 4.1 5.8 5.2 3.5 2.1 8.7 9.5 5.4 3.7 6.0 0.9 2.9 2.2 2.4 2.6 7.7 2.0 4.1 6.3 7.8 7.0 4.4 3.0 3.6 2.9 0.0 1.0 0.1 1.3 0.6 0.9 0.5 0.6 0.9 0.6 1.1 1.3 0.9 1.3 8.3 0.4 0.6 0.4 0.7 6.9 12.4 11.4 12.6 6.6 5.5 9.1 7.0 8.8 9.3 0.0 0.3 0.5 0.9 0.7 3.0 0.8 0.0 2.7 3.4 1.8 21.6 0.8 0.0 2.0 0.7 0.7 1.1 0.0 1.4 0.7 1.1 0.6 0.0 1.0 0.8 4.8 0.0 1.3 1.9 1.3 2.8 0.4 0.0 1.8 0.8 1.5 1.5 0.0 2.5 0.8 5.8 6.5 1.1 3.1 1.9 0.9 0.6 1.5 1.1 0.9 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" "Q70YC4, Q70YC5" 10 62374192-62672011 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 12.6;Horizontal cells: 17.5;Rod photoreceptor cells: 4.9;Urothelial cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5" "Group enriched" "Detected in many" 51 "NK-cells: 7.4;T-cells: 7.5" "Cell line enhanced" "Detected in many" "HaCaT: 17.3;PC-3: 11.2;U-251 MG: 14.4;U-87 MG: 10.3" "Group enriched" "Detected in all" 4 "amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9" "Low region specificity" "Detected in all" HPA052446 Enhanced Supported "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA052446: AB_2681836" "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.9 2.5 11.8 1.0 19.4 1.0 1.3 8.4 41.3 2.0 0.9 13.1 0.0 1.1 1.2 1.5 11.7 1.0 4.0 2.0 9.6 7.4 1.1 1.2 3.1 1.1 7.5 16.0 1.0 1.3 9.0 1.8 1.2 6.9 3.0 1.1 1.0 1.2 3.3 1.0 2.6 0.9 0.9 10.5 1.3 1.0 1.6 9.1 0.0 1.6 0.0 2.2 1.9 1.2 0.1 0.0 0.1 0.1 7.4 7.5 1.0 5.7 0.8 0.5 0.7 0.6 0.3 0.3 4.3 4.5 2.2 1.9 0.6 1.4 0.4 0.7 2.6 7.4 17.3 0.5 0.3 3.0 0.2 0.4 0.3 1.5 0.4 0.2 0.3 1.4 0.3 0.3 5.9 0.8 6.2 0.7 0.3 0.4 0.6 4.3 2.1 0.7 0.5 0.9 0.3 11.2 0.4 0.5 0.4 0.5 2.6 0.2 0.9 1.1 0.9 0.4 0.6 0.1 0.3 3.1 1.2 5.6 0.6 14.4 0.2 0.5 0.3 10.3 0.6 1.9 0.0 0.0 0.0 3.4 0.1 0.0 0.0 3.1 3.5 0.0 0.1 0.6 3.7 0.1 7.4 0.1 0.0 7.5 1.0 11.8 19.4 8.4 32.3 9.6 7.4 7.5 16.0 6.9 9.1 0.0 0.0 0.0 3.3 0.5 12.6 2.4 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.1 17.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.6 4.9 0.0 1.2 0.0 0.4 0.4 0.0 0.0 0.0 6.7 ZNF549 FLJ34917 ENSG00000121406 "Zinc finger protein 549" Q6P9A3 19 57527325-57557542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 13.4" "Group enriched" "Detected in all" 4 "B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 16.5" HPA039511 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039511: AB_10671998" "unprognostic (6.27e-2)" "unprognostic (9.03e-3)" "unprognostic (2.02e-2)" "unprognostic (1.20e-2)" "unprognostic (4.28e-2)" "unprognostic (2.80e-1)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (7.07e-2)" "unprognostic (4.01e-4)" "unprognostic (4.03e-3)" "unprognostic (2.51e-8)" "unprognostic (2.88e-2)" "unprognostic (9.92e-2)" "unprognostic (9.89e-3)" "unprognostic (9.11e-3)" 4.7 6.2 7.3 11.8 11.0 5.9 9.3 18.8 10.3 5.2 5.8 8.0 4.0 3.6 7.2 7.7 3.9 8.0 6.9 5.4 9.0 6.2 5.6 2.6 7.6 8.8 9.5 7.0 11.2 4.5 12.5 13.8 6.9 7.0 8.3 4.4 6.5 5.6 6.7 5.4 7.3 6.1 7.3 10.6 9.9 5.2 7.2 8.5 11.2 9.1 3.0 9.7 6.5 11.6 4.7 1.8 1.8 1.2 13.4 5.8 2.1 1.4 1.8 7.4 6.1 2.2 1.8 1.8 3.4 4.2 3.4 16.5 1.9 1.3 2.0 2.5 3.1 4.2 0.8 2.3 5.0 5.6 0.2 13.6 9.2 1.4 2.8 3.2 7.6 6.5 3.3 3.9 3.4 4.8 4.9 2.1 5.3 0.1 0.3 6.1 0.8 8.5 3.2 6.3 0.2 4.9 6.1 6.1 4.1 1.3 3.5 3.0 5.3 0.1 0.5 4.0 6.6 4.1 6.0 1.8 6.5 4.5 0.3 5.0 3.5 10.1 6.4 1.1 2.6 5.9 0.7 1.0 1.8 3.0 0.8 4.1 2.7 4.1 4.6 1.8 4.7 5.8 3.7 0.8 13.4 1.2 1.6 2.4 2.1 7.3 11.0 18.8 10.3 9.0 6.2 9.5 7.0 7.0 8.5 0.0 3.2 2.7 1.0 1.4 8.6 2.7 5.1 8.1 0.0 1.8 13.7 1.4 3.3 1.2 0.4 2.9 0.4 0.0 0.6 0.7 2.1 1.4 5.8 0.6 1.3 7.9 3.5 4.9 1.6 0.0 2.8 1.1 5.0 0.0 0.3 4.1 0.6 1.5 2.1 0.6 14.6 6.5 1.4 0.7 3.8 1.4 0.9 2.9 0.8 0.9 ZNF578 FLJ31384 ENSG00000258405 "Zinc finger protein 578" Q96N58 19 52453576-52512154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.3" "Cell type enhanced" "Detected in some" 7 "Early spermatids: 4.5;Horizontal cells: 6.4;Rod photoreceptor cells: 7.4" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 5.8;SuSa: 8.2;U-266/84: 12.6" NA NA "unprognostic (6.57e-3)" "unprognostic (1.43e-2)" "unprognostic (1.56e-2)" "unprognostic (3.77e-2)" "unprognostic (1.60e-3)" "unprognostic (2.96e-3)" "unprognostic (5.42e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-2)" "unprognostic (8.14e-2)" "unprognostic (9.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.81e-1)" "unprognostic (2.64e-1)" "unprognostic (1.82e-1)" "unprognostic (3.96e-2)" "unprognostic (2.42e-1)" 1.9 1.2 1.9 2.5 5.6 1.0 1.9 4.4 2.5 2.4 1.5 1.5 0.7 2.0 4.9 0.8 0.9 2.1 1.2 1.9 1.7 2.0 1.6 0.8 1.6 1.5 1.6 1.6 3.3 1.7 2.1 5.2 5.1 2.6 2.9 1.1 4.6 2.0 1.8 1.0 1.4 1.6 2.5 2.0 3.3 1.6 15.3 2.3 0.7 3.8 2.1 1.4 1.6 2.7 2.0 0.9 0.8 0.9 10.2 5.3 1.6 1.1 0.0 2.3 2.3 0.5 1.1 2.2 2.5 0.7 0.1 0.8 0.1 0.8 0.5 0.4 2.7 3.9 1.9 0.0 0.4 0.2 0.1 1.4 0.4 0.7 0.3 0.9 0.0 3.3 2.3 0.1 0.9 0.1 0.9 1.0 0.0 0.4 0.0 3.8 0.3 0.0 0.4 5.8 0.3 0.7 0.0 0.0 0.3 0.2 3.9 0.4 3.3 0.9 0.4 0.1 8.2 2.4 0.8 1.0 0.1 0.4 0.8 0.6 0.5 12.6 1.7 0.1 0.0 2.3 0.8 0.6 0.8 5.3 0.3 2.7 2.0 1.4 2.4 0.9 1.8 1.9 2.6 0.1 10.2 0.9 0.2 0.8 1.6 1.9 5.6 4.4 2.3 1.7 2.0 1.6 1.6 2.6 2.3 0.0 0.0 0.8 1.1 0.8 4.0 3.0 0.0 0.0 0.0 0.0 3.9 0.6 0.0 0.1 4.5 0.7 0.0 0.0 0.2 0.6 0.4 0.5 1.1 0.0 0.2 6.4 0.0 0.6 0.0 3.9 0.6 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 7.4 0.0 0.0 0.0 2.3 0.4 0.7 1.5 0.0 1.4 ZNF600 "DKFZp686F06123, KR-ZNF1" ENSG00000189190 "Zinc finger protein 600" Q6ZNG1 19 52764195-52786791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "granulocytes: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 22.9" "Group enriched" "Detected in all" 5 "NK-cells: 22.9;T-cells: 10.3" "Cell line enhanced" "Detected in many" "RT4: 19.5" NA NA "unprognostic (6.36e-2)" "unprognostic (1.67e-1)" "unprognostic (8.41e-2)" "unprognostic (2.12e-2)" "unprognostic (1.85e-1)" "unprognostic (6.54e-2)" "unprognostic (5.19e-6)" "unprognostic (1.34e-1)" "unprognostic (2.75e-3)" "unprognostic (2.19e-1)" "unprognostic (6.73e-2)" "unprognostic (2.61e-3)" "prognostic unfavorable (4.98e-7)" "unprognostic (2.07e-2)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "prognostic favorable (1.11e-5)" 6.6 4.0 2.6 15.8 4.5 6.2 6.1 15.7 3.1 6.7 12.4 0.9 6.9 7.3 7.5 4.6 8.4 5.4 3.9 4.3 1.6 1.2 4.9 5.0 11.3 10.3 4.4 1.0 6.5 8.8 3.9 7.7 18.1 2.6 9.2 7.6 3.5 5.7 22.7 2.6 8.0 12.7 4.1 5.3 11.2 7.9 2.3 2.6 6.9 9.4 5.1 12.9 7.5 8.6 3.3 2.0 1.8 1.8 22.9 10.3 2.8 4.8 0.0 0.2 2.1 3.0 2.7 12.0 3.9 3.2 2.6 6.4 3.8 4.4 5.4 1.8 2.5 5.0 5.7 0.0 3.4 4.5 1.1 2.3 3.2 2.7 3.2 3.6 0.0 7.7 3.9 5.4 2.6 4.3 2.2 1.4 0.1 4.2 0.0 2.8 1.7 0.0 3.0 1.3 4.6 5.2 0.0 0.0 4.2 4.6 19.5 2.2 2.7 5.1 4.0 0.6 8.3 2.6 4.5 3.5 0.7 1.6 0.7 3.6 2.9 4.4 6.7 0.0 0.0 2.8 1.8 1.1 1.4 10.3 0.8 6.0 3.3 3.6 5.4 2.0 3.1 3.5 6.3 0.3 22.9 1.8 0.5 2.0 2.8 2.6 4.5 15.7 3.1 1.6 1.2 4.4 1.0 2.6 2.6 23.8 11.1 6.9 13.0 18.0 0.7 2.8 7.6 20.1 5.7 5.2 0.0 8.2 0.0 5.5 6.1 5.4 9.3 0.0 8.5 8.9 4.3 10.2 31.1 2.4 2.9 0.0 4.1 1.3 1.9 0.6 2.6 4.3 1.7 3.6 4.9 1.7 7.8 8.6 1.8 2.1 1.2 0.0 4.7 0.3 2.3 21.2 12.2 15.8 8.8 23.3 ZNF827 ENSG00000151612 "Zinc finger protein 827" Q17R98 4 145757627-145938635 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 23.5;WM-115: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021166 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021166: AB_2670608" "unprognostic (2.75e-2)" "unprognostic (3.46e-3)" "unprognostic (2.79e-1)" "unprognostic (3.64e-1)" "unprognostic (3.90e-2)" "unprognostic (2.40e-2)" "unprognostic (3.77e-1)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.90e-2)" "unprognostic (7.64e-2)" "unprognostic (3.47e-1)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (7.85e-2)" "unprognostic (4.03e-2)" "unprognostic (1.88e-2)" 3.8 9.5 8.2 9.6 15.6 3.9 6.5 37.3 12.3 6.0 7.1 8.1 7.7 8.1 10.7 6.5 3.8 8.3 6.3 7.0 5.9 5.8 6.3 1.1 4.7 6.4 5.8 8.2 11.0 4.3 14.9 28.3 2.2 7.4 26.3 6.4 4.3 28.1 9.3 24.9 3.4 10.0 11.4 13.0 5.5 6.3 4.5 9.5 14.0 10.9 3.3 7.7 10.2 5.0 1.9 2.6 5.4 0.0 12.3 3.4 1.2 2.7 4.4 8.0 5.2 3.5 3.9 0.0 4.6 4.4 3.6 2.8 2.2 7.2 0.7 1.6 8.4 3.2 1.7 4.6 3.5 3.8 5.6 2.2 2.2 4.3 2.5 3.7 1.6 0.0 5.3 3.2 2.8 7.9 7.8 6.4 1.2 0.4 4.4 3.0 0.0 2.4 0.1 3.9 0.0 5.8 7.2 4.2 1.4 3.8 4.1 7.3 6.7 4.0 6.9 10.4 4.4 3.1 0.1 23.5 9.6 7.8 0.6 5.3 3.1 0.2 3.0 3.1 9.0 36.4 5.4 0.0 0.0 3.3 0.0 0.9 1.5 1.2 3.1 0.0 1.9 2.1 3.4 0.0 12.3 0.0 2.6 0.1 1.2 8.2 15.6 37.3 12.3 5.9 5.8 5.8 8.2 7.4 9.5 11.9 13.7 4.2 7.6 5.7 12.7 18.9 2.5 10.7 11.4 22.7 9.8 2.1 3.3 8.9 11.8 4.3 10.3 0.0 6.3 0.4 6.6 19.8 2.3 1.3 1.1 17.5 24.8 7.4 1.2 5.8 8.3 1.0 1.7 1.0 19.5 4.8 10.4 3.5 15.9 9.8 1.1 6.5 4.7 1.6 1.7 4.3 1.1 6.4 18.6 9.5 ZNF831 "C20orf174, dJ492J12.1" ENSG00000124203 "Zinc finger protein 831" Q5JPB2 20 59123381-59259113 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.8;pituitary gland: 6.6" "Cell type enriched" "Detected in some" 5 "T-cells: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 4.1;MAIT T-cell: 3.3;memory CD4 T-cell: 2.3;memory CD8 T-cell: 3.3;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.4;NK-cell: 2.3;T-reg: 4.2" "Group enriched" "Detected in many" 6 "NK-cells: 2.3;T-cells: 4.2" "Group enriched" "Detected in some" 6 "Daudi: 9.3;HMC-1: 2.6" "Group enriched" "Detected in many" 4 "amygdala: 5.3;basal ganglia: 4.3;cerebral cortex: 5.1;hippocampal formation: 6.0;olfactory region: 4.7" "Group enriched" "Detected in many" 26 "amygdala: 6.5;basal ganglia: 5.1;cerebral cortex: 4.5;hippocampal formation: 7.1;olfactory region: 11.1" HPA016839 Uncertain NA NA "HPA016839: AB_1859466" "unprognostic (2.90e-3)" "unprognostic (7.70e-6)" "unprognostic (9.71e-4)" "unprognostic (1.31e-3)" "unprognostic (7.00e-2)" "unprognostic (3.00e-5)" "unprognostic (3.08e-3)" "unprognostic (2.23e-2)" "unprognostic (2.89e-3)" "unprognostic (2.21e-3)" "unprognostic (2.80e-3)" "unprognostic (4.31e-1)" "unprognostic (3.40e-3)" "unprognostic (2.39e-1)" "unprognostic (3.42e-2)" "unprognostic (2.21e-1)" "unprognostic (1.93e-2)" 0.6 0.1 1.7 9.1 3.6 1.3 0.4 0.2 1.2 0.2 0.4 0.2 0.2 0.3 0.2 0.4 0.8 0.4 0.8 0.2 1.5 0.6 0.3 0.3 1.3 10.0 0.2 0.2 0.2 0.3 0.0 6.6 0.2 0.2 0.2 0.5 0.2 0.5 0.2 0.2 0.1 4.2 0.2 0.2 9.3 0.9 0.4 0.2 0.4 0.7 0.9 13.8 3.1 0.2 0.4 0.0 0.5 0.0 2.3 4.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 4.1 0.0 3.3 0.4 2.3 3.3 0.0 0.4 1.9 2.4 0.2 2.3 0.0 0.0 4.2 0.8 1.7 3.6 0.2 1.2 1.5 0.6 0.2 0.2 0.2 0.2 0.0 1.1 2.7 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 13.8 0.0 0.0